1	Available	JJ	O	available	amod	2	SENT_1	[p1l664t82r814b112],
2	online	NN	O	online	_	0	SENT_1	[p1l825t82r927b112],
3	at	IN	O	at	_	0	SENT_1	[p1l938t87r969b112],
4	www.sciencedirect.com	NNP	O	www.sciencedirect.com	prep_at	2	SENT_1	[p1l979t82r1373b112],

1	ScIENcE@DIREcTo	NNP	O	ScIENcE@DIREcTo	_	0	SENT_2	[p1l793t134r1244b224],
2	`	``	O	`	_	0	SENT_2	[p1l1769t139r2121b267],
3	A	DT	O	a	dep	1	SENT_2	[p1l1769t139r2121b267],
4	+	CC	O	+	rcmod	3	SENT_2	[p1l1769t139r2121b267],

1	ELSEVIER	NNP	O	ELSEVIER	nn	3	SENT_3	[p1l37t296r268b330],
2	Biochemical	JJ	O	biochemical	amod	3	SENT_3	[p1l701t305r868b329],
3	Pharmacology	NN	O	pharmacology	_	0	SENT_3	[p1l880t305r1071b336],
4	67	CD	NUMBER	67	number	5	SENT_3	[p1l1084t305r1115b329],
5	(	CD	NUMBER	(	dep	3	SENT_3	[p1l1128t305r1214b334],
6	2004	CD	DATE	2004	dep	5	SENT_3	[p1l1128t305r1214b334],
7	)	CD	NUMBER	)	num	8	SENT_3	[p1l1128t305r1214b334],
8	285-292	CD	NUMBER	285-292	dep	3	SENT_3	[p1l1227t305r1342b329],

1	www.elsevier.com/locate/biochempharm	NN	O	www.elsevier.com/locate/biochempharm	_	0	SENT_4	[p1l1580t340r2125b370],

1	Inﬂuence	NN	O	inﬂuence	_	0	SENT_5	[p1l76t427r336b476],
2	of	IN	O	of	_	0	SENT_5	[p1l364t427r424b476],
3	lipid	NN	O	lipid	prep_of	1	SENT_5	[p1l445t427r574b491],
4	lowering	VBG	O	lower	partmod	3	SENT_5	[p1l599t427r846b491],
5	ﬁbrates	NNS	O	ﬁbrates	dobj	4	SENT_5	[p1l873t427r1077b476],
6	on	IN	O	on	_	0	SENT_5	[p1l1105t443r1173b476],
7	P-glycoprotein	NN	O	p-glycoprotein	nn	8	SENT_5	[p1l1198t427r1617b491],
8	activity	NN	O	activity	prep_on	5	SENT_5	[p1l1644t427r1851b491],
9	in	FW	O	in	nn	10	SENT_5	[p1l1880t429r1930b476],
10	vitro	FW	O	vitro	advmod	4	SENT_5	[p1l1954t429r2082b477],

1	Manuela	NNP	PERSON	Manuela	nn	2	SENT_6	[p1l425t550r614b588],
2	Ehrhardt	NNP	PERSON	Ehrhardt	_	0	SENT_6	[p1l632t550r832b595],
3	,	,	O	,	_	0	SENT_6	[p1l632t550r832b595],
4	Heike	NNP	PERSON	Heike	nn	5	SENT_6	[p1l854t550r981b588],
5	Lindenmaier	NNP	PERSON	Lindenmaier	dep	2	SENT_6	[p1l1001t550r1286b595],
6	,	,	O	,	_	0	SENT_6	[p1l1001t550r1286b595],
7	Juergen	NNP	PERSON	Juergen	nn	8	SENT_6	[p1l1308t551r1474b599],
8	Burhenne	NNP	PERSON	Burhenne	appos	5	SENT_6	[p1l1493t550r1714b595],
9	,	,	O	,	_	0	SENT_6	[p1l1493t550r1714b595],

1	Walter	NNP	PERSON	Walter	nn	2	SENT_7	[p1l670t611r814b649],
2	Emil	NNP	PERSON	Emil	_	0	SENT_7	[p1l832t611r936b649],
3	Haefeli	NNP	PERSON	Haefeli	nn	6	SENT_7	[p1l956t611r1125b656],
4	,	,	O	,	_	0	SENT_7	[p1l956t611r1125b656],
5	Johanna	NNP	PERSON	Johanna	appos	6	SENT_7	[p1l1147t611r1323b650],
6	Weiss	NNP	PERSON	Weiss	dep	2	SENT_7	[p1l1342t600r1487b649],
7	*	IN	O	*	amod	6	SENT_7	[p1l1342t600r1487b649],

1	Department	NNP	ORGANIZATION	Department	_	0	SENT_8	[p1l443t701r608b731],
2	of	IN	ORGANIZATION	of	_	0	SENT_8	[p1l619t700r650b731],
3	Internal	NNP	ORGANIZATION	Internal	nn	5	SENT_8	[p1l656t700r767b724],
4	Medicine	NNP	ORGANIZATION	Medicine	nn	5	SENT_8	[p1l778t700r906b724],
5	VI	NNP	ORGANIZATION	VI	prep_of	1	SENT_8	[p1l921t701r956b728],
6	,	,	O	,	_	0	SENT_8	[p1l921t701r956b728],
7	Clinical	JJ	O	clinical	amod	8	SENT_8	[p1l973t700r1082b725],
8	Pharmacology	NN	O	pharmacology	appos	5	SENT_8	[p1l1093t700r1295b731],
9	and	CC	O	and	_	0	SENT_8	[p1l1307t700r1359b724],
10	Pharmacoepidemiology	NN	O	pharmacoepidemiology	appos	5	SENT_8	[p1l1369t700r1701b731],
11	,	,	O	,	_	0	SENT_8	[p1l1369t700r1701b731],

1	University	NNP	ORGANIZATION	University	_	0	SENT_9	[p1l514t743r654b773],
2	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l666t742r697b773],
3	Heidelberg	NNP	ORGANIZATION	Heidelberg	nn	6	SENT_9	[p1l703t742r862b773],
4	,	,	O	,	_	0	SENT_9	[p1l703t742r862b773],
5	Bergheimer	NNP	ORGANIZATION	Bergheimer	appos	6	SENT_9	[p1l877t742r1039b773],
6	Strasse	NNP	ORGANIZATION	Strasse	prep_of	1	SENT_9	[p1l1050t742r1147b767],
7	58	CD	NUMBER	58	num	6	SENT_9	[p1l1160t742r1199b770],
8	,	,	O	,	_	0	SENT_9	[p1l1160t742r1199b770],
9	D-69115	NNP	O	D-69115	nn	10	SENT_9	[p1l1213t742r1335b767],
10	Heidelberg	NNP	LOCATION	Heidelberg	appos	6	SENT_9	[p1l1347t742r1505b773],
11	,	,	O	,	_	0	SENT_9	[p1l1347t742r1505b773],
12	Germany	NNP	LOCATION	Germany	dep	1	SENT_9	[p1l1522t742r1647b773],

1	Received	VBN	O	receive	_	0	SENT_10	[p1l673t784r800b808],
2	28	CD	DATE	28	dobj	1	SENT_10	[p1l812t784r844b808],
3	February	NNP	DATE	February	tmod	1	SENT_10	[p1l857t784r980b815],
4	2003	CD	DATE	2003	num	3	SENT_10	[p1l993t784r1068b812],
5	;	:	O	;	_	0	SENT_10	[p1l993t784r1068b812],
6	accepted	VBN	O	accept	parataxis	1	SENT_10	[p1l1083t784r1202b815],
7	19	CD	DATE	19	dobj	6	SENT_10	[p1l1217t784r1247b809],
8	September	NNP	DATE	September	tmod	6	SENT_10	[p1l1261t784r1407b815],
9	2003	CD	DATE	2003	num	8	SENT_10	[p1l1419t784r1484b808],

1	Abstract	JJ	O	abstract	_	0	SENT_11	[p1l33t927r176b954],

1	Statin	NN	O	statin	_	0	SENT_12	[p1l73t1020r270b1047],
2	/	:	O	/	punct	1	SENT_12	[p1l73t1020r270b1047],
3	ﬁbrate	JJ	O	ﬁbrate	amod	4	SENT_12	[p1l73t1020r270b1047],
4	combinations	NNS	O	combination	nsubjpass	7	SENT_12	[p1l282t1020r487b1047],
5	are	VBP	O	be	auxpass	7	SENT_12	[p1l500t1028r545b1047],
6	frequently	RB	O	frequently	advmod	7	SENT_12	[p1l557t1020r714b1055],
7	used	VBN	O	use	dep	1	SENT_12	[p1l725t1020r795b1047],
8	to	TO	O	to	aux	9	SENT_12	[p1l806t1024r835b1047],
9	treat	VB	O	treat	xcomp	7	SENT_12	[p1l847t1024r915b1047],
10	mixed	JJ	O	mixed	amod	11	SENT_12	[p1l925t1020r1021b1047],
11	dyslipidemia	NN	O	dyslipidemia	dobj	9	SENT_12	[p1l1032t1020r1238b1055],
12	.	.	O	.	_	0	SENT_12	[p1l1032t1020r1238b1055],

1	However	RB	O	however	advmod	6	SENT_13	[p1l1251t1021r1396b1052],
2	,	,	O	,	_	0	SENT_13	[p1l1251t1021r1396b1052],
3	these	DT	O	these	det	4	SENT_13	[p1l1409t1020r1486b1047],
4	combinations	NNS	O	combination	nsubj	6	SENT_13	[p1l1498t1020r1704b1047],
5	may	MD	O	may	aux	6	SENT_13	[p1l1716t1028r1781b1055],
6	cause	VB	O	cause	_	0	SENT_13	[p1l1793t1028r1877b1047],
7	life-threatening	JJ	O	life-threatening	acomp	6	SENT_13	[p1l1889t1020r2125b1055],
8	drug	NN	O	drug	nn	9	SENT_13	[p1l34t1066r103b1101],
9	interactions	NNS	O	interaction	nsubj	10	SENT_13	[p1l114t1066r292b1093],
10	(	VBP	O	(	ccomp	7	SENT_13	[p1l304t1067r369b1101],
11	e.g.	FW	O	e.g.	nn	13	SENT_13	[p1l304t1067r369b1101],
12	rhabdomyolysis	FW	O	rhabdomyolysis	nn	13	SENT_13	[p1l381t1066r637b1101],
13	)	FW	O	)	dobj	10	SENT_13	[p1l381t1066r637b1101],
14	possibly	RB	O	possibly	advmod	15	SENT_13	[p1l649t1066r776b1101],
15	induced	VBN	O	induce	dep	10	SENT_13	[p1l787t1066r908b1093],
16	by	IN	O	by	_	0	SENT_13	[p1l918t1066r955b1101],
17	modiﬁcations	NNS	O	modiﬁcations	prep_by	15	SENT_13	[p1l966t1066r1174b1093],
18	of	IN	O	of	_	0	SENT_13	[p1l1186t1066r1219b1093],
19	cytochrome	NN	O	cytochrome	nn	22	SENT_13	[p1l1227t1066r1407b1101],
20	P450	NN	O	p450	nn	22	SENT_13	[p1l1418t1066r1496b1093],
21	isozyme	NN	O	isozyme	nn	22	SENT_13	[p1l1507t1066r1634b1101],
22	activities	NNS	O	activity	prep_of	17	SENT_13	[p1l1645t1066r1790b1093],
23	.	.	O	.	_	0	SENT_13	[p1l1645t1066r1790b1093],

1	Some	DT	O	some	det	2	SENT_14	[p1l1804t1066r1889b1093],
2	statins	NNS	O	statin	nsubjpass	5	SENT_14	[p1l1901t1066r1996b1093],
3	are	VBP	O	be	auxpass	5	SENT_14	[p1l2008t1075r2053b1093],
4	also	RB	O	also	advmod	5	SENT_14	[p1l2065t1066r2125b1093],
5	transported	VBN	O	transport	_	0	SENT_14	[p1l34t1112r206b1147],
6	by	IN	O	by	_	0	SENT_14	[p1l219t1112r257b1147],
7	P-glycoprotein	NN	O	p-glycoprotein	nn	10	SENT_14	[p1l270t1112r498b1147],
8	(	CD	NUMBER	(	num	10	SENT_14	[p1l513t1112r595b1147],
9	Pgp	NN	O	pgp	nn	10	SENT_14	[p1l513t1112r595b1147],
10	)	NN	O	)	agent	5	SENT_14	[p1l513t1112r595b1147],
11	and	CC	O	and	_	0	SENT_14	[p1l611t1112r665b1139],
12	may	MD	O	may	aux	13	SENT_14	[p1l678t1121r743b1147],
13	act	VB	O	act	conj_and	5	SENT_14	[p1l758t1116r802b1139],
14	as	IN	O	as	_	0	SENT_14	[p1l816t1121r845b1139],
15	inhibitors	NNS	O	inhibitor	prep_as	13	SENT_14	[p1l860t1112r1005b1139],
16	of	IN	O	of	_	0	SENT_14	[p1l1020t1112r1054b1139],
17	this	DT	O	this	det	20	SENT_14	[p1l1065t1112r1118b1139],
18	drug	NN	O	drug	nn	20	SENT_14	[p1l1133t1112r1202b1147],
19	efﬂux	NN	O	efﬂux	nn	20	SENT_14	[p1l1216t1112r1304b1139],
20	pump	NN	O	pump	prep_of	15	SENT_14	[p1l1318t1121r1412b1147],
21	.	.	O	.	_	0	SENT_14	[p1l1318t1121r1412b1147],

1	So	RB	O	so	advmod	2	SENT_15	[p1l1429t1112r1467b1139],
2	far	RB	O	far	advmod	6	SENT_15	[p1l1481t1112r1530b1144],
3	,	,	O	,	_	0	SENT_15	[p1l1481t1112r1530b1144],
4	nothing	NN	O	nothing	nsubjpass	6	SENT_15	[p1l1545t1112r1661b1147],
5	is	VBZ	O	be	auxpass	6	SENT_15	[p1l1675t1112r1699b1139],
6	known	VBN	O	know	_	0	SENT_15	[p1l1713t1112r1816b1139],
7	about	IN	O	about	_	0	SENT_15	[p1l1831t1112r1915b1139],
8	possible	JJ	O	possible	amod	9	SENT_15	[p1l1928t1112r2053b1147],
9	Pgp	NNP	O	Pgp	prep_about	6	SENT_15	[p1l2067t1113r2125b1147],
10	modulating	VBG	O	modulate	xcomp	6	SENT_15	[p1l34t1158r208b1193],
11	effects	NNS	O	effect	dobj	10	SENT_15	[p1l222t1158r322b1185],
12	of	IN	O	of	_	0	SENT_15	[p1l336t1158r370b1185],
13	ﬁbrates	NNS	O	ﬁbrates	prep_of	11	SENT_15	[p1l381t1158r500b1185],
14	.	.	O	.	_	0	SENT_15	[p1l381t1158r500b1185],

1	We	PRP	O	we	nsubj	2	SENT_16	[p1l515t1159r565b1185],
2	tested	VBD	O	test	_	0	SENT_16	[p1l579t1158r668b1185],
3	whether	IN	O	whether	complm	13	SENT_16	[p1l681t1158r805b1185],
4	gemﬁbrozil	NN	O	gemﬁbrozil	nsubj	13	SENT_16	[p1l818t1158r1002b1193],
5	,	,	O	,	_	0	SENT_16	[p1l818t1158r1002b1193],
6	fenoﬁbrate	NN	O	fenoﬁbrate	nsubj	13	SENT_16	[p1l1017t1158r1191b1190],
7	,	,	O	,	_	0	SENT_16	[p1l1017t1158r1191b1190],
8	fenoﬁbric	JJ	O	fenoﬁbric	amod	9	SENT_16	[p1l1206t1158r1353b1185],
9	acid	NN	O	acid	conj_and	4	SENT_16	[p1l1368t1158r1439b1190],
10	,	,	O	,	_	0	SENT_16	[p1l1368t1158r1439b1190],
11	and	CC	O	and	_	0	SENT_16	[p1l1455t1158r1509b1185],
12	bezaﬁbrate	NN	O	bezaﬁbrate	conj_and	4	SENT_16	[p1l1521t1158r1690b1185],
13	inhibit	VBP	O	inhibit	ccomp	2	SENT_16	[p1l1704t1158r1804b1185],
14	Pgp	NN	O	pgp	dobj	13	SENT_16	[p1l1817t1159r1875b1193],
15	in	FW	O	in	nn	16	SENT_16	[p1l1890t1159r1917b1185],
16	vitro	FW	O	vitro	advmod	17	SENT_16	[p1l1930t1159r2000b1185],
17	using	VBG	O	use	partmod	14	SENT_16	[p1l2013t1158r2095b1193],
18	a	DT	O	a	det	23	SENT_16	[p1l2110t1167r2126b1185],
19	calcein	NN	O	calcein	nn	23	SENT_16	[p1l34t1205r142b1232],
20	acetoxymethylester	NN	O	acetoxymethylester	nn	23	SENT_16	[p1l153t1205r452b1240],
21	(	CD	NUMBER	(	num	23	SENT_16	[p1l462t1205r668b1238],
22	calcein-AM	NN	O	calcein-am	nn	23	SENT_16	[p1l462t1205r668b1238],
23	)	NN	O	)	dobj	17	SENT_16	[p1l462t1205r668b1238],
24	uptake	NN	O	uptake	nn	25	SENT_16	[p1l679t1205r781b1240],
25	assay	NN	O	assay	dep	23	SENT_16	[p1l792t1213r873b1240],
26	and	CC	O	and	_	0	SENT_16	[p1l884t1205r938b1232],
27	confocal	JJ	O	confocal	amod	30	SENT_16	[p1l948t1205r1079b1232],
28	laser	NN	O	laser	nn	30	SENT_16	[p1l1089t1205r1162b1232],
29	scanning	NN	O	scanning	nn	30	SENT_16	[p1l1172t1205r1306b1240],
30	microscopy	NN	O	microscopy	conj_and	23	SENT_16	[p1l1317t1205r1495b1240],
31	with	IN	O	with	_	0	SENT_16	[p1l1505t1205r1572b1232],
32	bodipy-verapamil	NN	O	bodipy-verapamil	prep_with	30	SENT_16	[p1l1582t1205r1854b1240],
33	as	IN	O	as	_	0	SENT_16	[p1l1865t1213r1895b1232],
34	substrate	NN	O	substrate	prep_as	17	SENT_16	[p1l1907t1205r2041b1232],
35	in	IN	O	in	_	0	SENT_16	[p1l2051t1205r2080b1232],
36	LMDRI	NN	O	lmdrus	nn	37	SENT_16	[p1l2090t1205r2124b1232, p1l33t1251r135b1278],
37	cells	NNS	O	cell	prep_in	34	SENT_16	[p1l154t1251r232b1283],
38	,	,	O	,	_	0	SENT_16	[p1l154t1251r232b1283],
39	which	WDT	O	which	nsubj	40	SENT_16	[p1l248t1251r341b1278],
40	overexpress	VBP	O	overexpress	rcmod	37	SENT_16	[p1l356t1260r537b1286],
41	human	JJ	O	human	amod	42	SENT_16	[p1l551t1251r656b1278],
42	Pgp	NNP	O	Pgp	dobj	40	SENT_16	[p1l670t1252r737b1286],
43	.	.	O	.	_	0	SENT_16	[p1l670t1252r737b1286],

1	In	IN	O	in	_	0	SENT_17	[p1l753t1252r784b1278],
2	uptake	NN	O	uptake	nn	3	SENT_17	[p1l799t1251r901b1286],
3	assays	NNS	O	assay	prep_in	19	SENT_17	[p1l917t1260r1012b1286],
4	in	IN	O	in	_	0	SENT_17	[p1l1028t1251r1057b1278],
5	cells	NNS	O	cell	prep_in	3	SENT_17	[p1l1072t1251r1140b1278],
6	with	IN	O	with	_	0	SENT_17	[p1l1156t1251r1223b1278],
7	(	NN	O	(	nn	9	SENT_17	[p1l1239t1251r1404b1285],
8	L-MDRl	NN	O	l-mdrl	nn	9	SENT_17	[p1l1239t1251r1404b1285],
9	)	NN	O	)	prep_with	5	SENT_17	[p1l1239t1251r1404b1285],
10	and	CC	O	and	_	0	SENT_17	[p1l1421t1251r1475b1278],
11	without	IN	O	without	_	0	SENT_17	[p1l1490t1251r1607b1278],
12	(	CD	NUMBER	(	num	13	SENT_17	[p1l1622t1251r1798b1285],
13	LLC-PK1	NN	O	llc-pk1	prep_without	5	SENT_17	[p1l1622t1251r1798b1285],
14	)	CD	NUMBER	)	num	16	SENT_17	[p1l1622t1251r1798b1285],
15	human	JJ	O	human	amod	16	SENT_17	[p1l1814t1251r1918b1278],
16	Pgp	NN	O	pgp	dep	5	SENT_17	[p1l1932t1252r1991b1286],
17	we	PRP	O	we	nsubj	19	SENT_17	[p1l2006t1260r2049b1278],
18	also	RB	O	also	advmod	19	SENT_17	[p1l2065t1251r2125b1278],
19	investigated	VBD	O	investigate	_	0	SENT_17	[p1l34t1297r218b1332],
20	whether	IN	O	whether	complm	24	SENT_17	[p1l231t1297r355b1324],
21	these	DT	O	these	det	22	SENT_17	[p1l368t1297r446b1324],
22	compounds	NNS	O	compound	nsubjpass	24	SENT_17	[p1l461t1297r636b1332],
23	are	VBP	O	be	auxpass	24	SENT_17	[p1l652t1306r697b1324],
24	transported	VBN	O	transport	ccomp	19	SENT_17	[p1l711t1297r884b1332],
25	by	IN	O	by	_	0	SENT_17	[p1l897t1297r935b1332],
26	Pgp	NNP	O	Pgp	agent	24	SENT_17	[p1l949t1298r1015b1332],
27	.	.	O	.	_	0	SENT_17	[p1l949t1298r1015b1332],

1	Intracellular	JJ	O	intracellular	amod	2	SENT_18	[p1l1031t1297r1220b1324],
2	concentrations	NNS	O	concentration	nsubjpass	4	SENT_18	[p1l1233t1297r1456b1324],
3	were	VBD	O	be	auxpass	4	SENT_18	[p1l1471t1306r1544b1324],
4	measured	VBN	O	measure	_	0	SENT_18	[p1l1559t1297r1706b1324],
5	by	IN	O	by	_	0	SENT_18	[p1l1719t1297r1757b1332],
6	liquid	JJ	O	liquid	amod	10	SENT_18	[p1l1771t1297r1860b1332],
7	chromatography	NN	O	chromatography	nn	10	SENT_18	[p1l1874t1297r2125b1332],
8	tandem	JJ	O	tandem	amod	10	SENT_18	[p1l34t1343r146b1370],
9	mass	NN	O	mass	nn	10	SENT_18	[p1l156t1351r231b1370],
10	spectrometry	NN	O	spectrometry	agent	4	SENT_18	[p1l243t1347r447b1378],
11	.	.	O	.	_	0	SENT_18	[p1l243t1347r447b1378],

1	Of	IN	O	of	_	0	SENT_19	[p1l460t1343r502b1370],
2	the	DT	O	the	det	4	SENT_19	[p1l509t1343r555b1370],
3	tested	VBN	O	test	amod	4	SENT_19	[p1l565t1343r654b1370],
4	ﬁbrates	NNS	O	ﬁbrates	prep_of	8	SENT_19	[p1l665t1343r784b1375],
5	,	,	O	,	_	0	SENT_19	[p1l665t1343r784b1375],
6	only	RB	O	only	advmod	7	SENT_19	[p1l797t1343r863b1378],
7	fenoﬁbrate	NN	O	fenoﬁbrate	nsubj	8	SENT_19	[p1l873t1343r1039b1370],
8	increased	VBD	O	increase	_	0	SENT_19	[p1l1049t1343r1194b1370],
9	calcein-AM	JJ	O	calcein-am	amod	10	SENT_19	[p1l1204t1343r1387b1370],
10	uptake	NN	O	uptake	dobj	8	SENT_19	[p1l1397t1343r1499b1378],
11	into	IN	O	into	_	0	SENT_19	[p1l1509t1343r1567b1370],
12	cells	NNS	O	cell	prep_into	8	SENT_19	[p1l1578t1343r1647b1370],
13	indicating	VBG	O	indicate	xcomp	8	SENT_19	[p1l1658t1343r1811b1378],
14	an	DT	O	a	det	15	SENT_19	[p1l1822t1351r1857b1370],
15	inhibition	NN	O	inhibition	nsubj	18	SENT_19	[p1l1867t1343r2016b1370],
16	of	IN	O	of	_	0	SENT_19	[p1l2026t1343r2059b1370],
17	Pgp	NNP	ORGANIZATION	Pgp	prep_of	15	SENT_19	[p1l2067t1343r2125b1378],
18	mediated	VBD	O	mediate	ccomp	13	SENT_19	[p1l34t1389r175b1416],
19	transport	NN	O	transport	dobj	18	SENT_19	[p1l184t1393r320b1424],
20	by	IN	O	by	_	0	SENT_19	[p1l328t1389r366b1424],
21	this	DT	O	this	det	22	SENT_19	[p1l375t1389r429b1416],
22	compound	NN	O	compound	prep_by	18	SENT_19	[p1l439t1389r608b1424],
23	.	.	O	.	_	0	SENT_19	[p1l439t1389r608b1424],

1	The	DT	O	the	det	2	SENT_20	[p1l619t1389r678b1416],
2	potency	NN	O	potency	nsubj	6	SENT_20	[p1l687t1393r808b1424],
3	of	IN	O	of	_	0	SENT_20	[p1l817t1389r851b1416],
4	fenoﬁbrate	JJ	O	fenoﬁbrate	amod	5	SENT_20	[p1l857t1389r1022b1416],
5	(	NN	O	(	prep_of	2	SENT_20	[p1l1032t1390r1127b1422],
6	mean	VB	O	mean	_	0	SENT_20	[p1l1032t1390r1127b1422],
7	SD	NN	O	sd	dobj	6	SENT_20	[p1l1176t1389r1230b1416],
8	:	:	O	:	_	0	SENT_20	[p1l1176t1389r1230b1416],
9	7.1	CD	NUMBER	7.1	number	10	SENT_20	[p1l1243t1389r1287b1416],
10	3.2	CD	NUMBER	3.2	num	12	SENT_20	[p1l1339t1389r1385b1416],
11	uM	NN	O	um	nn	12	SENT_20	[p1l1398t1389r1471b1424],
12	)	NN	O	)	nsubj	29	SENT_20	[p1l1398t1389r1471b1424],
13	,	,	O	,	_	0	SENT_20	[p1l1398t1389r1471b1424],
14	evaluated	VBN	O	evaluate	partmod	12	SENT_20	[p1l1482t1389r1628b1416],
15	by	IN	O	by	_	0	SENT_20	[p1l1636t1389r1674b1424],
16	calculating	VBG	O	calculate	agent	14	SENT_20	[p1l1684t1389r1851b1424],
17	the	DT	O	the	det	18	SENT_20	[p1l1861t1389r1907b1416],
18	concentration	NN	O	concentration	dobj	16	SENT_20	[p1l1917t1389r2125b1416],
19	needed	VBN	O	need	partmod	18	SENT_20	[p1l34t1435r142b1462],
20	to	TO	O	to	aux	21	SENT_20	[p1l155t1439r184b1462],
21	double	VB	O	double	xcomp	19	SENT_20	[p1l198t1435r301b1462],
22	baseline	NN	O	baseline	nn	23	SENT_20	[p1l314t1435r440b1462],
23	ﬂuorescence	NN	O	ﬂuorescence	nsubj	26	SENT_20	[p1l454t1435r645b1462],
24	(	CD	NUMBER	(	num	26	SENT_20	[p1l660t1435r724b1468],
25	f2	NN	O	f2	nn	26	SENT_20	[p1l660t1435r724b1468],
26	)	NN	O	)	xcomp	21	SENT_20	[p1l660t1435r724b1468],
27	,	,	O	,	_	0	SENT_20	[p1l660t1435r724b1468],
28	was	VBD	O	be	cop	29	SENT_20	[p1l739t1444r796b1462],
29	similar	JJ	O	similar	parataxis	6	SENT_20	[p1l812t1435r918b1462],
30	to	TO	O	to	_	0	SENT_20	[p1l930t1439r959b1462],
31	that	DT	O	that	prep_to	29	SENT_20	[p1l973t1435r1030b1462],
32	of	IN	O	of	_	0	SENT_20	[p1l1044t1435r1077b1462],
33	simvastatin	NN	O	simvastatin	prep_of	31	SENT_20	[p1l1089t1435r1261b1462],
34	(	CD	NUMBER	(	number	35	SENT_20	[p1l1276t1435r1334b1468],
35	5.8	CD	NUMBER	5.8	dep	33	SENT_20	[p1l1276t1435r1334b1468],
36	:	:	O	:	_	0	SENT_20	[p1l1347t1448r1373b1462],
37	:	:	O	:	_	0	SENT_20	[p1l1347t1448r1373b1462],
38	1.5	CD	NUMBER	1.5	num	39	SENT_20	[p1l1387t1435r1430b1462],
39	uM	NN	O	um	dep	33	SENT_20	[p1l1443t1435r1517b1470],
40	)	NN	O	)	dep	39	SENT_20	[p1l1443t1435r1517b1470],
41	,	,	O	,	_	0	SENT_20	[p1l1443t1435r1517b1470],
42	lovastatin	NN	O	lovastatin	nn	43	SENT_20	[p1l1532t1435r1679b1462],
43	(	NN	O	(	appos	39	SENT_20	[p1l1694t1435r1770b1468],
44	10.1	CD	NUMBER	10.1	dep	43	SENT_20	[p1l1694t1435r1770b1468],
45	:	:	O	:	_	0	SENT_20	[p1l1784t1448r1810b1462],
46	:	:	O	:	_	0	SENT_20	[p1l1784t1448r1810b1462],
47	1.0	CD	NUMBER	1.0	num	48	SENT_20	[p1l1824t1435r1890b1468],
48	)	NN	O	)	dep	31	SENT_20	[p1l1824t1435r1890b1468],
49	,	,	O	,	_	0	SENT_20	[p1l1824t1435r1890b1468],
50	and	CC	O	and	_	0	SENT_20	[p1l1905t1435r1959b1462],
51	verapamil	NN	O	verapamil	conj_and	31	SENT_20	[p1l1973t1435r2125b1470],
52	(	CD	NUMBER	(	number	53	SENT_20	[p1l35t1481r93b1514],
53	4.7	CD	NUMBER	4.7	dep	51	SENT_20	[p1l35t1481r93b1514],
54	:	:	O	:	_	0	SENT_20	[p1l105t1494r131b1508],
55	:	:	O	:	_	0	SENT_20	[p1l105t1494r131b1508],
56	0.8	CD	NUMBER	0.8	num	58	SENT_20	[p1l142t1481r188b1508],
57	uM	NN	O	um	nn	58	SENT_20	[p1l202t1481r275b1516],
58	)	NN	O	)	dep	6	SENT_20	[p1l202t1481r275b1516],
59	.	.	O	.	_	0	SENT_20	[p1l202t1481r275b1516],

1	For	IN	O	for	_	0	SENT_21	[p1l291t1482r344b1508],
2	simvastatin	NN	O	simvastatin	nn	5	SENT_21	[p1l359t1481r532b1508],
3	and	CC	O	and	_	0	SENT_21	[p1l547t1481r601b1508],
4	fenoﬁbrate	JJ	O	fenoﬁbrate	nn	5	SENT_21	[p1l616t1481r781b1508],
5	Pgp	NN	O	pgp	prep_for	8	SENT_21	[p1l796t1482r854b1516],
6	inhibition	NN	O	inhibition	nsubjpass	8	SENT_21	[p1l869t1481r1018b1508],
7	was	VBD	O	be	auxpass	8	SENT_21	[p1l1033t1489r1091b1508],
8	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_21	[p1l1107t1481r1261b1508],
9	with	IN	O	with	_	0	SENT_21	[p1l1276t1481r1343b1508],
10	confocal	JJ	O	confocal	amod	13	SENT_21	[p1l1358t1481r1489b1508],
11	laser	NN	O	laser	nn	13	SENT_21	[p1l1505t1481r1577b1508],
12	scanning	NN	O	scanning	nn	13	SENT_21	[p1l1592t1481r1726b1516],
13	microscopy	NN	O	microscopy	prep_with	8	SENT_21	[p1l1741t1481r1925b1516],
14	.	.	O	.	_	0	SENT_21	[p1l1741t1481r1925b1516],

1	Fenoﬁbrate	NNP	O	Fenoﬁbrate	nsubj	10	SENT_22	[p1l1941t1481r2124b1513],
2	,	,	O	,	_	0	SENT_22	[p1l1941t1481r2124b1513],
3	fenoﬁbric	JJ	O	fenoﬁbric	amod	4	SENT_22	[p1l34t1527r181b1554],
4	acid	NN	O	acid	nsubj	10	SENT_22	[p1l193t1527r263b1559],
5	,	,	O	,	_	0	SENT_22	[p1l193t1527r263b1559],
6	gemﬁbrozil	NN	O	gemﬁbrozil	nsubj	10	SENT_22	[p1l275t1527r459b1562],
7	,	,	O	,	_	0	SENT_22	[p1l275t1527r459b1562],
8	and	CC	O	and	_	0	SENT_22	[p1l471t1527r525b1554],
9	bezaﬁbrate	NN	O	bezaﬁbrate	conj_and	1	SENT_22	[p1l534t1527r703b1554],
10	showed	VBD	O	show	_	0	SENT_22	[p1l714t1527r829b1554],
11	no	DT	O	no	det	12	SENT_22	[p1l838t1536r875b1554],
12	difference	NN	O	difference	dobj	10	SENT_22	[p1l885t1527r1039b1554],
13	in	IN	O	in	_	0	SENT_22	[p1l1049t1527r1078b1554],
14	the	DT	O	the	det	16	SENT_22	[p1l1088t1527r1134b1554],
15	cellular	JJ	O	cellular	amod	16	SENT_22	[p1l1144t1527r1260b1554],
16	uptake	NN	O	uptake	prep_in	10	SENT_22	[p1l1268t1527r1370b1562],
17	between	IN	O	between	_	0	SENT_22	[p1l1380t1527r1508b1554],
18	LLC	NNP	O	LLC	prep_between	16	SENT_22	[p1l1517t1527r1666b1554],
19	.	.	O	.	_	0	SENT_22	[p1l1517t1527r1666b1554],

1	—	NN	O	—	_	0	SENT_23	[p1l1517t1527r1666b1554],
2	.	.	O	.	_	0	SENT_23	[p1l1517t1527r1666b1554],

1	PKl	NN	O	pkl	_	0	SENT_24	[p1l1517t1527r1666b1554],
2	and	CC	O	and	_	0	SENT_24	[p1l1680t1527r1735b1554],
3	L	NN	O	l	conj_and	1	SENT_24	[p1l1744t1527r1894b1559],
4	.	.	O	.	_	0	SENT_24	[p1l1744t1527r1894b1559],

1	—	NN	O	—	_	0	SENT_25	[p1l1744t1527r1894b1559],
2	.	.	O	.	_	0	SENT_25	[p1l1744t1527r1894b1559],

1	MDRl	NN	O	mdrl	nsubj	11	SENT_26	[p1l1744t1527r1894b1559],
2	,	,	O	,	_	0	SENT_26	[p1l1744t1527r1894b1559],
3	indicating	VBG	O	indicate	partmod	11	SENT_26	[p1l1905t1527r2058b1562],
4	that	IN	O	that	complm	6	SENT_26	[p1l2068t1527r2126b1554],
5	the	DT	O	the	nsubj	6	SENT_26	[p1l34t1573r79b1600],
6	tested	VBN	O	test	ccomp	3	SENT_26	[p1l89t1573r178b1600],
7	ﬁbrates	NNS	O	ﬁbrates	dobj	6	SENT_26	[p1l187t1573r298b1600],
8	are	VBP	O	be	cop	11	SENT_26	[p1l308t1582r353b1600],
9	not	RB	O	not	neg	11	SENT_26	[p1l362t1577r411b1600],
10	Pgp	NNP	O	Pgp	nn	11	SENT_26	[p1l419t1574r477b1608],
11	substrates	NNS	O	substrate	_	0	SENT_26	[p1l487t1573r644b1600],
12	.	.	O	.	_	0	SENT_26	[p1l487t1573r644b1600],

1	In	IN	O	in	_	0	SENT_27	[p1l655t1574r686b1600],
2	conclusion	NN	O	conclusion	prep_in	6	SENT_27	[p1l695t1573r869b1605],
3	,	,	O	,	_	0	SENT_27	[p1l695t1573r869b1605],
4	this	DT	O	this	det	5	SENT_27	[p1l879t1573r933b1600],
5	study	NN	O	study	nsubj	6	SENT_27	[p1l943t1573r1024b1608],
6	demonstrates	VBZ	O	demonstrate	_	0	SENT_27	[p1l1033t1573r1234b1600],
7	that	IN	O	that	complm	9	SENT_27	[p1l1244t1573r1301b1600],
8	fenoﬁbrate	NN	O	fenoﬁbrate	nsubj	9	SENT_27	[p1l1310t1573r1475b1600],
9	inhibits	VBZ	O	inhibit	ccomp	6	SENT_27	[p1l1484t1573r1598b1600],
10	Pgp	NNP	O	Pgp	dobj	9	SENT_27	[p1l1607t1574r1665b1608],
11	in	FW	O	in	nn	12	SENT_27	[p1l1676t1574r1703b1600],
12	vitro	FW	O	vitro	advmod	9	SENT_27	[p1l1711t1574r1781b1600],
13	with	IN	O	with	_	0	SENT_27	[p1l1789t1573r1856b1600],
14	a	DT	O	a	det	15	SENT_27	[p1l1866t1582r1882b1600],
15	potency	NN	O	potency	prep_with	9	SENT_27	[p1l1890t1577r2010b1608],
16	similar	JJ	O	similar	amod	15	SENT_27	[p1l2021t1573r2126b1600],
17	to	TO	O	to	_	0	SENT_27	[p1l34t1623r62b1646],
18	simvastatin	NN	O	simvastatin	prep_to	16	SENT_27	[p1l78t1619r258b1646],
19	.	.	O	.	_	0	SENT_27	[p1l78t1619r258b1646],

1	©	RB	O	©	advmod	2	SENT_28	[p1l36t1665r69b1698],
2	2003	CD	DATE	2003	_	0	SENT_28	[p1l85t1665r159b1692],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	4	SENT_28	[p1l174t1665r300b1692],
4	Inc.	NNP	ORGANIZATION	Inc.	dep	2	SENT_28	[p1l313t1665r368b1692],
5	.	.	O	.	_	0	SENT_28	[p1l313t1665r368b1692],

1	All	DT	O	all	det	2	SENT_29	[p1l384t1665r432b1692],
2	rights	NNS	O	rights	nsubj	3	SENT_29	[p1l446t1665r532b1700],
3	reserved	VBN	O	reserve	_	0	SENT_29	[p1l546t1665r684b1692],
4	.	.	O	.	_	0	SENT_29	[p1l546t1665r684b1692],

1	Keywords	NNS	O	keyword	_	0	SENT_30	[p1l33t1752r172b1782],
2	:	:	O	:	_	0	SENT_30	[p1l33t1752r172b1782],
3	Fibrates	NNS	O	fibrate	dep	1	SENT_30	[p1l191t1752r305b1780],
4	;	:	O	;	_	0	SENT_30	[p1l191t1752r305b1780],
5	P-glycoprotein	NN	O	p-glycoprotein	dep	3	SENT_30	[p1l318t1752r523b1782],
6	;	:	O	;	_	0	SENT_30	[p1l318t1752r523b1782],
7	In	FW	O	in	nn	8	SENT_30	[p1l535t1753r562b1775],
8	vitro	FW	O	vitro	dep	3	SENT_30	[p1l574t1753r642b1780],
9	;	:	O	;	_	0	SENT_30	[p1l574t1753r642b1780],
10	Drug	NN	O	drug	nn	11	SENT_30	[p1l655t1753r722b1782],
11	interactions	NNS	O	interaction	dep	8	SENT_30	[p1l734t1752r897b1780],
12	;	:	O	;	_	0	SENT_30	[p1l734t1752r897b1780],
13	Calcein-acetoxymethylester	NN	O	calcein-acetoxymethylester	dep	3	SENT_30	[p1l910t1752r1289b1782],
14	;	:	O	;	_	0	SENT_30	[p1l910t1752r1289b1782],
15	Inhibition	NN	O	inhibition	dep	13	SENT_30	[p1l1302t1752r1432b1775],

1	1	LS	NUMBER	1	_	0	SENT_31	[p1l12t1985r69b2046],
2	.	.	O	.	_	0	SENT_31	[p1l12t1985r69b2046],

1	Introduction	NN	O	introduction	_	0	SENT_32	[p1l116t1984r581b2046],

1	Lipid	NN	O	lipid	nn	3	SENT_33	[p1l94t2190r280b2268],
2	lowering	NN	O	lowering	nn	3	SENT_33	[p1l304t2190r606b2268],
3	ﬁbrates	NNS	O	ﬁbrates	nsubj	7	SENT_33	[p1l633t2190r881b2250],
4	are	VBP	O	be	cop	7	SENT_33	[p1l909t2209r1009b2250],
5	an	DT	O	a	det	7	SENT_33	[p1l1037t2209r1115b2250],
6	established	JJ	O	established	amod	7	SENT_33	[p1l1140t2190r1522b2250],
7	class	NN	O	class	_	0	SENT_33	[p1l1546t2190r1709b2250],
8	of	IN	O	of	_	0	SENT_33	[p1l1737t2190r1811b2250],
9	drugs	NNS	O	drug	prep_of	7	SENT_33	[p1l1831t2190r2017b2268],
10	for	IN	O	for	_	0	SENT_33	[p1l9t2293r108b2353],
11	the	DT	O	the	det	12	SENT_33	[p1l133t2293r236b2353],
12	treatment	NN	O	treatment	prep_for	9	SENT_33	[p1l263t2302r589b2353],
13	of	IN	O	of	_	0	SENT_33	[p1l617t2293r691b2353],
14	hypertriglyceridemia	NN	O	hypertriglyceridemia	prep_of	12	SENT_33	[p1l711t2293r1451b2371],
15	.	.	O	.	_	0	SENT_33	[p1l711t2293r1451b2371],

1	Combined	VBN	O	combine	prep	26	SENT_34	[p1l1484t2293r1841b2353],
2	with	IN	O	with	pcomp	1	SENT_34	[p1l1867t2293r2019b2353],
3	3-hydroxy	JJ	O	3-hydroxy	amod	7	SENT_34	[p1l11t2395r974b2473],
4	—	NN	O	—	nn	7	SENT_34	[p1l11t2395r974b2473],
5	3-methylglutaryl	NN	O	3-methylglutaryl	nn	7	SENT_34	[p1l11t2395r974b2473],
6	coenzyme	NN	O	coenzyme	nn	7	SENT_34	[p1l1039t2414r1385b2473],
7	A	NN	O	a	pobj	2	SENT_34	[p1l1449t2396r1509b2454],
8	(	CD	NUMBER	(	num	9	SENT_34	[p1l1575t2395r2015b2469],
9	HMG-CoA	NN	O	hmg-coa	nsubj	13	SENT_34	[p1l1575t2395r2015b2469],
10	)	CD	NUMBER	)	num	12	SENT_34	[p1l1575t2395r2015b2469],
11	reductase	NN	O	reductase	nn	12	SENT_34	[p1l7t2496r331b2556],
12	inhibitors	NNS	O	inhibitor	dep	9	SENT_34	[p1l378t2496r705b2556],
13	(	VBP	O	(	rcmod	7	SENT_34	[p1l755t2496r1045b2570],
14	statins	NNS	O	statin	dobj	13	SENT_34	[p1l755t2496r1045b2570],
15	)	RB	O	)	advmod	13	SENT_34	[p1l755t2496r1045b2570],
16	,	,	O	,	_	0	SENT_34	[p1l755t2496r1045b2570],
17	which	WDT	O	which	nsubjpass	19	SENT_34	[p1l1095t2496r1304b2557],
18	are	VBP	O	be	auxpass	19	SENT_34	[p1l1350t2515r1451b2556],
19	used	VBN	O	use	rcmod	7	SENT_34	[p1l1497t2496r1654b2556],
20	primarily	RB	O	primarily	advmod	19	SENT_34	[p1l1697t2496r2018b2574],
21	to	TO	O	to	aux	22	SENT_34	[p1l8t2608r72b2659],
22	treat	VB	O	treat	xcomp	19	SENT_34	[p1l102t2608r254b2659],
23	hypercholesterolemia	NN	O	hypercholesterolemia	dobj	22	SENT_34	[p1l282t2599r1042b2677],
24	,	,	O	,	_	0	SENT_34	[p1l282t2599r1042b2677],
25	they	PRP	O	they	nsubj	26	SENT_34	[p1l1075t2599r1221b2677],
26	represent	VBP	O	represent	_	0	SENT_34	[p1l1248t2608r1564b2677],
27	an	DT	O	a	det	29	SENT_34	[p1l1594t2618r1672b2659],
28	attractive	JJ	O	attractive	amod	29	SENT_34	[p1l1702t2599r2018b2659],
29	approach	NN	O	approach	dobj	26	SENT_34	[p1l10t2701r323b2778],
30	for	IN	O	for	_	0	SENT_34	[p1l347t2700r447b2761],
31	the	DT	O	the	det	32	SENT_34	[p1l469t2701r572b2761],
32	treatment	NN	O	treatment	prep_for	29	SENT_34	[p1l597t2710r923b2761],
33	of	IN	O	of	_	0	SENT_34	[p1l948t2700r1022b2761],
34	mixed	JJ	O	mixed	amod	35	SENT_34	[p1l1041t2701r1254b2761],
35	dyslipidemia	NN	O	dyslipidemia	prep_of	32	SENT_34	[p1l1279t2700r1723b2778],
36	because	IN	O	because	_	0	SENT_34	[p1l1746t2701r2017b2761],
37	of	IN	O	of	_	0	SENT_34	[p1l9t2803r83b2864],
38	their	PRP$	O	they	poss	40	SENT_34	[p1l126t2804r284b2864],
39	different	JJ	O	different	amod	40	SENT_34	[p1l332t2803r625b2864],
40	mechanisms	NNS	O	mechanism	prep_because_of	26	SENT_34	[p1l672t2804r1096b2864],
41	of	IN	O	of	_	0	SENT_34	[p1l1147t2803r1221b2864],
42	action	NN	O	action	prep_of	40	SENT_34	[p1l1265t2804r1490b2864],
43	.	.	O	.	_	0	SENT_34	[p1l1265t2804r1490b2864],

1	While	IN	O	while	mark	2	SENT_35	[p1l1541t2804r1751b2864],
2	statins	NNS	O	statin	_	0	SENT_35	[p1l1803t2804r2016b2864],

1	*	NN	O	*	_	0	SENT_36	[p1l77t2990r507b3066],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_36	[p1l77t2990r507b3066],
3	author	NN	O	author	dobj	2	SENT_36	[p1l533t3005r711b3052],
4	.	.	O	.	_	0	SENT_36	[p1l533t3005r711b3052],

1	Tel.	NNP	O	Tel.	_	0	SENT_37	[p1l739t3005r853b3052],
2	:	:	O	:	_	0	SENT_37	[p1l739t3005r853b3052],
3	+49	CD	NUMBER	+49	num	5	SENT_37	[p1l885t3004r1394b3060],
4	—	CD	NUMBER	—	num	5	SENT_37	[p1l885t3004r1394b3060],
5	622l	NN	O	622l	dep	1	SENT_37	[p1l885t3004r1394b3060],
6	—	CD	NUMBER	—	num	7	SENT_37	[p1l885t3004r1394b3060],
7	565582	CD	NUMBER	565582	dep	1	SENT_37	[p1l885t3004r1394b3060],
8	;	:	O	;	_	0	SENT_37	[p1l885t3004r1394b3060],

1	fax	NN	O	fax	_	0	SENT_38	[p1l8t3088r106b3135],
2	:	:	O	:	_	0	SENT_38	[p1l8t3088r106b3135],
3	+49	CD	NUMBER	+49	number	4	SENT_38	[p1l138t3088r644b3140],
4	—	CD	NUMBER	—	num	5	SENT_38	[p1l138t3088r644b3140],
5	622l-564642	NN	O	622l-564642	dep	1	SENT_38	[p1l138t3088r644b3140],
6	.	.	O	.	_	0	SENT_38	[p1l138t3088r644b3140],

1	E-mail	NN	O	e-mail	nn	2	SENT_39	[p1l85t3171r269b3219],
2	address	NN	O	address	_	0	SENT_39	[p1l291t3171r513b3219],
3	:	:	O	:	_	0	SENT_39	[p1l291t3171r513b3219],
4	johanna_weiss@med.uni-heidelberg.de	NN	O	johanna_weiss@med.uni-heidelberg.de	dep	2	SENT_39	[p1l535t3171r1598b3232],
5	(	CD	NUMBER	(	num	8	SENT_39	[p1l1625t3172r1682b3229],
6	J.	NNP	PERSON	J.	nn	8	SENT_39	[p1l1625t3172r1682b3229],
7	Weiss	NNP	PERSON	Weiss	nn	8	SENT_39	[p1l1708t3171r1903b3229],
8	)	NN	O	)	dep	4	SENT_39	[p1l1708t3171r1903b3229],
9	.	.	O	.	_	0	SENT_39	[p1l1708t3171r1903b3229],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_40	[p1l82t3255r477b3302],
2	:	:	O	:	_	0	SENT_40	[p1l82t3255r477b3302],
3	APCI	NN	O	apcus	dep	1	SENT_40	[p1l515t3255r680b3310],
4	,	,	O	,	_	0	SENT_40	[p1l515t3255r680b3310],
5	atmospheric	JJ	O	atmospheric	amod	8	SENT_40	[p1l716t3254r1039b3316],
6	pressure	NN	O	pressure	nn	8	SENT_40	[p1l1072t3269r1294b3316],
7	chemical	NN	O	chemical	nn	8	SENT_40	[p1l1328t3255r1569b3302],
8	ionization	NN	O	ionization	appos	3	SENT_40	[p1l1601t3255r1884b3310],
9	;	:	O	;	_	0	SENT_40	[p1l1601t3255r1884b3310],
10	calcein-AM	NN	O	calcein-am	dep	3	SENT_40	[p1l1920t3255r2017b3302, p1l9t3338r263b3393],
11	,	,	O	,	_	0	SENT_40	[p1l1920t3255r2017b3302, p1l9t3338r263b3393],
12	calcein	NN	O	calcein	nn	14	SENT_40	[p1l303t3338r1052b3399],
13	—	NN	O	—	nn	14	SENT_40	[p1l303t3338r1052b3399],
14	acetoxymethylester	NN	O	acetoxymethylester	appos	10	SENT_40	[p1l303t3338r1052b3399],
15	;	:	O	;	_	0	SENT_40	[p1l303t3338r1052b3399],
16	CYP	NNP	O	CYP	dep	3	SENT_40	[p1l1093t3338r1227b3393],
17	,	,	O	,	_	0	SENT_40	[p1l1093t3338r1227b3393],
18	cytochrome	NN	O	cytochrome	nn	19	SENT_40	[p1l1268t3338r1582b3399],
19	P450	NN	O	p450	appos	16	SENT_40	[p1l1620t3337r1771b3393],
20	;	:	O	;	_	0	SENT_40	[p1l1620t3337r1771b3393],
21	DMSO	NN	ORGANIZATION	dmso	dep	3	SENT_40	[p1l1811t3338r2017b3393],
22	,	,	O	,	_	0	SENT_40	[p1l1811t3338r2017b3393],
23	dimethyl	JJ	O	dimethyl	amod	24	SENT_40	[p1l9t3420r245b3481],
24	sulfoxide	NN	O	sulfoxide	appos	21	SENT_40	[p1l270t3420r532b3476],
25	;	:	O	;	_	0	SENT_40	[p1l270t3420r532b3476],
26	ESI	NNP	ORGANIZATION	ESI	dep	3	SENT_40	[p1l556t3421r669b3476],
27	,	,	O	,	_	0	SENT_40	[p1l556t3421r669b3476],
28	electrospray	JJ	O	electrospray	amod	29	SENT_40	[p1l695t3420r1020b3481],
29	ionization	NN	O	ionization	appos	26	SENT_40	[p1l1042t3420r1326b3476],
30	;	:	O	;	_	0	SENT_40	[p1l1042t3420r1326b3476],
31	f2	NN	O	f2	dep	3	SENT_40	[p1l1351t3420r1419b3476],
32	,	,	O	,	_	0	SENT_40	[p1l1351t3420r1419b3476],
33	concentration	NN	O	concentration	appos	31	SENT_40	[p1l1445t3420r1808b3467],
34	needed	VBD	O	need	rcmod	33	SENT_40	[p1l1830t3420r2019b3467],
35	to	TO	O	to	aux	36	SENT_40	[p1l8t3512r58b3552],
36	double	VB	O	double	xcomp	34	SENT_40	[p1l94t3505r274b3552],
37	baseline	NN	O	baseline	nn	38	SENT_40	[p1l307t3505r526b3552],
38	ﬂuorescence	NN	O	ﬂuorescence	dobj	36	SENT_40	[p1l561t3504r910b3560],
39	;	:	O	;	_	0	SENT_40	[p1l561t3504r910b3560],
40	HBSS	NN	O	hbss	dep	1	SENT_40	[p1l947t3505r1126b3560],
41	,	,	O	,	_	0	SENT_40	[p1l947t3505r1126b3560],
42	Hanks	NNP	PERSON	Hanks	appos	40	SENT_40	[p1l1162t3505r1348b3552],
43	’	CD	NUMBER	’	num	42	SENT_40	[p1l1162t3505r1348b3552],
44	balanced	JJ	O	balanced	amod	46	SENT_40	[p1l1387t3505r1627b3552],
45	salt	NN	O	salt	nn	46	SENT_40	[p1l1662t3505r1752b3552],
46	solution	NN	O	solution	dep	42	SENT_40	[p1l1788t3505r2016b3560],
47	;	:	O	;	_	0	SENT_40	[p1l1788t3505r2016b3560],
48	HHBSS	NNP	LOCATION	HHBSS	nn	50	SENT_40	[p1l8t3588r236b3643],
49	,	,	O	,	_	0	SENT_40	[p1l8t3588r236b3643],
50	HBSS	NNP	O	HBSS	dep	1	SENT_40	[p1l282t3588r444b3635],
51	supplemented	VBN	O	supplement	partmod	50	SENT_40	[p1l493t3588r862b3649],
52	with	IN	O	with	_	0	SENT_40	[p1l906t3588r1024b3635],
53	10	CD	PERCENT	10	number	54	SENT_40	[p1l1074t3588r1186b3635],
54	%	NN	PERCENT	%	amod	55	SENT_40	[p1l1074t3588r1186b3635],
55	HEPES	NN	O	hepe	prep_with	51	SENT_40	[p1l1233t3588r1451b3643],
56	;	:	O	;	_	0	SENT_40	[p1l1233t3588r1451b3643],
57	IC50	NN	O	ic50	dep	50	SENT_40	[p1l1498t3601r1608b3646],
58	,	,	O	,	_	0	SENT_40	[p1l1498t3601r1608b3646],
59	concentration	NN	O	concentration	appos	57	SENT_40	[p1l1655t3588r2020b3635],
60	inducing	VBG	O	induce	partmod	59	SENT_40	[p1l8t3671r241b3732],
61	half	NN	O	half	nn	63	SENT_40	[p1l262t3671r370b3718],
62	maximal	JJ	O	maximal	amod	63	SENT_40	[p1l387t3671r621b3718],
63	effect	NN	O	effect	dobj	60	SENT_40	[p1l644t3671r809b3726],
64	;	:	O	;	_	0	SENT_40	[p1l644t3671r809b3726],
65	LC/MS/MS	NNP	O	LC/MS/MS	dep	50	SENT_40	[p1l834t3671r1162b3726],
66	,	,	O	,	_	0	SENT_40	[p1l834t3671r1162b3726],
67	liquid	JJ	O	liquid	amod	71	SENT_40	[p1l1186t3671r1342b3732],
68	chromatography	NN	O	chromatography	nn	71	SENT_40	[p1l1364t3671r1800b3732],
69	tandem	JJ	O	tandem	amod	71	SENT_40	[p1l1823t3671r2020b3718],
70	mass	NN	O	mass	nn	71	SENT_40	[p2l8t32r143b65],
71	spectrometry	NN	O	spectrometry	appos	65	SENT_40	[p2l195t24r572b78],
72	;	:	O	;	_	0	SENT_40	[p2l195t24r572b78],
73	LDH	NNP	ORGANIZATION	LDH	dep	50	SENT_40	[p2l624t19r778b73],
74	,	,	O	,	_	0	SENT_40	[p2l624t19r778b73],
75	lactate	NN	O	lactate	nn	76	SENT_40	[p2l829t17r1010b65],
76	dehydrogenase	NN	O	dehydrogenase	appos	73	SENT_40	[p2l1061t17r1492b78],
77	;	:	O	;	_	0	SENT_40	[p2l1061t17r1492b78],
78	MRP	NN	ORGANIZATION	mrp	dep	50	SENT_40	[p2l1544t19r1694b73],
79	,	,	O	,	_	0	SENT_40	[p2l1544t19r1694b73],
80	multidrug	JJ	O	multidrug	amod	82	SENT_40	[p2l1746t17r2018b78],
81	resistance-associated	JJ	O	resistance-associated	amod	82	SENT_40	[p2l7t101r570b148],
82	protein	NN	O	protein	appos	78	SENT_40	[p2l593t100r798b162],
83	;	:	O	;	_	0	SENT_40	[p2l593t100r798b162],
84	Pgp	NNP	O	Pgp	dep	50	SENT_40	[p2l825t102r941b162],
85	,	,	O	,	_	0	SENT_40	[p2l825t102r941b162],
86	P	NN	O	p	nn	88	SENT_40	[p2l967t100r1378b162],
87	—	CD	NUMBER	—	num	88	SENT_40	[p2l967t100r1378b162],
88	glycoprotein	NN	O	glycoprotein	appos	84	SENT_40	[p2l967t100r1378b162],
89	.	.	O	.	_	0	SENT_40	[p2l967t100r1378b162],

1	0006-2952	CD	DURATION	0006-2952	_	0	SENT_41	[p2l9t283r347b339],
2	/	:	O	/	punct	1	SENT_41	[p2l9t283r347b339],
3	$	$	MONEY	$	nsubj	5	SENT_41	[p2l9t283r347b339],
4	—	CD	MONEY	—	num	3	SENT_41	[p2l371t315r406b319],
5	see	VBP	O	see	dep	1	SENT_41	[p2l431t301r512b333],
6	front	JJ	O	front	amod	7	SENT_41	[p2l536t286r666b333],
7	matter	NN	O	matter	dobj	5	SENT_41	[p2l689t293r861b334],
8	©	CD	NUMBER	©	num	11	SENT_41	[p2l888t287r945b344],
9	2003	CD	DATE	2003	num	11	SENT_41	[p2l974t287r1102b334],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	11	SENT_41	[p2l1129t286r1347b333],
11	Inc.	NNP	ORGANIZATION	Inc.	dep	7	SENT_41	[p2l1370t288r1467b334],
12	.	.	O	.	_	0	SENT_41	[p2l1370t288r1467b334],

1	All	DT	O	all	det	2	SENT_42	[p2l1495t286r1578b333],
2	rights	NNS	O	rights	nsubj	3	SENT_42	[p2l1602t286r1752b347],
3	reserved	VBN	O	reserve	_	0	SENT_42	[p2l1777t286r2016b334],
4	.	.	O	.	_	0	SENT_42	[p2l1777t286r2016b334],

1	doi	FW	O	doi	_	0	SENT_43	[p2l9t369r828b431],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_43	[p2l9t369r828b431],
3	/	:	O	/	punct	5	SENT_43	[p2l9t369r828b431],
4	j.	NN	O	j.	nn	5	SENT_43	[p2l9t369r828b431],
5	bcp	NN	O	bcp	dep	2	SENT_43	[p2l9t369r828b431],
6	.2003.09.008	CD	NUMBER	.2003.09.008	dep	2	SENT_43	[p2l9t369r828b431],

1	reduce	VB	O	reduce	_	0	SENT_44	[p2l77t728r312b790],
2	cholesterol	NN	O	cholesterol	nn	3	SENT_44	[p2l352t728r739b790],
3	synthesis	NN	O	synthesis	nsubj	4	SENT_44	[p2l781t728r1099b808],
4	ﬁbrates	VBZ	O	ﬁbrates	ccomp	1	SENT_44	[p2l1141t728r1396b790],
5	increase	NN	O	increase	nn	6	SENT_44	[p2l1437t728r1725b790],
6	catabolism	NN	O	catabolism	dobj	4	SENT_44	[p2l1766t728r2150b790],
7	of	IN	O	of	_	0	SENT_44	[p2l80t834r156b895],
8	triglyceride	NN	O	triglyceride	nn	10	SENT_44	[p2l174t834r582b914],
9	rich	JJ	O	rich	amod	10	SENT_44	[p2l607t834r745b895],
10	lipoproteins	NNS	O	lipoprotein	prep_of	6	SENT_44	[p2l770t834r1190b914],
11	and	CC	O	and	_	0	SENT_44	[p2l1219t834r1344b895],
12	increase	VB	O	increase	conj_and	1	SENT_44	[p2l1368t834r1656b895],
13	HDL	NNP	O	HDL	iobj	12	SENT_44	[p2l1683t834r2146b895, p2l78t938r257b1000],
14	—	CD	NUMBER	—	num	15	SENT_44	[p2l1683t834r2146b895, p2l78t938r257b1000],
15	cholesterol	NN	O	cholesterol	dobj	12	SENT_44	[p2l1683t834r2146b895, p2l78t938r257b1000],
16	.	.	O	.	_	0	SENT_44	[p2l1683t834r2146b895, p2l78t938r257b1000],

1	For	IN	O	for	_	0	SENT_45	[p2l280t940r402b1000],
2	both	DT	O	both	prep_for	43	SENT_45	[p2l418t938r593b1011],
3	,	,	O	,	_	0	SENT_45	[p2l418t938r593b1011],
4	statins	NNS	O	statin	conj_and	2	SENT_45	[p2l619t938r838b1000],
5	and	CC	O	and	_	0	SENT_45	[p2l862t938r986b1000],
6	ﬁbrates	NNS	O	ﬁbrates	conj_and	2	SENT_45	[p2l1006t938r1282b1011],
7	,	,	O	,	_	0	SENT_45	[p2l1006t938r1282b1011],
8	drug-induced	JJ	O	drug-induced	amod	9	SENT_45	[p2l1306t938r1777b1018],
9	myopathy	NN	O	myopathy	nsubj	43	SENT_45	[p2l1795t938r2147b1018],
10	is	VBZ	O	be	cop	43	SENT_45	[p2l78t1043r133b1105],
11	a	DT	O	a	det	43	SENT_45	[p2l163t1063r199b1105],
12	rare	JJ	O	rare	amod	43	SENT_45	[p2l223t1063r359b1105],
13	but	CC	O	but	dep	15	SENT_45	[p2l385t1043r497b1105],
14	well	RB	O	well	advmod	15	SENT_45	[p2l523t1043r673b1105],
15	documented	VBN	O	document	dep	12	SENT_45	[p2l701t1043r1133b1105],
16	adverse	JJ	O	adverse	amod	18	SENT_45	[p2l1160t1043r1426b1105],
17	reaction	NN	O	reaction	nn	18	SENT_45	[p2l1452t1043r1737b1105],
18	[	NN	O	[	dobj	15	SENT_45	[p2l1769t1044r1858b1118],
19	1	CD	NUMBER	1	num	20	SENT_45	[p2l1769t1044r1858b1118],
20	]	NN	O	]	nsubjpass	30	SENT_45	[p2l1769t1044r1858b1118],
21	and	CC	O	and	_	0	SENT_45	[p2l1892t1043r2017b1105],
22	the	DT	O	the	det	23	SENT_45	[p2l2042t1043r2148b1105],
23	risk	NN	O	risk	nsubjpass	30	SENT_45	[p2l77t1149r211b1210],
24	for	IN	O	for	_	0	SENT_45	[p2l241t1149r343b1210],
25	progression	NN	O	progression	prep_for	23	SENT_45	[p2l372t1149r785b1229],
26	to	TO	O	to	_	0	SENT_45	[p2l817t1158r883b1210],
27	life-threatening	JJ	O	life-threatening	amod	28	SENT_45	[p2l916t1149r1462b1229],
28	rhabdomyolysis	NN	O	rhabdomyolysis	prep_to	25	SENT_45	[p2l1494t1149r2057b1229],
29	is	VBZ	O	be	auxpass	30	SENT_45	[p2l2091t1149r2146b1210],
30	increased	VBN	O	increase	rcmod	18	SENT_45	[p2l78t1252r413b1314],
31	when	WRB	O	when	advmod	36	SENT_45	[p2l433t1252r622b1314],
32	statins	NNS	O	statin	nsubjpass	36	SENT_45	[p2l645t1252r864b1314],
33	and	CC	O	and	_	0	SENT_45	[p2l889t1252r1013b1314],
34	ﬁbrates	NNS	O	ﬁbrates	nsubjpass	36	SENT_45	[p2l1034t1252r1290b1314],
35	are	VBP	O	be	auxpass	36	SENT_45	[p2l1313t1272r1417b1314],
36	used	VBN	O	use	advcl	30	SENT_45	[p2l1438t1252r1599b1314],
37	in	IN	O	in	_	0	SENT_45	[p2l1619t1252r1686b1313],
38	combination	NN	O	combination	nn	39	SENT_45	[p2l1707t1252r2149b1314],
39	[	NN	O	[	prep_in	36	SENT_45	[p2l85t1359r286b1433],
40	l	NN	O	l	tmod	36	SENT_45	[p2l85t1359r286b1433],
41	—	CD	NUMBER	—	number	42	SENT_45	[p2l85t1359r286b1433],
42	3	CD	NUMBER	3	num	43	SENT_45	[p2l85t1359r286b1433],
43	]	NN	O	]	_	0	SENT_45	[p2l85t1359r286b1433],
44	.	.	O	.	_	0	SENT_45	[p2l85t1359r286b1433],

1	The	DT	O	the	det	2	SENT_46	[p2l320t1358r455b1419],
2	incidence	NN	O	incidence	nsubj	6	SENT_46	[p2l485t1358r824b1419],
3	of	IN	O	of	_	0	SENT_46	[p2l856t1358r931b1419],
4	these	DT	O	these	det	5	SENT_46	[p2l955t1358r1135b1419],
5	interactions	NNS	O	interaction	prep_of	2	SENT_46	[p2l1165t1358r1577b1419],
6	depends	VBZ	O	depend	_	0	SENT_46	[p2l1609t1358r1894b1438],
7	on	IN	O	on	_	0	SENT_46	[p2l1927t1378r2012b1419],
8	the	DT	O	the	det	10	SENT_46	[p2l2042t1358r2147b1419],
9	individual	JJ	O	individual	amod	10	SENT_46	[p2l78t1462r434b1524],
10	drug	NN	O	drug	prep_on	6	SENT_46	[p2l457t1462r615b1542],
11	and	CC	O	and	_	0	SENT_46	[p2l640t1462r764b1524],
12	the	DT	O	the	det	14	SENT_46	[p2l785t1462r891b1524],
13	drug	NN	O	drug	nn	14	SENT_46	[p2l914t1462r1072b1542],
14	combination	NN	O	combination	conj_and	10	SENT_46	[p2l1096t1462r1538b1524],
15	used	VBN	O	use	partmod	14	SENT_46	[p2l1558t1462r1719b1524],
16	as	IN	O	as	mark	27	SENT_46	[p2l1743t1482r1810b1524],
17	shown	VBN	O	show	csubj	27	SENT_46	[p2l1837t1462r2060b1524],
18	in	IN	O	in	_	0	SENT_46	[p2l2082t1462r2149b1523],
19	an	DT	O	a	det	20	SENT_46	[p2l80t1587r160b1629],
20	analysis	NN	O	analysis	prep_in	17	SENT_46	[p2l185t1567r464b1647],
21	of	IN	O	of	_	0	SENT_46	[p2l491t1567r567b1629],
22	all	DT	O	all	det	24	SENT_46	[p2l586t1568r671b1629],
23	fatal	JJ	O	fatal	amod	24	SENT_46	[p2l695t1568r850b1629],
24	cases	NNS	O	case	prep_of	20	SENT_46	[p2l874t1587r1057b1629],
25	of	IN	O	of	_	0	SENT_46	[p2l1083t1567r1160b1629],
26	rhabdomyolysis	NN	O	rhabdomyolysis	prep_of	24	SENT_46	[p2l1176t1568r1740b1647],
27	reported	VBD	O	report	advcl	15	SENT_46	[p2l1764t1568r2059b1647],
28	to	TO	O	to	_	0	SENT_46	[p2l2082t1577r2147b1629],
29	the	DT	O	the	det	31	SENT_46	[p2l78t1672r184b1734],
30	American	JJ	ORGANIZATION	american	amod	31	SENT_46	[p2l214t1672r563b1734],
31	Food	NNP	ORGANIZATION	Food	prep_to	27	SENT_46	[p2l591t1672r771b1734],
32	and	CC	ORGANIZATION	and	_	0	SENT_46	[p2l801t1672r926b1734],
33	Drug	NNP	ORGANIZATION	Drug	nn	34	SENT_46	[p2l954t1674r1132b1752],
34	Administration	NNP	ORGANIZATION	Administration	conj_and	31	SENT_46	[p2l1163t1672r1699b1734],
35	(	CD	NUMBER	(	num	36	SENT_46	[p2l1731t1673r1955b1748],
36	FDA	NNP	ORGANIZATION	FDA	dep	31	SENT_46	[p2l1731t1673r1955b1748],
37	)	CD	NUMBER	)	num	36	SENT_46	[p2l1731t1673r1955b1748],
38	until	IN	O	until	_	0	SENT_46	[p2l1987t1672r2148b1734],
39	June	NNP	DATE	June	prep_until	27	SENT_46	[p2l78t1779r237b1839],
40	2001	CD	DATE	2001	num	39	SENT_46	[p2l259t1778r449b1839],
41	.	.	O	.	_	0	SENT_46	[p2l259t1778r449b1839],

1	In	IN	O	in	_	0	SENT_47	[p2l473t1779r544b1838],
2	this	DT	O	this	det	3	SENT_47	[p2l562t1777r687b1839],
3	series	NN	O	series	prep_in	12	SENT_47	[p2l710t1777r906b1839],
4	no	DT	O	no	det	5	SENT_47	[p2l926t1797r1011b1839],
5	case	NN	O	case	nsubjpass	12	SENT_47	[p2l1032t1797r1181b1839],
6	of	IN	O	of	_	0	SENT_47	[p2l1202t1777r1278b1839],
7	fatal	JJ	O	fatal	amod	8	SENT_47	[p2l1289t1777r1445b1839],
8	rhabdomyolysis	NN	O	rhabdomyolysis	prep_of	5	SENT_47	[p2l1463t1777r2026b1857],
9	for	IN	O	for	_	0	SENT_47	[p2l2048t1777r2150b1839],
10	ﬂuvastatin	NN	O	ﬂuvastatin	prep_for	8	SENT_47	[p2l80t1883r444b1945],
11	was	VBD	O	be	auxpass	12	SENT_47	[p2l486t1902r619b1945],
12	reported	VBN	O	report	_	0	SENT_47	[p2l661t1883r957b1963],
13	whereas	IN	O	whereas	mark	17	SENT_47	[p2l998t1883r1285b1945],
14	this	DT	O	this	det	15	SENT_47	[p2l1328t1883r1452b1944],
15	rate	NN	O	rate	nsubj	17	SENT_47	[p2l1494t1892r1626b1944],
16	was	VBD	O	be	cop	17	SENT_47	[p2l1667t1902r1800b1945],
17	3.16	CD	NUMBER	3.16	advcl	12	SENT_47	[p2l1846t1883r1994b1945],
18	per	IN	O	per	_	0	SENT_47	[p2l2036t1902r2150b1963],
19	million	CD	NUMBER	million	num	21	SENT_47	[p2l78t1987r333b2049],
20	cerivastatin	NN	O	cerivastatin	nn	21	SENT_47	[p2l378t1987r783b2049],
21	prescriptions	NNS	O	prescription	prep_per	17	SENT_47	[p2l825t1987r1281b2067],
22	[	VBP	O	[	dep	21	SENT_47	[p2l1334t1988r1446b2062],
23	3	CD	NUMBER	3	num	24	SENT_47	[p2l1334t1988r1446b2062],
24	]	NN	O	]	dobj	22	SENT_47	[p2l1334t1988r1446b2062],
25	.	.	O	.	_	0	SENT_47	[p2l1334t1988r1446b2062],

1	Twelve	CD	NUMBER	twelve	nsubj	6	SENT_48	[p2l1495t1987r1752b2049],
2	of	IN	O	of	_	0	SENT_48	[p2l1797t1987r1873b2049],
3	the	DT	O	the	det	5	SENT_48	[p2l1911t1987r2017b2049],
4	31	CD	NUMBER	31	num	5	SENT_48	[p2l2064t1988r2140b2049],
5	cases	NNS	O	case	prep_of	1	SENT_48	[p2l79t2113r261b2154],
6	reported	VBD	O	report	_	0	SENT_48	[p2l281t2093r577b2173],
7	to	TO	O	to	dep	10	SENT_48	[p2l596t2102r661b2154],
8	the	DT	O	the	det	9	SENT_48	[p2l682t2093r787b2154],
9	FDA	NNP	ORGANIZATION	FDA	nsubj	10	SENT_48	[p2l807t2094r979b2154],
10	occurred	VBD	O	occur	ccomp	6	SENT_48	[p2l999t2093r1306b2154],
11	during	IN	O	during	_	0	SENT_48	[p2l1327t2093r1554b2173],
12	combined	VBN	O	combine	amod	13	SENT_48	[p2l1575t2093r1923b2154],
13	use	NN	O	use	prep_during	10	SENT_48	[p2l1942t2113r2057b2154],
14	of	IN	O	of	_	0	SENT_48	[p2l2078t2093r2154b2154],
15	cerivastatin	NN	O	cerivastatin	prep_of	13	SENT_48	[p2l79t2198r483b2260],
16	and	CC	O	and	_	0	SENT_48	[p2l508t2198r633b2259],
17	gemﬁbrozil	NN	O	gemﬁbrozil	prep_of	13	SENT_48	[p2l657t2198r1081b2278],
18	.	.	O	.	_	0	SENT_48	[p2l657t2198r1081b2278],

1	The	DT	O	the	det	4	SENT_49	[p2l1109t2198r1244b2259],
2	most	RBS	O	most	advmod	3	SENT_49	[p2l1269t2207r1440b2259],
3	common	JJ	O	common	amod	4	SENT_49	[p2l1463t2218r1771b2259],
4	source	NN	O	source	nsubjpass	12	SENT_49	[p2l1798t2218r2023b2259],
5	for	IN	O	for	_	0	SENT_49	[p2l2048t2198r2150b2259],
6	such	JJ	O	such	amod	10	SENT_49	[p2l82t2303r238b2364],
7	drug	NN	O	drug	nn	10	SENT_49	[p2l285t2303r650b2382],
8	—	NN	O	—	nn	10	SENT_49	[p2l285t2303r650b2382],
9	drug	NN	O	drug	nn	10	SENT_49	[p2l285t2303r650b2382],
10	interactions	NNS	O	interaction	prep_for	4	SENT_49	[p2l698t2302r1109b2364],
11	is	VBZ	O	be	auxpass	12	SENT_49	[p2l1157t2303r1212b2364],
12	thought	VBN	O	think	_	0	SENT_49	[p2l1259t2303r1530b2382],
13	to	TO	O	to	aux	21	SENT_49	[p2l1575t2312r1641b2364],
14	be	VB	O	be	cop	21	SENT_49	[p2l1687t2303r1769b2364],
15	the	DT	O	the	det	21	SENT_49	[p2l1816t2303r1921b2364],
16	cytochrome	NN	O	cytochrome	nn	21	SENT_49	[p2l1970t2312r2146b2382, p2l79t2407r341b2469],
17	P450	NN	O	p450	nn	21	SENT_49	[p2l381t2407r560b2469],
18	(	CD	NUMBER	(	num	21	SENT_49	[p2l602t2408r824b2483],
19	CYP	NN	O	cyp	nn	21	SENT_49	[p2l602t2408r824b2483],
20	)	NN	O	)	nn	21	SENT_49	[p2l602t2408r824b2483],
21	system	NN	O	system	xcomp	12	SENT_49	[p2l869t2416r1128b2487],
22	.	.	O	.	_	0	SENT_49	[p2l869t2416r1128b2487],

1	Whereas	IN	O	whereas	mark	5	SENT_50	[p2l1170t2407r1478b2469],
2	pravastatin	NN	O	pravastatin	nsubjpass	5	SENT_50	[p2l1517t2407r1903b2487],
3	is	VBZ	O	be	auxpass	5	SENT_50	[p2l1942t2407r1997b2469],
4	not	RB	O	not	neg	5	SENT_50	[p2l2037t2416r2149b2469],
5	metabolized	VBN	O	metabolize	advcl	18	SENT_50	[p2l78t2513r512b2574],
6	by	IN	O	by	_	0	SENT_50	[p2l551t2513r638b2593],
7	the	DT	O	the	det	10	SENT_50	[p2l679t2513r785b2574],
8	CYP	NN	O	cyp	nn	10	SENT_50	[p2l827t2513r996b2575],
9	system	NN	O	system	nn	10	SENT_50	[p2l1039t2522r1281b2593],
10	simvastatin	NN	O	simvastatin	agent	5	SENT_50	[p2l1324t2513r1740b2586],
11	,	,	O	,	_	0	SENT_50	[p2l1324t2513r1740b2586],
12	lovastatin	NN	O	lovastatin	nsubjpass	18	SENT_50	[p2l1785t2513r2145b2586],
13	,	,	O	,	_	0	SENT_50	[p2l1785t2513r2145b2586],
14	and	CC	O	and	_	0	SENT_50	[p2l80t2618r205b2679],
15	atorvastatin	NN	O	atorvastatin	conj_and	12	SENT_50	[p2l239t2618r649b2680],
16	are	VBP	O	be	auxpass	18	SENT_50	[p2l684t2637r788b2679],
17	mainly	RB	O	mainly	advmod	18	SENT_50	[p2l822t2618r1066b2698],
18	metabolized	VBN	O	metabolize	_	0	SENT_50	[p2l1100t2618r1534b2679],
19	by	IN	O	by	_	0	SENT_50	[p2l1566t2618r1653b2698],
20	the	DT	O	the	det	21	SENT_50	[p2l1687t2618r1792b2679],
21	CYP3A4	NN	O	cyp3a4	agent	18	SENT_50	[p2l1828t2618r2147b2680],

1	286	CD	NUMBER	286	num	3	SENT_51	[p2l330t2773r378b2797],
2	M.	NN	NUMBER	m.	nn	3	SENT_51	[p2l919t2774r952b2797],
3	Ehrhardt	NNP	PERSON	Ehrhardt	_	0	SENT_51	[p2l967t2773r1088b2797],
4	et	FW	O	et	nn	5	SENT_51	[p2l1099t2778r1123b2797],
5	al.	FW	O	al.	dep	3	SENT_51	[p2l1134t2773r1164b2797],
6	/	:	O	/	punct	3	SENT_51	[p2l1171t2773r1186b2797],
7	Biochemical	JJ	O	biochemical	amod	8	SENT_51	[p2l1188t2773r1354b2797],
8	Pharmacology	NN	O	pharmacology	dep	3	SENT_51	[p2l1365t2773r1560b2803],
9	67	CD	NUMBER	67	number	10	SENT_51	[p2l1572t2773r1606b2797],
10	(	CD	NUMBER	(	num	11	SENT_51	[p2l1617t2773r1703b2802],
11	2004	CD	DATE	2004	dep	8	SENT_51	[p2l1617t2773r1703b2802],
12	)	CD	NUMBER	)	number	13	SENT_51	[p2l1617t2773r1703b2802],
13	285-292	CD	NUMBER	285-292	num	11	SENT_51	[p2l1715t2773r1830b2797],

1	isoform	NN	O	isoform	_	0	SENT_52	[p2l8t2941r310b3017],
2	,	,	O	,	_	0	SENT_52	[p2l8t2941r310b3017],
3	ﬂuvastatin	NN	O	ﬂuvastatin	appos	1	SENT_52	[p2l378t2941r754b3005],
4	by	IN	O	by	_	0	SENT_52	[p2l817t2941r906b3024],
5	CYP2C9	NN	O	cyp2c9	prep_by	3	SENT_52	[p2l971t2941r1317b3017],
6	,	,	O	,	_	0	SENT_52	[p2l971t2941r1317b3017],
7	and	CC	O	and	_	0	SENT_52	[p2l1386t2941r1515b3005],
8	cerivastatin	NN	O	cerivastatin	appos	1	SENT_52	[p2l1578t2941r1996b3005],
9	by	IN	O	by	_	0	SENT_52	[p2l2057t2941r2147b3024],
10	CYP3A4	NN	O	cyp3a4	prep_by	8	SENT_52	[p2l9t3049r339b3113],
11	and	CC	O	and	_	0	SENT_52	[p2l363t3048r491b3112],
12	CYP2C8	NN	O	cyp2c8	conj_and	10	SENT_52	[p2l511t3049r835b3113],
13	[	CD	NUMBER	[	number	14	SENT_52	[p2l865t3048r1050b3126],
14	4,5	CD	NUMBER	4,5	num	15	SENT_52	[p2l865t3048r1050b3126],
15	]	NN	O	]	dep	8	SENT_52	[p2l865t3048r1050b3126],
16	.	.	O	.	_	0	SENT_52	[p2l865t3048r1050b3126],

1	Also	RB	O	also	advmod	9	SENT_53	[p2l1075t3048r1243b3112],
2	gemﬁbrozil	NN	O	gemﬁbrozil	nsubj	9	SENT_53	[p2l1266t3048r1705b3131],
3	,	,	O	,	_	0	SENT_53	[p2l1266t3048r1705b3131],
4	fenoﬁbrate	NN	O	fenoﬁbrate	nsubj	9	SENT_53	[p2l1729t3048r2143b3124],
5	,	,	O	,	_	0	SENT_53	[p2l1729t3048r2143b3124],
6	and	CC	O	and	_	0	SENT_53	[p2l9t3158r139b3221],
7	bezaﬁbrate	NN	O	bezaﬁbrate	conj_and	2	SENT_53	[p2l181t3157r582b3221],
8	are	VBP	O	be	dep	2	SENT_53	[p2l628t3178r735b3221],
9	metabolizes	VBZ	O	metabolize	_	0	SENT_53	[p2l780t3158r1216b3221],
10	via	IN	O	via	_	0	SENT_53	[p2l1262t3158r1372b3221],
11	CYP3A4	NN	O	cyp3a4	prep_via	9	SENT_53	[p2l1416t3158r1747b3221],
12	[	CD	NUMBER	[	number	13	SENT_53	[p2l1798t3157r1914b3234],
13	6	CD	NUMBER	6	num	14	SENT_53	[p2l1798t3157r1914b3234],
14	]	NN	O	]	dep	9	SENT_53	[p2l1798t3157r1914b3234],
15	.	.	O	.	_	0	SENT_53	[p2l1798t3157r1914b3234],

1	Even	RB	O	even	advmod	4	SENT_54	[p2l1961t3159r2149b3221],
2	though	IN	O	though	dep	4	SENT_54	[p2l8t3265r261b3348],
3	gemﬁbrozil	NN	O	gemﬁbrozil	nsubj	4	SENT_54	[p2l311t3265r730b3348],
4	elevates	VBZ	O	elevate	advcl	15	SENT_54	[p2l782t3265r1069b3329],
5	the	DT	O	the	det	6	SENT_54	[p2l1121t3265r1230b3329],
6	risk	NN	O	risk	dobj	4	SENT_54	[p2l1280t3265r1418b3329],
7	to	TO	O	to	aux	8	SENT_54	[p2l1466t3275r1534b3329],
8	develop	VB	O	develop	infmod	6	SENT_54	[p2l1585t3265r1868b3348],
9	statininduced	JJ	O	statininduced	amod	11	SENT_54	[p2l1923t3265r2144b3329, p2l7t3375r297b3438],
10	muscle	NN	O	muscle	nn	11	SENT_54	[p2l333t3375r590b3438],
11	disorders	NNS	O	disorder	dobj	8	SENT_54	[p2l628t3375r959b3438],
12	it	PRP	O	it	nsubj	15	SENT_54	[p2l997t3375r1047b3438],
13	does	VBZ	O	do	aux	15	SENT_54	[p2l1083t3375r1246b3438],
14	not	RB	O	not	neg	15	SENT_54	[p2l1284t3384r1400b3438],
15	inhibit	VB	O	inhibit	_	0	SENT_54	[p2l1435t3375r1674b3438],
16	CYP3A4	NN	O	cyp3a4	dobj	15	SENT_54	[p2l1711t3375r2041b3438],
17	in	IN	O	in	_	0	SENT_54	[p2l2078t3375r2148b3437],
18	human	JJ	O	human	amod	20	SENT_54	[p2l7t3484r255b3548],
19	liver	NN	O	liver	nn	20	SENT_54	[p2l278t3484r443b3548],
20	microsomes	NNS	O	microsome	prep_in	15	SENT_54	[p2l462t3484r902b3548],
21	suggesting	VBG	O	suggest	partmod	20	SENT_54	[p2l928t3484r1313b3567],
22	a	DT	O	a	det	24	SENT_54	[p2l1339t3504r1376b3548],
23	different	JJ	O	different	amod	24	SENT_54	[p2l1398t3484r1710b3548],
24	mechanism	NN	O	mechanism	dobj	21	SENT_54	[p2l1731t3484r2148b3548],
25	of	IN	O	of	_	0	SENT_54	[p2l9t3591r87b3655],
26	drug	NN	O	drug	nn	28	SENT_54	[p2l109t3591r272b3674],
27	interaction	NN	O	interaction	nn	28	SENT_54	[p2l300t3591r691b3655],
28	[	NN	O	[	prep_of	24	SENT_54	[p2l724t3593r840b3669],
29	7	CD	NUMBER	7	num	30	SENT_54	[p2l724t3593r840b3669],
30	]	NN	O	]	dep	28	SENT_54	[p2l724t3593r840b3669],
31	.	.	O	.	_	0	SENT_54	[p2l724t3593r840b3669],

1	Another	DT	O	another	det	4	SENT_55	[p2l871t3591r1171b3655],
2	possible	JJ	O	possible	amod	4	SENT_55	[p2l1194t3591r1492b3674],
3	interaction	NN	O	interaction	nn	4	SENT_55	[p2l1520t3591r1911b3655],
4	site	NN	O	site	nsubj	6	SENT_55	[p2l1941t3591r2062b3655],
5	is	VBZ	O	be	cop	6	SENT_55	[p2l2089t3591r2146b3655],
6	Pgp	NNP	O	Pgp	_	0	SENT_55	[p2l8t3704r167b3785],
7	,	,	O	,	_	0	SENT_55	[p2l8t3704r167b3785],
8	a	DT	O	a	det	9	SENT_55	[p2l197t3722r234b3766],
9	member	NN	O	member	appos	6	SENT_55	[p2l259t3702r560b3766],
10	of	IN	O	of	_	0	SENT_55	[p2l583t3702r662b3766],
11	the	DT	O	the	det	12	SENT_55	[p2l681t3702r790b3766],
12	superfamily	NN	O	superfamily	prep_of	9	SENT_55	[p2l819t3702r1251b3785],
13	of	IN	O	of	_	0	SENT_55	[p2l1278t3702r1356b3766],
14	ATP	NN	O	atp	nn	16	SENT_55	[p2l1375t3703r1536b3765],
15	binding	NN	O	binding	nn	16	SENT_55	[p2l1559t3702r1838b3785],
16	cassette	NN	O	cassette	prep_of	12	SENT_55	[p2l1865t3711r2146b3766],

1	(	NN	O	(	_	0	SENT_56	[p3l10t20r252b99],
2	ABC	NNP	ORGANIZATION	ABC	dep	1	SENT_56	[p3l10t20r252b99],
3	)	CD	NUMBER	)	num	4	SENT_56	[p3l10t20r252b99],
4	transporters	NNS	O	transporter	dep	2	SENT_56	[p3l314t29r763b102],
5	.	.	O	.	_	0	SENT_56	[p3l314t29r763b102],

1	This	DT	O	this	det	3	SENT_57	[p3l828t20r987b84],
2	efﬂux	NN	O	efﬂux	nn	3	SENT_57	[p3l1050t19r1259b84],
3	transporter	NN	O	transporter	nsubj	24	SENT_57	[p3l1320t29r1717b102],
4	is	VBZ	O	be	auxpass	6	SENT_57	[p3l1776t20r1832b84],
5	mainly	RB	O	mainly	advmod	6	SENT_57	[p3l1895t20r2147b102],
6	expressed	VBN	O	express	_	0	SENT_57	[p3l8t129r366b211],
7	at	IN	O	at	_	0	SENT_57	[p3l398t138r462b193],
8	the	DT	O	the	det	12	SENT_57	[p3l491t129r600b193],
9	blood	NN	O	blood	nn	12	SENT_57	[p3l631t129r1073b193],
10	—	NN	O	—	nn	12	SENT_57	[p3l631t129r1073b193],
11	brain	NN	O	brain	nn	12	SENT_57	[p3l631t129r1073b193],
12	barrier	NN	O	barrier	prep_at	6	SENT_57	[p3l1102t129r1348b193],
13	[	CD	NUMBER	[	number	14	SENT_57	[p3l1383t129r1474b206],
14	8	CD	NUMBER	8	num	15	SENT_57	[p3l1383t129r1474b206],
15	]	NN	O	]	dep	12	SENT_57	[p3l1383t129r1474b206],
16	and	CC	O	and	_	0	SENT_57	[p3l1513t129r1642b193],
17	the	DT	O	the	det	19	SENT_57	[p3l1671t129r1780b193],
18	intestinal	JJ	O	intestinal	amod	19	SENT_57	[p3l1812t129r2147b193],
19	barrier	NN	O	barrier	prep_at	6	SENT_57	[p3l6t237r252b301],
20	[	CD	NUMBER	[	number	21	SENT_57	[p3l292t238r384b315],
21	9	CD	NUMBER	9	num	22	SENT_57	[p3l292t238r384b315],
22	]	NN	O	]	dep	19	SENT_57	[p3l292t238r384b315],
23	and	CC	O	and	_	0	SENT_57	[p3l428t237r557b301],
24	participates	VBZ	O	participate	conj_and	6	SENT_57	[p3l591t237r1012b320],
25	in	IN	O	in	mark	33	SENT_57	[p3l1050t237r1118b300],
26	the	DT	O	the	det	30	SENT_57	[p3l1153t237r1262b301],
27	renal	JJ	O	renal	amod	30	SENT_57	[p3l1298t237r1480b301],
28	and	CC	O	and	_	0	SENT_57	[p3l1518t237r1647b301],
29	biliary	JJ	O	biliary	conj_and	27	SENT_57	[p3l1681t237r1919b320],
30	elimination	NN	O	elimination	nsubj	33	SENT_57	[p3l1956t237r2144b301, p3l8t348r261b412],
31	of	IN	O	of	_	0	SENT_57	[p3l313t348r392b412],
32	drugs	NNS	O	drug	prep_of	30	SENT_57	[p3l438t348r635b431],
33	[	VBP	O	[	advcl	24	SENT_57	[p3l695t348r971b425],
34	10,11	CD	NUMBER	10,11	number	35	SENT_57	[p3l695t348r971b425],
35	]	CD	NUMBER	]	dobj	33	SENT_57	[p3l695t348r971b425],
36	.	.	O	.	_	0	SENT_57	[p3l695t348r971b425],

1	It	PRP	O	it	nsubj	2	SENT_58	[p3l1027t349r1082b412],
2	prevents	VBZ	O	prevent	_	0	SENT_58	[p3l1130t357r1435b431],
3	intracellular	JJ	O	intracellular	amod	5	SENT_58	[p3l1488t348r1933b412],
4	drug	NN	O	drug	nn	5	SENT_58	[p3l1983t348r2146b431],
5	accumulation	NN	O	accumulation	dobj	2	SENT_58	[p3l9t457r502b521],
6	by	IN	O	by	_	0	SENT_58	[p3l536t457r625b540],
7	actively	RB	O	actively	advmod	8	SENT_58	[p3l664t457r948b540],
8	removing	VBG	O	remove	prepc_by	2	SENT_58	[p3l984t457r1333b540],
9	compounds	NNS	O	compound	dobj	8	SENT_58	[p3l1370t457r1788b540],
10	from	IN	O	from	_	0	SENT_58	[p3l1826t457r2002b521],
11	the	DT	O	the	det	12	SENT_58	[p3l2038t457r2147b521],
12	cell	NN	O	cell	prep_from	8	SENT_58	[p3l8t564r157b628],
13	.	.	O	.	_	0	SENT_58	[p3l8t564r157b628],

1	Therefore	RB	O	therefore	advmod	4	SENT_59	[p3l183t564r563b640],
2	,	,	O	,	_	0	SENT_59	[p3l183t564r563b640],
3	Pgp	NNP	ORGANIZATION	Pgp	nsubj	4	SENT_59	[p3l588t566r726b647],
4	plays	VBZ	O	play	_	0	SENT_59	[p3l748t564r938b647],
5	a	DT	O	a	det	6	SENT_59	[p3l964t585r1002b628],
6	role	NN	O	role	dobj	4	SENT_59	[p3l1021t564r1162b628],
7	in	IN	O	in	_	0	SENT_59	[p3l1184t564r1253b628],
8	absorption	NN	O	absorption	prep_in	4	SENT_59	[p3l1277t564r1679b647],
9	,	,	O	,	_	0	SENT_59	[p3l1277t564r1679b647],
10	distribution	NN	O	distribution	prep_in	4	SENT_59	[p3l1706t564r2144b640],
11	,	,	O	,	_	0	SENT_59	[p3l1706t564r2144b640],
12	and	CC	O	and	_	0	SENT_59	[p3l9t675r139b739],
13	excretion	NN	O	excretion	prep_in	4	SENT_59	[p3l176t675r515b739],
14	of	IN	O	of	_	0	SENT_59	[p3l553t675r632b739],
15	certain	JJ	O	certain	amod	16	SENT_59	[p3l664t675r912b739],
16	drugs	NNS	O	drug	prep_of	8	SENT_59	[p3l950t675r1148b758],
17	and	CC	O	and	_	0	SENT_59	[p3l1189t675r1318b739],
18	may	MD	O	may	aux	22	SENT_59	[p3l1355t695r1510b758],
19	be	VB	O	be	cop	22	SENT_59	[p3l1547t675r1632b739],
20	an	DT	O	a	det	22	SENT_59	[p3l1672t695r1755b739],
21	important	JJ	O	important	amod	22	SENT_59	[p3l1792t675r2149b758],
22	site	NN	O	site	conj_and	4	SENT_59	[p3l11t783r133b847],
23	of	IN	O	of	_	0	SENT_59	[p3l184t782r263b847],
24	drug	NN	O	drug	nn	27	SENT_59	[p3l309t783r685b865],
25	—	CD	NUMBER	—	num	27	SENT_59	[p3l309t783r685b865],
26	drug	NN	O	drug	nn	27	SENT_59	[p3l309t783r685b865],
27	interactions	NNS	O	interaction	prep_of	22	SENT_59	[p3l737t782r1182b847],
28	.	.	O	.	_	0	SENT_59	[p3l737t782r1182b847],

1	Indeed	RB	O	indeed	advmod	23	SENT_60	[p3l1237t783r1504b858],
2	,	,	O	,	_	0	SENT_60	[p3l1237t783r1504b858],
3	in	FW	O	in	nn	4	SENT_60	[p3l1561t785r1626b847],
4	vitro	FW	O	vitro	advmod	8	SENT_60	[p3l1675t785r1840b847],
5	several	JJ	O	several	amod	6	SENT_60	[p3l1896t782r2147b847],
6	statins	NNS	O	statin	nsubj	8	SENT_60	[p3l11t892r238b956],
7	are	VBP	O	be	cop	8	SENT_60	[p3l280t912r387b956],
8	inhibitors	NNS	O	inhibitor	dep	23	SENT_60	[p3l425t891r773b956],
9	of	IN	O	of	_	0	SENT_60	[p3l813t891r892b956],
10	Pgp	NNP	O	Pgp	prep_of	8	SENT_60	[p3l923t893r1062b974],
11	[	CD	NUMBER	[	num	10	SENT_60	[p3l1107t891r1408b969],
12	12	CD	NUMBER	12	number	13	SENT_60	[p3l1107t891r1408b969],
13	—	CD	NUMBER	—	nsubj	23	SENT_60	[p3l1107t891r1408b969],
14	15	CD	NUMBER	15	num	15	SENT_60	[p3l1107t891r1408b969],
15	]	NN	O	]	dep	13	SENT_60	[p3l1107t891r1408b969],
16	,	,	O	,	_	0	SENT_60	[p3l1107t891r1408b969],
17	and	CC	O	and	_	0	SENT_60	[p3l1450t892r1580b956],
18	many	JJ	O	many	conj_and	13	SENT_60	[p3l1616t912r1817b974],
19	of	IN	O	of	_	0	SENT_60	[p3l1856t891r1935b956],
20	them	PRP	O	they	prep_of	18	SENT_60	[p3l1966t892r2148b956],
21	are	VBP	O	be	cop	23	SENT_60	[p3l9t1020r117b1064],
22	also	RB	O	also	advmod	23	SENT_60	[p3l153t1000r295b1064],
23	substrates	NNS	O	substrate	_	0	SENT_60	[p3l334t1000r688b1064],
24	of	IN	O	of	_	0	SENT_60	[p3l724t1000r803b1064],
25	the	DT	O	the	det	30	SENT_60	[p3l831t1000r940b1064],
26	efﬂux	NN	O	efﬂux	nn	30	SENT_60	[p3l975t1000r1185b1064],
27	pump	NN	O	pump	nn	30	SENT_60	[p3l1218t1020r1424b1083],
28	[	CD	NUMBER	[	number	29	SENT_60	[p3l1466t1000r1718b1078],
29	13,16	CD	NUMBER	13,16	num	30	SENT_60	[p3l1466t1000r1718b1078],
30	]	NN	O	]	prep_of	23	SENT_60	[p3l1466t1000r1718b1078],
31	suggesting	VBG	O	suggest	partmod	30	SENT_60	[p3l1761t1000r2146b1083],
32	that	IN	O	that	complm	37	SENT_60	[p3l7t1111r144b1175],
33	drug	NN	O	drug	nn	34	SENT_60	[p3l193t1111r356b1194],
34	interactions	NNS	O	interaction	nsubj	37	SENT_60	[p3l405t1111r830b1175],
35	might	MD	O	might	aux	37	SENT_60	[p3l880t1111r1093b1194],
36	also	RB	O	also	advmod	37	SENT_60	[p3l1141t1111r1284b1175],
37	occur	VB	O	occur	ccomp	31	SENT_60	[p3l1334t1131r1536b1175],
38	at	IN	O	at	_	0	SENT_60	[p3l1584t1120r1648b1175],
39	the	DT	O	the	det	40	SENT_60	[p3l1694t1111r1803b1175],
40	level	NN	O	level	prep_at	37	SENT_60	[p3l1852t1111r2025b1175],
41	of	IN	O	of	_	0	SENT_60	[p3l2075t1111r2154b1175],
42	Pgp	NNP	O	Pgp	prep_of	40	SENT_60	[p3l8t1220r166b1301],
43	.	.	O	.	_	0	SENT_60	[p3l8t1220r166b1301],

1	Thus	RB	O	thus	advmod	2	SENT_61	[p3l216t1218r395b1282],
2	far	RB	O	far	advmod	13	SENT_61	[p3l443t1218r559b1294],
3	,	,	O	,	_	0	SENT_61	[p3l443t1218r559b1294],
4	the	DT	O	the	det	5	SENT_61	[p3l608t1218r717b1282],
5	interaction	NN	O	interaction	nsubjpass	13	SENT_61	[p3l765t1218r1156b1282],
6	of	IN	O	of	_	0	SENT_61	[p3l1203t1218r1282b1282],
7	ﬁbrates	NNS	O	ﬁbrates	prep_of	5	SENT_61	[p3l1323t1218r1588b1282],
8	with	IN	O	with	_	0	SENT_61	[p3l1636t1218r1797b1283],
9	Pgp	NNP	ORGANIZATION	Pgp	prep_with	7	SENT_61	[p3l1842t1220r1981b1301],
10	has	VBZ	O	have	aux	13	SENT_61	[p3l2027t1218r2146b1282],
11	not	RB	O	not	neg	13	SENT_61	[p3l8t1337r123b1392],
12	been	VBN	O	be	auxpass	13	SENT_61	[p3l154t1327r327b1392],
13	evaluated	VBN	O	evaluate	_	0	SENT_61	[p3l361t1327r725b1392],
14	.	.	O	.	_	0	SENT_61	[p3l361t1327r725b1392],

1	The	DT	O	the	det	2	SENT_62	[p3l99t1438r239b1502],
2	aim	NN	O	aim	nsubj	7	SENT_62	[p3l287t1438r421b1502],
3	of	IN	O	of	_	0	SENT_62	[p3l467t1438r546b1502],
4	the	DT	O	the	det	6	SENT_62	[p3l584t1438r693b1502],
5	present	JJ	DATE	present	amod	6	SENT_62	[p3l738t1448r1004b1521],
6	study	NN	O	study	prep_of	2	SENT_62	[p3l1051t1438r1242b1521],
7	was	VBD	O	be	_	0	SENT_62	[p3l1289t1458r1426b1502],
8	to	TO	O	to	aux	9	SENT_62	[p3l1473t1448r1540b1502],
9	assess	VB	O	assess	ccomp	7	SENT_62	[p3l1589t1458r1806b1502],
10	the	DT	O	the	det	13	SENT_62	[p3l1853t1438r1962b1502],
11	Pgp	NNP	O	Pgp	nn	13	SENT_62	[p3l2008t1440r2146b1521],
12	modulating	VBG	O	modulate	amod	13	SENT_62	[p3l8t1545r423b1628],
13	effect	NN	O	effect	dobj	9	SENT_62	[p3l464t1545r669b1610],
14	of	IN	O	of	_	0	SENT_62	[p3l707t1545r786b1610],
15	ﬁbrates	NNS	O	ﬁbrates	prep_of	13	SENT_62	[p3l820t1545r1083b1610],
16	and	CC	O	and	_	0	SENT_62	[p3l1126t1546r1255b1610],
17	to	TO	O	to	aux	18	SENT_62	[p3l1292t1555r1360b1610],
18	compare	VB	O	compare	conj_and	9	SENT_62	[p3l1400t1566r1712b1628],
19	it	PRP	O	it	dobj	18	SENT_62	[p3l1752t1546r1802b1610],
20	with	IN	O	with	_	0	SENT_62	[p3l1839t1546r1999b1610],
21	the	DT	O	the	det	25	SENT_62	[p3l2038t1546r2147b1610],
22	known	JJ	O	known	amod	25	SENT_62	[p3l7t1654r252b1719],
23	Pgp	NNP	O	Pgp	nn	25	SENT_62	[p3l282t1656r420b1737],
24	inhibitor	NN	O	inhibitor	nn	25	SENT_62	[p3l451t1654r767b1718],
25	effects	NNS	O	effect	prep_with	18	SENT_62	[p3l796t1654r1033b1718],
26	of	IN	O	of	_	0	SENT_62	[p3l1066t1654r1145b1718],
27	simvastatin	NN	O	simvastatin	prep_of	25	SENT_62	[p3l1172t1654r1583b1718],
28	and	CC	O	and	_	0	SENT_62	[p3l1614t1654r1743b1718],
29	lovastatin	NN	O	lovastatin	conj_and	27	SENT_62	[p3l1772t1654r2142b1718],
30	.	.	O	.	_	0	SENT_62	[p3l1772t1654r2142b1718],

1	Therefore	RB	O	therefore	advmod	4	SENT_63	[p3l8t1763r387b1839],
2	,	,	O	,	_	0	SENT_63	[p3l8t1763r387b1839],
3	we	PRP	O	we	nsubj	4	SENT_63	[p3l426t1783r529b1827],
4	investigated	VBD	O	investigate	_	0	SENT_63	[p3l565t1763r1004b1846],
5	the	DT	O	the	det	8	SENT_63	[p3l1037t1763r1147b1827],
6	Pgp	NNP	O	Pgp	nn	8	SENT_63	[p3l1182t1765r1321b1846],
7	inhibitory	JJ	O	inhibitory	amod	8	SENT_63	[p3l1357t1763r1716b1846],
8	potency	NN	O	potency	dobj	4	SENT_63	[p3l1750t1773r2039b1846],
9	of	IN	O	of	_	0	SENT_63	[p3l2075t1763r2154b1827],
10	lipid	NN	O	lipid	nn	13	SENT_63	[p3l8t1874r175b1957],
11	lowering	NN	O	lowering	nn	13	SENT_63	[p3l226t1874r547b1957],
12	ﬁbrate	NN	O	ﬁbrate	nn	13	SENT_63	[p3l600t1874r830b1938],
13	derivatives	NNS	O	derivative	prep_of	8	SENT_63	[p3l883t1874r1276b1938],
14	in	FW	O	in	nn	15	SENT_63	[p3l1331t1876r1396b1938],
15	vitro	FW	O	vitro	advmod	4	SENT_63	[p3l1446t1876r1611b1938],
16	in	IN	O	in	_	0	SENT_63	[p3l1664t1874r1733b1937],
17	a	DT	O	a	det	22	SENT_63	[p3l1786t1894r1824b1938],
18	porcine	NN	O	porcine	nn	22	SENT_63	[p3l1873t1874r2146b1957],
19	kidney	NN	O	kidney	nn	22	SENT_63	[p3l7t1981r254b2064],
20	epithelial	JJ	O	epithelial	amod	22	SENT_63	[p3l289t1981r627b2064],
21	cell	NN	O	cell	nn	22	SENT_63	[p3l663t1981r792b2045],
22	line	NN	O	line	prep_in	4	SENT_63	[p3l826t1981r961b2045],
23	overexpressing	VBG	O	overexpress	partmod	22	SENT_63	[p3l997t1981r1544b2064],
24	human	JJ	O	human	amod	25	SENT_63	[p3l1579t1981r1826b2045],
25	Pgp	NNP	O	Pgp	dobj	23	SENT_63	[p3l1860t1983r1998b2064],
26	(	CD	NUMBER	(	num	27	SENT_63	[p3l2036t1982r2145b2060, p3l7t2091r287b2169],
27	LMDR1	NN	O	lmdr1	dep	25	SENT_63	[p3l2036t1982r2145b2060, p3l7t2091r287b2169],
28	)	CD	NUMBER	)	number	29	SENT_63	[p3l2036t1982r2145b2060, p3l7t2091r287b2169],
29	[	CD	NUMBER	[	dep	25	SENT_63	[p3l351t2091r488b2168],
30	17	CD	NUMBER	17	num	31	SENT_63	[p3l351t2091r488b2168],
31	]	NN	O	]	dep	29	SENT_63	[p3l351t2091r488b2168],
32	and	CC	O	and	_	0	SENT_63	[p3l551t2090r680b2154],
33	the	DT	O	the	det	37	SENT_63	[p3l734t2090r844b2154],
34	corresponding	JJ	O	corresponding	amod	37	SENT_63	[p3l900t2090r1421b2173],
35	parental	JJ	O	parental	amod	37	SENT_63	[p3l1475t2090r1770b2173],
36	cell	NN	O	cell	nn	37	SENT_63	[p3l1827t2090r1956b2154],
37	line	NN	O	line	conj_and	25	SENT_63	[p3l2012t2090r2147b2154],
38	(	NN	O	(	nn	39	SENT_63	[p3l10t2201r430b2280],
39	LLC	NN	O	llc	dep	37	SENT_63	[p3l10t2201r430b2280],
40	.	.	O	.	_	0	SENT_63	[p3l10t2201r430b2280],

1	—	NN	O	—	_	0	SENT_64	[p3l10t2201r430b2280],
2	.	.	O	.	_	0	SENT_64	[p3l10t2201r430b2280],

1	PK1	NN	O	pk1	_	0	SENT_65	[p3l10t2201r430b2280],
2	)	CD	NUMBER	)	num	1	SENT_65	[p3l10t2201r430b2280],
3	as	IN	O	as	_	0	SENT_65	[p3l493t2221r562b2265],
4	a	DT	O	a	det	6	SENT_65	[p3l623t2221r661b2265],
5	negative	JJ	O	negative	amod	6	SENT_65	[p3l717t2201r1023b2284],
6	control	NN	O	control	prep_as	1	SENT_65	[p3l1082t2201r1338b2265],
7	without	IN	O	without	_	0	SENT_65	[p3l1397t2201r1676b2265],
8	the	DT	O	the	det	11	SENT_65	[p3l1732t2201r1841b2265],
9	human	JJ	O	human	amod	11	SENT_65	[p3l1899t2201r2147b2265],
10	ABC	NNP	ORGANIZATION	ABC	nn	11	SENT_65	[p3l7t2309r191b2373],
11	transporter	NN	O	transporter	prep_without	1	SENT_65	[p3l232t2318r641b2391],
12	.	.	O	.	_	0	SENT_65	[p3l232t2318r641b2391],

1	In	IN	O	in	_	0	SENT_66	[p3l684t2310r758b2372],
2	particular	JJ	O	particular	prep_in	4	SENT_66	[p3l796t2309r1148b2391],
3	we	PRP	O	we	nsubj	4	SENT_66	[p3l1186t2329r1289b2373],
4	studied	VBD	O	study	_	0	SENT_66	[p3l1332t2308r1592b2373],
5	the	DT	O	the	det	6	SENT_66	[p3l1630t2309r1739b2373],
6	lipid	NN	O	lipid	dobj	4	SENT_66	[p3l1780t2309r1946b2391],
7	lowering	VBG	O	lower	partmod	6	SENT_66	[p3l1984t2309r2145b2373, p3l8t2419r192b2502],
8	active	JJ	O	active	amod	10	SENT_66	[p3l245t2419r457b2483],
9	parent	NN	O	parent	nn	10	SENT_66	[p3l505t2429r735b2502],
10	compounds	NNS	O	compound	dobj	7	SENT_66	[p3l783t2419r1201b2502],
11	gemﬁbrozil	NN	O	gemﬁbrozil	nn	14	SENT_66	[p3l1253t2419r1672b2502],
12	and	CC	O	and	_	0	SENT_66	[p3l1723t2419r1852b2483],
13	bezaﬁ	NN	O	bezaﬁ	conj_and	11	SENT_66	[p3l1899t2419r2144b2483],
14	brate	NN	O	brate	dep	10	SENT_66	[p3l6t2526r209b2602],
15	,	,	O	,	_	0	SENT_66	[p3l6t2526r209b2602],
16	and	CC	O	and	_	0	SENT_66	[p3l248t2526r376b2590],
17	the	DT	O	the	det	20	SENT_66	[p3l409t2526r518b2590],
18	inactive	JJ	O	inactive	amod	20	SENT_66	[p3l552t2526r838b2591],
19	prodrug	NN	O	prodrug	nn	20	SENT_66	[p3l871t2526r1160b2609],
20	fenoﬁbrate	NN	O	fenoﬁbrate	conj_and	10	SENT_66	[p3l1194t2526r1588b2590],
21	with	IN	O	with	_	0	SENT_66	[p3l1621t2526r1781b2590],
22	its	PRP$	O	its	poss	26	SENT_66	[p3l1815t2526r1897b2590],
23	active	JJ	O	active	amod	26	SENT_66	[p3l1934t2526r2148b2590],
24	metabolite	NN	O	metabolite	nn	26	SENT_66	[p3l8t2637r393b2701],
25	fenoﬁbric	JJ	O	fenoﬁbric	amod	26	SENT_66	[p3l444t2637r796b2701],
26	acid	NN	O	acid	prep_with	20	SENT_66	[p3l850t2637r1017b2701],
27	.	.	O	.	_	0	SENT_66	[p3l850t2637r1017b2701],

1	For	IN	O	for	_	0	SENT_67	[p3l1070t2638r1197b2701],
2	this	DT	O	this	det	3	SENT_67	[p3l1244t2637r1372b2701],
3	assay	NN	O	assay	prep_for	5	SENT_67	[p3l1425t2657r1618b2720],
4	we	PRP	O	we	nsubj	5	SENT_67	[p3l1669t2657r1772b2701],
5	used	VBD	O	use	_	0	SENT_67	[p3l1822t2637r1989b2701],
6	the	DT	O	the	det	8	SENT_67	[p3l2038t2637r2147b2701],
7	ﬂuorogenic	JJ	O	ﬂuorogenic	amod	8	SENT_67	[p3l9t2744r421b2827],
8	calcein	NN	O	calcein	dobj	5	SENT_67	[p3l466t2744r901b2808],
9	.	.	O	.	_	0	SENT_67	[p3l466t2744r901b2808],

1	—	NN	O	—	_	0	SENT_68	[p3l466t2744r901b2808],
2	.	.	O	.	_	0	SENT_68	[p3l466t2744r901b2808],

1	AM	NNP	O	AM	_	0	SENT_69	[p3l466t2744r901b2808],
2	as	IN	O	as	_	0	SENT_69	[p3l945t2764r1015b2808],
3	Pgp	NNP	O	Pgp	nn	4	SENT_69	[p3l1059t2746r1197b2827],
4	substrate	NN	O	substrate	prep_as	1	SENT_69	[p3l1243t2744r1563b2808],
5	and	CC	O	and	_	0	SENT_69	[p3l1608t2744r1737b2808],
6	conﬁrmed	VBD	O	conﬁrmed	conj_and	1	SENT_69	[p3l1779t2744r2148b2808],
7	the	DT	O	the	det	8	SENT_69	[p3l7t2855r117b2919],
8	results	NNS	O	result	dobj	6	SENT_69	[p3l170t2855r406b2919],
9	using	VBG	O	use	xcomp	6	SENT_69	[p3l461t2855r656b2938],
10	a	DT	O	a	det	18	SENT_69	[p3l713t2875r750b2919],
11	different	JJ	O	different	amod	18	SENT_69	[p3l804t2855r1117b2919],
12	technique	NN	O	technique	npadvmod	14	SENT_69	[p3l1169t2855r1524b2938],
13	(	CD	NUMBER	(	num	12	SENT_69	[p3l1581t2855r1922b2934],
14	confocal	JJ	O	confocal	amod	18	SENT_69	[p3l1581t2855r1922b2934],
15	laser	NN	O	laser	nn	18	SENT_69	[p3l1976t2855r2149b2919],
16	scanning	NN	O	scanning	nn	18	SENT_69	[p3l11t2964r331b3047],
17	microscopy	NN	O	microscopy	nn	18	SENT_69	[p3l366t2964r820b3047],
18	)	NN	O	)	dobj	9	SENT_69	[p3l366t2964r820b3047],
19	with	IN	O	with	_	0	SENT_69	[p3l857t2964r1017b3028],
20	an	DT	O	a	det	23	SENT_69	[p3l1053t2984r1135b3028],
21	independent	JJ	O	independent	amod	23	SENT_69	[p3l1169t2964r1617b3047],
22	Pgp	NNP	O	Pgp	nn	23	SENT_69	[p3l1650t2966r1789b3047],
23	substrate	NN	O	substrate	prep_with	18	SENT_69	[p3l1827t2964r2146b3028],
24	(	CD	NUMBER	(	num	26	SENT_69	[p3l10t3071r737b3154],
25	bodipy-verapamil	NN	O	bodipy-verapamil	nn	26	SENT_69	[p3l10t3071r737b3154],
26	)	NN	O	)	dep	23	SENT_69	[p3l10t3071r737b3154],
27	.	.	O	.	_	0	SENT_69	[p3l10t3071r737b3154],

1	Furthermore	RB	O	furthermore	advmod	15	SENT_70	[p3l772t3071r1248b3147],
2	,	,	O	,	_	0	SENT_70	[p3l772t3071r1248b3147],
3	intracellular	JJ	O	intracellular	amod	5	SENT_70	[p3l1282t3071r1727b3135],
4	drug	NN	O	drug	nn	5	SENT_70	[p3l1756t3071r1919b3154],
5	accumulation	NN	O	accumulation	nsubjpass	15	SENT_70	[p3l1953t3092r2145b3135, p3l8t3181r333b3245],
6	of	IN	O	of	_	0	SENT_70	[p3l368t3181r447b3245],
7	each	DT	O	each	det	8	SENT_70	[p3l476t3181r642b3245],
8	ﬁbrate	NN	O	ﬁbrate	prep_of	5	SENT_70	[p3l677t3181r907b3245],
9	in	IN	O	in	_	0	SENT_70	[p3l942t3181r1012b3244],
10	L-MDR1	NN	O	l-mdr1	nn	13	SENT_70	[p3l1045t3182r1376b3244],
11	and	CC	O	and	_	0	SENT_70	[p3l1421t3181r1549b3245],
12	LLC-PK1	NN	O	llc-pk1	conj_and	10	SENT_70	[p3l1582t3181r1939b3245],
13	cells	NNS	O	cell	prep_in	8	SENT_70	[p3l1982t3181r2146b3245],
14	was	VBD	O	be	auxpass	15	SENT_70	[p3l8t3309r145b3353],
15	measured	VBN	O	measure	_	0	SENT_70	[p3l186t3289r536b3353],
16	directly	RB	O	directly	advmod	15	SENT_70	[p3l575t3289r852b3372],
17	by	IN	O	by	_	0	SENT_70	[p3l890t3289r980b3372],
18	LC/MS/MS	NN	O	lc/ms/ms	agent	15	SENT_70	[p3l1019t3290r1444b3354],
19	to	TO	O	to	aux	20	SENT_70	[p3l1487t3299r1555b3353],
20	assess	VB	O	assess	xcomp	15	SENT_70	[p3l1597t3309r1814b3353],
21	whether	IN	O	whether	complm	26	SENT_70	[p3l1855t3289r2149b3354],
22	test	NN	O	test	nn	23	SENT_70	[p3l7t3408r135b3463],
23	compounds	NNS	O	compound	nsubj	26	SENT_70	[p3l167t3399r585b3481],
24	are	VBP	O	be	cop	26	SENT_70	[p3l622t3419r729b3463],
25	Pgp	NNP	O	Pgp	nn	26	SENT_70	[p3l763t3400r901b3481],
26	substrates	NNS	O	substrate	ccomp	20	SENT_70	[p3l939t3399r1312b3463],
27	.	.	O	.	_	0	SENT_70	[p3l939t3399r1312b3463],

1	2	LS	NUMBER	2	_	0	SENT_71	[p3l8t3642r72b3707],
2	.	.	O	.	_	0	SENT_71	[p3l8t3642r72b3707],

1	Material	NN	O	material	_	0	SENT_72	[p3l122t3642r462b3707],
2	and	CC	O	and	_	0	SENT_72	[p3l496t3643r640b3707],
3	methods	NNS	O	method	conj_and	1	SENT_72	[p3l673t3643r1000b3707],

1	2	LS	NUMBER	2	_	0	SENT_73	[p4l7t97r133b161],
2	.	.	O	.	_	0	SENT_73	[p4l7t97r133b161],
3	]	SYM	O	]	dep	1	SENT_73	[p4l7t97r133b161],

1	.	.	O	.	_	0	SENT_74	[p4l7t97r133b161],

1	Drugs	NNS	O	drug	_	0	SENT_75	[p4l189t99r417b178],

1	Gemﬁbrozil	NNP	O	Gemﬁbrozil	nsubjpass	17	SENT_76	[p4l101t315r560b390],
2	,	,	O	,	_	0	SENT_76	[p4l101t315r560b390],
3	fenoﬁbrate	NN	O	fenoﬁbrate	nn	11	SENT_76	[p4l601t315r1016b391],
4	,	,	O	,	_	0	SENT_76	[p4l601t315r1016b391],
5	bezaﬁbrate	NN	O	bezaﬁbrate	dep	11	SENT_76	[p4l1056t315r1477b391],
6	,	,	O	,	_	0	SENT_76	[p4l1056t315r1477b391],
7	lovastatin	NN	O	lovastatin	dep	11	SENT_76	[p4l1519t315r1891b391],
8	,	,	O	,	_	0	SENT_76	[p4l1519t315r1891b391],
9	loper	NN	O	loper	dep	11	SENT_76	[p4l1932t315r2146b398],
10	—	NN	O	—	nn	11	SENT_76	[p4l1932t315r2146b398],
11	amide	NN	O	amide	conj_and	1	SENT_76	[p4l9t424r250b499],
12	,	,	O	,	_	0	SENT_76	[p4l9t424r250b499],
13	and	CC	O	and	_	0	SENT_76	[p4l292t424r421b488],
14	Verapamil	NNP	O	Verapamil	nn	15	SENT_76	[p4l458t424r822b507],
15	hydrochloride	NN	O	hydrochloride	nsubjpass	17	SENT_76	[p4l859t424r1371b507],
16	were	VBD	O	be	auxpass	17	SENT_76	[p4l1408t444r1582b488],
17	obtained	VBN	O	obtain	_	0	SENT_76	[p4l1622t424r1936b488],
18	from	IN	O	from	_	0	SENT_76	[p4l1972t424r2148b488],
19	Sigma	NNP	O	Sigma	prep_from	17	SENT_76	[p4l10t531r569b614],
20	.	.	O	.	_	0	SENT_76	[p4l10t531r569b614],

1	—	NN	O	—	_	0	SENT_77	[p4l10t531r569b614],
2	.	.	O	.	_	0	SENT_77	[p4l10t531r569b614],

1	Aldrich	NNP	PERSON	Aldrich	_	0	SENT_78	[p4l10t531r569b614],
2	.	.	O	.	_	0	SENT_78	[p4l10t531r569b614],

1	Vincristine	NN	MISC	vincristine	nn	2	SENT_79	[p4l623t531r1024b595],
2	sulfate	NN	O	sulfate	nsubjpass	4	SENT_79	[p4l1077t531r1316b595],
3	was	VBD	O	be	auxpass	4	SENT_79	[p4l1364t552r1501b596],
4	purchased	VBN	O	purchase	_	0	SENT_79	[p4l1552t531r1923b614],
5	from	IN	O	from	_	0	SENT_79	[p4l1972t531r2148b595],
6	Calbiochem	NNP	LOCATION	Calbiochem	prep_from	4	SENT_79	[p4l9t642r450b706],
7	and	CC	O	and	_	0	SENT_79	[p4l485t642r614b706],
8	LY335979	NNP	O	LY335979	nsubj	12	SENT_79	[p4l647t641r1031b707],
9	was	VBD	O	be	cop	12	SENT_79	[p4l1067t662r1204b706],
10	a	DT	O	a	det	12	SENT_79	[p4l1241t662r1279b706],
11	generous	JJ	O	generous	amod	12	SENT_79	[p4l1313t662r1638b725],
12	gift	NN	O	gift	conj_and	4	SENT_79	[p4l1675t642r1800b725],
13	from	IN	O	from	_	0	SENT_79	[p4l1833t642r2009b706],
14	Eli	NNP	ORGANIZATION	Eli	nn	16	SENT_79	[p4l2042t642r2146b705],
15	Lilly	NNP	ORGANIZATION	Lilly	nn	16	SENT_79	[p4l7t749r184b832],
16	Co.	NNP	ORGANIZATION	Co.	prep_from	12	SENT_79	[p4l219t750r340b814],
17	.	.	O	.	_	0	SENT_79	[p4l219t750r340b814],

1	2.2	CD	NUMBER	2.2	_	0	SENT_80	[p4l7t968r133b1032],
2	.	.	O	.	_	0	SENT_80	[p4l7t968r133b1032],

1	Solvents	NNS	O	solvent	_	0	SENT_81	[p4l191t968r508b1043],
2	,	,	O	,	_	0	SENT_81	[p4l191t968r508b1043],
3	chemicals	NNS	O	chemical	conj_and	1	SENT_81	[p4l552t968r929b1043],
4	,	,	O	,	_	0	SENT_81	[p4l552t968r929b1043],
5	and	CC	O	and	_	0	SENT_81	[p4l971t968r1110b1032],
6	cell	NN	O	cell	nn	8	SENT_81	[p4l1140t968r1271b1032],
7	culture	NN	O	culture	nn	8	SENT_81	[p4l1305t968r1556b1032],
8	accessory	NN	O	accessory	conj_and	1	SENT_81	[p4l1591t990r1950b1050],

1	Methanol	NNP	O	Methanol	nn	2	SENT_82	[p4l99t1186r448b1250],
2	Uvasol	NNP	O	Uvasol	nsubj	28	SENT_82	[p4l490t1186r764b1262],
3	,	,	O	,	_	0	SENT_82	[p4l490t1186r764b1262],
4	hexane	NN	O	hexane	nn	5	SENT_82	[p4l808t1186r1066b1250],
5	Uvasol	NNP	O	Uvasol	appos	2	SENT_82	[p4l1107t1186r1381b1262],
6	,	,	O	,	_	0	SENT_82	[p4l1107t1186r1381b1262],
7	methylene	NN	O	methylene	nn	9	SENT_82	[p4l1426t1186r1806b1269],
8	chloride	NN	O	chloride	nn	9	SENT_82	[p4l1849t1186r2147b1250],
9	Uvasol	NNP	O	Uvasol	appos	2	SENT_82	[p4l7t1295r282b1370],
10	,	,	O	,	_	0	SENT_82	[p4l7t1295r282b1370],
11	acetonitrile	NN	O	acetonitrile	nn	12	SENT_82	[p4l316t1295r725b1358],
12	LiChrosolV	NN	O	lichrosolv	conj_and	5	SENT_82	[p4l754t1295r1183b1370],
13	,	,	O	,	_	0	SENT_82	[p4l754t1295r1183b1370],
14	water	NN	O	water	nn	15	SENT_82	[p4l1215t1304r1418b1358],
15	LiChrosolV	NN	O	lichrosolv	conj_and	5	SENT_82	[p4l1444t1295r1874b1370],
16	,	,	O	,	_	0	SENT_82	[p4l1444t1295r1874b1370],
17	formic	JJ	O	formic	amod	18	SENT_82	[p4l1905t1295r2146b1358],
18	acid	NN	O	acid	conj_and	5	SENT_82	[p4l9t1404r159b1468],
19	for	IN	O	for	_	0	SENT_82	[p4l182t1404r288b1468],
20	analysis	NN	O	analysis	prep_for	18	SENT_82	[p4l311t1404r621b1487],
21	,	,	O	,	_	0	SENT_82	[p4l311t1404r621b1487],
22	hydrochloric	JJ	O	hydrochloric	amod	23	SENT_82	[p4l647t1404r1113b1487],
23	acid	NN	O	acid	appos	20	SENT_82	[p4l1140t1404r1308b1480],
24	,	,	O	,	_	0	SENT_82	[p4l1140t1404r1308b1480],
25	and	CC	O	and	_	0	SENT_82	[p4l1336t1404r1465b1468],
26	sodium	NN	O	sodium	nn	27	SENT_82	[p4l1490t1404r1755b1468],
27	hydroxide	NN	O	hydroxide	appos	2	SENT_82	[p4l1777t1404r2146b1487],
28	were	VBD	O	be	_	0	SENT_82	[p4l8t1531r182b1575],
29	from	IN	O	from	_	0	SENT_82	[p4l220t1511r396b1575],
30	Merck	NNP	PERSON	Merck	prep_from	28	SENT_82	[p4l431t1511r687b1575],
31	.	.	O	.	_	0	SENT_82	[p4l431t1511r687b1575],

1	Cell	NN	O	cell	nn	4	SENT_83	[p4l728t1511r878b1575],
2	culture	NN	O	culture	nn	4	SENT_83	[p4l915t1511r1167b1575],
3	medium	NN	O	medium	nn	4	SENT_83	[p4l1204t1511r1504b1575],
4	M199	NN	O	m199	_	0	SENT_83	[p4l1539t1512r1774b1586],
5	,	,	O	,	_	0	SENT_83	[p4l1539t1512r1774b1586],
6	fetal	JJ	O	fetal	amod	11	SENT_83	[p4l1814t1511r1975b1575],
7	calf	NN	O	calf	nn	11	SENT_83	[p4l2012t1511r2153b1575],
8	serum	NN	O	serum	nn	11	SENT_83	[p4l11t1640r230b1684],
9	(	CD	NUMBER	(	num	11	SENT_83	[p4l253t1620r490b1699],
10	FCS	NN	ORGANIZATION	fc	nn	11	SENT_83	[p4l253t1620r490b1699],
11	)	NN	O	)	appos	4	SENT_83	[p4l253t1620r490b1699],
12	,	,	O	,	_	0	SENT_83	[p4l253t1620r490b1699],
13	glutamine	NN	O	glutamine	appos	4	SENT_83	[p4l515t1619r899b1702],
14	,	,	O	,	_	0	SENT_83	[p4l515t1619r899b1702],
15	100	CD	NUMBER	100	num	17	SENT_83	[p4l932t1620r1057b1684],
16	U/mL	NN	O	u/ml	nn	17	SENT_83	[p4l1083t1620r1300b1684],
17	penicillin	NN	O	penicillin	appos	4	SENT_83	[p4l1320t1620r1666b1702],
18	with	IN	O	with	_	0	SENT_83	[p4l1687t1620r1848b1684],
19	100	CD	NUMBER	100	num	20	SENT_83	[p4l1876t1620r2002b1684],
20	ug	NN	O	ug	prep_with	17	SENT_83	[p4l2031t1620r2150b1702],
21	/	:	O	/	punct	4	SENT_83	[p4l2031t1620r2150b1702],
22	mL	NN	O	ml	nn	24	SENT_83	[p4l8t1730r133b1791],
23	streptomycin	NN	O	streptomycin	nn	24	SENT_83	[p4l156t1728r631b1811],
24	sulfate	NN	O	sulfate	nsubj	32	SENT_83	[p4l654t1728r913b1804],
25	,	,	O	,	_	0	SENT_83	[p4l654t1728r913b1804],
26	HBSS	NN	O	hbss	nsubj	32	SENT_83	[p4l937t1729r1182b1804],
27	,	,	O	,	_	0	SENT_83	[p4l937t1729r1182b1804],
28	HEPES	NN	LOCATION	hepe	nsubj	32	SENT_83	[p4l1206t1729r1502b1804],
29	,	,	O	,	_	0	SENT_83	[p4l1206t1729r1502b1804],
30	and	CC	O	and	_	0	SENT_83	[p4l1528t1728r1657b1792],
31	Versene	NNP	O	Versene	nsubj	32	SENT_83	[p4l1677t1748r1952b1792],
32	were	VBD	O	be	dep	4	SENT_83	[p4l1972t1748r2147b1792],
33	from	IN	O	from	_	0	SENT_83	[p4l8t1839r184b1903],
34	Invitrogen	NNP	ORGANIZATION	Invitrogen	prep_from	32	SENT_83	[p4l231t1839r626b1922],
35	.	.	O	.	_	0	SENT_83	[p4l231t1839r626b1922],

1	Collagen	NNP	MISC	Collagen	_	0	SENT_84	[p4l680t1839r1101b1922],
2	.	.	O	.	_	0	SENT_84	[p4l680t1839r1101b1922],

1	—	NN	O	—	_	0	SENT_85	[p4l680t1839r1101b1922],
2	.	.	O	.	_	0	SENT_85	[p4l680t1839r1101b1922],

1	R	NN	O	r	nsubjpass	3	SENT_86	[p4l680t1839r1101b1922],
2	was	VBD	O	be	auxpass	3	SENT_86	[p4l1148t1859r1285b1903],
3	obtained	VBN	O	obtain	_	0	SENT_86	[p4l1336t1839r1650b1903],
4	from	IN	O	from	_	0	SENT_86	[p4l1697t1839r1873b1903],
5	Serva	FW	LOCATION	serva	prep_from	3	SENT_86	[p4l1923t1839r2143b1903],
6	.	.	O	.	_	0	SENT_86	[p4l1923t1839r2143b1903],

1	DMSO	NN	ORGANIZATION	dmso	nn	4	SENT_87	[p4l8t1948r267b2012],
2	and	CC	O	and	_	0	SENT_87	[p4l318t1948r447b2012],
3	Triton	NNP	ORGANIZATION	Triton	conj_and	1	SENT_87	[p4l494t1948r719b2012],
4	X-100	NN	O	x-100	nsubjpass	6	SENT_87	[p4l766t1948r997b2012],
5	were	VBD	O	be	auxpass	6	SENT_87	[p4l1047t1968r1220b2012],
6	purchased	VBN	O	purchase	_	0	SENT_87	[p4l1268t1948r1639b2031],
7	from	IN	O	from	_	0	SENT_87	[p4l1687t1948r1864b2012],
8	AppliChem	NNP	O	AppliChem	prep_from	6	SENT_87	[p4l1910t1948r2145b2031, p4l9t2055r244b2131],
9	,	,	O	,	_	0	SENT_87	[p4l1910t1948r2145b2031, p4l9t2055r244b2131],
10	calcein-AM	NN	O	calcein-am	appos	8	SENT_87	[p4l291t2055r726b2119],
11	from	IN	O	from	_	0	SENT_87	[p4l769t2055r946b2119],
12	MoBiTec	NNP	O	MoBiTec	prep_from	10	SENT_87	[p4l987t2055r1350b2131],
13	,	,	O	,	_	0	SENT_87	[p4l987t2055r1350b2131],
14	48-well	JJ	O	48-well	amod	15	SENT_87	[p4l1396t2055r1674b2120],
15	plates	NNS	O	plate	prep_from	6	SENT_87	[p4l1715t2055r1927b2138],
16	from	IN	O	from	_	0	SENT_87	[p4l1972t2055r2149b2119],
17	Falcon	NNP	O	Falcon	prep_from	15	SENT_87	[p4l7t2165r274b2241],
18	,	,	O	,	_	0	SENT_87	[p4l7t2165r274b2241],
19	and	CC	O	and	_	0	SENT_87	[p4l321t2165r449b2229],
20	96-well	JJ	O	96-well	amod	21	SENT_87	[p4l491t2165r767b2230],
21	plates	NNS	O	plate	conj_and	8	SENT_87	[p4l808t2165r1019b2248],
22	and	CC	O	and	_	0	SENT_87	[p4l1065t2165r1193b2229],
23	80	CD	NUMBER	80	num	26	SENT_87	[p4l1238t2166r1322b2229],
24	cm2	NN	O	cm2	nn	26	SENT_87	[p4l1349t2146r1492b2229],
25	culturing	NN	O	culturing	nn	26	SENT_87	[p4l1535t2165r1863b2248],
26	bottles	NNS	O	bottle	conj_and	8	SENT_87	[p4l1903t2165r2145b2229],
27	from	IN	O	from	_	0	SENT_87	[p4l8t2273r184b2338],
28	Nunc	NNP	O	Nunc	prep_from	6	SENT_87	[p4l217t2275r431b2338],
29	.	.	O	.	_	0	SENT_87	[p4l217t2275r431b2338],

1	2.3	CD	NUMBER	2.3	_	0	SENT_88	[p4l7t2493r134b2556],
2	.	.	O	.	_	0	SENT_88	[p4l7t2493r134b2556],

1	Isolation	NN	O	isolation	nn	2	SENT_89	[p4l189t2492r514b2557],
2	procedures	NNS	O	procedure	_	0	SENT_89	[p4l540t2492r951b2574],

1	2.3	CD	NUMBER	2.3	nsubj	3	SENT_90	[p4l7t2711r202b2774],
2	.	.	O	.	_	0	SENT_90	[p4l7t2711r202b2774],
3	]	SYM	O	]	_	0	SENT_90	[p4l7t2711r202b2774],

1	.	.	O	.	_	0	SENT_91	[p4l7t2711r202b2774],

1	Simvastotin	NN	PERSON	simvastotin	_	0	SENT_92	[p4l260t2712r684b2774],

1	According	VBG	O	accord	_	0	SENT_93	[p4l99t2819r483b2902],
2	to	TO	O	to	prepc_according_to	25	SENT_93	[p4l506t2829r574b2883],
3	Bogman	NNP	PERSON	Bogman	pobj	25	SENT_93	[p4l597t2821r905b2902],
4	et	FW	O	et	nn	6	SENT_93	[p4l928t2832r994b2883],
5	al.	FW	O	al.	nn	6	SENT_93	[p4l1013t2819r1096b2883],
6	[	FW	O	[	dep	3	SENT_93	[p4l1133t2820r1270b2896],
7	14	CD	NUMBER	14	num	10	SENT_93	[p4l1133t2820r1270b2896],
8	]	CD	NUMBER	]	num	10	SENT_93	[p4l1133t2820r1270b2896],
9	50	CD	NUMBER	50	num	10	SENT_93	[p4l1300t2819r1387b2883],
10	tablets	NNS	O	tablet	dobj	6	SENT_93	[p4l1409t2819r1646b2883],
11	Zocor	NNP	O	Zocor	nn	13	SENT_93	[p4l1668t2800r1951b2883],
12	®	CD	NUMBER	®	num	13	SENT_93	[p4l1668t2800r1951b2883],
13	forte	NN	O	forte	dep	10	SENT_93	[p4l1977t2819r2146b2883],
14	containing	VBG	O	contain	xcomp	6	SENT_93	[p4l8t2929r392b3012],
15	40	CD	NUMBER	40	num	17	SENT_93	[p4l456t2929r545b2993],
16	mg	NN	O	mg	nn	17	SENT_93	[p4l571t2949r685b3012],
17	simvastatin	NN	O	simvastatin	dobj	14	SENT_93	[p4l751t2929r1163b2993],
18	from	IN	O	from	_	0	SENT_93	[p4l1226t2929r1402b2993],
19	Merck	NNP	ORGANIZATION	Merck	nn	20	SENT_93	[p4l1464t2929r1703b2993],
20	Sharpe	NNP	ORGANIZATION	Sharpe	prep_from	14	SENT_93	[p4l1766t2929r2015b3012],
21	&	CC	ORGANIZATION	&	_	0	SENT_93	[p4l2081t2929r2146b2993],
22	Dohme	NNP	ORGANIZATION	Dohme	nn	23	SENT_93	[p4l8t3037r274b3101],
23	Limited	NNP	ORGANIZATION	Limited	conj_and	20	SENT_93	[p4l334t3037r624b3101],
24	were	VBD	O	be	auxpass	25	SENT_93	[p4l682t3057r857b3101],
25	mortared	VBN	O	mortar	_	0	SENT_93	[p4l917t3037r1247b3101],
26	and	CC	O	and	_	0	SENT_93	[p4l1308t3037r1436b3101],
27	stirred	VBN	O	stir	conj_and	25	SENT_93	[p4l1497t3036r1727b3101],
28	2	CD	DURATION	2	num	29	SENT_93	[p4l1787t3037r1828b3100],
29	hr	NN	DURATION	hr	dobj	25	SENT_93	[p4l1853t3037r1930b3100],
30	with	IN	O	with	_	0	SENT_93	[p4l1987t3037r2148b3101],
31	100	CD	NUMBER	100	num	32	SENT_93	[p4l17t3146r142b3210],
32	mL	NN	O	ml	nsubj	37	SENT_93	[p4l168t3147r293b3208],
33	of	IN	O	of	_	0	SENT_93	[p4l342t3145r421b3209],
34	an	DT	O	a	det	36	SENT_93	[p4l465t3165r548b3209],
35	extraction	NN	O	extraction	nn	36	SENT_93	[p4l597t3145r961b3209],
36	solution	NN	O	solution	prep_of	32	SENT_93	[p4l1012t3145r1303b3209],
37	containing	VBG	O	contain	prepc_with	25	SENT_93	[p4l1351t3145r1735b3228],
38	methanol	NN	O	methanol	dobj	37	SENT_93	[p4l1784t3145r2144b3221],
39	,	,	O	,	_	0	SENT_93	[p4l1784t3145r2144b3221],
40	hexane	NN	O	hexane	dobj	37	SENT_93	[p4l7t3256r285b3332],
41	,	,	O	,	_	0	SENT_93	[p4l7t3256r285b3332],
42	and	CC	O	and	_	0	SENT_93	[p4l317t3256r446b3320],
43	methylene	NN	O	methylene	dobj	37	SENT_93	[p4l472t3256r852b3339],
44	chloride	NN	O	chloride	nsubjpass	25	SENT_93	[p4l881t3256r1178b3320],
45	in	IN	O	in	_	0	SENT_93	[p4l1207t3256r1276b3319],
46	equal	JJ	O	equal	amod	48	SENT_93	[p4l1303t3256r1498b3339],
47	Volumetric	JJ	O	volumetric	amod	48	SENT_93	[p4l1527t3256r1920b3320],
48	parts	NNS	O	part	prep_in	44	SENT_93	[p4l1947t3265r2143b3339],
49	.	.	O	.	_	0	SENT_93	[p4l1947t3265r2143b3339],

1	The	DT	O	the	det	3	SENT_94	[p4l8t3365r147b3429],
2	extraction	NN	O	extraction	nn	3	SENT_94	[p4l198t3365r563b3429],
3	solution	NN	O	solution	nsubjpass	5	SENT_94	[p4l615t3365r906b3429],
4	was	VBD	O	be	auxpass	5	SENT_94	[p4l955t3385r1092b3429],
5	ﬁltered	VBN	O	ﬁltered	_	0	SENT_94	[p4l1146t3365r1403b3429],
6	and	CC	O	and	_	0	SENT_94	[p4l1454t3365r1582b3429],
7	evaporated	VBN	O	evaporate	conj_and	5	SENT_94	[p4l1632t3365r2030b3448],
8	to	TO	O	to	_	0	SENT_94	[p4l2079t3375r2146b3429],
9	dryness	NN	O	dryness	prep_to	5	SENT_94	[p4l9t3472r283b3555],
10	under	IN	O	under	_	0	SENT_94	[p4l315t3472r523b3536],
11	a	DT	O	a	det	12	SENT_94	[p4l554t3493r592b3536],
12	stream	NN	O	stream	prep_under	5	SENT_94	[p4l624t3482r864b3536],
13	of	IN	O	of	_	0	SENT_94	[p4l896t3472r974b3536],
14	nitrogen	NN	O	nitrogen	prep_of	12	SENT_94	[p4l998t3472r1303b3555],
15	at	IN	O	at	_	0	SENT_94	[p4l1335t3482r1399b3536],
16	50	CD	NUMBER	50	number	17	SENT_94	[p4l1429t3471r1570b3537],
17	°	CD	NUMBER	°	prep_at	5	SENT_94	[p4l1429t3471r1570b3537],
18	.	.	O	.	_	0	SENT_94	[p4l1429t3471r1570b3537],

1	The	DT	O	the	det	3	SENT_95	[p4l1606t3472r1745b3536],
2	remaining	VBG	O	remain	amod	3	SENT_95	[p4l1776t3472r2147b3555],
3	residue	NN	O	residue	nsubjpass	11	SENT_95	[p4l7t3583r270b3647],
4	was	VBD	O	be	auxpass	5	SENT_95	[p4l298t3603r435b3647],
5	weighed	VBN	O	weigh	_	0	SENT_95	[p4l467t3583r776b3666],
6	and	CC	O	and	_	0	SENT_95	[p4l806t3583r935b3647],
7	redissolved	VBN	O	redissolve	conj_and	5	SENT_95	[p4l962t3583r1378b3647],
8	in	IN	O	in	_	0	SENT_95	[p4l1407t3583r1476b3646],
9	acetonitrile/water	NN	O	acetonitrile/water	prep_in	5	SENT_95	[p4l1507t3583r2149b3647],
10	and	CC	O	and	_	0	SENT_95	[p4l9t3691r138b3755],
11	deuterated	VBD	O	deuterate	conj_and	5	SENT_95	[p4l197t3691r578b3755],
12	DMSO	NN	ORGANIZATION	dmso	nn	14	SENT_95	[p4l636t3691r896b3755],
13	(	CD	NUMBER	(	num	14	SENT_95	[p4l958t3691r1406b3770],
14	d3	NN	O	d3	dobj	11	SENT_95	[p4l958t3691r1406b3770],
15	.	.	O	.	_	0	SENT_95	[p4l958t3691r1406b3770],

1	—	NN	O	—	_	0	SENT_96	[p4l958t3691r1406b3770],
2	.	.	O	.	_	0	SENT_96	[p4l958t3691r1406b3770],

1	DMSO	NN	ORGANIZATION	dmso	_	0	SENT_97	[p4l958t3691r1406b3770],
2	)	NN	O	)	dep	1	SENT_97	[p4l958t3691r1406b3770],
3	.	.	O	.	_	0	SENT_97	[p4l958t3691r1406b3770],

1	Subsequently	RB	O	subsequently	advmod	6	SENT_98	[p4l1472t3691r1976b3773],
2	,	,	O	,	_	0	SENT_98	[p4l1472t3691r1976b3773],
3	the	DT	O	the	det	4	SENT_98	[p4l2037t3691r2147b3755],
4	solutions	NNS	O	solution	nsubjpass	6	SENT_98	[p5l11t21r335b85],
5	were	VBD	O	be	auxpass	6	SENT_98	[p5l372t41r547b85],
6	analyzed	VBN	O	analyze	_	0	SENT_98	[p5l585t21r908b103],
7	to	TO	O	to	aux	8	SENT_98	[p5l943t30r1011b85],
8	determine	VB	O	determine	xcomp	6	SENT_98	[p5l1049t21r1413b85],
9	purity	NN	O	purity	dobj	8	SENT_98	[p5l1449t21r1666b103],
10	and	CC	O	and	_	0	SENT_98	[p5l1705t21r1834b85],
11	identity	NN	O	identity	conj_and	9	SENT_98	[p5l1869t21r2146b103],
12	by	IN	O	by	_	0	SENT_98	[p5l6t129r96b212],
13	HPLC	NN	ORGANIZATION	hplc	nn	16	SENT_98	[p5l130t130r359b194],
14	and	CC	O	and	_	0	SENT_98	[p5l396t129r525b193],
15	spectroscopic	JJ	O	spectroscopic	nn	16	SENT_98	[p5l561t129r1053b212],
16	measures	NNS	O	measure	prep_by	8	SENT_98	[p5l1088t149r1446b193],
17	.	.	O	.	_	0	SENT_98	[p5l1088t149r1446b193],

1	2.3.2	CD	NUMBER	2.3.2	_	0	SENT_99	[p5l7t345r202b409],
2	.	.	O	.	_	0	SENT_99	[p5l7t345r202b409],

1	Fenofibric	JJ	O	fenofibric	amod	2	SENT_100	[p5l259t345r638b427],
2	acid	NN	O	acid	_	0	SENT_100	[p5l671t345r831b409],

1	An	DT	O	a	det	2	SENT_101	[p5l99t454r208b517],
2	amount	NN	O	amount	nsubjpass	9	SENT_101	[p5l245t463r517b517],
3	of	IN	O	of	_	0	SENT_101	[p5l552t453r631b517],
4	1.06	CD	NUMBER	1.06	num	5	SENT_101	[p5l667t453r815b518],
5	g	NN	O	g	prep_of	2	SENT_101	[p5l843t474r884b536],
6	of	IN	O	of	_	0	SENT_101	[p5l921t453r1000b517],
7	fenoﬁbrate	NN	O	fenoﬁbrate	prep_of	5	SENT_101	[p5l1026t453r1421b517],
8	was	VBD	O	be	auxpass	9	SENT_101	[p5l1455t473r1592b518],
9	dissolved	VBN	O	dissolve	_	0	SENT_101	[p5l1629t453r1973b518],
10	in	IN	O	in	_	0	SENT_101	[p5l2006t453r2074b517],
11	a	DT	O	a	det	12	SENT_101	[p5l2111t474r2149b517],
12	mixture	NN	O	mixture	prep_in	9	SENT_101	[p5l8t562r290b627],
13	of	IN	O	of	_	0	SENT_101	[p5l324t562r403b627],
14	8	CD	NUMBER	8	num	16	SENT_101	[p5l432t563r468b627],
15	mL	NN	O	ml	nn	16	SENT_101	[p5l497t564r622b626],
16	acetonitrile	NN	O	acetonitrile	prep_of	12	SENT_101	[p5l657t563r1067b627],
17	and	CC	O	and	_	0	SENT_101	[p5l1101t563r1230b627],
18	4	CD	NUMBER	4	num	20	SENT_101	[p5l1260t563r1303b626],
19	mL	NN	O	ml	nn	20	SENT_101	[p5l1329t564r1454b626],
20	water	NN	O	water	prep_of	12	SENT_101	[p5l1487t573r1702b627],
21	.	.	O	.	_	0	SENT_101	[p5l1487t573r1702b627],

1	After	IN	O	after	_	0	SENT_102	[p5l1738t563r1931b627],
2	addition	NN	O	addition	prep_after	11	SENT_102	[p5l1963t563r2144b627, p5l8t671r148b735],
3	of	IN	O	of	_	0	SENT_102	[p5l171t671r249b735],
4	40	CD	NUMBER	40	num	7	SENT_102	[p5l264t672r353b736],
5	pellets	NNS	O	pellet	nn	7	SENT_102	[p5l374t671r611b754],
6	sodium	NN	O	sodium	nn	7	SENT_102	[p5l638t671r903b735],
7	hydroxide	NN	O	hydroxide	prep_of	2	SENT_102	[p5l922t671r1292b754],
8	the	DT	O	the	det	9	SENT_102	[p5l1314t671r1423b735],
9	mixture	NN	O	mixture	nsubjpass	11	SENT_102	[p5l1446t671r1728b735],
10	was	VBD	O	be	auxpass	11	SENT_102	[p5l1749t691r1886b736],
11	heated	VBN	O	heat	_	0	SENT_102	[p5l1909t671r2148b735],
12	to	TO	O	to	_	0	SENT_102	[p5l7t790r76b844],
13	90	CD	NUMBER	90	number	14	SENT_102	[p5l110t779r229b845],
14	°	CD	NUMBER	°	prep_to	11	SENT_102	[p5l110t779r229b845],
15	in	IN	O	in	_	0	SENT_102	[p5l265t781r334b843],
16	a	DT	O	a	det	18	SENT_102	[p5l368t801r405b844],
17	water	NN	O	water	nn	18	SENT_102	[p5l435t790r638b844],
18	bath	NN	O	bath	prep_in	11	SENT_102	[p5l667t781r824b844],
19	for	IN	O	for	_	0	SENT_102	[p5l856t781r962b844],
20	90	CD	DURATION	90	num	21	SENT_102	[p5l994t781r1081b845],
21	min	NN	DURATION	min	prep_for	18	SENT_102	[p5l1107t781r1266b844],
22	.	.	O	.	_	0	SENT_102	[p5l1107t781r1266b844],

1	After	IN	O	after	_	0	SENT_103	[p5l1302t781r1495b844],
2	1	CD	DURATION	1	num	3	SENT_103	[p5l1534t781r1561b843],
3	hr	NN	DURATION	hr	prep_after	16	SENT_103	[p5l1594t781r1684b856],
4	,	,	O	,	_	0	SENT_103	[p5l1594t781r1684b856],
5	2	CD	NUMBER	2	num	7	SENT_103	[p5l1721t781r1762b843],
6	mL	NN	O	ml	nn	7	SENT_103	[p5l1788t782r1913b843],
7	water	NN	O	water	prep_after	16	SENT_103	[p5l1946t790r2149b844],
8	and	CC	O	and	_	0	SENT_103	[p5l9t890r138b954],
9	40	CD	NUMBER	40	num	10	SENT_103	[p5l168t890r257b954],
10	mL	NN	O	ml	conj_and	3	SENT_103	[p5l283t891r408b953],
11	1	CD	NUMBER	1	num	14	SENT_103	[p5l448t890r474b953],
12	M	NN	O	m	nn	14	SENT_103	[p5l507t891r586b953],
13	hydrochloric	JJ	O	hydrochloric	amod	14	SENT_103	[p5l616t890r1081b973],
14	acid	NN	O	acid	nsubjpass	16	SENT_103	[p5l1116t890r1266b954],
15	were	VBD	O	be	auxpass	16	SENT_103	[p5l1296t910r1470b954],
16	added	VBN	O	add	_	0	SENT_103	[p5l1504t890r1737b954],
17	.	.	O	.	_	0	SENT_103	[p5l1504t890r1737b954],

1	For	IN	O	for	_	0	SENT_104	[p5l1772t891r1898b954],
2	separating	VBG	O	separate	prepc_for	20	SENT_104	[p5l1930t910r2145b973, p5l9t997r188b1080],
3	the	DT	O	the	det	5	SENT_104	[p5l212t997r321b1061],
4	two	CD	NUMBER	two	num	5	SENT_104	[p5l345t1007r479b1062],
5	phases	NNS	O	phase	dobj	2	SENT_104	[p5l502t997r743b1080],
6	the	DT	O	the	det	7	SENT_104	[p5l768t997r877b1061],
7	mixture	NN	O	mixture	nsubjpass	9	SENT_104	[p5l901t997r1184b1061],
8	was	VBD	O	be	auxpass	9	SENT_104	[p5l1207t1018r1343b1062],
9	allowed	VBN	O	allow	rcmod	5	SENT_104	[p5l1370t997r1656b1062],
10	to	TO	O	to	aux	11	SENT_104	[p5l1678t1007r1746b1061],
11	cool	VB	O	cool	xcomp	9	SENT_104	[p5l1770t997r1925b1061],
12	down	RB	O	down	advmod	11	SENT_104	[p5l1950t997r2148b1062],
13	and	CC	O	and	_	0	SENT_104	[p5l9t1108r138b1172],
14	further	RB	O	further	advmod	11	SENT_104	[p5l178t1108r427b1172],
15	20	CD	NUMBER	20	num	18	SENT_104	[p5l466t1108r553b1172],
16	mL	NN	O	ml	nn	18	SENT_104	[p5l579t1109r704b1171],
17	hydrochloric	JJ	O	hydrochloric	amod	18	SENT_104	[p5l743t1108r1209b1191],
18	acid	NN	O	acid	nsubjpass	20	SENT_104	[p5l1253t1108r1402b1172],
19	were	VBD	O	be	auxpass	20	SENT_104	[p5l1441t1128r1616b1172],
20	added	VBN	O	add	_	0	SENT_104	[p5l1659t1108r1892b1172],
21	.	.	O	.	_	0	SENT_104	[p5l1659t1108r1892b1172],

1	Feno	NNP	O	Feno	dep	3	SENT_105	[p5l1936t1109r2144b1172],
2	—	CD	NUMBER	—	num	1	SENT_105	[p5l1936t1109r2144b1172],
3	ﬁbric	JJ	O	ﬁbric	amod	4	SENT_105	[p5l9t1215r197b1279],
4	acid	NN	O	acid	nsubjpass	6	SENT_105	[p5l244t1215r394b1279],
5	was	VBD	O	be	auxpass	6	SENT_105	[p5l437t1235r574b1280],
6	precipitated	VBN	O	precipitate	_	0	SENT_105	[p5l618t1215r1052b1298],
7	from	IN	O	from	_	0	SENT_105	[p5l1096t1215r1272b1279],
8	the	DT	O	the	det	10	SENT_105	[p5l1314t1215r1423b1279],
9	aqueous	JJ	O	aqueous	amod	10	SENT_105	[p5l1469t1236r1764b1298],
10	phase	NN	O	phase	prep_from	6	SENT_105	[p5l1808t1215r2014b1298],
11	by	IN	O	by	_	0	SENT_105	[p5l2057t1215r2147b1298],
12	acidiﬁcation	NN	O	acidiﬁcation	agent	6	SENT_105	[p5l9t1325r460b1389],
13	with	IN	O	with	_	0	SENT_105	[p5l503t1324r663b1389],
14	1	CD	NUMBER	1	num	15	SENT_105	[p5l713t1325r739b1388],
15	M	NN	O	m	prep_with	6	SENT_105	[p5l773t1326r851b1388],
16	hydrochloric	JJ	O	hydrochloric	amod	21	SENT_105	[p5l893t1324r1359b1407],
17	acid	NN	O	acid	nn	21	SENT_105	[p5l1405t1324r1554b1389],
18	(	NN	O	(	nn	21	SENT_105	[p5l1598t1325r1760b1404],
19	200	CD	NUMBER	200	num	21	SENT_105	[p5l1598t1325r1760b1404],
20	mL	NN	O	ml	nn	21	SENT_105	[p5l1786t1325r1960b1403],
21	)	NN	O	)	dep	15	SENT_105	[p5l1786t1325r1960b1403],
22	.	.	O	.	_	0	SENT_105	[p5l1786t1325r1960b1403],

1	The	DT	O	the	det	2	SENT_106	[p5l2007t1325r2147b1389],
2	precipitate	NN	O	precipitate	nsubjpass	4	SENT_106	[p5l7t1435r393b1518],
3	was	VBD	O	be	auxpass	4	SENT_106	[p5l426t1455r563b1499],
4	centrifuged	VBN	O	centrifuge	_	0	SENT_106	[p5l599t1435r1016b1518],
5	for	IN	O	for	_	0	SENT_106	[p5l1048t1435r1154b1499],
6	10	CD	DURATION	10	num	7	SENT_106	[p5l1194t1435r1274b1499],
7	min	NN	DURATION	min	prep_for	4	SENT_106	[p5l1299t1435r1440b1498],
8	at	IN	O	at	_	0	SENT_106	[p5l1475t1445r1538b1499],
9	3000	CD	NUMBER	3000	num	10	SENT_106	[p5l1572t1435r1750b1499],
10	g	NN	O	g	prep_at	7	SENT_106	[p5l1768t1457r1811b1517],
11	and	CC	O	and	_	0	SENT_106	[p5l1847t1435r1976b1499],
12	was	VBD	O	be	auxpass	13	SENT_106	[p5l2009t1455r2146b1499],
13	dried	VBN	O	dry	conj_and	4	SENT_106	[p5l9t1543r194b1607],
14	at	IN	O	at	_	0	SENT_106	[p5l223t1553r287b1607],
15	90	CD	NUMBER	90	num	16	SENT_106	[p5l314t1541r456b1608],
16	°	NN	O	°	prep_at	13	SENT_106	[p5l314t1541r456b1608],
17	.	.	O	.	_	0	SENT_106	[p5l314t1541r456b1608],

1	The	DT	O	the	det	3	SENT_107	[p5l488t1543r628b1607],
2	remaining	VBG	O	remain	amod	3	SENT_107	[p5l655t1543r1026b1625],
3	residue	NN	O	residue	nsubjpass	8	SENT_107	[p5l1054t1543r1317b1607],
4	was	VBD	O	be	auxpass	6	SENT_107	[p5l1343t1563r1480b1607],
5	also	RB	O	also	advmod	6	SENT_107	[p5l1512t1543r1654b1607],
6	weighed	VBN	O	weigh	_	0	SENT_107	[p5l1682t1543r1991b1625],
7	and	CC	O	and	_	0	SENT_107	[p5l2019t1543r2148b1607],
8	redissolved	VBN	O	redissolve	conj_and	6	SENT_107	[p5l7t1651r423b1715],
9	in	IN	O	in	_	0	SENT_107	[p5l461t1651r530b1715],
10	acetonitrile/water	NN	O	acetonitrile/water	prep_in	6	SENT_107	[p5l570t1651r1213b1716],
11	and	CC	O	and	_	0	SENT_107	[p5l1252t1651r1381b1715],
12	d3-DMSO	NN	O	d3-dmso	conj_and	10	SENT_107	[p5l1420t1651r1789b1731],
13	to	TO	O	to	aux	14	SENT_107	[p5l1828t1661r1896b1715],
14	determine	VB	O	determine	xcomp	6	SENT_107	[p5l1937t1651r2145b1715, p5l8t1760r188b1824],
15	purity	NN	O	purity	dobj	14	SENT_107	[p5l221t1760r438b1843],
16	and	CC	O	and	_	0	SENT_107	[p5l475t1760r603b1824],
17	identity	NN	O	identity	dobj	14	SENT_107	[p5l636t1760r927b1843],
18	.	.	O	.	_	0	SENT_107	[p5l636t1760r927b1843],

1	2.4	CD	NUMBER	2.4	_	0	SENT_108	[p5l7t1979r134b2042],
2	.	.	O	.	_	0	SENT_108	[p5l7t1979r134b2042],

1	Purity	NN	O	purity	_	0	SENT_109	[p5l190t1981r418b2060],
2	and	CC	O	and	_	0	SENT_109	[p5l452t1978r590b2043],
3	identity	NN	O	identity	conj_and	1	SENT_109	[p5l623t1978r893b2060],

1	Purity	NN	O	purity	nsubjpass	9	SENT_110	[p5l99t2197r320b2279],
2	of	IN	O	of	_	0	SENT_110	[p5l362t2196r441b2261],
3	isolated	VBN	O	isolate	amod	4	SENT_110	[p5l474t2197r758b2261],
4	simvastatin	NN	O	simvastatin	prep_of	1	SENT_110	[p5l800t2197r1212b2261],
5	and	CC	O	and	_	0	SENT_110	[p5l1254t2197r1383b2261],
6	fenoﬁbric	JJ	O	fenoﬁbric	amod	7	SENT_110	[p5l1423t2196r1775b2261],
7	acid	NN	O	acid	prep_of	1	SENT_110	[p5l1819t2196r1968b2261],
8	was	VBD	O	be	auxpass	9	SENT_110	[p5l2009t2217r2145b2261],
9	determined	VBN	O	determine	_	0	SENT_110	[p5l9t2306r420b2370],
10	by	IN	O	by	_	0	SENT_110	[p5l444t2306r534b2388],
11	HPLC/UV	NN	O	hplc/uv	nn	12	SENT_110	[p5l561t2306r948b2370],
12	(	NN	O	(	agent	9	SENT_110	[p5l978t2305r1136b2384],
13	215	CD	NUMBER	215	num	17	SENT_110	[p5l978t2305r1136b2384],
14	and	CC	O	and	_	0	SENT_110	[p5l1169t2306r1297b2370],
15	254	CD	NUMBER	254	num	17	SENT_110	[p5l1324t2305r1456b2370],
16	nm	NN	O	nm	nn	17	SENT_110	[p5l1483t2306r1625b2384],
17	)	NN	O	)	dobj	9	SENT_110	[p5l1483t2306r1625b2384],
18	using	VBG	O	use	partmod	17	SENT_110	[p5l1654t2306r1849b2388],
19	a	DT	O	a	det	22	SENT_110	[p5l1878t2326r1916b2370],
20	pump	NN	O	pump	nn	22	SENT_110	[p5l1940t2326r2147b2388],
21	gradient	NN	O	gradient	nn	22	SENT_110	[p5l9t2414r308b2497],
22	program	NN	O	program	nsubj	25	SENT_110	[p5l337t2434r648b2497],
23	(	CD	PERCENT	(	number	24	SENT_110	[p5l681t2415r915b2493],
24	100	CD	PERCENT	100	num	25	SENT_110	[p5l681t2415r915b2493],
25	%	NN	PERCENT	%	xcomp	18	SENT_110	[p5l681t2415r915b2493],
26	aqueous	JJ	O	aqueous	amod	27	SENT_110	[p5l952t2434r1246b2497],
27	eluent	JJ	O	eluent	amod	25	SENT_110	[p5l1280t2414r1503b2478],
28	to	TO	O	to	_	0	SENT_110	[p5l1533t2424r1601b2478],
29	100	CD	PERCENT	100	number	30	SENT_110	[p5l1642t2415r1840b2479],
30	%	NN	PERCENT	%	amod	33	SENT_110	[p5l1642t2415r1840b2479],
31	organic	JJ	O	organic	amod	33	SENT_110	[p5l1877t2414r2145b2497],
32	eluent	JJ	O	eluent	amod	33	SENT_110	[p5l8t2525r279b2604],
33	)	NN	O	)	prep_to	18	SENT_110	[p5l8t2525r279b2604],
34	.	.	O	.	_	0	SENT_110	[p5l8t2525r279b2604],

1	The	DT	O	the	det	2	SENT_111	[p5l314t2525r453b2589],
2	purity	NN	O	purity	nsubj	4	SENT_111	[p5l483t2525r700b2608],
3	was	VBD	O	be	cop	4	SENT_111	[p5l732t2545r868b2589],
4	>	JJR	O	>	_	0	SENT_111	[p5l901t2525r1113b2590],
5	99	CD	PERCENT	99	number	6	SENT_111	[p5l901t2525r1113b2590],
6	%	NN	PERCENT	%	amod	4	SENT_111	[p5l901t2525r1113b2590],
7	for	IN	O	for	mark	8	SENT_111	[p5l1148t2525r1253b2589],
8	either	CC	O	either	dep	4	SENT_111	[p5l1282t2525r1490b2589],
9	compound	NN	O	compound	dep	8	SENT_111	[p5l1520t2525r1922b2608],
10	.	.	O	.	_	0	SENT_111	[p5l1520t2525r1922b2608],

1	Identity	NN	O	identity	nsubjpass	7	SENT_112	[p5l1956t2525r2145b2589, p5l7t2632r127b2715],
2	of	IN	O	of	_	0	SENT_112	[p5l153t2632r231b2696],
3	both	DT	O	both	det	5	SENT_112	[p5l247t2632r409b2696],
4	isolated	VBN	O	isolate	amod	5	SENT_112	[p5l432t2632r716b2696],
5	compounds	NNS	O	compound	prep_of	1	SENT_112	[p5l739t2632r1157b2715],
6	was	VBD	O	be	auxpass	7	SENT_112	[p5l1182t2653r1319b2697],
7	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_112	[p5l1345t2632r1714b2696],
8	by	IN	O	by	_	0	SENT_112	[p5l1736t2632r1825b2715],
9	ESI	NNP	ORGANIZATION	ESI	nn	10	SENT_112	[p5l1849t2633r1983b2697],
10	LC	NNP	O	LC	agent	7	SENT_112	[p5l2007t2633r2149b2697],
11	/	:	O	/	punct	43	SENT_112	[p5l2007t2633r2149b2697],
12	MS/MS	NNP	O	MS/MS	dep	26	SENT_112	[p5l7t2742r290b2806],
13	in	IN	O	in	_	0	SENT_112	[p5l334t2741r403b2805],
14	the	DT	O	the	det	18	SENT_112	[p5l442t2741r551b2805],
15	daughter	NN	O	daughter	nn	18	SENT_112	[p5l593t2741r913b2824],
16	ion	NN	O	ion	nn	18	SENT_112	[p5l950t2741r1065b2805],
17	scanning	NN	O	scanning	nn	18	SENT_112	[p5l1108t2741r1428b2824],
18	mode	NN	O	mode	prep_in	12	SENT_112	[p5l1468t2741r1669b2805],
19	and	CC	O	and	_	0	SENT_112	[p5l1711t2741r1840b2805],
20	nuclear	JJ	O	nuclear	amod	22	SENT_112	[p5l1879t2741r2149b2805],
21	magnetic	JJ	O	magnetic	amod	22	SENT_112	[p5l8t2852r341b2935],
22	resonance	NN	O	resonance	conj_and	18	SENT_112	[p5l404t2872r767b2916],
23	(	CD	NUMBER	(	num	24	SENT_112	[p5l833t2853r1094b2931],
24	NMR	NN	O	nmr	dep	26	SENT_112	[p5l833t2853r1094b2931],
25	)	CD	NUMBER	)	num	26	SENT_112	[p5l833t2853r1094b2931],
26	spectroscopy	NN	O	spectroscopy	dep	43	SENT_112	[p5l1162t2862r1634b2935],
27	(	CD	NUMBER	(	number	28	SENT_112	[p5l1698t2852r2144b2931],
28	one	CD	NUMBER	one	num	33	SENT_112	[p5l1698t2852r2144b2931],
29	—	NN	O	—	nn	33	SENT_112	[p5l1698t2852r2144b2931],
30	dimen	NN	O	diman	nn	33	SENT_112	[p5l1698t2852r2144b2931],
31	—	CD	NUMBER	—	num	33	SENT_112	[p5l1698t2852r2144b2931],
32	sional	JJ	O	sional	amod	33	SENT_112	[p5l11t2960r224b3024],
33	1H	NN	O	1h	dep	26	SENT_112	[p5l265t2946r359b3023],
34	and	CC	O	and	_	0	SENT_112	[p5l395t2960r524b3024],
35	13C	NN	O	13c	dep	43	SENT_112	[p5l564t2946r705b3035],
36	,	,	O	,	_	0	SENT_112	[p5l564t2946r705b3035],
37	as	RB	O	as	_	0	SENT_112	[p5l745t2980r815b3024],
38	well	RB	O	well	_	0	SENT_112	[p5l852t2960r1006b3024],
39	as	IN	O	as	_	0	SENT_112	[p5l1044t2980r1114b3024],
40	two	CD	NUMBER	two	num	41	SENT_112	[p5l1150t2959r1765b3024],
41	—	CD	NUMBER	—	conj_and	35	SENT_112	[p5l1150t2959r1765b3024],
42	dimensional	JJ	O	dimensional	amod	43	SENT_112	[p5l1150t2959r1765b3024],
43	HH	NN	O	hh	dep	10	SENT_112	[p5l1800t2960r2147b3042],
44	.	.	O	.	_	0	SENT_112	[p5l1800t2960r2147b3042],

1	—	NN	O	—	_	0	SENT_113	[p5l1800t2960r2147b3042],
2	.	.	O	.	_	0	SENT_113	[p5l1800t2960r2147b3042],

1	Cosy	JJ	O	cosy	_	0	SENT_114	[p5l1800t2960r2147b3042],
2	and	CC	O	and	_	0	SENT_114	[p5l9t3068r138b3132],
3	CH	NN	O	ch	conj_and	1	SENT_114	[p5l172t3069r563b3151],
4	.	.	O	.	_	0	SENT_114	[p5l172t3069r563b3151],

1	—	NN	O	—	_	0	SENT_115	[p5l172t3069r563b3151],
2	.	.	O	.	_	0	SENT_115	[p5l172t3069r563b3151],

1	Cosy	JJ	O	cosy	amod	2	SENT_116	[p5l172t3069r563b3151],
2	)	NN	O	)	_	0	SENT_116	[p5l172t3069r563b3151],
3	.	.	O	.	_	0	SENT_116	[p5l172t3069r563b3151],

1	2.5	CD	NUMBER	2.5	_	0	SENT_117	[p5l7t3287r134b3351],
2	.	.	O	.	_	0	SENT_117	[p5l7t3287r134b3351],

1	Stock	NNP	O	Stock	nn	2	SENT_118	[p5l191t3287r390b3352],
2	solutions	NNS	O	solution	_	0	SENT_118	[p5l420t3287r749b3351],

1	Stock	NNP	O	Stock	nn	2	SENT_119	[p5l102t3505r308b3569],
2	solutions	NNS	O	solution	nsubjpass	7	SENT_119	[p5l347t3505r671b3569],
3	of	IN	O	of	_	0	SENT_119	[p5l712t3505r791b3569],
4	test	NN	O	test	nn	5	SENT_119	[p5l823t3514r950b3569],
5	compounds	NNS	O	compound	prep_of	2	SENT_119	[p5l988t3505r1406b3588],
6	were	VBD	O	be	auxpass	7	SENT_119	[p5l1446t3525r1620b3569],
7	prepared	VBN	O	prepare	_	0	SENT_119	[p5l1659t3505r1979b3588],
8	following	VBG	O	follow	_	0	SENT_119	[p5l2018t3505r2145b3569, p5l8t3612r257b3695],
9	the	DT	O	the	det	10	SENT_119	[p5l306t3612r416b3676],
10	manufacturers	NNS	O	manufacturer	prep_following	7	SENT_119	[p5l465t3612r1009b3676],
11	’	VBP	O	’	dep	10	SENT_119	[p5l465t3612r1009b3676],
12	instructions	NNS	O	instruction	dobj	11	SENT_119	[p5l1067t3612r1510b3676],
13	.	.	O	.	_	0	SENT_119	[p5l1067t3612r1510b3676],

1	All	DT	O	all	_	0	SENT_120	[p5l1564t3612r1678b3676],
2	compounds	NNS	O	compound	dep	1	SENT_120	[p5l1728t3612r2146b3695],

1	M.	NNP	PERSON	M.	nn	2	SENT_121	[p5l329t3771r362b3794],
2	Ehrhardt	NNP	PERSON	Ehrhardt	_	0	SENT_121	[p5l376t3770r497b3794],
3	et	FW	O	et	nn	4	SENT_121	[p5l509t3775r533b3794],
4	al.	FW	O	al.	dep	2	SENT_121	[p5l543t3770r763b3794],
5	/	:	O	/	punct	2	SENT_121	[p5l543t3770r763b3794],
6	Biochemical	JJ	O	biochemical	amod	7	SENT_121	[p5l543t3770r763b3794],
7	Pharmacology	NN	O	pharmacology	dep	2	SENT_121	[p5l774t3770r969b3800],
8	67	CD	NUMBER	67	number	9	SENT_121	[p5l982t3770r1015b3794],
9	(	CD	NUMBER	(	num	10	SENT_121	[p5l1026t3770r1112b3799],
10	2004	CD	DATE	2004	dep	7	SENT_121	[p5l1026t3770r1112b3799],
11	)	CD	NUMBER	)	number	12	SENT_121	[p5l1026t3770r1112b3799],
12	285-292 287	CD	NUMBER	285-292 287	num	10	SENT_121	[p5l1783t3770r1830b3794],[p5l1125t3770r1239b3794],

1	were	VBD	O	be	auxpass	2	SENT_122	[p6l9t148r184b192],
2	dissolved	VBN	O	dissolve	_	0	SENT_122	[p6l209t128r553b192],
3	in	IN	O	in	_	0	SENT_122	[p6l575t128r645b191],
4	DMSO	NN	ORGANIZATION	dmso	prep_in	2	SENT_122	[p6l668t128r948b192],
5	.	.	O	.	_	0	SENT_122	[p6l668t128r948b192],

1	The	DT	O	the	det	3	SENT_123	[p6l976t128r1116b192],
2	DMSO	NN	ORGANIZATION	dmso	nn	3	SENT_123	[p6l1141t128r1400b192],
3	concentration	NN	O	concentration	nsubj	8	SENT_123	[p6l1426t128r1925b192],
4	in	IN	O	in	_	0	SENT_123	[p6l1948t128r2018b191],
5	the	DT	O	the	det	6	SENT_123	[p6l2041t128r2151b192],
6	assays	NNS	O	assay	prep_in	3	SENT_123	[p6l10t256r238b319],
7	never	RB	O	never	neg	8	SENT_123	[p6l270t256r471b300],
8	exceeded	VBD	O	exceed	_	0	SENT_123	[p6l500t236r840b300],
9	1	CD	PERCENT	1	num	10	SENT_123	[p6l877t237r984b301],
10	%	NN	PERCENT	%	iobj	8	SENT_123	[p6l877t237r984b301],
11	(	CD	NUMBER	(	num	13	SENT_123	[p6l1022t237r1214b315],
12	v/v	NN	O	v/v	nn	13	SENT_123	[p6l1022t237r1214b315],
13	)	NN	O	)	dobj	8	SENT_123	[p6l1022t237r1214b315],
14	,	,	O	,	_	0	SENT_123	[p6l1022t237r1214b315],
15	a	DT	O	a	det	16	SENT_123	[p6l1250t256r1287b300],
16	concentration	NN	O	concentration	appos	13	SENT_123	[p6l1317t236r1816b300],
17	that	WDT	O	that	nsubjpass	19	SENT_123	[p6l1845t236r1982b300],
18	was	VBD	O	be	auxpass	19	SENT_123	[p6l2012t256r2149b301],
19	found	VBN	O	find	rcmod	16	SENT_123	[p6l9t346r220b410],
20	not	RB	O	not	neg	22	SENT_123	[p6l265t355r381b410],
21	to	TO	O	to	aux	22	SENT_123	[p6l424t356r493b410],
22	inﬂuence	VB	O	inﬂuence	xcomp	19	SENT_123	[p6l539t345r873b410],
23	the	DT	O	the	det	24	SENT_123	[p6l918t346r1028b410],
24	results	NNS	O	result	dobj	22	SENT_123	[p6l1073t346r1309b410],
25	of	IN	O	of	_	0	SENT_123	[p6l1357t345r1436b410],
26	the	DT	O	the	det	27	SENT_123	[p6l1474t346r1584b410],
27	assay	NN	O	assay	prep_of	24	SENT_123	[p6l1632t366r1825b428],
28	in	IN	O	in	_	0	SENT_123	[p6l1871t346r1940b409],
29	pilot	NN	O	pilot	nn	30	SENT_123	[p6l1984t346r2152b428],
30	experiments	NNS	O	experiment	prep_in	27	SENT_123	[p6l9t455r473b538],
31	.	.	O	.	_	0	SENT_123	[p6l9t455r473b538],

1	2.6	CD	NUMBER	2.6	_	0	SENT_124	[p6l8t673r135b737],
2	.	.	O	.	_	0	SENT_124	[p6l8t673r135b737],

1	Calcein	NN	O	calcein	_	0	SENT_125	[p6l196t673r476b738],
2	uptake	NN	O	uptake	nn	3	SENT_125	[p6l512t673r750b755],
3	assay	NN	O	assay	dep	1	SENT_125	[p6l786t695r986b755],

1	The	DT	O	the	det	2	SENT_126	[p6l100t892r240b956],
2	assay	NN	O	assay	nsubjpass	17	SENT_126	[p6l294t912r487b975],
3	was	VBD	O	be	auxpass	4	SENT_126	[p6l540t912r677b956],
4	used	VBN	O	use	_	0	SENT_126	[p6l729t892r896b956],
5	to	TO	O	to	aux	6	SENT_126	[p6l947t901r1015b956],
6	determine	VB	O	determine	xcomp	4	SENT_126	[p6l1068t892r1433b956],
7	the	DT	O	the	det	10	SENT_126	[p6l1484t892r1594b956],
8	Pgp	NNP	O	Pgp	nn	10	SENT_126	[p6l1646t894r1785b975],
9	inhibitor	NN	O	inhibitor	nn	10	SENT_126	[p6l1837t892r2153b956],
10	potency	NN	O	potency	dobj	6	SENT_126	[p6l7t1010r296b1082],
11	of	IN	O	of	_	0	SENT_126	[p6l347t999r426b1064],
12	the	DT	O	the	det	14	SENT_126	[p6l470t1000r580b1064],
13	test	NN	O	test	nn	14	SENT_126	[p6l630t1009r757b1064],
14	compounds	NNS	O	compound	prep_of	10	SENT_126	[p6l807t1000r1225b1082],
15	and	CC	O	and	_	0	SENT_126	[p6l1279t1000r1408b1064],
16	was	VBD	O	be	auxpass	17	SENT_126	[p6l1458t1020r1595b1064],
17	performed	VBN	O	perform	conj_and	4	SENT_126	[p6l1646t999r2028b1082],
18	as	IN	O	as	mark	20	SENT_126	[p6l2079t1020r2149b1064],
19	previously	RB	DATE	previously	advmod	20	SENT_126	[p6l7t1108r392b1191],
20	described	VBN	O	describe	advcl	17	SENT_126	[p6l449t1108r799b1172],
21	[	NN	O	[	nn	23	SENT_126	[p6l861t1109r998b1186],
22	18	CD	NUMBER	18	num	23	SENT_126	[p6l861t1109r998b1186],
23	]	NN	O	]	dobj	20	SENT_126	[p6l861t1109r998b1186],
24	with	IN	O	with	_	0	SENT_126	[p6l1061t1108r1222b1172],
25	ca1cein	NN	O	ca1cein	prep_with	20	SENT_126	[p6l1278t1108r1715b1172],
26	.	.	O	.	_	0	SENT_126	[p6l1278t1108r1715b1172],

1	—	NN	O	—	_	0	SENT_127	[p6l1278t1108r1715b1172],
2	.	.	O	.	_	0	SENT_127	[p6l1278t1108r1715b1172],

1	AM	NNP	O	AM	_	0	SENT_128	[p6l1278t1108r1715b1172],
2	in	IN	O	in	_	0	SENT_128	[p6l1771t1108r1840b1171],
3	a	DT	O	a	det	5	SENT_128	[p6l1898t1128r1936b1172],
4	ﬁnal	JJ	O	ﬁnal	amod	5	SENT_128	[p6l1991t1108r2150b1172],
5	concentration	NN	O	concentration	prep_in	1	SENT_128	[p6l9t1218r508b1282],
6	of	IN	O	of	_	0	SENT_128	[p6l542t1218r621b1282],
7	0.5	CD	NUMBER	0.5	num	8	SENT_128	[p6l649t1218r756b1282],
8	uM	NN	O	um	prep_of	1	SENT_128	[p6l790t1219r933b1300],
9	.	.	O	.	_	0	SENT_128	[p6l790t1219r933b1300],

1	Quenching	VBG	O	quench	csubjpass	7	SENT_129	[p6l102t1328r500b1411],
2	test	NN	O	test	nn	5	SENT_129	[p6l535t1337r662b1392],
3	and	CC	O	and	_	0	SENT_129	[p6l697t1328r826b1392],
4	cytotoxicity	NN	O	cytotoxicity	conj_and	2	SENT_129	[p6l860t1328r1296b1411],
5	assay	NN	O	assay	dobj	1	SENT_129	[p6l1332t1348r1525b1411],
6	were	VBD	O	be	auxpass	7	SENT_129	[p6l1561t1348r1735b1392],
7	performed	VBN	O	perform	_	0	SENT_129	[p6l1769t1328r2152b1411],
8	for	IN	O	for	_	0	SENT_129	[p6l9t1435r115b1499],
9	each	DT	O	each	det	11	SENT_129	[p6l147t1435r313b1499],
10	test	NN	O	test	nn	11	SENT_129	[p6l345t1445r472b1499],
11	compound	NN	O	compound	prep_for	7	SENT_129	[p6l505t1435r891b1518],
12	as	IN	O	as	mark	14	SENT_129	[p6l925t1456r995b1499],
13	previously	RB	DATE	previously	advmod	14	SENT_129	[p6l1029t1435r1413b1518],
14	described	VBN	O	describe	advcl	7	SENT_129	[p6l1448t1435r1798b1499],
15	[	CD	NUMBER	[	number	16	SENT_129	[p6l1837t1436r2114b1513],
16	18,19	CD	NUMBER	18,19	num	17	SENT_129	[p6l1837t1436r2114b1513],
17	]	NN	O	]	dobj	14	SENT_129	[p6l1837t1436r2114b1513],
18	.	.	O	.	_	0	SENT_129	[p6l1837t1436r2114b1513],

1	2.7	CD	NUMBER	2.7	_	0	SENT_130	[p6l8t1654r135b1718],
2	.	.	O	.	_	0	SENT_130	[p6l8t1654r135b1718],

1	Confocal	JJ	O	confocal	amod	2	SENT_131	[p6l196t1654r528b1735],
2	laser	NN	O	laser	_	0	SENT_131	[p6l562t1654r746b1718],
3	scanning	NN	O	scanning	nn	4	SENT_131	[p6l774t1656r1102b1735],
4	microscopy	NN	O	microscopy	dep	2	SENT_131	[p6l1137t1656r1553b1735],

1	Intracellular	JJ	O	intracellular	amod	2	SENT_132	[p6l100t1872r550b1936],
2	accumulation	NN	O	accumulation	nsubj	5	SENT_132	[p6l579t1872r1072b1936],
3	of	IN	O	of	_	0	SENT_132	[p6l1101t1872r1180b1936],
4	the	DT	O	the	prep_of	2	SENT_132	[p6l1203t1872r1312b1936],
5	dye	VB	O	dye	_	0	SENT_132	[p6l1342t1872r1471b1955],
6	bodipy	JJ	O	bodipy	amod	8	SENT_132	[p6l1499t1872r2151b1955],
7	—	NN	O	—	nn	8	SENT_132	[p6l1499t1872r2151b1955],
8	verapamil	NN	O	verapamil	dobj	5	SENT_132	[p6l1499t1872r2151b1955],
9	in	IN	O	in	_	0	SENT_132	[p6l8t1982r78b2045],
10	the	DT	O	the	det	11	SENT_132	[p6l103t1982r212b2046],
11	presence	NN	O	presence	prep_in	8	SENT_132	[p6l236t2002r556b2065],
12	of	IN	O	of	_	0	SENT_132	[p6l583t1982r662b2046],
13	the	DT	O	the	det	15	SENT_132	[p6l681t1982r790b2046],
14	test	NN	O	test	nn	15	SENT_132	[p6l816t1991r942b2046],
15	compounds	NNS	O	compound	prep_of	11	SENT_132	[p6l967t1982r1385b2065],
16	was	VBD	O	be	auxpass	17	SENT_132	[p6l1412t2002r1550b2046],
17	analyzed	VBN	O	analyze	dep	8	SENT_132	[p6l1579t1982r1903b2065],
18	with	IN	O	with	_	0	SENT_132	[p6l1928t1982r2088b2046],
19	a	DT	O	a	det	21	SENT_132	[p6l2115t2002r2153b2046],
20	DM	NN	O	dm	nn	21	SENT_132	[p6l8t2091r153b2153],
21	IRE	NN	O	ire	prep_with	17	SENT_132	[p6l181t2091r327b2153],
22	2	CD	NUMBER	2	num	24	SENT_132	[p6l356t2090r397b2153],
23	TCS	NN	ORGANIZATION	tc	nn	24	SENT_132	[p6l427t2090r588b2154],
24	SP	NN	O	sp	nsubjpass	17	SENT_132	[p6l623t2090r720b2154],
25	II	CD	NUMBER	ii	num	29	SENT_132	[p6l748t2091r806b2153],
26	confocal	JJ	O	confocal	amod	29	SENT_132	[p6l835t2089r1148b2153],
27	laser	NN	O	laser	nn	29	SENT_132	[p6l1178t2089r1350b2153],
28	scanning	NN	O	scanning	nn	29	SENT_132	[p6l1380t2089r1700b2172],
29	microscope	NN	O	microscope	dep	17	SENT_132	[p6l1730t2089r2151b2172],
30	from	IN	O	from	_	0	SENT_132	[p6l9t2200r185b2264],
31	Leica	NNP	LOCATION	Leica	prep_from	17	SENT_132	[p6l229t2200r433b2264],
32	as	IN	O	as	mark	33	SENT_132	[p6l478t2220r549b2264],
33	described	VBN	O	describe	dep	17	SENT_132	[p6l595t2200r945b2264],
34	earlier	JJR	O	earlier	advmod	33	SENT_132	[p6l990t2200r1224b2264],
35	[	CD	NUMBER	[	num	37	SENT_132	[p6l1273t2200r1436b2277],
36	19	CD	NUMBER	19	num	37	SENT_132	[p6l1273t2200r1436b2277],
37	]	NN	O	]	dobj	33	SENT_132	[p6l1273t2200r1436b2277],
38	.	.	O	.	_	0	SENT_132	[p6l1273t2200r1436b2277],

1	Bodipy	JJ	O	bodipy	amod	3	SENT_133	[p6l1485t2200r2151b2283],
2	—	NN	O	—	nn	3	SENT_133	[p6l1485t2200r2151b2283],
3	verapamil	NN	O	verapamil	nsubjpass	8	SENT_133	[p6l1485t2200r2151b2283],
4	instead	RB	O	instead	_	0	SENT_133	[p6l8t2309r267b2373],
5	of	IN	O	of	_	0	SENT_133	[p6l289t2309r368b2373],
6	calcein-AM	NN	O	calcein-am	prep_instead_of	3	SENT_133	[p6l384t2309r820b2373],
7	was	VBD	O	be	auxpass	8	SENT_133	[p6l842t2329r979b2373],
8	chosen	VBN	O	choose	_	0	SENT_133	[p6l1004t2309r1256b2373],
9	as	IN	O	as	_	0	SENT_133	[p6l1279t2329r1349b2373],
10	a	DT	O	a	det	11	SENT_133	[p6l1374t2329r1412b2373],
11	substrate	NN	O	substrate	prep_as	8	SENT_133	[p6l1436t2309r1755b2373],
12	to	TO	O	to	aux	13	SENT_133	[p6l1778t2319r1846b2373],
13	conﬁrm	VB	O	conﬁrm	xcomp	8	SENT_133	[p6l1869t2309r2152b2373],
14	the	DT	O	the	det	15	SENT_133	[p6l8t2417r118b2481],
15	interaction	NN	O	interaction	dobj	13	SENT_133	[p6l174t2417r566b2481],
16	with	IN	O	with	_	0	SENT_133	[p6l622t2417r783b2482],
17	calcein	NN	O	calcein	prep_with	15	SENT_133	[p6l838t2417r1097b2481],
18	with	IN	O	with	_	0	SENT_133	[p6l1153t2417r1313b2482],
19	an	DT	O	a	det	22	SENT_133	[p6l1371t2437r1453b2481],
20	independent	JJ	O	independent	amod	22	SENT_133	[p6l1509t2417r1956b2500],
21	Pgp	NNP	O	Pgp	nn	22	SENT_133	[p6l2012t2419r2150b2500],
22	substrate	NN	O	substrate	prep_with	13	SENT_133	[p6l11t2528r351b2592],
23	.	.	O	.	_	0	SENT_133	[p6l11t2528r351b2592],

1	In	IN	O	in	_	0	SENT_134	[p6l421t2530r494b2591],
2	addition	NN	O	addition	prep_in	7	SENT_134	[p6l561t2528r878b2604],
3	,	,	O	,	_	0	SENT_134	[p6l561t2528r878b2604],
4	bodipy	JJ	O	bodipy	amod	6	SENT_134	[p6l946t2528r1598b2611],
5	—	NN	O	—	nn	6	SENT_134	[p6l946t2528r1598b2611],
6	verapamil	NN	O	verapamil	nsubj	7	SENT_134	[p6l946t2528r1598b2611],
7	provides	VBZ	O	provide	_	0	SENT_134	[p6l1662t2528r1975b2611],
8	the	DT	O	the	det	9	SENT_134	[p6l2041t2528r2150b2592],
9	advantage	NN	O	advantage	dobj	7	SENT_134	[p6l10t2636r377b2718],
10	to	TO	O	to	aux	13	SENT_134	[p6l414t2645r482b2700],
11	be	VB	O	be	cop	13	SENT_134	[p6l518t2636r603b2700],
12	more	RBR	O	more	advmod	13	SENT_134	[p6l640t2656r826b2700],
13	resistant	JJ	O	resistant	infmod	9	SENT_134	[p6l862t2636r1168b2700],
14	to	TO	O	to	_	0	SENT_134	[p6l1203t2645r1271b2700],
15	photobleaching	JJ	O	photobleaching	amod	16	SENT_134	[p6l1307t2636r1872b2718],
16	effects	NNS	O	effect	prep_to	13	SENT_134	[p6l1912t2635r2150b2700],
17	caused	VBN	O	cause	partmod	16	SENT_134	[p6l9t2745r257b2809],
18	by	IN	O	by	_	0	SENT_134	[p6l288t2745r378b2827],
19	the	DT	O	the	det	20	SENT_134	[p6l412t2745r521b2809],
20	laser	NN	O	laser	agent	17	SENT_134	[p6l556t2745r740b2809],
21	.	.	O	.	_	0	SENT_134	[p6l556t2745r740b2809],

1	2.8	CD	NUMBER	2.8	_	0	SENT_135	[p6l8t2963r135b3027],
2	.	.	O	.	_	0	SENT_135	[p6l8t2963r135b3027],

1	Uptake	NN	O	uptake	nn	2	SENT_136	[p6l200t2963r454b3045],
2	assay	NN	O	assay	_	0	SENT_136	[p6l488t2985r689b3045],

1	To	TO	O	to	aux	2	SENT_137	[p6l100t3183r192b3245],
2	evaluate	VB	O	evaluate	_	0	SENT_137	[p6l232t3181r532b3245],
3	the	DT	O	the	det	6	SENT_137	[p6l570t3181r680b3245],
4	substrate	NN	O	substrate	nn	6	SENT_137	[p6l722t3181r1042b3245],
5	characteristics	NNS	O	characteristic	nn	6	SENT_137	[p6l1082t3181r1604b3245],
6	L-MDR1	NN	O	l-mdr1	dobj	2	SENT_137	[p6l1644t3182r1975b3244],
7	and	CC	O	and	_	0	SENT_137	[p6l2023t3181r2152b3245],
8	LLC	NN	O	llc	dobj	2	SENT_137	[p6l8t3290r365b3354],
9	.	.	O	.	_	0	SENT_137	[p6l8t3290r365b3354],

1	—	NN	O	—	_	0	SENT_138	[p6l8t3290r365b3354],
2	.	.	O	.	_	0	SENT_138	[p6l8t3290r365b3354],

1	PK1	NN	O	pk1	nn	2	SENT_139	[p6l8t3290r365b3354],
2	cells	NNS	O	cell	nsubjpass	4	SENT_139	[p6l421t3290r584b3354],
3	were	VBD	O	be	auxpass	4	SENT_139	[p6l634t3310r808b3354],
4	incubated	VBN	O	incubate	conj_and	4	SENT_139	[p6l856t3290r1213b3354],
5	with	IN	O	with	_	0	SENT_139	[p6l1260t3290r1421b3354],
6	the	DT	O	the	det	9	SENT_139	[p6l1467t3290r1576b3354],
7	test	NN	O	test	nn	9	SENT_139	[p6l1624t3299r1750b3354],
8	substance	NN	O	substance	nn	9	SENT_139	[p6l1800t3290r2150b3354],
9	(	NN	O	(	prep_with	4	SENT_139	[p6l11t3399r173b3478],
10	100	CD	NUMBER	100	number	11	SENT_139	[p6l11t3399r173b3478],
11	[	CD	NUMBER	[	num	12	SENT_139	[p6l203t3400r328b3481],
12	JM	NN	O	jm	dep	9	SENT_139	[p6l203t3400r328b3481],
13	for	IN	O	for	_	0	SENT_139	[p6l365t3398r470b3463],
14	gemﬁbrozil	NN	O	gemﬁbrozil	prep_for	12	SENT_139	[p6l504t3398r944b3481],
15	,	,	O	,	_	0	SENT_139	[p6l504t3398r944b3481],
16	fenoﬁbric	JJ	O	fenoﬁbric	amod	17	SENT_139	[p6l984t3398r1337b3463],
17	acid	NN	O	acid	prep_for	12	SENT_139	[p6l1376t3398r1545b3475],
18	,	,	O	,	_	0	SENT_139	[p6l1376t3398r1545b3475],
19	and	CC	O	and	_	0	SENT_139	[p6l1586t3399r1715b3463],
20	bezaﬁbrate	NN	O	bezaﬁbrate	prep_for	12	SENT_139	[p6l1749t3399r2151b3463],
21	and	CC	O	and	_	0	SENT_139	[p6l10t3507r139b3571],
22	25	CD	NUMBER	25	num	23	SENT_139	[p6l167t3507r251b3572],
23	uM	NN	O	um	conj_and	9	SENT_139	[p6l284t3509r409b3589],
24	for	IN	O	for	_	0	SENT_139	[p6l437t3507r542b3571],
25	fenoﬁbrate	JJ	O	fenoﬁbrate	amod	26	SENT_139	[p6l568t3507r990b3586],
26	)	NN	O	)	prep_for	23	SENT_139	[p6l568t3507r990b3586],
27	with	IN	O	with	_	0	SENT_139	[p6l1021t3507r1182b3571],
28	and	CC	O	and	_	0	SENT_139	[p6l1210t3507r1339b3571],
29	without	IN	O	without	_	0	SENT_139	[p6l1366t3507r1645b3572],
30	Pgp	NNP	O	Pgp	nn	32	SENT_139	[p6l1670t3509r1809b3590],
31	inhibitor	NN	O	inhibitor	nn	32	SENT_139	[p6l1837t3507r2153b3571],
32	(	NN	O	(	prep_without	4	SENT_139	[p6l11t3618r474b3697],
33	LY335979	NN	O	ly335979	nn	34	SENT_139	[p6l11t3618r474b3697],
34	)	NN	O	)	prep_with	4	SENT_139	[p6l11t3618r474b3697],
35	.	.	O	.	_	0	SENT_139	[p6l11t3618r474b3697],

1	To	TO	O	to	aux	2	SENT_140	[p6l516t3619r608b3682],
2	demonstrate	VB	O	demonstrate	dep	10	SENT_140	[p6l647t3618r1093b3682],
3	the	DT	O	the	det	4	SENT_140	[p6l1130t3618r1239b3682],
4	suitability	NN	O	suitability	dobj	2	SENT_140	[p6l1281t3618r1643b3701],
5	of	IN	O	of	_	0	SENT_140	[p6l1682t3618r1760b3682],
6	the	DT	O	the	det	7	SENT_140	[p6l1791t3618r1900b3682],
7	assay	NN	O	assay	prep_of	4	SENT_140	[p6l1940t3638r2148b3701],
8	,	,	O	,	_	0	SENT_140	[p6l1940t3638r2148b3701],
9	loperamide	NN	O	loperamide	nn	10	SENT_140	[p6l9t3727r420b3810],
10	(	NN	O	(	_	0	SENT_140	[p6l477t3727r540b3806],
11	1	CD	NUMBER	1	num	13	SENT_140	[p6l477t3727r540b3806],
12	uM	NN	O	um	nn	13	SENT_140	[p6l577t3728r731b3809],
13	)	NN	O	)	nsubjpass	15	SENT_140	[p6l577t3728r731b3809],
14	was	VBD	O	be	auxpass	15	SENT_140	[p6l788t3747r925b3791],
15	used	VBN	O	use	rcmod	10	SENT_140	[p6l980t3727r1147b3791],
16	as	IN	O	as	_	0	SENT_140	[p6l1202t3747r1272b3791],
17	a	DT	O	a	det	19	SENT_140	[p6l1329t3747r1367b3791],
18	Pgp	NNP	O	Pgp	nn	19	SENT_140	[p6l1419t3728r1558b3810],
19	substrate	NN	O	substrate	prep_as	15	SENT_140	[p6l1616t3727r1936b3791],
20	in	IN	O	in	_	0	SENT_140	[p6l1990t3727r2060b3790],
21	a	DT	O	a	det	23	SENT_140	[p6l2115t3747r2153b3791],
22	separate	JJ	O	separate	amod	23	SENT_140	[p7l11t29r307b102],
23	experiment	NN	O	experiment	prep_in	15	SENT_140	[p7l354t19r766b102],
24	in	IN	O	in	_	0	SENT_140	[p7l810t19r879b83],
25	both	DT	O	both	det	27	SENT_140	[p7l923t19r1086b83],
26	cell	NN	O	cell	nn	27	SENT_140	[p7l1132t19r1261b83],
27	lines	NNS	O	line	prep_in	23	SENT_140	[p7l1308t19r1497b83],
28	.	.	O	.	_	0	SENT_140	[p7l1308t19r1497b83],

1	One	CD	DURATION	one	num	2	SENT_141	[p7l1549t20r1697b84],
2	day	NN	DURATION	day	nsubjpass	10	SENT_141	[p7l1744t19r1872b102],
3	before	IN	O	before	_	0	SENT_141	[p7l1917t19r2151b83],
4	performing	VBG	O	perform	prepc_before	2	SENT_141	[p7l7t130r419b213],
5	the	DT	O	the	det	8	SENT_141	[p7l467t130r577b194],
6	assay	NN	O	assay	nn	8	SENT_141	[p7l627t150r820b213],
7	culture	NN	O	culture	nn	8	SENT_141	[p7l870t130r1122b194],
8	medium	NN	O	medium	dobj	4	SENT_141	[p7l1170t130r1470b194],
9	was	VBD	O	be	auxpass	10	SENT_141	[p7l1518t150r1655b194],
10	replaced	VBN	O	replace	_	0	SENT_141	[p7l1704t130r2015b213],
11	by	IN	O	by	_	0	SENT_141	[p7l2061t130r2151b213],
12	Vincristine	NN	O	vincristine	agent	10	SENT_141	[p7l9t237r567b302],
13	—	CD	NUMBER	—	num	12	SENT_141	[p7l9t237r567b302],
14	free	JJ	O	free	dep	15	SENT_141	[p7l9t237r567b302],
15	medium	NN	O	medium	amod	12	SENT_141	[p7l625t238r943b302],
16	.	.	O	.	_	0	SENT_141	[p7l625t238r943b302],

1	The	DT	O	the	det	2	SENT_142	[p7l1004t238r1144b302],
2	assay	NN	O	assay	nsubjpass	4	SENT_142	[p7l1203t258r1396b320],
3	was	VBD	O	be	auxpass	4	SENT_142	[p7l1454t258r1591b302],
4	conducted	VBN	O	conduct	_	0	SENT_142	[p7l1651t238r2027b302],
5	in	IN	O	in	_	0	SENT_142	[p7l2083t238r2152b301],
6	collagen	NN	O	collagen	nn	10	SENT_142	[p7l9t347r590b429],
7	—	JJ	O	—	amod	10	SENT_142	[p7l9t347r590b429],
8	coated	JJ	O	coated	amod	10	SENT_142	[p7l9t347r590b429],
9	48-well	JJ	O	48-well	amod	10	SENT_142	[p7l630t347r909b411],
10	microtiter	NN	O	microtiter	prep_in	4	SENT_142	[p7l951t347r1314b411],
11	plates	VBZ	O	plate	dep	10	SENT_142	[p7l1353t347r1564b429],
12	(	CD	NUMBER	(	number	13	SENT_142	[p7l1610t346r1932b426],
13	150,000	CD	NUMBER	150,000	num	14	SENT_142	[p7l1610t346r1932b426],
14	cells	NNS	O	cell	dobj	11	SENT_142	[p7l1960t346r2153b411],
15	/	:	O	/	punct	17	SENT_142	[p7l1960t346r2153b411],
16	cmz	NN	O	cmz	nn	17	SENT_142	[p7l9t436r202b534],
17	)	NN	O	)	dep	14	SENT_142	[p7l9t436r202b534],
18	.	.	O	.	_	0	SENT_142	[p7l9t436r202b534],

1	All	DT	O	all	det	3	SENT_143	[p7l230t455r344b519],
2	incubation	NN	O	incubation	nn	3	SENT_143	[p7l369t455r756b519],
3	steps	NNS	O	step	nsubjpass	8	SENT_143	[p7l783t465r959b538],
4	and	CC	O	and	_	0	SENT_143	[p7l986t455r1115b519],
5	cell	NN	O	cell	nn	6	SENT_143	[p7l1139t455r1269b519],
6	lysis	NN	O	lysis	conj_and	3	SENT_143	[p7l1294t455r1457b538],
7	were	VBD	O	be	auxpass	8	SENT_143	[p7l1483t476r1658b519],
8	performed	VBN	O	perform	_	0	SENT_143	[p7l1681t455r2064b538],
9	at	IN	O	at	_	0	SENT_143	[p7l2089t465r2152b519],
10	room	NN	O	room	nn	11	SENT_143	[p7l7t586r201b630],
11	temperature	NN	O	temperature	prep_at	8	SENT_143	[p7l225t576r662b649],
12	on	IN	O	on	_	0	SENT_143	[p7l690t586r778b630],
13	a	DT	O	a	det	15	SENT_143	[p7l806t586r844b630],
14	rotary	JJ	O	rotary	amod	15	SENT_143	[p7l867t576r1084b649],
15	shaker	NN	O	shaker	prep_on	8	SENT_143	[p7l1114t566r1350b630],
16	at	IN	O	at	_	0	SENT_143	[p7l1376t576r1439b630],
17	450	CD	NUMBER	450	num	18	SENT_143	[p7l1463t566r1598b630],
18	rpm	NN	O	rpm	prep_at	15	SENT_143	[p7l1624t586r1788b649],
19	.	.	O	.	_	0	SENT_143	[p7l1624t586r1788b649],

1	The	DT	O	the	det	2	SENT_144	[p7l1818t566r1958b630],
2	cells	NNS	O	cell	nsubjpass	9	SENT_144	[p7l1986t566r2149b630],
3	were	VBD	O	be	auxpass	4	SENT_144	[p7l9t694r184b738],
4	washed	VBN	O	wash	_	0	SENT_144	[p7l222t673r494b738],
5	with	IN	O	with	_	0	SENT_144	[p7l532t673r694b738],
6	prewarmed	JJ	O	prewarmed	amod	7	SENT_144	[p7l730t673r1142b756],
7	HHBSS	NNS	O	hhbss	prep_with	4	SENT_144	[p7l1179t674r1467b738],
8	and	CC	O	and	_	0	SENT_144	[p7l1511t673r1640b737],
9	preincubated	VBN	O	preincubate	conj_and	4	SENT_144	[p7l1677t673r2152b756],
10	for	IN	O	for	_	0	SENT_144	[p7l9t782r115b846],
11	1	CD	DURATION	1	num	12	SENT_144	[p7l152t783r179b846],
12	hr	NN	DURATION	hr	prep_for	9	SENT_144	[p7l212t782r288b846],
13	with	IN	O	with	_	0	SENT_144	[p7l318t782r479b847],
14	HHBSS	NN	O	hhbss	prep_with	12	SENT_144	[p7l510t783r820b847],
15	.	.	O	.	_	0	SENT_144	[p7l510t783r820b847],

1	Subsequently	RB	O	subsequently	advmod	33	SENT_145	[p7l857t782r1362b865],
2	,	,	O	,	_	0	SENT_145	[p7l857t782r1362b865],
3	HHBSS	NN	O	hhbss	nsubjpass	33	SENT_145	[p7l1396t783r1684b847],
4	as	IN	O	as	_	0	SENT_145	[p7l1721t803r1790b846],
5	a	DT	O	a	det	6	SENT_145	[p7l1826t803r1863b846],
6	control	NN	O	control	prep_as	3	SENT_145	[p7l1894t782r2151b846],
7	or	CC	O	or	_	0	SENT_145	[p7l10t913r84b957],
8	LY335979	NN	O	ly335979	prep_as	3	SENT_145	[p7l114t893r499b958],
9	(	CD	NUMBER	(	num	11	SENT_145	[p7l536t893r723b972],
10	ﬁnal	JJ	O	ﬁnal	amod	11	SENT_145	[p7l536t893r723b972],
11	concentration	NN	O	concentration	dep	6	SENT_145	[p7l757t893r1255b957],
12	5	CD	NUMBER	5	num	13	SENT_145	[p7l1289t893r1327b957],
13	uM	NN	O	um	dep	6	SENT_145	[p7l1360t895r1486b975],
14	in	IN	O	in	_	0	SENT_145	[p7l1518t893r1587b956],
15	uptake	NN	O	uptake	nn	16	SENT_145	[p7l1619t893r1861b976],
16	experiments	NNS	O	experiment	prep_in	13	SENT_145	[p7l1895t893r2149b976, p7l8t1010r224b1065],
17	with	IN	O	with	_	0	SENT_145	[p7l253t1001r414b1065],
18	ﬁbrates	NNS	O	ﬁbrates	prep_with	16	SENT_145	[p7l441t1000r706b1065],
19	and	CC	O	and	_	0	SENT_145	[p7l736t1001r865b1065],
20	1	CD	NUMBER	1	num	21	SENT_145	[p7l900t1001r927b1064],
21	uM	NN	O	um	conj_and	6	SENT_145	[p7l964t1002r1089b1083],
22	for	IN	O	for	_	0	SENT_145	[p7l1117t1000r1223b1065],
23	uptake	NN	O	uptake	nn	24	SENT_145	[p7l1247t1001r1489b1083],
24	experiments	NNS	O	experiment	prep_for	21	SENT_145	[p7l1518t1000r1962b1083],
25	with	IN	O	with	_	0	SENT_145	[p7l1991t1001r2152b1065],
26	loperamide	NN	O	loperamide	nn	27	SENT_145	[p7l9t1110r449b1192],
27	)	NN	O	)	prep_with	24	SENT_145	[p7l9t1110r449b1192],
28	as	IN	O	as	_	0	SENT_145	[p7l482t1130r552b1174],
29	a	DT	O	a	det	31	SENT_145	[p7l583t1130r621b1174],
30	Pgp	NNP	O	Pgp	nn	31	SENT_145	[p7l648t1111r787b1192],
31	inhibitor	NN	O	inhibitor	prep_as	27	SENT_145	[p7l816t1110r1132b1174],
32	was	VBD	O	be	auxpass	33	SENT_145	[p7l1159t1130r1296b1174],
33	added	VBN	O	add	_	0	SENT_145	[p7l1328t1109r1544b1174],
34	for	IN	O	for	_	0	SENT_145	[p7l1572t1110r1678b1174],
35	15	CD	DURATION	15	num	36	SENT_145	[p7l1712t1109r1789b1174],
36	min	NN	DURATION	min	prep_for	33	SENT_145	[p7l1819t1110r1978b1174],
37	.	.	O	.	_	0	SENT_145	[p7l1819t1110r1978b1174],

1	The	DT	O	the	det	3	SENT_146	[p7l2011t1110r2151b1174],
2	test	NN	O	test	nn	3	SENT_146	[p7l8t1228r135b1282],
3	compound	NN	O	compound	nsubjpass	5	SENT_146	[p7l195t1218r581b1301],
4	was	VBD	O	be	auxpass	5	SENT_146	[p7l640t1238r777b1282],
5	applied	VBN	O	apply	_	0	SENT_146	[p7l841t1218r1110b1301],
6	and	CC	O	and	_	0	SENT_146	[p7l1171t1218r1299b1282],
7	the	DT	O	the	det	8	SENT_146	[p7l1359t1218r1468b1282],
8	supernatant	NN	O	supernatant	nsubj	9	SENT_146	[p7l1533t1228r1953b1301],
9	was	VBD	O	be	conj_and	5	SENT_146	[p7l2012t1238r2149b1282],

1	Table	NNP	O	Table	nsubj	4	SENT_147	[p7l8t1447r164b1497],
2	1	CD	NUMBER	1	num	4	SENT_147	[p7l197t1447r218b1496],
3	LC/MS/MS	NN	O	lc/ms/ms	nn	4	SENT_147	[p7l8t1536r341b1586],
4	parameters	NNS	O	parameter	_	0	SENT_147	[p7l368t1544r680b1601],
5	for	IN	O	for	_	0	SENT_147	[p7l707t1536r790b1586],
6	quantiﬁcation	NN	O	quantiﬁcation	prep_for	4	SENT_147	[p7l814t1536r1206b1601],
7	of	IN	O	of	_	0	SENT_147	[p7l1232t1536r1294b1586],
8	the	DT	O	the	det	11	SENT_147	[p7l1314t1536r1400b1586],
9	intracellular	JJ	O	intracellular	amod	11	SENT_147	[p7l1426t1536r1772b1586],
10	drug	NN	O	drug	nn	11	SENT_147	[p7l1798t1536r1925b1601],
11	uptake	NN	O	uptake	prep_of	6	SENT_147	[p7l1951t1536r2140b1601],
12	detached	VBN	O	detach	partmod	11	SENT_147	[p7l9t1762r333b1826],
13	after	IN	O	after	_	0	SENT_147	[p7l369t1762r535b1826],
14	2	CD	NUMBER	2	prep_after	12	SENT_147	[p7l569t1762r631b1838],
15	,	,	O	,	_	0	SENT_147	[p7l569t1762r631b1838],
16	10	CD	NUMBER	10	nn	26	SENT_147	[p7l677t1762r777b1838],
17	,	,	O	,	_	0	SENT_147	[p7l677t1762r777b1838],
18	30	CD	NUMBER	30	num	16	SENT_147	[p7l818t1762r923b1838],
19	,	,	O	,	_	0	SENT_147	[p7l818t1762r923b1838],
20	or	CC	O	or	_	0	SENT_147	[p7l963t1782r1037b1826],
21	60	CD	DURATION	60	nn	26	SENT_147	[p7l1071t1762r1158b1826],
22	min	NN	DURATION	min	nn	25	SENT_147	[p7l1184t1762r1325b1825],
23	(	CD	NUMBER	(	num	25	SENT_147	[p7l1362t1762r1720b1845],
24	sextuplet	NN	O	sextuplet	nn	25	SENT_147	[p7l1362t1762r1720b1845],
25	determination	NN	O	determination	dep	16	SENT_147	[p7l1754t1762r2148b1826, p7l7t1868r197b1947],
26	)	NN	O	)	dobj	4	SENT_147	[p7l1754t1762r2148b1826, p7l7t1868r197b1947],
27	.	.	O	.	_	0	SENT_147	[p7l1754t1762r2148b1826, p7l7t1868r197b1947],

1	The	DT	O	the	det	2	SENT_148	[p7l244t1868r384b1932],
2	cells	NNS	O	cell	nsubjpass	13	SENT_148	[p7l428t1868r591b1932],
3	were	VBD	O	be	auxpass	4	SENT_148	[p7l636t1888r811b1933],
4	washed	VBN	O	wash	_	0	SENT_148	[p7l852t1868r1126b1932],
5	twice	RB	O	twice	advmod	4	SENT_148	[p7l1167t1868r1364b1932],
6	with	IN	O	with	_	0	SENT_148	[p7l1405t1868r1565b1933],
7	precooled	JJ	O	precooled	amod	8	SENT_148	[p7l1606t1868r1969b1951],
8	(	NN	O	(	prep_with	5	SENT_148	[p7l2013t1867r2148b1947],
9	40	CD	NUMBER	40	number	10	SENT_148	[p7l2013t1867r2148b1947],
10	)	CD	NUMBER	)	num	11	SENT_148	[p7l2013t1867r2148b1947],
11	HHBSS	NNS	O	hhbss	dobj	4	SENT_148	[p7l8t1977r295b2041],
12	and	CC	O	and	_	0	SENT_148	[p7l335t1977r465b2041],
13	lyzed	VBN	O	lyze	conj_and	4	SENT_148	[p7l499t1977r696b2059],
14	with	IN	O	with	_	0	SENT_148	[p7l730t1977r891b2041],
15	1	CD	PERCENT	1	number	16	SENT_148	[p7l934t1977r1041b2041],
16	%	NN	PERCENT	%	amod	18	SENT_148	[p7l934t1977r1041b2041],
17	Triton	NNP	ORGANIZATION	Triton	nn	18	SENT_148	[p7l1079t1977r1304b2041],
18	X-100	NN	O	x-100	prep_with	13	SENT_148	[p7l1338t1977r1570b2041],
19	within	IN	O	within	_	0	SENT_148	[p7l1605t1977r1837b2041],
20	30	CD	DURATION	30	num	21	SENT_148	[p7l1874t1977r1960b2041],
21	min	NN	DURATION	min	prep_within	18	SENT_148	[p7l1987t1976r2145b2041],
22	.	.	O	.	_	0	SENT_148	[p7l1987t1976r2145b2041],

1	After	IN	O	after	_	0	SENT_149	[p7l8t2084r200b2148],
2	adding	VBG	O	add	prepc_after	10	SENT_149	[p7l222t2084r467b2167],
3	internal	JJ	O	internal	amod	4	SENT_149	[p7l489t2084r768b2148],
4	standard	NN	O	standard	dobj	2	SENT_149	[p7l793t2084r1100b2148],
5	the	DT	O	the	det	7	SENT_149	[p7l1120t2084r1230b2148],
6	cell	NN	O	cell	nn	7	SENT_149	[p7l1253t2084r1382b2148],
7	lysates	NNS	O	lysate	nsubjpass	10	SENT_149	[p7l1405t2084r1650b2167],
8	were	VBD	O	be	auxpass	10	SENT_149	[p7l1674t2104r1848b2148],
9	directly	RB	O	directly	advmod	10	SENT_149	[p7l1872t2084r2150b2167],
10	analyzed	VBN	O	analyze	_	0	SENT_149	[p7l9t2194r333b2277],
11	by	IN	O	by	_	0	SENT_149	[p7l364t2194r454b2277],
12	LC/MS/MS	NN	O	lc/ms/ms	agent	10	SENT_149	[p7l488t2194r937b2258],
13	.	.	O	.	_	0	SENT_149	[p7l488t2194r937b2258],

1	2.9	CD	NUMBER	2.9	_	0	SENT_150	[p7l7t2413r134b2477],
2	.	.	O	.	_	0	SENT_150	[p7l7t2413r134b2477],

1	Analytical	NNP	O	Analytical	nn	2	SENT_151	[p7l185t2412r568b2494],
2	methods	NNS	O	method	_	0	SENT_151	[p7l601t2412r904b2477],

1	For	IN	O	for	_	0	SENT_152	[p7l98t2632r224b2695],
2	the	DT	O	the	det	3	SENT_152	[p7l263t2631r372b2695],
3	quantiﬁcation	NN	O	quantiﬁcation	prep_for	19	SENT_152	[p7l415t2631r918b2713],
4	of	IN	O	of	_	0	SENT_152	[p7l960t2630r1039b2695],
5	intracellular	JJ	O	intracellular	amod	7	SENT_152	[p7l1073t2631r1518b2695],
6	drug	NN	O	drug	nn	7	SENT_152	[p7l1558t2631r1722b2713],
7	concentrations	NNS	O	concentration	prep_of	3	SENT_152	[p7l1765t2641r2148b2695, p7l7t2739r182b2803],
8	in	IN	O	in	_	0	SENT_152	[p7l213t2739r282b2802],
9	the	DT	O	the	det	11	SENT_152	[p7l311t2739r420b2803],
10	uptake	NN	O	uptake	nn	11	SENT_152	[p7l451t2739r693b2822],
11	assays	NNS	O	assay	prep_in	7	SENT_152	[p7l725t2759r953b2822],
12	methods	NNS	O	method	nsubjpass	19	SENT_152	[p7l985t2739r1292b2803],
13	depending	VBG	O	depend	_	0	SENT_152	[p7l1324t2739r1703b2822],
14	on	IN	O	on	prepc_depending_on	12	SENT_152	[p7l1734t2759r1822b2803],
15	LC/MS	NN	O	lc/ms	pobj	12	SENT_152	[p7l1851t2740r2152b2804],
16	/	:	O	/	punct	17	SENT_152	[p7l1851t2740r2152b2804],
17	MS	NN	O	m	dep	12	SENT_152	[p7l7t2850r133b2914],
18	were	VBD	O	be	auxpass	19	SENT_152	[p7l189t2870r364b2914],
19	developed	VBN	O	develop	_	0	SENT_152	[p7l417t2850r808b2933],
20	.	.	O	.	_	0	SENT_152	[p7l417t2850r808b2933],

1	The	DT	O	the	det	4	SENT_153	[p7l865t2850r1004b2914],
2	mass	NN	O	mass	nn	4	SENT_153	[p7l1057t2870r1237b2914],
3	spectrometric	NN	O	spectrometric	nn	4	SENT_153	[p7l1293t2850r1787b2933],
4	analyses	NNS	O	analysis	nsubjpass	6	SENT_153	[p7l1843t2850r2148b2933],
5	were	VBD	O	be	auxpass	6	SENT_153	[p7l8t2979r183b3023],
6	performed	VBN	O	perform	_	0	SENT_153	[p7l222t2959r604b3042],
7	on	IN	O	on	_	0	SENT_153	[p7l644t2979r733b3023],
8	a	DT	O	a	det	12	SENT_153	[p7l774t2979r812b3023],
9	triple	JJ	O	triple	amod	12	SENT_153	[p7l850t2959r1041b3042],
10	stage	NN	O	stage	nn	12	SENT_153	[p7l1085t2968r1267b3042],
11	quadrupole	NN	O	quadrupole	nn	12	SENT_153	[p7l1309t2959r1719b3042],
12	instrument	NN	O	instrument	prep_on	6	SENT_153	[p7l1759t2959r2151b3023],
13	(	CD	NUMBER	(	num	14	SENT_153	[p7l10t3067r208b3146],
14	TSQ	NNP	O	TSQ	tmod	6	SENT_153	[p7l10t3067r208b3146],
15	7000	CD	NUMBER	7000	num	14	SENT_153	[p7l257t3067r456b3142],
16	,	,	O	,	_	0	SENT_153	[p7l257t3067r456b3142],
17	Thermo	NNP	PERSON	Thermo	nn	19	SENT_153	[p7l508t3066r795b3130],
18	Finnigan	NNP	PERSON	Finnigan	nn	19	SENT_153	[p7l845t3066r1218b3149],
19	)	NN	O	)	appos	14	SENT_153	[p7l845t3066r1218b3149],
20	.	.	O	.	_	0	SENT_153	[p7l845t3066r1218b3149],

1	Sample	NN	O	sample	nn	2	SENT_154	[p7l1273t3066r1544b3149],
2	admission	NN	O	admission	nsubjpass	4	SENT_154	[p7l1594t3066r1963b3130],
3	was	VBD	O	be	auxpass	4	SENT_154	[p7l2011t3087r2148b3131],
4	done	VBN	O	do	_	0	SENT_154	[p7l9t3177r183b3241],
5	by	IN	O	by	_	0	SENT_154	[p7l207t3177r296b3260],
6	an	DT	O	a	det	8	SENT_154	[p7l324t3197r406b3241],
7	autosampler	NN	O	autosampler	nn	8	SENT_154	[p7l432t3177r880b3260],
8	Type	NN	O	type	agent	4	SENT_154	[p7l903t3179r1082b3260],
9	232XL	CD	NUMBER	232xl	dobj	24	SENT_154	[p7l1109t3177r1364b3241],
10	from	IN	O	from	_	0	SENT_154	[p7l1390t3177r1566b3241],
11	Gilson	NNP	PERSON	Gilson	nn	12	SENT_154	[p7l1592t3177r1832b3241],
12	Abimed	NNP	PERSON	Abimed	prep_from	9	SENT_154	[p7l1857t3177r2151b3241],
13	and	CC	O	and	_	0	SENT_154	[p7l9t3286r138b3350],
14	an	DT	O	a	det	17	SENT_154	[p7l172t3306r255b3350],
15	LC	NN	O	lc	nn	17	SENT_154	[p7l287t3286r400b3350],
16	gradient	NN	O	gradient	nn	17	SENT_154	[p7l436t3286r735b3369],
17	pump	NN	O	pump	conj_and	12	SENT_154	[p7l766t3306r972b3369],
18	(	CD	NUMBER	(	num	19	SENT_154	[p7l1009t3286r1268b3365],
19	P4000	NN	O	p4000	dep	17	SENT_154	[p7l1009t3286r1268b3365],
20	Thermo	NNP	PERSON	Thermo	nn	22	SENT_154	[p7l1301t3286r1589b3350],
21	Finnigan	NNP	PERSON	Finnigan	nn	22	SENT_154	[p7l1623t3286r1975b3369],
22	)	NN	O	)	nsubjpass	24	SENT_154	[p7l1623t3286r1975b3369],
23	was	VBD	O	be	auxpass	24	SENT_154	[p7l2011t3306r2148b3350],
24	used	VBN	O	use	rcmod	8	SENT_154	[p7l7t3394r174b3458],
25	with	IN	O	with	_	0	SENT_154	[p7l195t3393r356b3458],
26	a	DT	O	a	det	27	SENT_154	[p7l380t3414r418b3458],
27	degasser	NN	O	degasser	prep_with	24	SENT_154	[p7l440t3394r765b3476],
28	.	.	O	.	_	0	SENT_154	[p7l440t3394r765b3476],

1	Chromatography	NN	O	chromatography	nsubjpass	3	SENT_155	[p7l794t3394r1412b3476],
2	was	VBD	O	be	auxpass	3	SENT_155	[p7l1436t3414r1573b3458],
3	performed	VBN	O	perform	_	0	SENT_155	[p7l1596t3394r1979b3476],
4	on	IN	O	on	_	0	SENT_155	[p7l2002t3414r2090b3458],
5	a	DT	O	a	det	8	SENT_155	[p7l2114t3414r2152b3458],
6	Kromasil	NNP	O	Kromasil	nn	8	SENT_155	[p7l9t3502r346b3566],
7	RP18	NN	O	rp18	nn	8	SENT_155	[p7l403t3503r601b3567],
8	CC	NN	O	cc	prep_on	3	SENT_155	[p7l662t3503r779b3567],
9	125/3	CD	NUMBER	125/3	dep	8	SENT_155	[p7l846t3502r1066b3578],
10	;	:	O	;	_	0	SENT_155	[p7l846t3502r1066b3578],
11	100	CD	NUMBER	100	number	12	SENT_155	[p7l1135t3502r1402b3567],
12	—	CD	NUMBER	—	dep	8	SENT_155	[p7l1135t3502r1402b3567],
13	3.5	CD	NUMBER	3.5	num	15	SENT_155	[p7l1135t3502r1402b3567],
14	analytical	JJ	O	analytical	amod	15	SENT_155	[p7l1465t3502r1820b3585],
15	column	NN	O	column	dep	12	SENT_155	[p7l1877t3502r2150b3566],
16	(	CD	NUMBER	(	num	18	SENT_155	[p7l10t3613r402b3696],
17	Macherey	NNP	O	Macherey	nn	18	SENT_155	[p7l10t3613r402b3696],
18	und	NN	O	und	tmod	3	SENT_155	[p7l454t3613r590b3677],
19	Nagel	NNP	PERSON	Nagel	dep	18	SENT_155	[p7l640t3613r886b3696],
20	)	CD	NUMBER	)	num	19	SENT_155	[p7l640t3613r886b3696],
21	using	VBG	O	use	xcomp	3	SENT_155	[p7l940t3613r1136b3696],
22	an	DT	O	a	det	29	SENT_155	[p7l1191t3633r1273b3677],
23	isocratic	JJ	O	isocratic	amod	29	SENT_155	[p7l1325t3613r1633b3677],
24	eluent	JJ	O	eluent	amod	29	SENT_155	[p7l1688t3613r1911b3677],
25	(	NN	O	(	nn	29	SENT_155	[p7l1964t3613r2150b3692],
26	ﬂow	NN	O	ﬂow	nn	29	SENT_155	[p7l1964t3613r2150b3692],
27	0.35	CD	NUMBER	0.35	num	29	SENT_155	[p7l8t3721r161b3786],
28	mL/min	NN	O	ml/min	nn	29	SENT_155	[p7l191t3722r513b3801],
29	)	NN	O	)	dobj	21	SENT_155	[p7l191t3722r513b3801],
30	consisting	VBG	O	consist	partmod	29	SENT_155	[p7l562t3722r930b3805],
31	of	IN	O	of	_	0	SENT_155	[p7l977t3722r1056b3786],
32	water	NN	O	water	prep_of	30	SENT_155	[p7l1095t3731r1298b3786],
33	with	IN	O	with	_	0	SENT_155	[p7l1342t3722r1502b3786],
34	1	CD	PERCENT	1	number	35	SENT_155	[p7l1555t3722r1662b3786],
35	%	NN	PERCENT	%	amod	37	SENT_155	[p7l1555t3722r1662b3786],
36	formic	JJ	O	formic	amod	37	SENT_155	[p7l1711t3722r1953b3786],
37	acid	NN	O	acid	prep_with	30	SENT_155	[p7l2001t3722r2151b3786],

1	(	NN	O	(	nn	4	SENT_156	[p8l10t19r261b98],
2	eluent	NN	O	eluent	nn	4	SENT_156	[p8l10t19r261b98],
3	A	NN	O	a	nn	4	SENT_156	[p8l303t20r394b99],
4	)	NN	O	)	_	0	SENT_156	[p8l303t20r394b99],
5	and	CC	O	and	_	0	SENT_156	[p8l441t19r570b84],
6	acetonitrile	NN	O	acetonitrile	nn	7	SENT_156	[p8l613t19r1024b84],
7	(	NN	O	(	conj_and	4	SENT_156	[p8l1070t19r1321b98],
8	eluent	JJ	O	eluent	amod	10	SENT_156	[p8l1070t19r1321b98],
9	B	NN	O	b	nn	10	SENT_156	[p8l1363t20r1449b98],
10	)	NN	O	)	dep	4	SENT_156	[p8l1363t20r1449b98],
11	in	IN	O	in	_	0	SENT_156	[p8l1494t19r1563b83],
12	different	JJ	O	different	amod	14	SENT_156	[p8l1606t19r1919b84],
13	Volumetric	JJ	O	volumetric	amod	14	SENT_156	[p8l1960t19r2148b84, p8l8t130r239b194],
14	parts	NNS	O	part	prep_in	10	SENT_156	[p8l262t140r437b213],
15	depending	VBG	O	depend	partmod	4	SENT_156	[p8l462t130r841b213],
16	on	IN	O	on	_	0	SENT_156	[p8l865t150r953b194],
17	the	DT	O	the	det	18	SENT_156	[p8l976t130r1085b194],
18	drug	NN	O	drug	prep_on	15	SENT_156	[p8l1109t130r1273b213],
19	(	NNP	O	(	nn	20	SENT_156	[p8l1299t130r1527b209],
20	Table	NNP	O	Table	dep	18	SENT_156	[p8l1299t130r1527b209],
21	1	CD	NUMBER	1	number	22	SENT_156	[p8l1559t131r1642b209],
22	)	CD	NUMBER	)	dep	20	SENT_156	[p8l1559t131r1642b209],
23	.	.	O	.	_	0	SENT_156	[p8l1559t131r1642b209],

1	For	IN	O	for	_	0	SENT_157	[p8l1668t132r1794b194],
2	detection	NN	O	detection	prep_for	46	SENT_157	[p8l1816t130r2151b194],
3	of	IN	O	of	_	0	SENT_157	[p8l9t237r88b301],
4	fenoﬁbrate	NN	O	fenoﬁbrate	prep_of	2	SENT_157	[p8l106t237r521b313],
5	,	,	O	,	_	0	SENT_157	[p8l106t237r521b313],
6	fenoﬁbric	JJ	O	fenoﬁbric	amod	7	SENT_157	[p8l551t237r903b301],
7	acid	NN	O	acid	dep	22	SENT_157	[p8l933t237r1101b313],
8	,	,	O	,	_	0	SENT_157	[p8l933t237r1101b313],
9	bezaﬁbrate	NN	O	bezaﬁbrate	conj_and	7	SENT_157	[p8l1130t237r1552b313],
10	,	,	O	,	_	0	SENT_157	[p8l1130t237r1552b313],
11	and	CC	O	and	_	0	SENT_157	[p8l1584t237r1713b301],
12	loperamide	NN	O	loperamide	conj_and	7	SENT_157	[p8l1738t237r2150b320],
13	[	CD	NUMBER	[	num	12	SENT_157	[p8l14t347r151b424],
14	20	CD	NUMBER	20	num	15	SENT_157	[p8l14t347r151b424],
15	]	NN	O	]	dep	22	SENT_157	[p8l14t347r151b424],
16	single	JJ	O	single	amod	22	SENT_157	[p8l188t347r400b429],
17	reaction	NN	O	reaction	nn	22	SENT_157	[p8l428t347r723b411],
18	monitoring	NN	O	monitoring	nn	22	SENT_157	[p8l750t347r1156b429],
19	(	CD	NUMBER	(	num	22	SENT_157	[p8l1186t347r1529b426],
20	MS/MS	NN	O	ms/ms	nn	22	SENT_157	[p8l1186t347r1529b426],
21	)	NN	O	)	nn	22	SENT_157	[p8l1186t347r1529b426],
22	mode	NN	O	mode	dep	27	SENT_157	[p8l1559t347r1760b411],
23	with	IN	O	with	_	0	SENT_157	[p8l1786t347r1946b411],
24	electrospray	NN	O	electrospray	prep_with	22	SENT_157	[p8l1974t347r2147b411, p8l7t465r305b538],
25	ionization	NN	O	ionization	nn	27	SENT_157	[p8l338t455r704b519],
26	(	CD	NUMBER	(	num	27	SENT_157	[p8l738t456r920b534],
27	ESI	NNP	ORGANIZATION	ESI	dep	38	SENT_157	[p8l738t456r920b534],
28	,	,	O	,	_	0	SENT_157	[p8l738t456r920b534],
29	4.5	CD	NUMBER	4.5	num	30	SENT_157	[p8l955t455r1064b520],
30	kV	NN	O	kv	conj_and	27	SENT_157	[p8l1093t455r1211b531],
31	,	,	O	,	_	0	SENT_157	[p8l1093t455r1211b531],
32	Sheath/Aux	NN	O	sheath/aux	nn	35	SENT_157	[p8l1248t455r1677b520],
33	gas	NN	O	gas	nn	35	SENT_157	[p8l1710t475r1826b538],
34	N2	NN	O	n2	nn	35	SENT_157	[p8l1860t456r1986b534],
35	)	NN	O	)	conj_and	27	SENT_157	[p8l1860t456r1986b534],
36	and	CC	O	and	_	0	SENT_157	[p8l2022t455r2151b519],
37	argon	NNP	O	argon	dep	38	SENT_157	[p8l9t586r214b649],
38	as	IN	O	as	dep	46	SENT_157	[p8l240t586r310b630],
39	collision	NN	O	collision	nn	41	SENT_157	[p8l338t566r652b630],
40	gas	NN	O	gas	nn	41	SENT_157	[p8l679t586r795b649],
41	(	NN	O	(	pobj	38	SENT_157	[p8l825t566r892b645],
42	3	CD	NUMBER	3	num	44	SENT_157	[p8l825t566r892b645],
43	mbar	NN	O	mbar	nn	44	SENT_157	[p8l922t566r1137b645],
44	)	NN	O	)	nsubjpass	46	SENT_157	[p8l922t566r1137b645],
45	was	VBD	O	be	auxpass	46	SENT_157	[p8l1165t586r1302b630],
46	used	VBN	O	use	_	0	SENT_157	[p8l1329t566r1513b630],
47	.	.	O	.	_	0	SENT_157	[p8l1329t566r1513b630],

1	Gemﬁbrozil	NNP	O	Gemﬁbrozil	nsubjpass	3	SENT_158	[p8l1545t566r1984b630],
2	was	VBD	O	be	auxpass	3	SENT_158	[p8l2011t586r2148b630],
3	detected	VBN	O	detect	_	0	SENT_158	[p8l9t673r313b737],
4	in	IN	O	in	_	0	SENT_158	[p8l344t673r413b736],
5	single	JJ	O	single	amod	8	SENT_158	[p8l448t673r661b756],
6	ion	NN	O	ion	nn	8	SENT_158	[p8l694t673r809b737],
7	monitoring	NN	O	monitoring	nn	8	SENT_158	[p8l840t673r1246b756],
8	mode	NN	O	mode	prep_in	3	SENT_158	[p8l1279t673r1480b737],
9	with	IN	O	with	_	0	SENT_158	[p8l1511t673r1671b737],
10	atmospheric	JJ	O	atmospheric	amod	13	SENT_158	[p8l1705t673r2148b756],
11	pressure	NN	O	pressure	nn	13	SENT_158	[p8l7t803r309b865],
12	chemical	NN	O	chemical	nn	13	SENT_158	[p8l335t782r665b846],
13	ionization	NN	O	ionization	prep_with	8	SENT_158	[p8l689t782r1056b846],
14	(	CD	NUMBER	(	num	15	SENT_158	[p8l1082t783r1334b861],
15	APCI	NN	O	apcus	dep	3	SENT_158	[p8l1082t783r1334b861],
16	,	,	O	,	_	0	SENT_158	[p8l1082t783r1334b861],
17	5.0	CD	NUMBER	5.0	num	18	SENT_158	[p8l1363t782r1473b847],
18	uA	NN	O	ua	appos	15	SENT_158	[p8l1503t783r1633b864],
19	,	,	O	,	_	0	SENT_158	[p8l1503t783r1633b864],
20	500	CD	NUMBER	500	num	21	SENT_158	[p8l1661t781r1850b858],
21	°	NN	O	°	appos	15	SENT_158	[p8l1661t781r1850b858],
22	,	,	O	,	_	0	SENT_158	[p8l1661t781r1850b858],
23	Sheathl	NNP	O	Sheathl	nn	24	SENT_158	[p8l1879t782r2152b847],
24	Aux	NNP	O	Aux	appos	15	SENT_158	[p8l7t894r162b957],
25	gas	NN	O	gas	nn	27	SENT_158	[p8l203t913r319b976],
26	N2	NN	O	n2	nn	27	SENT_158	[p8l359t894r507b972],
27	)	NN	O	)	dep	24	SENT_158	[p8l359t894r507b972],
28	.	.	O	.	_	0	SENT_158	[p8l359t894r507b972],

1	Details	NNS	O	detail	nsubjpass	10	SENT_159	[p8l550t893r807b957],
2	of	IN	O	of	_	0	SENT_159	[p8l848t893r927b957],
3	the	DT	O	the	det	4	SENT_159	[p8l960t893r1069b957],
4	LC	NN	O	lc	prep_of	1	SENT_159	[p8l1108t893r1222b957],
5	and	CC	O	and	_	0	SENT_159	[p8l1264t893r1393b957],
6	mass	NN	O	mass	nn	8	SENT_159	[p8l1432t913r1610b957],
7	spectrometric	JJ	O	spectrometric	amod	8	SENT_159	[p8l1654t893r2148b976],
8	parameters	NNS	O	parameter	prep_of	1	SENT_159	[p8l7t1010r407b1083],
9	are	VBP	O	be	auxpass	10	SENT_159	[p8l444t1021r552b1064],
10	shown	VBN	O	show	_	0	SENT_159	[p8l589t1000r820b1065],
11	in	IN	O	in	_	0	SENT_159	[p8l853t1000r923b1064],
12	Table	NNP	O	Table	prep_in	10	SENT_159	[p8l956t1000r1155b1064],
13	1	CD	NUMBER	1	num	12	SENT_159	[p8l1199t1001r1251b1064],
14	.	.	O	.	_	0	SENT_159	[p8l1199t1001r1251b1064],

1	The	DT	O	the	det	3	SENT_160	[p8l99t1110r239b1174],
2	calibration	NN	O	calibration	nn	3	SENT_160	[p8l280t1109r672b1174],
3	range	NN	O	range	nsubj	14	SENT_160	[p8l711t1130r912b1192],
4	for	IN	O	for	_	0	SENT_160	[p8l953t1109r1059b1174],
5	gemﬁbrozil	NN	O	gemﬁbrozil	prep_for	3	SENT_160	[p8l1098t1109r1538b1192],
6	,	,	O	,	_	0	SENT_160	[p8l1098t1109r1538b1192],
7	fenoﬁbric	JJ	O	fenoﬁbric	amod	8	SENT_160	[p8l1582t1109r1934b1174],
8	acid	NN	O	acid	prep_for	3	SENT_160	[p8l1978t1109r2147b1186],
9	,	,	O	,	_	0	SENT_160	[p8l1978t1109r2147b1186],
10	and	CC	O	and	_	0	SENT_160	[p8l9t1218r139b1282],
11	bezaﬁbrate	NN	O	bezaﬁbrate	conj_and	5	SENT_160	[p8l178t1218r580b1282],
12	was	VBD	O	be	cop	14	SENT_160	[p8l621t1238r758b1282],
13	0.1	CD	NUMBER	0.1	num	14	SENT_160	[p8l803t1219r1097b1283],
14	—	NN	O	—	_	0	SENT_160	[p8l803t1219r1097b1283],
15	200	CD	NUMBER	200	num	16	SENT_160	[p8l803t1219r1097b1283],
16	uM	NN	O	um	dep	14	SENT_160	[p8l1127t1220r1272b1300],
17	,	,	O	,	_	0	SENT_160	[p8l1127t1220r1272b1300],
18	for	IN	O	for	_	0	SENT_160	[p8l1317t1218r1423b1282],
19	fenoﬁbrate	JJ	O	fenoﬁbrate	amod	21	SENT_160	[p8l1463t1218r1858b1282],
20	0.02550	CD	NUMBER	0.02550	tmod	19	SENT_160	[p8l1901t1218r2152b1283, p8l9t1327r96b1392],
21	uM	NN	O	um	prep_for	14	SENT_160	[p8l125t1329r251b1410],
22	and	CC	O	and	_	0	SENT_160	[p8l274t1328r403b1392],
23	0.0025	CD	NUMBER	0.0025	number	24	SENT_160	[p8l424t1327r830b1392],
24	—	CD	NUMBER	—	conj_and	14	SENT_160	[p8l424t1327r830b1392],
25	0.5	CD	NUMBER	0.5	num	26	SENT_160	[p8l424t1327r830b1392],
26	uM	NN	O	um	dep	24	SENT_160	[p8l863t1329r988b1410],
27	for	IN	O	for	_	0	SENT_160	[p8l1009t1327r1115b1392],
28	loperamide	NN	O	loperamide	prep_for	14	SENT_160	[p8l1135t1328r1565b1410],
29	.	.	O	.	_	0	SENT_160	[p8l1135t1328r1565b1410],

1	The	DT	O	the	det	3	SENT_161	[p8l1591t1328r1730b1392],
2	lower	JJR	O	lower	amod	3	SENT_161	[p8l1753t1328r1958b1392],
3	limit	NN	O	limit	nsubj	8	SENT_161	[p8l1979t1327r2152b1392],
4	of	IN	O	of	_	0	SENT_161	[p8l9t1436r88b1500],
5	quantiﬁcation	NN	O	quantiﬁcation	prep_of	3	SENT_161	[p8l124t1436r627b1519],
6	was	VBD	O	be	cop	8	SENT_161	[p8l671t1456r808b1500],
7	0.1	CD	NUMBER	0.1	num	8	SENT_161	[p8l853t1437r957b1501],
8	uM	NN	O	um	_	0	SENT_161	[p8l994t1438r1119b1518],
9	for	IN	O	for	_	0	SENT_161	[p8l1163t1436r1268b1500],
10	gemﬁbrozil	NN	O	gemﬁbrozil	prep_for	8	SENT_161	[p8l1310t1436r1750b1519],
11	,	,	O	,	_	0	SENT_161	[p8l1310t1436r1750b1519],
12	fenoﬁbric	JJ	O	fenoﬁbric	amod	13	SENT_161	[p8l1796t1436r2148b1500],
13	acid	NN	O	acid	prep_for	8	SENT_161	[p8l9t1545r178b1621],
14	,	,	O	,	_	0	SENT_161	[p8l9t1545r178b1621],
15	and	CC	O	and	_	0	SENT_161	[p8l205t1545r334b1609],
16	bezaﬁbrate	NN	O	bezaﬁbrate	prep_for	8	SENT_161	[p8l354t1545r776b1621],
17	,	,	O	,	_	0	SENT_161	[p8l354t1545r776b1621],
18	0.025	CD	NUMBER	0.025	conj_and	8	SENT_161	[p8l802t1545r1001b1610],
19	for	IN	O	for	_	0	SENT_161	[p8l1028t1545r1133b1609],
20	fenoﬁbrate	NN	O	fenoﬁbrate	prep_for	18	SENT_161	[p8l1154t1545r1569b1621],
21	,	,	O	,	_	0	SENT_161	[p8l1154t1545r1569b1621],
22	and	CC	O	and	_	0	SENT_161	[p8l1595t1545r1725b1609],
23	0.0025	CD	NUMBER	0.0025	num	24	SENT_161	[p8l1746t1545r1991b1610],
24	uM	NN	O	um	conj_and	8	SENT_161	[p8l2025t1547r2150b1627],
25	for	IN	O	for	_	0	SENT_161	[p8l8t1656r114b1720],
26	loperamide	NN	O	loperamide	prep_for	24	SENT_161	[p8l145t1656r575b1739],
27	.	.	O	.	_	0	SENT_161	[p8l145t1656r575b1739],

1	2.10	CD	NUMBER	2.10	_	0	SENT_162	[p8l7t1874r179b1938],
2	.	.	O	.	_	0	SENT_162	[p8l7t1874r179b1938],

1	Statistical	JJ	O	statistical	amod	2	SENT_163	[p8l237t1874r604b1939],
2	analysis	NN	O	analysis	_	0	SENT_163	[p8l637t1874r934b1956],

1	Due	JJ	O	due	_	0	SENT_164	[p8l99t2094r248b2156],
2	to	TO	O	to	_	0	SENT_164	[p8l272t2102r340b2156],
3	cytotoxic	JJ	O	cytotoxic	amod	4	SENT_164	[p8l365t2092r702b2175],
4	inﬂuences	NNS	O	inﬂuences	prep_due_to	11	SENT_164	[p8l727t2092r1116b2168],
5	,	,	O	,	_	0	SENT_164	[p8l727t2092r1116b2168],
6	plateau	NN	O	plateau	nn	7	SENT_164	[p8l1142t2092r1406b2175],
7	effects	NNS	O	effect	appos	4	SENT_164	[p8l1431t2092r1669b2156],
8	and	CC	O	and	_	0	SENT_164	[p8l1696t2092r1825b2156],
9	thus	RB	O	thus	conj_and	11	SENT_164	[p8l1847t2092r1996b2156],
10	IC50	NN	O	ic50	nn	11	SENT_164	[p8l2020t2111r2150b2171],
11	Values	NNS	O	value	nsubj	12	SENT_164	[p8l8t2201r236b2265],
12	(	VBP	O	(	_	0	SENT_164	[p8l273t2201r411b2280],
13	the	DT	O	the	det	14	SENT_164	[p8l273t2201r411b2280],
14	concentration	NN	O	concentration	dobj	12	SENT_164	[p8l445t2201r944b2265],
15	leading	VBG	O	lead	partmod	14	SENT_164	[p8l977t2201r1244b2284],
16	to	TO	O	to	_	0	SENT_164	[p8l1278t2211r1346b2265],
17	half	DT	O	half	det	20	SENT_164	[p8l1380t2201r1873b2265],
18	—	JJ	O	—	amod	20	SENT_164	[p8l1380t2201r1873b2265],
19	maximal	JJ	O	maximal	amod	20	SENT_164	[p8l1380t2201r1873b2265],
20	inhibition	NN	O	inhibition	prep_to	15	SENT_164	[p8l1907t2201r2148b2265, p8l7t2312r148b2376],
21	of	IN	O	of	_	0	SENT_164	[p8l176t2312r255b2376],
22	the	DT	O	the	det	23	SENT_164	[p8l275t2312r384b2376],
23	calcein	NN	O	calcein	prep_of	20	SENT_164	[p8l413t2312r849b2376],
24	.	.	O	.	_	0	SENT_164	[p8l413t2312r849b2376],

1	—	NN	O	—	_	0	SENT_165	[p8l413t2312r849b2376],
2	.	.	O	.	_	0	SENT_165	[p8l413t2312r849b2376],

1	AM	NNP	O	AM	nn	3	SENT_166	[p8l413t2312r849b2376],
2	transport	NN	O	transport	nn	3	SENT_166	[p8l875t2313r1227b2395],
3	)	NN	O	)	nsubjpass	7	SENT_166	[p8l875t2313r1227b2395],
4	could	MD	O	could	aux	7	SENT_166	[p8l1258t2312r1460b2376],
5	not	RB	O	not	neg	7	SENT_166	[p8l1485t2322r1602b2376],
6	be	VB	O	be	auxpass	7	SENT_166	[p8l1626t2312r1711b2376],
7	determined	VBN	O	determine	_	0	SENT_166	[p8l1739t2312r2151b2376],
8	for	IN	O	for	_	0	SENT_166	[p8l8t2419r114b2483],
9	all	DT	O	all	det	11	SENT_166	[p8l173t2419r260b2483],
10	test	NN	O	test	nn	11	SENT_166	[p8l320t2429r446b2483],
11	compounds	NNS	O	compound	prep_for	7	SENT_166	[p8l505t2419r943b2502],
12	.	.	O	.	_	0	SENT_166	[p8l505t2419r943b2502],

1	Based	VBN	O	base	_	0	SENT_167	[p8l1007t2419r1229b2483],
2	on	IN	O	on	_	0	SENT_167	[p8l1289t2440r1377b2483],
3	the	DT	O	the	det	5	SENT_167	[p8l1436t2419r1545b2483],
4	concentrationresponse	NN	O	concentrationresponse	nn	5	SENT_167	[p8l1606t2419r2151b2483, p8l7t2548r325b2611],
5	curve	NN	O	curve	prep_on	1	SENT_167	[p8l352t2549r551b2593],
6	we	PRP	O	we	nsubj	9	SENT_167	[p8l576t2549r679b2593],
7	therefore	RB	O	therefore	advmod	9	SENT_167	[p8l705t2528r1035b2592],
8	also	RB	O	also	advmod	9	SENT_167	[p8l1062t2528r1205b2592],
9	calculated	VBN	O	calculate	rcmod	5	SENT_167	[p8l1232t2528r1604b2592],
10	the	DT	O	the	det	11	SENT_167	[p8l1628t2528r1738b2592],
11	concentration	NN	O	concentration	dobj	9	SENT_167	[p8l1765t2538r2148b2592, p8l8t2639r148b2703],
12	needed	VBN	O	need	partmod	11	SENT_167	[p8l173t2639r431b2703],
13	to	TO	O	to	aux	14	SENT_167	[p8l456t2648r524b2703],
14	double	VB	O	double	xcomp	12	SENT_167	[p8l551t2639r797b2703],
15	baseline	NN	O	baseline	nn	16	SENT_167	[p8l822t2639r1122b2703],
16	ﬂuorescence	NN	O	ﬂuorescence	dobj	14	SENT_167	[p8l1149t2639r1604b2703],
17	(	CD	NUMBER	(	num	18	SENT_167	[p8l1633t2639r1762b2718],
18	f2	NN	O	f2	tmod	14	SENT_167	[p8l1633t2639r1762b2718],
19	)	CD	NUMBER	)	nsubj	25	SENT_167	[p8l1633t2639r1762b2718],
20	according	VBG	O	accord	_	0	SENT_167	[p8l1791t2639r2149b2722],
21	to	TO	O	to	prepc_according_to	19	SENT_167	[p8l7t2756r75b2811],
22	Weiss	NNP	PERSON	Weiss	dep	25	SENT_167	[p8l112t2746r326b2811],
23	et	FW	O	et	nn	25	SENT_167	[p8l366t2759r432b2811],
24	al.	FW	O	al.	nn	25	SENT_167	[p8l466t2747r549b2811],
25	[	FW	O	[	rcmod	18	SENT_167	[p8l601t2747r763b2824],
26	18	CD	NUMBER	18	num	27	SENT_167	[p8l601t2747r763b2824],
27	]	NN	O	]	dep	18	SENT_167	[p8l601t2747r763b2824],
28	.	.	O	.	_	0	SENT_167	[p8l601t2747r763b2824],

1	Unless	IN	O	unless	mark	2	SENT_168	[p8l805t2746r1049b2811],
2	indicated	VBN	O	indicate	advcl	6	SENT_168	[p8l1088t2747r1425b2811],
3	otherwise	RB	O	otherwise	advmod	2	SENT_168	[p8l1462t2747r1814b2811],
4	data	NNS	O	datum	nsubjpass	6	SENT_168	[p8l1853t2747r2004b2811],
5	are	VBP	O	be	auxpass	6	SENT_168	[p8l2042t2767r2150b2811],
6	expressed	VBN	O	express	_	0	SENT_168	[p8l8t2855r367b2938],
7	as	IN	O	as	_	0	SENT_168	[p8l397t2875r467b2919],
8	mean	NN	O	mean	prep_as	6	SENT_168	[p8l498t2875r694b2919],
9	:	:	O	:	_	0	SENT_168	[p8l722t2857r782b2918],
10	|	CD	NUMBER	|	dep	8	SENT_168	[p8l722t2857r782b2918],
11	:	:	O	:	_	0	SENT_168	[p8l722t2857r782b2918],
12	SD	NN	O	sd	dep	8	SENT_168	[p8l811t2856r941b2920],
13	.	.	O	.	_	0	SENT_168	[p8l811t2856r941b2920],

1	For	IN	O	for	_	0	SENT_169	[p8l974t2857r1101b2919],
2	the	DT	O	the	det	5	SENT_169	[p8l1127t2855r1236b2919],
3	f2	NN	O	f2	nn	5	SENT_169	[p8l1266t2855r1338b2918],
4	values	NNS	O	value	nn	5	SENT_169	[p8l1369t2855r1597b2919],
5	P	NN	O	p	prep_for	8	SENT_169	[p8l1626t2855r1943b2919],
6	—	NN	O	—	nn	7	SENT_169	[p8l1626t2855r1943b2919],
7	values	NNS	O	value	nsubj	8	SENT_169	[p8l1626t2855r1943b2919],
8	were	VBD	O	be	_	0	SENT_169	[p8l1975t2875r2149b2919],

1	Analyte	NNP	O	Analyte	nn	2	SENT_170	[p8l33t3036r138b3066],
2	Eluent	NNP	O	Eluent	_	0	SENT_170	[p8l329t3036r422b3063],
3	,	,	O	,	_	0	SENT_170	[p8l329t3036r422b3063],
4	%	NN	O	%	nn	5	SENT_170	[p8l437t3036r543b3059],
5	A	NN	O	a	appos	2	SENT_170	[p8l437t3036r543b3059],
6	/	:	PERCENT	/	punct	56	SENT_170	[p8l437t3036r543b3059],
7	%	NN	PERCENT	%	nn	9	SENT_170	[p8l437t3036r543b3059],
8	B	NN	O	b	nn	9	SENT_170	[p8l437t3036r543b3059],
9	Rt	NN	O	rt	dep	19	SENT_170	[p8l625t3036r656b3059],
10	(	CD	NUMBER	(	num	11	SENT_170	[p8l668t3036r739b3065],
11	min	NN	DURATION	min	dep	9	SENT_170	[p8l668t3036r739b3065],
12	)	CD	NUMBER	)	num	14	SENT_170	[p8l668t3036r739b3065],
13	Parent	NNP	O	Parent	nn	14	SENT_170	[p8l861t3036r945b3059],
14	mass	NN	O	mass	dep	11	SENT_170	[p8l957t3043r1022b3059],
15	(	CD	NUMBER	(	num	16	SENT_170	[p8l1035t3036r1101b3065],
16	m/z	NN	O	m/z	dep	19	SENT_170	[p8l1035t3036r1101b3065],
17	)	CD	NUMBER	)	num	19	SENT_170	[p8l1035t3036r1101b3065],
18	Center	NNP	O	Center	nn	19	SENT_170	[p8l1193t3036r1281b3059],
19	mass	NN	O	mass	dep	46	SENT_170	[p8l1292t3043r1357b3059],
20	(	CD	NUMBER	(	num	21	SENT_170	[p8l1370t3036r1436b3065],
21	m/z	NN	O	m/z	dep	19	SENT_170	[p8l1370t3036r1436b3065],
22	)	CD	NUMBER	)	num	37	SENT_170	[p8l1370t3036r1436b3065],
23	Ionization	NNP	O	Ionization	nn	37	SENT_170	[p8l1547t3036r1682b3059],
24	Collision	NNP	O	Collision	nn	37	SENT_170	[p8l1843t3036r1964b3059],
25	energy	NN	O	energy	nn	37	SENT_170	[p8l1976t3043r2064b3066],
26	(	CD	NUMBER	(	num	37	SENT_170	[p8l2078t3036r2121b3065],
27	V	NN	O	v	nn	37	SENT_170	[p8l2078t3036r2121b3065],
28	)	CD	NUMBER	)	num	37	SENT_170	[p8l2078t3036r2121b3065],
29	Gemﬁbrozil	NNP	O	Gemﬁbrozil	nn	37	SENT_170	[p8l34t3104r193b3127],
30	30/70	CD	NUMBER	30/70	num	37	SENT_170	[p8l330t3104r404b3127],
31	2.01	CD	NUMBER	2.01	num	37	SENT_170	[p8l625t3104r679b3127],
32	249.2	CD	NUMBER	249.2	num	37	SENT_170	[p8l862t3104r935b3128],
33	—	CD	NUMBER	—	num	37	SENT_170	[p8l1225t3118r1242b3120],
34	APCI	NN	O	apcus	nn	37	SENT_170	[p8l1547t3104r1622b3127],
35	negative	JJ	O	negative	amod	37	SENT_170	[p8l1633t3104r1744b3134],
36	—	NN	O	—	nn	37	SENT_170	[p8l1859t3118r1876b3120],
37	Fenoﬁbrate	NN	O	fenoﬁbrate	rcmod	21	SENT_170	[p8l33t3145r184b3168],
38	30/70	CD	NUMBER	30/70	number	39	SENT_170	[p8l330t3145r404b3168],
39	3.69	CD	NUMBER	3.69	num	41	SENT_170	[p8l625t3145r681b3169],
40	316.2	CD	NUMBER	316.2	number	41	SENT_170	[p8l862t3145r935b3168],
41	233.1	CD	NUMBER	233.1	dep	21	SENT_170	[p8l1193t3145r1263b3168],
42	ESI	NNP	ORGANIZATION	ESI	amod	43	SENT_170	[p8l1547t3145r1596b3168],
43	positive	JJ	O	positive	amod	41	SENT_170	[p8l1607t3145r1711b3175],
44	22	CD	NUMBER	22	num	46	SENT_170	[p8l1843t3145r1875b3168],
45	Fenoﬁbric	JJ	O	fenoﬁbric	amod	46	SENT_170	[p8l33t3186r169b3209],
46	acid	NN	O	acid	dep	56	SENT_170	[p8l182t3186r236b3209],
47	50/50	CD	NUMBER	50/50	num	48	SENT_170	[p8l330t3186r404b3209],
48	3.45	CD	NUMBER	3.45	dep	46	SENT_170	[p8l625t3186r680b3209],
49	316.9	CD	NUMBER	316.9	number	50	SENT_170	[p8l862t3186r935b3209],
50	230.8	CD	NUMBER	230.8	num	54	SENT_170	[p8l1193t3186r1265b3209],
51	ESI	NNP	ORGANIZATION	ESI	nn	54	SENT_170	[p8l1547t3186r1596b3209],
52	positive	JJ	O	positive	amod	54	SENT_170	[p8l1607t3186r1712b3216],
53	22	CD	NUMBER	22	tmod	52	SENT_170	[p8l1843t3186r1875b3209],
54	Bezaﬁbrate	NN	O	bezaﬁbrate	dep	48	SENT_170	[p8l33t3227r184b3250],
55	60/40	CD	NUMBER	60/40	num	56	SENT_170	[p8l330t3227r404b3250],
56	3.31	CD	NUMBER	3.31	dep	5	SENT_170	[p8l625t3227r679b3250],
57	362.2	CD	NUMBER	362.2	number	58	SENT_170	[p8l862t3227r935b3250],
58	316.1	CD	NUMBER	316.1	num	62	SENT_170	[p8l1193t3227r1263b3250],
59	ESI	NNP	ORGANIZATION	ESI	nn	62	SENT_170	[p8l1547t3227r1596b3250],
60	positive	JJ	O	positive	amod	62	SENT_170	[p8l1607t3227r1712b3257],
61	28	CD	NUMBER	28	tmod	60	SENT_170	[p8l1843t3227r1874b3250],
62	Loperamide	NN	O	loperamide	dep	5	SENT_170	[p8l33t3268r193b3298],
63	55/45	CD	NUMBER	55/45	number	64	SENT_170	[p8l330t3268r403b3291],
64	2.55	CD	NUMBER	2.55	num	62	SENT_170	[p8l625t3268r680b3291],
65	477.2	CD	NUMBER	477.2	number	66	SENT_170	[p8l861t3268r935b3291],
66	266.3	CD	NUMBER	266.3	num	67	SENT_170	[p8l1193t3268r1265b3291],
67	ESI	NNP	ORGANIZATION	ESI	dep	2	SENT_170	[p8l1547t3268r1596b3291],
68	positive	JJ	O	positive	amod	67	SENT_170	[p8l1607t3268r1711b3298],
69	28	CD	NUMBER	28	tmod	68	SENT_170	[p8l1843t3268r1874b3291],

1	A	DT	O	a	det	6	SENT_171	[p8l83t3331r106b3355],
2	=	JJ	O	=	amod	6	SENT_171	[p8l117t3342r140b3350],
3	1	CD	PERCENT	1	number	4	SENT_171	[p8l154t3331r193b3355],
4	%	NN	PERCENT	%	amod	6	SENT_171	[p8l154t3331r193b3355],
5	formic	JJ	O	formic	amod	6	SENT_171	[p8l206t3331r294b3355],
6	acid	NN	O	acid	_	0	SENT_171	[p8l307t3331r369b3359],
7	;	:	O	;	_	0	SENT_171	[p8l307t3331r369b3359],
8	B	NN	O	b	nn	10	SENT_171	[p8l382t3332r401b3355],
9	=	JJ	O	=	amod	10	SENT_171	[p8l414t3342r437b3350],
10	acetonitrile	NN	O	acetonitrile	dep	6	SENT_171	[p8l449t3331r605b3359],
11	;	:	O	;	_	0	SENT_171	[p8l449t3331r605b3359],
12	Rt	NN	O	rt	dep	10	SENT_171	[p8l618t3332r650b3355],
13	=	JJ	O	=	amod	15	SENT_171	[p8l660t3342r683b3350],
14	retention	NN	O	retention	nn	15	SENT_171	[p8l694t3331r811b3355],
15	time	NN	O	time	dep	12	SENT_171	[p8l823t3331r888b3355],
16	.	.	O	.	_	0	SENT_171	[p8l823t3331r888b3355],

1	288	CD	NUMBER	288	num	3	SENT_172	[p8l330t3434r377b3458],
2	M.	NN	NUMBER	m.	nn	3	SENT_172	[p8l919t3435r952b3458],
3	Ehrhardt	NNP	PERSON	Ehrhardt	_	0	SENT_172	[p8l967t3434r1088b3458],
4	et	FW	O	et	nn	5	SENT_172	[p8l1099t3439r1123b3458],
5	al.	FW	O	al.	dep	3	SENT_172	[p8l1134t3434r1164b3458],
6	/	:	O	/	punct	3	SENT_172	[p8l1171t3434r1186b3458],
7	Biochemical	JJ	O	biochemical	amod	8	SENT_172	[p8l1188t3434r1354b3458],
8	Pharmacology	NN	O	pharmacology	dep	3	SENT_172	[p8l1365t3434r1560b3464],
9	67	CD	NUMBER	67	number	10	SENT_172	[p8l1572t3434r1606b3458],
10	(	CD	NUMBER	(	num	11	SENT_172	[p8l1617t3434r1703b3463],
11	2004	CD	DATE	2004	dep	8	SENT_172	[p8l1617t3434r1703b3463],
12	)	CD	NUMBER	)	number	13	SENT_172	[p8l1617t3434r1703b3463],
13	285-292	CD	NUMBER	285-292	num	11	SENT_172	[p8l1715t3434r1830b3458],

1	determined	VBN	O	determine	csubj	18	SENT_173	[p8l9t3602r420b3666],
2	by	IN	O	by	_	0	SENT_173	[p8l454t3602r543b3685],
3	ANOVA	NNP	ORGANIZATION	ANOVA	prep_by	1	SENT_173	[p8l579t3603r891b3666],
4	with	IN	O	with	_	0	SENT_173	[p8l919t3602r1079b3666],
5	Dunnett	NNP	PERSON	Dunnett	poss	9	SENT_173	[p8l1114t3603r1467b3666],
6	’s	POS	O	’s	_	0	SENT_173	[p8l1114t3603r1467b3666],
7	multiple	JJ	O	multiple	amod	9	SENT_173	[p8l1504t3602r1808b3685],
8	comparison	NN	O	comparison	nn	9	SENT_173	[p8l1845t3622r2145b3685, p8l8t3709r158b3773],
9	test	NN	O	test	prep_with	1	SENT_173	[p8l182t3719r309b3773],
10	for	IN	O	for	_	0	SENT_173	[p8l332t3709r437b3773],
11	post	NN	O	post	amod	14	SENT_173	[p8l451t3722r612b3791],
12	hoc	FW	O	hoc	dep	11	SENT_173	[p8l634t3709r763b3773],
13	pairwise	JJ	O	pairwise	amod	14	SENT_173	[p8l787t3709r1096b3792],
14	comparison	NN	O	comparison	prep_for	1	SENT_173	[p8l1122t3709r1546b3792],
15	with	IN	O	with	_	0	SENT_173	[p8l1571t3709r1732b3773],
16	the	DT	O	the	det	17	SENT_173	[p8l1755t3709r1864b3773],
17	control	NN	O	control	prep_with	14	SENT_173	[p8l1890t3709r2147b3773],
18	results	VBZ	O	result	_	0	SENT_173	[p9l7t21r243b85],
19	obtained	VBN	O	obtain	dep	18	SENT_173	[p9l279t21r593b85],
20	with	IN	O	with	_	0	SENT_173	[p9l626t21r786b85],
21	Verapamil	NNP	O	Verapamil	prep_with	19	SENT_173	[p9l820t21r1203b103],
22	.	.	O	.	_	0	SENT_173	[p9l820t21r1203b103],

1	For	IN	O	for	_	0	SENT_174	[p9l1240t22r1367b85],
2	the	DT	O	the	det	4	SENT_174	[p9l1397t21r1507b85],
3	uptake	NN	O	uptake	nn	4	SENT_174	[p9l1540t21r1782b103],
4	assay	NN	O	assay	prep_for	8	SENT_174	[p9l1819t41r2026b103],
5	,	,	O	,	_	0	SENT_174	[p9l1819t41r2026b103],
6	PValues	NNS	O	pvalue	nsubjpass	8	SENT_174	[p9l2061t23r2145b84, p9l8t129r236b193],
7	were	VBD	O	be	auxpass	8	SENT_174	[p9l290t149r464b193],
8	determined	VBN	O	determine	_	0	SENT_174	[p9l517t129r928b193],
9	by	IN	O	by	_	0	SENT_174	[p9l978t129r1067b212],
10	ANOVA	NNP	ORGANIZATION	ANOVA	agent	8	SENT_174	[p9l1119t130r1432b194],
11	with	IN	O	with	_	0	SENT_174	[p9l1475t129r1635b193],
12	Bonferroni	NNP	PERSON	Bonferroni	poss	16	SENT_174	[p9l1686t129r2146b193],
13	’s	POS	O	’s	_	0	SENT_174	[p9l1686t129r2146b193],
14	multiple	JJ	O	multiple	amod	16	SENT_174	[p9l8t240r312b323],
15	comparison	NN	O	comparison	nn	16	SENT_174	[p9l333t240r759b323],
16	test	NN	O	test	prep_with	8	SENT_174	[p9l779t249r905b304],
17	for	IN	O	for	_	0	SENT_174	[p9l925t240r1030b304],
18	post	NN	O	post	amod	21	SENT_174	[p9l1041t252r1202b322],
19	hoc	FW	O	hoc	dep	18	SENT_174	[p9l1220t240r1349b304],
20	pairwise	JJ	O	pairwise	amod	21	SENT_174	[p9l1369t240r1678b323],
21	comparison	NN	O	comparison	prep_for	16	SENT_174	[p9l1699t240r2142b323],
22	.	.	O	.	_	0	SENT_174	[p9l1699t240r2142b323],

1	P	NN	O	p	_	0	SENT_175	[p9l6t349r323b413],
2	.	.	O	.	_	0	SENT_175	[p9l6t349r323b413],

1	—	NN	O	—	_	0	SENT_176	[p9l6t349r323b413],
2	.	.	O	.	_	0	SENT_176	[p9l6t349r323b413],

1	Values	NNS	O	value	nsubjpass	12	SENT_177	[p9l6t349r323b413],
2	for	IN	O	for	_	0	SENT_177	[p9l383t349r489b413],
3	the	DT	O	the	det	4	SENT_177	[p9l545t349r654b413],
4	experiments	NNS	O	experiment	prep_for	1	SENT_177	[p9l714t349r1157b432],
5	with	IN	O	with	_	0	SENT_177	[p9l1218t349r1378b413],
6	the	DT	O	the	det	10	SENT_177	[p9l1436t349r1545b413],
7	confocal	JJ	O	confocal	amod	10	SENT_177	[p9l1605t349r1918b413],
8	laser	NN	O	laser	nn	10	SENT_177	[p9l1976t349r2149b413],
9	scanning	NN	O	scanning	nn	10	SENT_177	[p9l11t456r330b539],
10	microscope	NN	O	microscope	prep_with	4	SENT_177	[p9l363t456r783b539],
11	were	VBD	O	be	auxpass	12	SENT_177	[p9l815t476r989b521],
12	calculated	VBN	O	calculate	_	0	SENT_177	[p9l1023t456r1393b520],
13	by	IN	O	by	_	0	SENT_177	[p9l1424t456r1513b539],
14	one-tailed	JJ	O	one-tailed	amod	15	SENT_177	[p9l1546t456r1912b520],
15	t-test	NN	O	t-test	agent	12	SENT_177	[p9l1945t466r2143b520],
16	.	.	O	.	_	0	SENT_177	[p9l1945t466r2143b520],

1	All	DT	O	all	det	3	SENT_178	[p9l8t567r121b630],
2	statistical	JJ	O	statistical	amod	3	SENT_178	[p9l183t567r524b631],
3	analysis	NN	O	analysis	nsubjpass	5	SENT_178	[p9l584t567r873b650],
4	was	VBD	O	be	auxpass	5	SENT_178	[p9l933t587r1070b631],
5	performed	VBN	O	perform	_	0	SENT_178	[p9l1128t567r1510b650],
6	with	IN	O	with	_	0	SENT_178	[p9l1567t567r1727b631],
7	GraphPad	NN	O	graphpad	nn	8	SENT_178	[p9l1786t567r2148b650],
8	InStat	NNP	ORGANIZATION	InStat	prep_with	5	SENT_178	[p9l8t675r244b750],
9	,	,	O	,	_	0	SENT_178	[p9l8t675r244b750],
10	Version	NNP	O	Version	appos	8	SENT_178	[p9l293t675r560b739],
11	3.05	CD	NUMBER	3.05	num	10	SENT_178	[p9l608t674r782b750],
12	,	,	O	,	_	0	SENT_178	[p9l608t674r782b750],
13	GraphPad	NNP	O	GraphPad	nn	14	SENT_178	[p9l833t675r1196b757],
14	Software	NNP	O	Software	appos	10	SENT_178	[p9l1243t675r1586b739],
15	.	.	O	.	_	0	SENT_178	[p9l1243t675r1586b739],

1	A	DT	O	a	det	2	SENT_179	[p9l1637t675r1701b738],
2	P-Value	NN	O	p-value	nsubjpass	7	SENT_179	[p9l1744t675r2027b739],
3	of	IN	O	of	_	0	SENT_179	[p9l2075t674r2154b739],
4	£	CD	MONEY	£	num	5	SENT_179	[p9l14t783r232b860],
5	0.05	CD	MONEY	0.05	prep_of	2	SENT_179	[p9l14t783r232b860],
6	was	VBD	O	be	auxpass	7	SENT_179	[p9l269t804r407b848],
7	considered	VBN	O	consider	_	0	SENT_179	[p9l442t783r838b848],
8	signiﬁcant	NN	O	signiﬁcant	dobj	7	SENT_179	[p9l874t783r1268b866],
9	.	.	O	.	_	0	SENT_179	[p9l874t783r1268b866],

1	3	LS	NUMBER	3	_	0	SENT_180	[p9l8t1027r72b1092],
2	.	.	O	.	_	0	SENT_180	[p9l8t1027r72b1092],

1	Results	NNS	O	result	_	0	SENT_181	[p9l123t1028r404b1092],

1	3.1	CD	NUMBER	3.1	_	0	SENT_182	[p9l8t1246r133b1310],
2	.	.	O	.	_	0	SENT_182	[p9l8t1246r133b1310],

1	Pgp	NNP	O	Pgp	_	0	SENT_183	[p9l190t1248r335b1327],
2	inhibitor	NN	O	inhibitor	nn	3	SENT_183	[p9l373t1246r693b1310],
3	potency	NN	O	potency	dep	1	SENT_183	[p9l713t1258r1005b1327],

1	None	NN	O	none	nsubj	6	SENT_184	[p9l99t1465r294b1528],
2	of	IN	O	of	_	0	SENT_184	[p9l317t1464r395b1528],
3	the	DT	O	the	det	5	SENT_184	[p9l409t1464r519b1528],
4	test	NN	O	test	nn	5	SENT_184	[p9l540t1473r666b1528],
5	substances	NNS	O	substance	prep_of	1	SENT_184	[p9l689t1464r1074b1528],
6	showed	VBD	O	show	_	0	SENT_184	[p9l1099t1464r1372b1528],
7	any	DT	O	any	det	9	SENT_184	[p9l1394t1484r1521b1546],
8	quenching	NN	O	quenching	nn	9	SENT_184	[p9l1542t1464r1920b1546],
9	effect	NN	O	effect	dobj	6	SENT_184	[p9l1943t1463r2149b1528],
10	in	IN	O	in	_	0	SENT_184	[p9l8t1574r77b1637],
11	the	DT	O	the	det	13	SENT_184	[p9l117t1574r226b1638],
12	concentration	NN	O	concentration	nn	13	SENT_184	[p9l267t1574r765b1638],
13	range	NN	O	range	prep_in	6	SENT_184	[p9l804t1594r1006b1657],
14	tested	VBN	O	test	partmod	13	SENT_184	[p9l1047t1574r1259b1638],
15	on	IN	O	on	_	0	SENT_184	[p9l1300t1594r1388b1638],
16	the	DT	O	the	det	17	SENT_184	[p9l1427t1574r1536b1638],
17	ﬂuorescence	NN	O	ﬂuorescence	prep_on	14	SENT_184	[p9l1579t1574r2033b1638],
18	of	IN	O	of	_	0	SENT_184	[p9l2075t1574r2154b1638],
19	calcein	NN	O	calcein	prep_of	17	SENT_184	[p9l8t1681r267b1746],
20	and	CC	O	and	_	0	SENT_184	[p9l310t1681r439b1746],
21	no	DT	O	no	det	22	SENT_184	[p9l480t1702r568b1746],
22	autoﬂuorescence	NN	O	autoﬂuorescence	conj_and	19	SENT_184	[p9l613t1681r1225b1746],
23	at	IN	O	at	_	0	SENT_184	[p9l1270t1691r1333b1746],
24	the	DT	O	the	det	26	SENT_184	[p9l1373t1681r1483b1746],
25	excitation	NN	O	excitation	nn	26	SENT_184	[p9l1526t1681r1886b1746],
26	wavelength	NN	O	wavelength	prep_at	14	SENT_184	[p9l1928t1702r2144b1746, p9l8t1792r236b1875],
27	used	VBN	O	use	partmod	26	SENT_184	[p9l261t1792r427b1856],
28	to	TO	O	to	aux	29	SENT_184	[p9l453t1801r521b1856],
29	measure	VB	O	measure	xcomp	27	SENT_184	[p9l548t1812r850b1856],
30	calcein	NN	O	calcein	nn	32	SENT_184	[p9l879t1792r1137b1856],
31	ﬂuorescence	NN	O	ﬂuorescence	nn	32	SENT_184	[p9l1165t1792r1619b1856],
32	(	NN	O	(	dobj	29	SENT_184	[p9l1649t1792r1807b1871],
33	485	CD	NUMBER	485	num	35	SENT_184	[p9l1649t1792r1807b1871],
34	nm	NN	O	nm	nn	35	SENT_184	[p9l1837t1793r1979b1871],
35	)	NN	O	)	nsubjpass	37	SENT_184	[p9l1837t1793r1979b1871],
36	was	VBD	O	be	auxpass	37	SENT_184	[p9l2008t1812r2145b1856],
37	observed	VBN	O	observe	rcmod	32	SENT_184	[p9l9t1899r353b1964],
38	.	.	O	.	_	0	SENT_184	[p9l9t1899r353b1964],

1	Moreover	RB	O	moreover	advmod	16	SENT_185	[p9l392t1901r766b1975],
2	,	,	O	,	_	0	SENT_185	[p9l392t1901r766b1975],
3	no	DT	O	no	det	5	SENT_185	[p9l805t1920r892b1963],
4	self	NN	O	self	nn	5	SENT_185	[p9l931t1899r1469b1982],
5	—	NN	O	—	nsubj	16	SENT_185	[p9l931t1899r1469b1982],
6	quenching	NN	O	quenching	nn	7	SENT_185	[p9l931t1899r1469b1982],
7	effects	NNS	O	effect	nsubjpass	11	SENT_185	[p9l1506t1899r1744b1963],
8	of	IN	O	of	_	0	SENT_185	[p9l1782t1899r1861b1963],
9	calcein	NN	O	calcein	prep_of	7	SENT_185	[p9l1889t1899r2148b1963],
10	were	VBD	O	be	auxpass	11	SENT_185	[p9l8t2029r182b2073],
11	observed	VBN	O	observe	rcmod	5	SENT_185	[p9l218t2008r546b2073],
12	in	IN	O	in	_	0	SENT_185	[p9l578t2008r646b2072],
13	the	DT	O	the	det	15	SENT_185	[p9l679t2008r789b2072],
14	concentration	NN	O	concentration	nn	15	SENT_185	[p9l824t2008r1321b2072],
15	range	NN	O	range	prep_in	11	SENT_185	[p9l1353t2029r1555b2091],
16	applied	VBD	O	apply	_	0	SENT_185	[p9l1591t2008r1876b2091],
17	.	.	O	.	_	0	SENT_185	[p9l1591t2008r1876b2091],

1	The	DT	O	the	det	5	SENT_186	[p9l99t2119r239b2183],
2	two	CD	NUMBER	two	num	5	SENT_186	[p9l314t2129r447b2183],
3	paradigm	NN	O	paradigm	nn	5	SENT_186	[p9l522t2119r868b2202],
4	Pgp	NN	O	pgp	nn	5	SENT_186	[p9l941t2121r1080b2202],
5	inhibitors	NNS	O	inhibitor	nsubj	65	SENT_186	[p9l1155t2119r1503b2183],
6	Verapamil	NNP	O	Verapamil	nsubj	14	SENT_186	[p9l1579t2119r1943b2202],
7	and	CC	O	and	_	0	SENT_186	[p9l2019t2119r2148b2183],
8	LY335979	NNP	O	LY335979	nsubj	14	SENT_186	[p9l7t2226r391b2292],
9	and	CC	O	and	_	0	SENT_186	[p9l450t2227r579b2291],
10	the	DT	O	the	det	11	SENT_186	[p9l633t2227r742b2291],
11	ﬁbrates	NNS	O	ﬁbrates	nsubj	14	SENT_186	[p9l799t2226r1063b2291],
12	were	VBD	O	be	cop	14	SENT_186	[p9l1121t2247r1294b2291],
13	not	RB	O	not	neg	14	SENT_186	[p9l1350t2236r1466b2291],
14	cytotoxic	JJ	O	cytotoxic	rcmod	5	SENT_186	[p9l1521t2227r1858b2309],
15	in	IN	O	in	_	0	SENT_186	[p9l1914t2227r1983b2290],
16	the	DT	O	the	det	18	SENT_186	[p9l2038t2227r2147b2291],
17	concentration	NN	O	concentration	nn	18	SENT_186	[p9l8t2335r506b2399],
18	range	NN	O	range	prep_in	14	SENT_186	[p9l533t2355r735b2418],
19	used	VBN	O	use	partmod	18	SENT_186	[p9l763t2335r930b2399],
20	in	IN	O	in	_	0	SENT_186	[p9l957t2335r1026b2398],
21	the	DT	O	the	det	22	SENT_186	[p9l1054t2335r1163b2399],
22	assays	NNS	O	assay	prep_in	19	SENT_186	[p9l1194t2355r1421b2418],
23	whereas	IN	O	whereas	mark	27	SENT_186	[p9l1452t2335r1747b2399],
24	the	DT	O	the	det	25	SENT_186	[p9l1777t2335r1886b2399],
25	statins	NNS	O	statin	nsubj	27	SENT_186	[p9l1918t2335r2145b2399],
26	were	VBD	O	be	cop	27	SENT_186	[p9l8t2464r182b2508],
27	cytotoxic	JJ	O	cytotoxic	conj_and	27	SENT_186	[p9l242t2444r579b2527],
28	in	IN	O	in	_	0	SENT_186	[p9l637t2444r706b2507],
29	concentrations	NNS	O	concentration	prep_in	27	SENT_186	[p9l765t2444r1295b2508],
30	higher	JJR	O	higher	advmod	27	SENT_186	[p9l1354t2444r1589b2527],
31	than	IN	O	than	_	0	SENT_186	[p9l1644t2444r1800b2508],
32	100	CD	NUMBER	100	num	33	SENT_186	[p9l1867t2445r1992b2509],
33	uM	NN	O	um	prep_than	27	SENT_186	[p9l2022t2446r2147b2526],
34	(	CD	NUMBER	(	num	36	SENT_186	[p9l10t2554r419b2633],
35	lovastatin	NN	O	lovastatin	nn	36	SENT_186	[p9l10t2554r419b2633],
36	)	NN	O	)	dep	33	SENT_186	[p9l10t2554r419b2633],
37	and	CC	O	and	_	0	SENT_186	[p9l449t2554r578b2618],
38	35	CD	NUMBER	35	num	39	SENT_186	[p9l604t2554r687b2618],
39	uM	NN	O	um	conj_and	33	SENT_186	[p9l720t2555r846b2636],
40	(	CD	NUMBER	(	num	42	SENT_186	[p9l874t2554r1343b2633],
41	simvastatin	NN	O	simvastatin	nn	42	SENT_186	[p9l874t2554r1343b2633],
42	)	NN	O	)	dep	39	SENT_186	[p9l874t2554r1343b2633],
43	in	IN	O	in	_	0	SENT_186	[p9l1372t2554r1441b2617],
44	the	DT	O	the	det	47	SENT_186	[p9l1466t2554r1575b2618],
45	LDH	NNP	ORGANIZATION	LDH	nn	47	SENT_186	[p9l1601t2555r1787b2617],
46	detection	NN	O	detection	nn	47	SENT_186	[p9l1813t2554r2147b2618],
47	assay	NN	O	assay	prep_in	42	SENT_186	[p9l9t2682r202b2745],
48	and	CC	O	and	_	0	SENT_186	[p9l230t2662r359b2726],
49	simvastatin	NN	O	simvastatin	conj_and	47	SENT_186	[p9l385t2662r797b2727],
50	as	RB	O	as	_	0	SENT_186	[p9l823t2682r893b2726],
51	well	RB	O	well	_	0	SENT_186	[p9l919t2662r1074b2727],
52	as	IN	O	as	_	0	SENT_186	[p9l1101t2683r1171b2726],
53	in	IN	O	in	_	0	SENT_186	[p9l1196t2662r1266b2726],
54	confocal	JJ	O	confocal	amod	59	SENT_186	[p9l1291t2662r1603b2726],
55	laser	NN	O	laser	nn	59	SENT_186	[p9l1628t2662r1801b2726],
56	scanning	NN	O	scanning	nn	59	SENT_186	[p9l1827t2662r2146b2745],
57	microscopy	NN	O	microscopy	nn	59	SENT_186	[p9l8t2773r433b2856],
58	(	CD	NUMBER	(	num	59	SENT_186	[p9l469t2773r902b2856],
59	manifesing	NN	O	manifesing	prep_in	27	SENT_186	[p9l469t2773r902b2856],
60	in	IN	O	in	_	0	SENT_186	[p9l937t2773r1006b2836],
61	deformations	NNS	O	deformation	prep_in	27	SENT_186	[p9l1040t2773r1519b2837],
62	of	IN	O	of	_	0	SENT_186	[p9l1555t2773r1634b2837],
63	the	DT	O	the	det	64	SENT_186	[p9l1661t2773r1770b2837],
64	cells	NNS	O	cell	prep_of	61	SENT_186	[p9l1805t2773r2019b2852],
65	)	VBP	O	)	_	0	SENT_186	[p9l1805t2773r2019b2852],
66	.	.	O	.	_	0	SENT_186	[p9l1805t2773r2019b2852],

1	Of	IN	O	of	_	0	SENT_187	[p9l101t2882r199b2946],
2	all	DT	O	all	prep_of	11	SENT_187	[p9l243t2882r330b2946],
3	tested	VBN	O	test	partmod	2	SENT_187	[p9l379t2882r592b2946],
4	compounds	NNS	O	compound	nsubj	11	SENT_187	[p9l641t2882r1059b2965],
5	simvastatin	NN	O	simvastatin	dep	4	SENT_187	[p9l1111t2882r1542b2958],
6	,	,	O	,	_	0	SENT_187	[p9l1111t2882r1542b2958],
7	lovastatin	NN	O	lovastatin	dep	4	SENT_187	[p9l1594t2882r1965b2958],
8	,	,	O	,	_	0	SENT_187	[p9l1594t2882r1965b2958],
9	and	CC	O	and	_	0	SENT_187	[p9l2019t2882r2148b2946],
10	fenoﬁbrate	NN	O	fenoﬁbrate	dep	4	SENT_187	[p9l8t2989r402b3054],
11	showed	VBD	O	show	_	0	SENT_187	[p9l457t2990r731b3054],
12	an	DT	O	a	det	14	SENT_187	[p9l783t3010r865b3054],
13	inhibitory	JJ	O	inhibitory	amod	14	SENT_187	[p9l917t2990r1277b3072],
14	effect	NN	O	effect	dobj	11	SENT_187	[p9l1329t2989r1535b3054],
15	on	IN	O	on	_	0	SENT_187	[p9l1587t3010r1675b3054],
16	Pgp	NNP	O	Pgp	prep_on	11	SENT_187	[p9l1726t2991r1864b3072],
17	in	IN	O	in	_	0	SENT_187	[p9l1917t2990r1986b3053],
18	the	DT	O	the	det	20	SENT_187	[p9l2037t2990r2146b3054],
19	calcein	NN	O	calcein	nn	20	SENT_187	[p9l8t3098r267b3162],
20	assay	NN	O	assay	prep_in	11	SENT_187	[p9l306t3118r512b3181],
21	.	.	O	.	_	0	SENT_187	[p9l306t3118r512b3181],

1	In	IN	O	in	_	0	SENT_188	[p9l554t3100r628b3161],
2	contrast	NN	O	contrast	prep_in	16	SENT_188	[p9l665t3108r953b3162],
3	to	TO	O	to	aux	4	SENT_188	[p9l989t3108r1057b3162],
4	fenoﬁbrate	VB	O	fenoﬁbrate	infmod	2	SENT_188	[p9l1095t3098r1510b3174],
5	,	,	O	,	_	0	SENT_188	[p9l1095t3098r1510b3174],
6	where	WRB	O	where	advmod	14	SENT_188	[p9l1551t3098r1770b3163],
7	a	DT	O	a	det	8	SENT_188	[p9l1811t3118r1848b3162],
8	plateau	NN	O	plateau	nsubj	14	SENT_188	[p9l1883t3098r2147b3181],
9	in	IN	O	in	_	0	SENT_188	[p9l8t3207r77b3270],
10	the	DT	O	the	det	13	SENT_188	[p9l106t3207r215b3271],
11	concentration	NN	O	concentration	nn	13	SENT_188	[p9l246t3207r1109b3290],
12	—	NN	O	—	nn	13	SENT_188	[p9l246t3207r1109b3290],
13	response	NN	O	response	prep_in	8	SENT_188	[p9l246t3207r1109b3290],
14	curve	NN	O	curve	advcl	16	SENT_188	[p9l1140t3227r1339b3272],
15	was	VBD	O	be	auxpass	16	SENT_188	[p9l1368t3227r1505b3272],
16	reached	VBN	O	reach	_	0	SENT_188	[p9l1535t3207r1821b3271],
17	(	CD	NUMBER	(	num	18	SENT_188	[p9l1852t3207r2017b3290],
18	Fig	NN	O	fig	dobj	16	SENT_188	[p9l1852t3207r2017b3290],
19	.	.	O	.	_	0	SENT_188	[p9l1852t3207r2017b3290],

1	1	CD	NUMBER	1	num	2	SENT_189	[p9l2060t3208r2144b3286],
2	)	NN	O	)	_	0	SENT_189	[p9l2060t3208r2144b3286],
3	,	,	O	,	_	0	SENT_189	[p9l2060t3208r2144b3286],
4	for	IN	O	for	dep	2	SENT_189	[p9l8t3318r114b3382],
5	simvastatin	NN	O	simvastatin	pobj	4	SENT_189	[p9l144t3318r555b3382],
6	and	CC	O	and	_	0	SENT_189	[p9l585t3318r714b3382],
7	lovastatin	NN	O	lovastatin	nn	9	SENT_189	[p9l742t3318r1094b3382],
8	(	CD	NUMBER	(	num	9	SENT_189	[p9l1125t3318r1291b3401],
9	Fig	NN	O	fig	conj_and	5	SENT_189	[p9l1125t3318r1291b3401],
10	.	.	O	.	_	0	SENT_189	[p9l1125t3318r1291b3401],

1	2	CD	NUMBER	2	num	2	SENT_190	[p9l1325t3318r1395b3397],
2	)	CD	NUMBER	)	nsubj	6	SENT_190	[p9l1325t3318r1395b3397],
3	this	DT	O	this	dep	2	SENT_190	[p9l1426t3318r1554b3382],
4	was	VBD	O	be	cop	6	SENT_190	[p9l1585t3338r1722b3382],
5	impossible	JJ	O	impossible	amod	6	SENT_190	[p9l1752t3318r2147b3401],
6	(	NN	O	(	_	0	SENT_190	[p9l10t3425r167b3504],
7	due	JJ	O	due	_	0	SENT_190	[p9l10t3425r167b3504],
8	to	TO	O	to	_	0	SENT_190	[p9l223t3435r291b3489],
9	cytotoxic	JJ	O	cytotoxic	amod	10	SENT_190	[p9l347t3425r684b3508],
10	effects	NNS	O	effect	prep_due_to	6	SENT_190	[p9l741t3425r1031b3504],
11	)	RB	O	)	advmod	6	SENT_190	[p9l741t3425r1031b3504],
12	,	,	O	,	_	0	SENT_190	[p9l741t3425r1031b3504],
13	and	CC	O	and	_	0	SENT_190	[p9l1091t3425r1220b3489],
14	thus	RB	O	thus	advmod	19	SENT_190	[p9l1273t3425r1422b3489],
15	no	DT	O	no	det	16	SENT_190	[p9l1479t3446r1566b3489],
16	IC50	NN	O	ic50	nsubjpass	19	SENT_190	[p9l1622t3444r1752b3505],
17	could	MD	O	could	aux	19	SENT_190	[p9l1808t3425r2009b3489],
18	be	VB	O	be	auxpass	19	SENT_190	[p9l2062t3425r2146b3489],
19	calculated	VBN	O	calculate	conj_and	6	SENT_190	[p9l8t3536r397b3600],
20	.	.	O	.	_	0	SENT_190	[p9l8t3536r397b3600],

1	On	IN	O	on	_	0	SENT_191	[p9l434t3536r542b3600],
2	the	DT	O	the	det	3	SENT_191	[p9l572t3536r681b3600],
3	basis	NN	O	basis	pobj	1	SENT_191	[p9l711t3536r892b3600],
4	of	IN	O	of	_	0	SENT_191	[p9l925t3536r1004b3600],
5	f2	NN	O	f2	prep_of	3	SENT_191	[p9l1026t3536r1361b3600],
6	.	.	O	.	_	0	SENT_191	[p9l1026t3536r1361b3600],

1	—	NN	O	—	_	0	SENT_192	[p9l1026t3536r1361b3600],
2	.	.	O	.	_	0	SENT_192	[p9l1026t3536r1361b3600],

1	Values	NNS	O	value	_	0	SENT_193	[p9l1026t3536r1361b3600],
2	the	DT	O	the	det	3	SENT_193	[p9l1394t3536r1503b3600],
3	potency	NN	O	potency	nsubj	7	SENT_193	[p9l1533t3546r1822b3619],
4	of	IN	O	of	_	0	SENT_193	[p9l1853t3536r1932b3600],
5	fenoﬁbrate	NN	O	fenoﬁbrate	prep_of	3	SENT_193	[p9l1957t3536r2144b3600, p9l9t3645r239b3709],
6	was	VBD	O	be	cop	7	SENT_193	[p9l294t3665r432b3709],
7	similar	JJ	O	similar	rcmod	1	SENT_193	[p9l493t3645r745b3709],
8	to	TO	O	to	_	0	SENT_193	[p9l799t3655r866b3709],
9	the	DT	O	the	det	10	SENT_193	[p9l924t3645r1033b3709],
10	potency	NN	O	potency	prep_to	7	SENT_193	[p9l1089t3654r1377b3728],
11	of	IN	O	of	_	0	SENT_193	[p9l1434t3645r1513b3709],
12	the	DT	O	the	det	13	SENT_193	[p9l1563t3645r1672b3709],
13	statins	NNS	O	statin	prep_of	10	SENT_193	[p9l1732t3645r1960b3709],
14	and	CC	O	and	advmod	7	SENT_193	[p9l2019t3645r2148b3709],

1	Verapamil	NNP	O	Verapamil	nsubj	6	SENT_194	[p10l8t20r392b102],
2	,	,	O	,	_	0	SENT_194	[p10l8t20r392b102],
3	a	DT	O	a	det	5	SENT_194	[p10l423t40r461b84],
4	well	RB	O	well	advmod	5	SENT_194	[p10l484t20r917b84],
5	—	RB	O	—	nsubj	6	SENT_194	[p10l484t20r917b84],
6	known	VBN	O	know	_	0	SENT_194	[p10l484t20r917b84],
7	Pgp	NNP	O	Pgp	nn	9	SENT_194	[p10l942t21r1080b102],
8	inhibitor	NN	O	inhibitor	nn	9	SENT_194	[p10l1107t19r1423b84],
9	(	NN	O	(	nsubj	12	SENT_194	[p10l1450t20r1677b99],
10	Table	NNP	O	Table	dep	12	SENT_194	[p10l1450t20r1677b99],
11	2	CD	NUMBER	2	num	12	SENT_194	[p10l1704t20r1795b99],
12	)	CD	NUMBER	)	ccomp	6	SENT_194	[p10l1704t20r1795b99],
13	.	.	O	.	_	0	SENT_194	[p10l1704t20r1795b99],

1	Comparing	VBG	O	compare	partmod	10	SENT_195	[p10l1825t20r2146b102, p10l8t128r121b211],
2	the	DT	O	the	det	4	SENT_195	[p10l160t128r269b192],
3	IC50	NN	MISC	ic50	nn	4	SENT_195	[p10l307t147r437b207],
4	Values	NNS	MISC	value	dobj	1	SENT_195	[p10l475t128r724b204],
5	,	,	O	,	_	0	SENT_195	[p10l475t128r724b204],
6	fenoﬁbrate	NN	O	fenoﬁbrate	nsubj	10	SENT_195	[p10l765t128r1160b192],
7	was	VBD	O	be	cop	10	SENT_195	[p10l1196t148r1333b192],
8	even	RB	O	even	advmod	10	SENT_195	[p10l1373t148r1541b192],
9	1.5	CD	NUMBER	1.5	number	10	SENT_195	[p10l1587t128r1686b193],
10	times	NNS	O	time	_	0	SENT_195	[p10l1727t128r1922b192],
11	more	RBR	O	more	quantmod	10	SENT_195	[p10l1961t148r2147b192],

1	o	NN	O	o	nn	2	SENT_196	[p10l770t519r812b561],
2	Feno	NN	O	feno	_	0	SENT_196	[p10l869t517r1003b564],
3	fibrate	JJ	O	fibrate	amod	4	SENT_196	[p10l1010t515r1189b564],
4	O	NN	O	o	dep	2	SENT_196	[p10l776t649r814b687],
5	Fenofibric	JJ	O	fenofibric	amod	6	SENT_196	[p10l873t642r1164b692],
6	acid	NN	O	acid	dep	2	SENT_196	[p10l1186t642r1302b692],

1	.9	CD	NUMBER	.9	num	2	SENT_197	[p10l475t644r524b699],
2	\	NN	O	\	_	0	SENT_197	[p10l533t645r566b699],
3	1	CD	NUMBER	1	num	4	SENT_197	[p10l533t645r566b699],
4	U1	NN	O	u1	dep	2	SENT_197	[p10l570t645r602b699],

1	.9	NN	NUMBER	.9	nn	2	SENT_198	[p10l475t916r524b971],
2	U1	NN	O	u1	_	0	SENT_198	[p10l534t917r564b971],
3	©	CD	NUMBER	©	dep	2	SENT_198	[p10l569t916r604b971],

1	Mean	NN	O	mean	_	0	SENT_199	[p10l244t1100r299b1291],
2	calcein	NN	O	calcein	nn	3	SENT_199	[p10l243t846r299b1075],
3	ﬂuorescence	NN	O	ﬂuorescence	dep	1	SENT_199	[p10l243t406r299b823],

1	[	NN	O	[	_	0	SENT_200	[p10l335t766r406b1091],
2	arbltrary	JJ	O	arbltrary	amod	3	SENT_200	[p10l335t766r406b1091],
3	unit	NN	O	unit	dep	1	SENT_200	[p10l335t600r403b745],
4	]	IN	O	]	amod	3	SENT_200	[p10l335t600r403b745],

1	Compound	NN	O	compound	_	0	SENT_201	[p10l980t1595r1345b1667],
2	[	CD	NUMBER	[	num	4	SENT_201	[p10l1371t1597r1527b1667],
3	uM	NN	O	um	nn	4	SENT_201	[p10l1371t1597r1527b1667],
4	]	NN	O	]	dep	1	SENT_201	[p10l1371t1597r1527b1667],

1	Fig	NN	O	fig	_	0	SENT_202	[p10l7t1763r115b1828],
2	.	.	O	.	_	0	SENT_202	[p10l7t1763r115b1828],

1	1	LS	NUMBER	1	_	0	SENT_203	[p10l159t1763r200b1813],
2	.	.	O	.	_	0	SENT_203	[p10l159t1763r200b1813],

1	Concentration	NN	O	concentration	nn	3	SENT_204	[p10l241t1763r644b1813],
2	response	NN	O	response	nn	3	SENT_204	[p10l677t1778r925b1828],
3	curve	NN	O	curve	nsubj	9	SENT_204	[p10l959t1779r1114b1813],
4	of	IN	O	of	_	0	SENT_204	[p10l1149t1763r1211b1813],
5	fenoﬁbrate	NN	O	fenoﬁbrate	nn	8	SENT_204	[p10l1238t1763r1549b1813],
6	and	CC	O	and	_	0	SENT_204	[p10l1584t1763r1684b1813],
7	fenoﬁbric	JJ	O	fenoﬁbric	conj_and	5	SENT_204	[p10l1717t1763r1995b1813],
8	acid	NN	O	acid	prep_of	3	SENT_204	[p10l2031t1763r2148b1813],
9	obtained	VBN	O	obtain	_	0	SENT_204	[p10l8t1851r252b1902],
10	with	IN	O	with	_	0	SENT_204	[p10l292t1851r417b1902],
11	calcein	NN	O	calcein	nn	12	SENT_204	[p10l457t1851r659b1902],
12	assay	NN	O	assay	prep_with	9	SENT_204	[p10l699t1867r850b1916],
13	in	IN	O	in	_	0	SENT_204	[p10l890t1851r944b1901],
14	L	NN	O	l	prep_in	12	SENT_204	[p10l983t1852r1241b1901],
15	.	.	O	.	_	0	SENT_204	[p10l983t1852r1241b1901],

1	—	NN	O	—	_	0	SENT_205	[p10l983t1852r1241b1901],
2	.	.	O	.	_	0	SENT_205	[p10l983t1852r1241b1901],

1	MDR1	NN	O	mdr1	nn	2	SENT_206	[p10l983t1852r1241b1901],
2	cells	NNS	O	cell	_	0	SENT_206	[p10l1287t1851r1430b1902],
3	.	.	O	.	_	0	SENT_206	[p10l1287t1851r1430b1902],

1	Data	NNS	O	datum	nsubjpass	3	SENT_207	[p10l1473t1853r1608b1902],
2	are	VBP	O	be	auxpass	3	SENT_207	[p10l1648t1867r1732b1902],
3	expressed	VBN	O	express	_	0	SENT_207	[p10l1773t1851r2051b1916],
4	as	IN	O	as	_	0	SENT_207	[p10l2092t1867r2147b1902],
5	mean	JJ	O	mean	amod	6	SENT_207	[p10l7t1956r161b1991],
6	i	FW	O	i	prep_as	3	SENT_207	[p10l181t1942r229b1990],
7	SD	NN	O	sd	dobj	3	SENT_207	[p10l251t1941r336b1991],
8	for	IN	O	for	_	0	SENT_207	[p10l363t1940r446b1991],
9	N	NN	O	n	prep_for	7	SENT_207	[p10l470t1942r520b1991],
10	=	JJ	O	=	amod	9	SENT_207	[p10l544t1963r592b1981],
11	8	CD	NUMBER	8	num	12	SENT_207	[p10l619t1941r647b1991],
12	wells	NNS	O	well	dep	10	SENT_207	[p10l676t1941r838b1991],
13	.	.	O	.	_	0	SENT_207	[p10l676t1941r838b1991],

1	O	NN	O	o	_	0	SENT_208	[p10l805t2306r841b2342],
2	Si	NNP	O	Si	nn	4	SENT_208	[p10l899t2301r948b2347],
3	mvastatin	NN	O	mvastatin	nn	4	SENT_208	[p10l956t2301r1237b2347],
4	r	NN	O	r	dep	1	SENT_208	[p10l532t2420r552b2472, p10l560t2420r593b2473],
5	—	CD	NUMBER	—	num	6	SENT_208	[p10l532t2420r552b2472, p10l560t2420r593b2473],
6	©	NN	O	©	dep	1	SENT_208	[p10l532t2420r552b2472, p10l560t2420r593b2473],

1	o	NN	O	o	nn	2	SENT_209	[p10l807t2446r846b2485],
2	Lovastatin	NN	O	lovastatin	_	0	SENT_209	[p10l901t2442r1206b2488],

1	Mean	NN	O	mean	_	0	SENT_210	[p10l321t2845r373b3026],
2	calcein	NN	O	calcein	nn	3	SENT_210	[p10l320t2604r373b2822],
3	ﬂuorescence	NN	O	ﬂuorescence	dep	1	SENT_210	[p10l320t2183r373b2581],

1	[	NN	O	[	nn	3	SENT_211	[p10l408t2527r475b2836],
2	arbltrary	NN	O	arbltrary	nn	3	SENT_211	[p10l408t2527r475b2836],
3	umt	NN	O	umt	_	0	SENT_211	[p10l408t2369r472b2508],
4	]	CD	NUMBER	]	dep	3	SENT_211	[p10l408t2369r472b2508],

1	N	NN	O	n	_	0	SENT_212	[p10l559t2956r593b3008],
2	-	:	O	-	_	0	SENT_212	[p10l559t2822r594b2874],
3	l	NN	O	l	amod	5	SENT_212	[p10l559t2822r594b2874],
4	>	JJR	O	>	dep	3	SENT_212	[p10l559t2822r594b2874],
5	o	NN	O	o	dep	1	SENT_212	[p10l561t2688r594b2741],
6	\	CD	NUMBER	\	num	7	SENT_212	[p10l561t2688r594b2741],
7	oo	NN	O	oo	dep	5	SENT_212	[p10l563t2554r592b2607],

1	Compound	NN	O	compound	_	0	SENT_213	[p10l951t3317r1299b3385],
2	[	CD	NUMBER	[	num	4	SENT_213	[p10l1324t3318r1473b3385],
3	uM	NN	O	um	nn	4	SENT_213	[p10l1324t3318r1473b3385],
4	]	NN	O	]	dep	1	SENT_213	[p10l1324t3318r1473b3385],

1	Fig	NN	O	fig	_	0	SENT_214	[p10l8t3481r116b3546],
2	.	.	O	.	_	0	SENT_214	[p10l8t3481r116b3546],

1	2	LS	NUMBER	2	_	0	SENT_215	[p10l175t3481r222b3531],
2	.	.	O	.	_	0	SENT_215	[p10l175t3481r222b3531],

1	Concentration	NN	O	concentration	nn	3	SENT_216	[p10l263t3481r667b3531],
2	response	NN	O	response	nn	3	SENT_216	[p10l720t3496r968b3546],
3	curve	NN	O	curve	nsubj	8	SENT_216	[p10l1023t3496r1178b3531],
4	of	IN	O	of	_	0	SENT_216	[p10l1234t3480r1296b3531],
5	simvastatin	NN	O	simvastatin	prep_of	3	SENT_216	[p10l1347t3480r1669b3531],
6	and	CC	O	and	_	0	SENT_216	[p10l1723t3481r1824b3531],
7	lovastatin	NN	O	lovastatin	prep_of	3	SENT_216	[p10l1878t3481r2153b3531],
8	obtained	VBN	O	obtain	_	0	SENT_216	[p10l9t3570r254b3620],
9	with	IN	O	with	_	0	SENT_216	[p10l294t3570r419b3620],
10	calcein	NN	O	calcein	nn	11	SENT_216	[p10l459t3570r660b3620],
11	assay	NN	O	assay	prep_with	8	SENT_216	[p10l701t3586r852b3635],
12	in	IN	O	in	_	0	SENT_216	[p10l893t3570r947b3619],
13	L	NN	O	l	prep_in	11	SENT_216	[p10l986t3570r1243b3619],
14	.	.	O	.	_	0	SENT_216	[p10l986t3570r1243b3619],

1	—	NN	O	—	_	0	SENT_217	[p10l986t3570r1243b3619],
2	.	.	O	.	_	0	SENT_217	[p10l986t3570r1243b3619],

1	MDR1	NN	O	mdr1	nn	2	SENT_218	[p10l986t3570r1243b3619],
2	cells	NNS	O	cell	_	0	SENT_218	[p10l1290t3570r1433b3620],
3	.	.	O	.	_	0	SENT_218	[p10l1290t3570r1433b3620],

1	Data	NNS	O	datum	nsubjpass	3	SENT_219	[p10l1477t3571r1612b3620],
2	are	VBP	O	be	auxpass	3	SENT_219	[p10l1651t3586r1735b3620],
3	expressed	VBN	O	express	_	0	SENT_219	[p10l1776t3570r2055b3635],
4	as	IN	O	as	_	0	SENT_219	[p10l2096t3586r2151b3620],
5	mean	NN	O	mean	prep_as	3	SENT_219	[p10l8t3674r162b3709],
6	:	:	O	:	_	0	SENT_219	[p10l182t3659r231b3708],
7	|	CD	NUMBER	|	dep	5	SENT_219	[p10l182t3659r231b3708],
8	:	:	O	:	_	0	SENT_219	[p10l182t3659r231b3708],
9	SD	NN	O	sd	dep	5	SENT_219	[p10l252t3659r339b3709],
10	for	IN	O	for	_	0	SENT_219	[p10l365t3658r448b3709],
11	N	NN	O	n	prep_for	5	SENT_219	[p10l471t3660r522b3709],
12	=	JJ	O	=	amod	11	SENT_219	[p10l546t3681r594b3698],
13	8	CD	NUMBER	8	num	14	SENT_219	[p10l621t3659r649b3709],
14	wells	NNS	O	well	dep	12	SENT_219	[p10l678t3658r841b3709],
15	.	.	O	.	_	0	SENT_219	[p10l678t3658r841b3709],

1	potent	JJ	O	potent	amod	5	SENT_220	[p11l8t116r237b189],
2	than	IN	O	than	_	0	SENT_220	[p11l266t107r422b171],
3	verapamil	NN	O	verapamil	prep_than	1	SENT_220	[p11l450t107r814b189],
4	(	CD	NUMBER	(	num	3	SENT_220	[p11l847t107r930b185],
5	P	NN	O	p	_	0	SENT_220	[p11l847t107r930b185],
6	<	JJR	O	<	dep	5	SENT_220	[p11l963t120r1019b173],
7	0.01	CD	NUMBER	0.01	num	8	SENT_220	[p11l1054t107r1262b186],
8	)	NN	O	)	dep	6	SENT_220	[p11l1054t107r1262b186],
9	.	.	O	.	_	0	SENT_220	[p11l1054t107r1262b186],

1	Except	IN	O	except	_	0	SENT_221	[p11l1296t108r1550b189],
2	for	IN	O	for	prepc_except_for	6	SENT_221	[p11l1580t106r1686b171],
3	simvastatin	NN	O	simvastatin	pobj	6	SENT_221	[p11l1717t106r2149b183],
4	,	,	O	,	_	0	SENT_221	[p11l1717t106r2149b183],
5	which	WDT	O	which	nsubj	6	SENT_221	[p11l9t215r231b279],
6	showed	VBD	O	show	_	0	SENT_221	[p11l270t215r543b279],
7	a	DT	O	a	det	9	SENT_221	[p11l581t235r618b279],
8	minor	JJ	O	minor	amod	9	SENT_221	[p11l653t215r872b279],
9	effect	NN	O	effect	dobj	6	SENT_221	[p11l907t215r1113b279],
10	also	RB	O	also	advmod	6	SENT_221	[p11l1150t215r1293b279],
11	in	IN	O	in	_	0	SENT_221	[p11l1330t215r1400b278],
12	LLC	NNP	O	LLC	prep_in	6	SENT_221	[p11l1435t216r1791b279],
13	.	.	O	.	_	0	SENT_221	[p11l1435t216r1791b279],

1	—	NN	O	—	_	0	SENT_222	[p11l1435t216r1791b279],
2	.	.	O	.	_	0	SENT_222	[p11l1435t216r1791b279],

1	PKl	NN	O	pkl	nn	2	SENT_223	[p11l1435t216r1791b279],
2	cells	NNS	O	cell	nsubj	8	SENT_223	[p11l1837t215r2022b290],
3	,	,	O	,	_	0	SENT_223	[p11l1837t215r2022b290],
4	all	DT	O	all	det	6	SENT_223	[p11l2064t215r2151b279],
5	other	JJ	O	other	amod	6	SENT_223	[p11l10t325r197b389],
6	compound	NN	O	compound	appos	2	SENT_223	[p11l217t325r602b408],
7	tested	VBN	O	test	partmod	6	SENT_223	[p11l622t325r835b389],
8	had	VBD	O	have	_	0	SENT_223	[p11l854t325r986b389],
9	no	DT	O	no	det	10	SENT_223	[p11l1006t345r1094b389],
10	effect	NN	O	effect	dobj	8	SENT_223	[p11l1116t325r1322b389],
11	in	IN	O	in	_	0	SENT_223	[p11l1342t325r1411b388],
12	the	DT	O	the	det	15	SENT_223	[p11l1431t325r1541b389],
13	control	NN	O	control	nn	15	SENT_223	[p11l1563t325r1819b389],
14	cell	NN	O	cell	nn	15	SENT_223	[p11l1842t325r1971b389],
15	line	NN	O	line	prep_in	10	SENT_223	[p11l1993t325r2147b389],
16	.	.	O	.	_	0	SENT_223	[p11l1993t325r2147b389],

1	For	IN	O	for	csubj	13	SENT_224	[p11l99t434r227b497],
2	simvastatin	NN	O	simvastatin	pobj	1	SENT_224	[p11l264t432r676b497],
3	and	CC	O	and	_	0	SENT_224	[p11l714t432r843b497],
4	fenoﬁbrate	VB	O	fenoﬁbrate	csubj	13	SENT_224	[p11l879t432r1274b497],
5	the	DT	O	the	det	6	SENT_224	[p11l1311t432r1420b497],
6	results	NNS	O	result	dobj	4	SENT_224	[p11l1456t432r1693b497],
7	obtained	VBN	O	obtain	partmod	6	SENT_224	[p11l1733t432r2047b497],
8	in	IN	O	in	_	0	SENT_224	[p11l2083t432r2152b496],
9	the	DT	O	the	det	11	SENT_224	[p11l8t541r118b605],
10	calcein	NN	O	calcein	nn	11	SENT_224	[p11l150t541r408b605],
11	assay	NN	O	assay	prep_in	7	SENT_224	[p11l441t562r634b624],
12	were	VBD	O	be	cop	13	SENT_224	[p11l665t561r840b606],
13	further	JJ	O	further	_	0	SENT_224	[p11l872t541r1121b605],
14	evaluated	VBN	O	evaluate	partmod	13	SENT_224	[p11l1150t541r1497b606],
15	with	IN	O	with	_	0	SENT_224	[p11l1527t541r1688b606],
16	an	DT	O	a	det	18	SENT_224	[p11l1719t562r1802b605],
17	independent	JJ	O	independent	amod	18	SENT_224	[p11l1832t541r2149b624, p11l10t652r166b716],
18	assay	NN	O	assay	prep_with	14	SENT_224	[p11l203t672r397b735],
19	based	VBN	O	base	partmod	18	SENT_224	[p11l433t652r642b716],
20	on	IN	O	on	_	0	SENT_224	[p11l679t672r767b716],
21	confocal	JJ	O	confocal	amod	24	SENT_224	[p11l805t652r1117b716],
22	laser	NN	O	laser	nn	24	SENT_224	[p11l1156t652r1328b716],
23	scanning	NN	O	scanning	nn	24	SENT_224	[p11l1367t652r1687b735],
24	microscopy	NN	O	microscopy	prep_on	19	SENT_224	[p11l1725t652r2151b735],
25	with	IN	O	with	_	0	SENT_224	[p11l9t760r170b824],
26	bodipy	JJ	O	bodipy	amod	28	SENT_224	[p11l203t760r855b842],
27	—	NN	O	—	nn	28	SENT_224	[p11l203t760r855b842],
28	verapamil	NN	O	verapamil	prep_with	24	SENT_224	[p11l203t760r855b842],
29	as	IN	O	as	mark	40	SENT_224	[p11l892t780r962b824],
30	a	DT	O	a	det	31	SENT_224	[p11l1001t780r1039b824],
31	substrate	NN	O	substrate	nsubj	40	SENT_224	[p11l1076t760r1395b824],
32	conﬁrming	VBG	O	conﬁrming	partmod	31	SENT_224	[p11l1432t759r1831b842],
33	the	DT	O	the	det	36	SENT_224	[p11l1867t760r1976b824],
34	Pgp	NNP	O	Pgp	nn	36	SENT_224	[p11l2012t761r2151b842],
35	inhibitor	NN	O	inhibitor	nn	36	SENT_224	[p11l9t868r326b932],
36	activity	NN	O	activity	dobj	32	SENT_224	[p11l351t868r621b951],
37	of	IN	O	of	_	0	SENT_224	[p11l648t868r727b932],
38	both	DT	O	both	det	39	SENT_224	[p11l746t868r908b932],
39	compounds	NNS	O	compound	prep_of	36	SENT_224	[p11l934t868r1352b951],
40	(	VBP	O	(	advcl	19	SENT_224	[p11l1382t868r1548b951],
41	Fig	NN	O	fig	dobj	40	SENT_224	[p11l1382t868r1548b951],
42	.	.	O	.	_	0	SENT_224	[p11l1382t868r1548b951],

1	3	CD	NUMBER	3	_	0	SENT_225	[p11l1581t869r1670b947],
2	)	NN	O	)	dep	1	SENT_225	[p11l1581t869r1670b947],
3	.	.	O	.	_	0	SENT_225	[p11l1581t869r1670b947],

1	In	IN	O	in	_	0	SENT_226	[p11l1701t870r1775b931],
2	this	DT	O	this	det	3	SENT_226	[p11l1800t868r1928b932],
3	assay	NN	O	assay	prep_in	6	SENT_226	[p11l1957t888r2151b951],
4	fenoﬁbrate	NN	O	fenoﬁbrate	nsubj	6	SENT_226	[p11l9t977r404b1041],
5	signiﬁcantly	RB	O	signiﬁcantly	advmod	6	SENT_226	[p11l451t977r900b1060],
6	increased	VBD	O	increase	_	0	SENT_226	[p11l944t977r1290b1041],
7	basal	JJ	O	basal	amod	8	SENT_226	[p11l1331t977r1518b1041],
8	ﬂuorescence	NN	O	ﬂuorescence	dobj	6	SENT_226	[p11l1564t977r2019b1041],
9	by	IN	O	by	_	0	SENT_226	[p11l2062t977r2151b1060],
10	1.46	CD	NUMBER	1.46	prep_by	6	SENT_226	[p11l17t1087r167b1151],
11	:	:	O	:	_	0	SENT_226	[p11l196t1088r257b1150],
12	|	CD	NUMBER	|	conj_and	10	SENT_226	[p11l196t1088r257b1150],
13	:	:	O	:	_	0	SENT_226	[p11l196t1088r257b1150],
14	0.12	CD	NUMBER	0.12	number	15	SENT_226	[p11l284t1087r442b1151],
15	(	CD	NUMBER	(	conj_and	10	SENT_226	[p11l467t1087r579b1166],
16	25	CD	NUMBER	25	num	18	SENT_226	[p11l467t1087r579b1166],
17	uM	NN	O	um	nn	18	SENT_226	[p11l613t1088r766b1169],
18	)	NN	O	)	dep	15	SENT_226	[p11l613t1088r766b1169],
19	and	CC	O	and	_	0	SENT_226	[p11l792t1087r921b1151],
20	1.69	CD	NUMBER	1.69	number	21	SENT_226	[p11l950t1087r1099b1152],
21	:1	CD	NUMBER	:1	conj_and	10	SENT_226	[p11l1128t1088r1189b1150],
22	:	:	O	:	_	0	SENT_226	[p11l1128t1088r1189b1150],
23	0.19	CD	NUMBER	0.19	dep	21	SENT_226	[p11l1216t1087r1373b1152],
24	(	CD	NUMBER	(	number	25	SENT_226	[p11l1399t1086r1516b1166],
25	50	CD	NUMBER	50	num	27	SENT_226	[p11l1399t1086r1516b1166],
26	uM	NN	O	um	nn	27	SENT_226	[p11l1546t1088r1699b1169],
27	)	NN	O	)	dep	23	SENT_226	[p11l1546t1088r1699b1169],
28	in	IN	O	in	_	0	SENT_226	[p11l1723t1087r1792b1150],
29	L	NN	O	l	prep_in	6	SENT_226	[p11l1813t1087r2144b1150],
30	.	.	O	.	_	0	SENT_226	[p11l1813t1087r2144b1150],

1	—	NN	O	—	_	0	SENT_227	[p11l1813t1087r2144b1150],
2	.	.	O	.	_	0	SENT_227	[p11l1813t1087r2144b1150],

1	MDRl	NN	O	mdrl	nn	2	SENT_228	[p11l1813t1087r2144b1150],
2	cells	NNS	O	cell	nsubj	3	SENT_228	[p11l9t1195r173b1259],
3	(	VBP	O	(	_	0	SENT_228	[p11l204t1196r286b1274],
4	P	NN	O	p	nsubj	5	SENT_228	[p11l204t1196r286b1274],
5	<	JJR	O	<	xcomp	3	SENT_228	[p11l320t1209r376b1262],
6	0.05	CD	NUMBER	0.05	num	7	SENT_228	[p11l411t1195r597b1274],
7	)	NN	O	)	dep	5	SENT_228	[p11l411t1195r597b1274],
8	whereas	IN	O	whereas	dep	5	SENT_228	[p11l627t1195r924b1260],
9	in	IN	O	in	pcomp	8	SENT_228	[p11l951t1195r1020b1259],
10	the	DT	O	the	det	14	SENT_228	[p11l1047t1195r1156b1260],
11	control	NN	O	control	nn	14	SENT_228	[p11l1184t1195r1440b1259],
12	cell	NN	O	cell	nn	14	SENT_228	[p11l1468t1195r1598b1259],
13	line	NN	O	line	nn	14	SENT_228	[p11l1625t1195r1760b1259],
14	LLC	NN	O	llc	pobj	9	SENT_228	[p11l1787t1196r2143b1260],
15	.	.	O	.	_	0	SENT_228	[p11l1787t1196r2143b1260],

1	—	NN	O	—	_	0	SENT_229	[p11l1787t1196r2143b1260],
2	.	.	O	.	_	0	SENT_229	[p11l1787t1196r2143b1260],

1	PKl	NN	O	pkl	nsubjpass	5	SENT_230	[p11l1787t1196r2143b1260],
2	no	DT	O	no	det	3	SENT_230	[p11l9t1324r97b1368],
3	effect	NN	O	effect	dep	1	SENT_230	[p11l152t1304r358b1368],
4	was	VBD	O	be	auxpass	5	SENT_230	[p11l411t1324r548b1369],
5	observed	VBN	O	observe	_	0	SENT_230	[p11l605t1304r933b1369],
6	(	RB	O	(	advmod	5	SENT_230	[p11l988t1304r1154b1387],
7	Fig	NN	O	fig	dobj	5	SENT_230	[p11l988t1304r1154b1387],
8	.	.	O	.	_	0	SENT_230	[p11l988t1304r1154b1387],

1	3	CD	NUMBER	3	_	0	SENT_231	[p11l1215t1305r1304b1383],
2	)	NN	O	)	dep	1	SENT_231	[p11l1215t1305r1304b1383],
3	.	.	O	.	_	0	SENT_231	[p11l1215t1305r1304b1383],

1	Simvastatin	NNP	O	Simvastatin	nsubj	7	SENT_232	[p11l1365t1304r1793b1369],
2	(	CD	NUMBER	(	num	1	SENT_232	[p11l1849t1304r1962b1383],
3	25	CD	NUMBER	25	num	5	SENT_232	[p11l1849t1304r1962b1383],
4	uM	NN	O	um	nn	5	SENT_232	[p11l1995t1305r2149b1386],
5	)	NN	O	)	dep	1	SENT_232	[p11l1995t1305r2149b1386],
6	signiﬁcantly	RB	O	signiﬁcantly	advmod	7	SENT_232	[p11l12t1415r460b1498],
7	increased	VBD	O	increase	_	0	SENT_232	[p11l482t1415r829b1479],
8	basal	JJ	O	basal	amod	9	SENT_232	[p11l848t1415r1035b1479],
9	ﬂuorescence	NN	O	ﬂuorescence	dobj	7	SENT_232	[p11l1058t1415r1513b1479],
10	in	IN	O	in	_	0	SENT_232	[p11l1535t1415r1605b1478],
11	L	NN	O	l	prep_in	7	SENT_232	[p11l1625t1416r1956b1478],
12	.	.	O	.	_	0	SENT_232	[p11l1625t1416r1956b1478],

1	—	NN	O	—	_	0	SENT_233	[p11l1625t1416r1956b1478],
2	.	.	O	.	_	0	SENT_233	[p11l1625t1416r1956b1478],

1	MDRl	NN	O	mdrl	nn	2	SENT_234	[p11l1625t1416r1956b1478],
2	cells	NNS	O	cell	_	0	SENT_234	[p11l1986t1415r2150b1479],
3	by	IN	O	by	_	0	SENT_234	[p11l7t1523r97b1605],
4	1.79	CD	NUMBER	1.79	prep_by	2	SENT_234	[p11l139t1523r288b1588],
5	:	:	O	:	_	0	SENT_234	[p11l317t1524r378b1586],
6	|	CD	NUMBER	|	dep	2	SENT_234	[p11l317t1524r378b1586],
7	:	:	O	:	_	0	SENT_234	[p11l317t1524r378b1586],
8	0.34	CD	NUMBER	0.34	number	9	SENT_234	[p11l405t1523r563b1587],
9	(	CD	NUMBER	(	num	10	SENT_234	[p11l599t1523r681b1602],
10	P	NN	O	p	npadvmod	11	SENT_234	[p11l599t1523r681b1602],
11	<	JJR	O	<	amod	13	SENT_234	[p11l715t1536r771b1589],
12	0.05	CD	NUMBER	0.05	num	13	SENT_234	[p11l806t1522r992b1601],
13	)	NN	O	)	dep	6	SENT_234	[p11l806t1522r992b1601],
14	(	CD	NUMBER	(	num	15	SENT_234	[p11l1031t1523r1196b1605],
15	Fig	NN	O	fig	dep	13	SENT_234	[p11l1031t1523r1196b1605],
16	.	.	O	.	_	0	SENT_234	[p11l1031t1523r1196b1605],

1	4	CD	NUMBER	4	num	2	SENT_235	[p11l1233t1523r1326b1602],
2	)	NN	O	)	nsubj	5	SENT_235	[p11l1233t1523r1326b1602],
3	,	,	O	,	_	0	SENT_235	[p11l1233t1523r1326b1602],
4	but	CC	O	but	dep	5	SENT_235	[p11l1361t1523r1478b1587],
5	also	RB	O	also	_	0	SENT_235	[p11l1510t1523r1652b1587],
6	in	IN	O	in	_	0	SENT_235	[p11l1686t1523r1755b1586],
7	LLC	NNP	O	LLC	prep_in	5	SENT_235	[p11l1787t1523r2143b1587],
8	.	.	O	.	_	0	SENT_235	[p11l1787t1523r2143b1587],

1	—	NN	O	—	_	0	SENT_236	[p11l1787t1523r2143b1587],
2	.	.	O	.	_	0	SENT_236	[p11l1787t1523r2143b1587],

1	PKl	NN	O	pkl	nn	2	SENT_237	[p11l1787t1523r2143b1587],
2	cells	NNS	O	cell	_	0	SENT_237	[p11l9t1633r173b1697],
3	by	IN	O	by	_	0	SENT_237	[p11l206t1633r296b1716],
4	1.19	CD	NUMBER	1.19	num	5	SENT_237	[p11l336t1634r485b1698],
5	:1	CD	NUMBER	:1	prep_by	2	SENT_237	[p11l515t1634r576b1696],
6	:	:	O	:	_	0	SENT_237	[p11l515t1634r576b1696],
7	0.06	CD	NUMBER	0.06	num	9	SENT_237	[p11l602t1633r761b1697],
8	(	CD	NUMBER	(	num	9	SENT_237	[p11l796t1634r878b1712],
9	P	NN	O	p	dep	10	SENT_237	[p11l796t1634r878b1712],
10	<	JJR	O	<	dep	2	SENT_237	[p11l912t1646r968b1700],
11	0.05	CD	NUMBER	0.05	num	12	SENT_237	[p11l1002t1633r1210b1712],
12	)	NN	O	)	dep	10	SENT_237	[p11l1002t1633r1210b1712],
13	.	.	O	.	_	0	SENT_237	[p11l1002t1633r1210b1712],

1	The	DT	O	the	det	2	SENT_238	[p11l1247t1633r1387b1697],
2	effect	NN	O	effect	nsubj	3	SENT_238	[p11l1420t1633r1626b1697],
3	seen	VBN	O	see	dep	9	SENT_238	[p11l1660t1653r1817b1697],
4	in	IN	O	in	_	0	SENT_238	[p11l1849t1633r1918b1696],
5	LLCPK1	NN	O	llcpk1	nn	6	SENT_238	[p11l1949t1633r2149b1697, p11l9t1741r160b1803],
6	cells	NNS	O	cell	prep_in	3	SENT_238	[p11l203t1740r368b1804],
7	was	VBD	O	be	cop	9	SENT_238	[p11l404t1760r541b1804],
8	clearly	RB	O	clearly	advmod	9	SENT_238	[p11l578t1740r825b1823],
9	smaller	JJR	O	smaller	_	0	SENT_238	[p11l864t1740r1131b1804],
10	than	IN	O	than	dep	9	SENT_238	[p11l1163t1740r1320b1804],
11	in	IN	O	in	_	0	SENT_238	[p11l1353t1740r1422b1803],
12	the	DT	O	the	det	17	SENT_238	[p11l1456t1740r1566b1804],
13	overexpressing	VBG	O	overexpress	amod	17	SENT_238	[p11l1602t1740r2150b1823],
14	cell	NN	O	cell	nn	17	SENT_238	[p11l9t1850r139b1914],
15	line	NN	O	line	nn	17	SENT_238	[p11l173t1850r308b1914],
16	(	NN	O	(	nn	17	SENT_238	[p11l345t1851r427b1929],
17	P	NN	O	p	prep_in	9	SENT_238	[p11l345t1851r427b1929],
18	<	JJR	O	<	amod	17	SENT_238	[p11l461t1863r517b1916],
19	0.05	CD	NUMBER	0.05	num	20	SENT_238	[p11l552t1850r760b1929],
20	)	NN	O	)	nsubj	9	SENT_238	[p11l552t1850r760b1929],
21	.	.	O	.	_	0	SENT_238	[p11l552t1850r760b1929],

1	3.2	CD	NUMBER	3.2	_	0	SENT_239	[p11l9t2068r135b2132],
2	.	.	O	.	_	0	SENT_239	[p11l9t2068r135b2132],

1	Pgp	NNP	O	Pgp	_	0	SENT_240	[p11l191t2070r337b2150],
2	substrate	NN	O	substrate	nn	3	SENT_240	[p11l371t2068r702b2132],
3	characteristics	NNS	O	characteristic	dep	1	SENT_240	[p11l738t2068r1279b2132],

1	To	TO	O	to	aux	2	SENT_241	[p11l100t2288r192b2350],
2	investigate	VB	O	investigate	_	0	SENT_241	[p11l234t2286r626b2369],
3	whether	IN	O	whether	complm	7	SENT_241	[p11l666t2286r961b2350],
4	the	DT	O	the	det	5	SENT_241	[p11l1000t2286r1110b2350],
5	ﬁbrates	NNS	O	ﬁbrates	nsubjpass	7	SENT_241	[p11l1153t2286r1417b2350],
6	are	VBP	O	be	auxpass	7	SENT_241	[p11l1461t2306r1568b2350],
7	transported	VBN	O	transport	ccomp	2	SENT_241	[p11l1610t2286r2023b2369],
8	by	IN	O	by	_	0	SENT_241	[p11l2061t2286r2151b2369],
9	Pgp	NNP	O	Pgp	agent	7	SENT_241	[p11l9t2397r147b2478],
10	an	DT	O	a	det	12	SENT_241	[p11l180t2415r263b2459],
11	uptake	NN	O	uptake	nn	12	SENT_241	[p11l292t2395r535b2478],
12	assay	NN	O	assay	dobj	7	SENT_241	[p11l568t2415r761b2478],
13	in	IN	O	in	_	0	SENT_241	[p11l793t2395r862b2458],
14	LLC	NNP	O	LLC	prep_in	12	SENT_241	[p11l891t2395r1248b2459],
15	.	.	O	.	_	0	SENT_241	[p11l891t2395r1248b2459],

1	—	NN	O	—	_	0	SENT_242	[p11l891t2395r1248b2459],
2	.	.	O	.	_	0	SENT_242	[p11l891t2395r1248b2459],

1	PKl	NN	O	pkl	_	0	SENT_243	[p11l891t2395r1248b2459],
2	and	CC	O	and	_	0	SENT_243	[p11l1288t2395r1417b2459],
3	L	NN	O	l	conj_and	1	SENT_243	[p11l1446t2396r1777b2458],
4	.	.	O	.	_	0	SENT_243	[p11l1446t2396r1777b2458],

1	—	NN	O	—	_	0	SENT_244	[p11l1446t2396r1777b2458],
2	.	.	O	.	_	0	SENT_244	[p11l1446t2396r1777b2458],

1	MDRl	NN	O	mdrl	nn	2	SENT_245	[p11l1446t2396r1777b2458],
2	cells	NNS	O	cell	nsubjpass	4	SENT_245	[p11l1816t2395r1980b2459],
3	was	VBD	O	be	auxpass	4	SENT_245	[p11l2013t2415r2150b2459],
4	performed	VBN	O	perform	_	0	SENT_245	[p11l8t2502r408b2585],
5	.	.	O	.	_	0	SENT_245	[p11l8t2502r408b2585],

1	First	RB	ORDINAL	first	_	0	SENT_246	[p11l456t2503r640b2578],
2	,	,	O	,	_	0	SENT_246	[p11l456t2503r640b2578],
3	the	DT	O	the	det	4	SENT_246	[p11l687t2503r797b2567],
4	suitability	NN	O	suitability	dep	5	SENT_246	[p11l844t2502r1207b2585],
5	of	IN	O	of	dep	1	SENT_246	[p11l1252t2502r1331b2567],
6	the	DT	O	the	det	8	SENT_246	[p11l1368t2503r1477b2567],
7	uptake	NN	O	uptake	nn	8	SENT_246	[p11l1521t2503r1763b2585],
8	assay	NN	O	assay	pobj	5	SENT_246	[p11l1810t2523r2003b2585],
9	for	IN	O	for	prep	8	SENT_246	[p11l2047t2502r2153b2567],

1	Table	NNP	O	Table	nn	3	SENT_247	[p11l8t2693r164b2743],
2	2	CD	NUMBER	2	num	3	SENT_247	[p11l191t2693r224b2742],
3	Inhibition	NN	O	inhibition	_	0	SENT_247	[p11l8t2782r290b2832],
4	of	IN	O	of	_	0	SENT_247	[p11l310t2781r371b2832],
5	Pgp	NN	ORGANIZATION	pgp	prep_of	3	SENT_247	[p11l387t2783r495b2847],
6	by	IN	O	by	dep	3	SENT_247	[p11l515t2781r585b2847],
7	lipid	NN	O	lipid	pobj	6	SENT_247	[p11l606t2782r736b2847],
8	lowering	VBG	O	lower	partmod	7	SENT_247	[p11l756t2782r1006b2847],
9	ﬁbrates	NNS	O	ﬁbrates	dobj	8	SENT_247	[p11l1028t2781r1234b2832],
10	and	CC	O	and	_	0	SENT_247	[p11l1257t2782r1357b2832],
11	typical	JJ	O	typical	amod	13	SENT_247	[p11l1377t2782r1570b2847],
12	Pgp	NN	O	pgp	nn	13	SENT_247	[p11l1591t2783r1699b2847],
13	inhibitors	NNS	O	inhibitor	conj_and	9	SENT_247	[p11l1720t2781r1991b2832],
14	in	IN	O	in	_	0	SENT_247	[p11l2012t2782r2066b2831],
15	LMDR1	NN	O	lmdr1	nn	16	SENT_247	[p11l2086t2783r2150b2831, p11l8t2871r199b2920],
16	cells	NNS	O	cell	prep_in	13	SENT_247	[p11l230t2871r358b2921],

1	Test	NN	O	test	nn	4	SENT_248	[p11l8t3017r127b3066],
2	compound	NN	O	compound	nn	4	SENT_248	[p11l152t3016r451b3081],
3	N	NN	O	n	nn	4	SENT_248	[p11l740t3017r790b3066],
4	f2	NN	O	f2	_	0	SENT_248	[p11l1091t3015r1149b3065],
5	(	CD	NUMBER	(	num	6	SENT_248	[p11l1176t3016r1321b3080],
6	uM	NN	O	um	dep	4	SENT_248	[p11l1176t3016r1321b3080],
7	)	CD	NUMBER	)	num	8	SENT_248	[p11l1176t3016r1321b3080],
8	IC50	NN	O	ic50	dep	6	SENT_248	[p11l1747t3030r1849b3078],
9	(	CD	NUMBER	(	num	11	SENT_248	[p11l1877t3016r2021b3080],
10	uM	NN	O	um	nn	11	SENT_248	[p11l1877t3016r2021b3080],
11	)	NN	O	)	dep	4	SENT_248	[p11l1877t3016r2021b3080],

1	Gemﬁbrozil	NNP	O	Gemﬁbrozil	nn	5	SENT_249	[p11l9t3160r352b3211],
2	4	CD	NUMBER	4	num	5	SENT_249	[p11l740t3161r774b3210],
3	n.d.	NNP	O	n.d.	nn	5	SENT_249	[p11l1091t3161r1193b3211],
4	n.d.	NNP	O	n.d.	nn	5	SENT_249	[p11l1747t3160r1849b3211],
5	Fenoﬁbrate	NNP	O	Fenoﬁbrate	_	0	SENT_249	[p11l8t3250r332b3300],
6	4	CD	NUMBER	4	number	7	SENT_249	[p11l740t3250r774b3299],
7	7.1	CD	NUMBER	7.1	dep	5	SENT_249	[p11l1092t3250r1172b3300],
8	i	FW	O	i	dep	7	SENT_249	[p11l1207t3251r1255b3299],
9	3.2	CD	NUMBER	3.2	num	10	SENT_249	[p11l1285t3250r1370b3300],
10	5.83	CD	NUMBER	5.83	dep	5	SENT_249	[p11l1748t3250r1867b3300],
11	3	CD	NUMBER	3	dep	10	SENT_249	[p11l1899t3251r1946b3299],
12	:	:	O	:	_	0	SENT_249	[p11l1899t3251r1946b3299],
13	23	CD	NUMBER	23	number	14	SENT_249	[p11l1975t3234r2086b3300],
14	*	CD	NUMBER	*	dep	10	SENT_249	[p11l1975t3234r2086b3300],
15	Fenoﬁbric	JJ	O	fenoﬁbric	amod	16	SENT_249	[p11l8t3338r299b3389],
16	acid	NN	O	acid	dep	14	SENT_249	[p11l327t3339r444b3389],
17	3	CD	NUMBER	3	num	19	SENT_249	[p11l742t3339r771b3389],
18	n.d.	NN	O	n.d.	nn	19	SENT_249	[p11l1091t3339r1193b3389],
19	n.d.	NN	O	n.d.	dep	5	SENT_249	[p11l1747t3338r1849b3389],
20	Bezaﬁbrate	NN	O	bezaﬁbrate	nn	24	SENT_249	[p11l8t3427r332b3478],
21	4	CD	NUMBER	4	num	24	SENT_249	[p11l740t3428r774b3477],
22	n.d.	NNP	O	n.d.	nn	24	SENT_249	[p11l1091t3428r1193b3478],
23	n.d.	NNP	O	n.d.	nn	24	SENT_249	[p11l1747t3427r1849b3478],
24	Simvastatin	NNP	O	Simvastatin	dep	19	SENT_249	[p11l10t3517r344b3567],
25	3	CD	NUMBER	3	number	26	SENT_249	[p11l742t3517r771b3567],
26	5.8	CD	NUMBER	5.8	dep	5	SENT_249	[p11l1092t3517r1176b3567],
27	i	FW	O	i	dep	26	SENT_249	[p11l1207t3518r1255b3566],
28	1.5	CD	NUMBER	1.5	dep	5	SENT_249	[p11l1290t3517r1367b3567],
29	n.d.	NNP	O	n.d.	nn	30	SENT_249	[p11l1747t3517r1849b3567],
30	Lovastatin	NNP	O	Lovastatin	dep	28	SENT_249	[p11l8t3622r307b3672],
31	3	CD	NUMBER	3	number	32	SENT_249	[p11l742t3622r771b3672],
32	10.1	CD	NUMBER	10.1	dep	5	SENT_249	[p11l1098t3622r1208b3672],
33	3	CD	NUMBER	3	num	35	SENT_249	[p11l1243t3623r1291b3672],
34	:	:	O	:	_	0	SENT_249	[p11l1243t3623r1291b3672],
35	1	CD	NUMBER	1	dep	32	SENT_249	[p11l1326t3607r1457b3672],
36	.	.	O	.	_	0	SENT_249	[p11l1326t3607r1457b3672],

1	o	NN	O	o	_	0	SENT_250	[p11l1326t3607r1457b3672],
2	**	CD	NUMBER	**	num	3	SENT_250	[p11l1326t3607r1457b3672],
3	n.d.	NN	O	n.d.	dep	1	SENT_250	[p11l1747t3622r1849b3672],

1	Verapamil	NNP	O	Verapamil	_	0	SENT_251	[p12l8t27r301b92],
2	3	CD	NUMBER	3	num	1	SENT_251	[p12l742t27r771b77],
3	4.7	CD	NUMBER	4.7	dep	1	SENT_251	[p12l1091t27r1177b77],
4	:	:	O	:	_	0	SENT_251	[p12l1207t28r1255b76],
5	|	CD	NUMBER	|	dep	1	SENT_251	[p12l1207t28r1255b76],
6	:	:	O	:	_	0	SENT_251	[p12l1207t28r1255b76],
7	0.8	CD	NUMBER	0.8	number	8	SENT_251	[p12l1284t27r1368b77],
8	20.0	CD	NUMBER	20.0	dep	5	SENT_251	[p12l1748t27r1870b77],
9	:4	CD	NUMBER	:4	dep	8	SENT_251	[p12l1899t28r1946b76],
10	:	:	O	:	_	0	SENT_251	[p12l1899t28r1946b76],
11	3.1	CD	NUMBER	3.1	num	12	SENT_251	[p12l1976t27r2056b77],
12	LY335979	NN	O	ly335979	dep	18	SENT_251	[p12l8t117r308b168],
13	4	CD	NUMBER	4	num	14	SENT_251	[p12l740t117r774b166],
14	0.02	CD	NUMBER	0.02	dep	12	SENT_251	[p12l1092t117r1214b167],
15	i	FW	O	i	dep	14	SENT_251	[p12l1243t118r1291b166],
16	0.01	CD	NUMBER	0.01	dep	18	SENT_251	[p12l1319t102r1493b167],
17	**	CD	NUMBER	**	num	18	SENT_251	[p12l1319t102r1493b167],
18	0.14	CD	NUMBER	0.14	dep	21	SENT_251	[p12l1748t117r1870b167],
19	i	FW	O	i	dep	18	SENT_251	[p12l1899t118r1946b166],
20	006	CD	NUMBER	006	num	21	SENT_251	[p12l1975t102r2122b167],
21	*	NN	O	*	dep	1	SENT_251	[p12l1975t102r2122b167],

1	N	NN	O	n	nn	3	SENT_252	[p12l115t255r165b304],
2	=	JJ	O	=	amod	3	SENT_252	[p12l189t276r238b293],
3	number	NN	O	number	nsubj	8	SENT_252	[p12l261t253r480b304],
4	of	IN	O	of	_	0	SENT_252	[p12l510t253r571b304],
5	experiments	NNS	O	experiment	prep_of	3	SENT_252	[p12l599t253r960b318],
6	,	,	O	,	_	0	SENT_252	[p12l599t253r960b318],
7	each	DT	O	each	appos	5	SENT_252	[p12l995t253r1124b304],
8	performed	VBN	O	perform	_	0	SENT_252	[p12l1155t253r1453b318],
9	in	IN	O	in	_	0	SENT_252	[p12l1483t253r1537b303],
10	octuplet	NN	O	octuplet	prep_in	8	SENT_252	[p12l1568t253r1811b318],
11	.	.	O	.	_	0	SENT_252	[p12l1568t253r1811b318],

1	Values	NNS	O	value	nsubjpass	3	SENT_253	[p12l1846t253r2034b304],
2	are	VBP	O	be	auxpass	3	SENT_253	[p12l2068t269r2152b304],
3	given	VBN	O	give	_	0	SENT_253	[p12l9t342r163b407],
4	as	IN	O	as	_	0	SENT_253	[p12l189t358r244b393],
5	mean	NN	O	mean	prep_as	3	SENT_253	[p12l271t358r424b393],
6	:	:	O	:	_	0	SENT_253	[p12l444t343r492b392],
7	|	CD	NUMBER	|	dep	5	SENT_253	[p12l444t343r492b392],
8	:	:	O	:	_	0	SENT_253	[p12l444t343r492b392],
9	SD	NN	O	sd	dep	5	SENT_253	[p12l514t343r616b393],
10	.	.	O	.	_	0	SENT_253	[p12l514t343r616b393],

1	P	NN	O	p	_	0	SENT_254	[p12l643t342r889b393],
2	.	.	O	.	_	0	SENT_254	[p12l643t342r889b393],

1	—	NN	O	—	_	0	SENT_255	[p12l643t342r889b393],
2	.	.	O	.	_	0	SENT_255	[p12l643t342r889b393],

1	Values	NNS	O	value	nsubjpass	3	SENT_256	[p12l643t342r889b393],
2	are	VBP	O	be	auxpass	3	SENT_256	[p12l917t358r1001b393],
3	determined	VBN	O	determine	_	0	SENT_256	[p12l1027t342r1348b393],
4	by	IN	O	by	_	0	SENT_256	[p12l1370t342r1440b407],
5	ANOVA	NNP	ORGANIZATION	ANOVA	agent	3	SENT_256	[p12l1465t343r1708b393],
6	with	IN	O	with	_	0	SENT_256	[p12l1726t342r1852b393],
7	Dunnett	NNP	PERSON	Dunnett	poss	11	SENT_256	[p12l1876t343r2151b393],
8	’s	POS	O	’s	_	0	SENT_256	[p12l1876t343r2151b393],
9	multiple	JJ	O	multiple	amod	11	SENT_256	[p12l8t431r246b497],
10	comparison	NN	O	comparison	nn	11	SENT_256	[p12l274t432r606b497],
11	test	NN	O	test	prep_with	3	SENT_256	[p12l633t439r732b482],
12	for	IN	O	for	_	0	SENT_256	[p12l758t431r841b482],
13	post	NN	O	post	amod	16	SENT_256	[p12l861t442r987b496],
14	hoc	FW	O	hoc	dep	13	SENT_256	[p12l1012t432r1113b482],
15	pairwise	JJ	O	pairwise	amod	16	SENT_256	[p12l1141t431r1381b497],
16	comparison	NN	O	comparison	prep_for	11	SENT_256	[p12l1410t432r1742b497],
17	of	IN	O	of	_	0	SENT_256	[p12l1770t431r1831b482],
18	the	DT	O	the	det	19	SENT_256	[p12l1854t432r1939b482],
19	results	NNS	O	result	prep_of	16	SENT_256	[p12l1967t432r2151b482],
20	with	IN	O	with	_	0	SENT_256	[p12l9t521r134b571],
21	the	DT	O	the	det	23	SENT_256	[p12l160t521r245b571],
22	Verapamil	NNP	O	Verapamil	nn	23	SENT_256	[p12l270t521r553b586],
23	control	NN	O	control	prep_with	3	SENT_256	[p12l580t521r794b571],
24	.	.	O	.	_	0	SENT_256	[p12l580t521r794b571],

1	f2	NN	O	f2	nn	3	SENT_257	[p12l823t521r884b570],
2	=	JJ	O	=	amod	3	SENT_257	[p12l909t543r957b561],
3	concentration	NN	O	concentration	_	0	SENT_257	[p12l982t521r1370b571],
4	needed	VBN	O	need	partmod	3	SENT_257	[p12l1395t521r1597b571],
5	to	TO	O	to	aux	6	SENT_257	[p12l1622t528r1675b571],
6	double	VB	O	double	xcomp	4	SENT_257	[p12l1702t521r1894b571],
7	baseline	NN	O	baseline	nn	8	SENT_257	[p12l1919t521r2152b571],
8	ﬂuorescence	NN	O	ﬂuorescence	dobj	6	SENT_257	[p12l9t609r364b660],
9	calculated	VBN	O	calculate	partmod	8	SENT_257	[p12l390t609r680b660],
10	according	VBG	O	accord	_	0	SENT_257	[p12l706t609r984b674],
11	to	TO	O	to	prepc_according_to	9	SENT_257	[p12l1010t617r1064b660],
12	[	CD	NUMBER	[	number	13	SENT_257	[p12l1095t610r1224b670],
13	21	CD	NUMBER	21	num	14	SENT_257	[p12l1095t610r1224b670],
14	]	NN	O	]	pobj	9	SENT_257	[p12l1095t610r1224b670],
15	;	:	O	;	_	0	SENT_257	[p12l1095t610r1224b670],
16	n.d.	NNP	O	n.d.	dep	3	SENT_257	[p12l1253t609r1374b660],
17	:	:	O	:	_	0	SENT_257	[p12l1253t609r1374b660],
18	not	RB	O	not	neg	19	SENT_257	[p12l1404t617r1494b660],
19	deﬁnable	JJ	O	deﬁnable	dep	16	SENT_257	[p12l1520t609r1794b660],
20	.	.	O	.	_	0	SENT_257	[p12l1520t609r1794b660],

1	*	NN	O	*	nn	2	SENT_258	[p12l118t685r185b749],
2	P	NN	O	p	_	0	SENT_258	[p12l118t685r185b749],
3	<	VBG	O	<	partmod	2	SENT_258	[p12l211t710r255b752],
4	0.01	CD	NUMBER	0.01	dobj	3	SENT_258	[p12l281t700r422b756],
5	;	:	O	;	_	0	SENT_258	[p12l281t700r422b756],
6	**	CD	NUMBER	**	num	7	SENT_258	[p12l454t685r547b749],
7	P	NN	O	p	dep	8	SENT_258	[p12l454t685r547b749],
8	<	JJR	O	<	dep	2	SENT_258	[p12l573t710r617b752],
9	0.05	CD	NUMBER	0.05	dep	8	SENT_258	[p12l643t699r781b750],
10	.	.	O	.	_	0	SENT_258	[p12l643t699r781b750],

1	M.	NNP	PERSON	M.	nn	2	SENT_259	[p12l329t832r362b855],
2	Ehrlzardt	NNP	PERSON	Ehrlzardt	_	0	SENT_259	[p12l376t831r497b855],
3	et	FW	O	et	nn	4	SENT_259	[p12l509t835r533b855],
4	al.	FW	O	al.	dep	2	SENT_259	[p12l543t831r763b855],
5	/	:	O	/	punct	2	SENT_259	[p12l543t831r763b855],
6	Biochemical	JJ	O	biochemical	amod	7	SENT_259	[p12l543t831r763b855],
7	Phamtacology	NN	O	phamtacology	dep	2	SENT_259	[p12l774t831r969b861],
8	67	CD	NUMBER	67	number	9	SENT_259	[p12l982t831r1015b855],
9	(	CD	NUMBER	(	num	10	SENT_259	[p12l1026t831r1112b860],
10	2004	CD	DATE	2004	dep	7	SENT_259	[p12l1026t831r1112b860],
11	)	CD	NUMBER	)	number	12	SENT_259	[p12l1026t831r1112b860],
12	285-292	CD	NUMBER	285-292	num	10	SENT_259	[p12l1125t831r1239b855],

1	Fig	NN	O	fig	_	0	SENT_260	[p13l34t3025r84b3055],
2	.	.	O	.	_	0	SENT_260	[p13l34t3025r84b3055],

1	3	LS	NUMBER	3	_	0	SENT_261	[p13l102t3025r124b3048],
2	.	.	O	.	_	0	SENT_261	[p13l102t3025r124b3048],

1	Confocal	JJ	O	confocal	amod	4	SENT_262	[p13l143t3025r264b3048],
2	laser	NN	O	laser	nn	4	SENT_262	[p13l279t3025r342b3048],
3	scanning	NN	O	scanning	nn	4	SENT_262	[p13l358t3025r474b3055],
4	microscopy	NN	O	microscopy	_	0	SENT_262	[p13l490t3025r652b3055],
5	:	:	O	:	_	0	SENT_262	[p13l490t3025r652b3055],
6	bodipy	JJ	O	bodipy	amod	9	SENT_262	[p13l669t3025r905b3055],
7	—	NN	O	—	nn	9	SENT_262	[p13l669t3025r905b3055],
8	verapamil	NN	O	verapamil	nn	9	SENT_262	[p13l669t3025r905b3055],
9	uptake	NN	O	uptake	dep	4	SENT_262	[p13l920t3025r1008b3055],
10	into	IN	O	into	_	0	SENT_262	[p13l1024t3025r1075b3048],
11	L	NN	O	l	prep_into	9	SENT_262	[p13l1090t3025r1210b3048],
12	.	.	O	.	_	0	SENT_262	[p13l1090t3025r1210b3048],

1	—	NN	O	—	_	0	SENT_263	[p13l1090t3025r1210b3048],
2	.	.	O	.	_	0	SENT_263	[p13l1090t3025r1210b3048],

1	MDRl	NN	O	mdrl	nn	2	SENT_264	[p13l1090t3025r1210b3048],
2	(	NN	O	(	_	0	SENT_264	[p13l1230t3025r1263b3053],
3	A	NN	O	a	nn	6	SENT_264	[p13l1230t3025r1263b3053],
4	and	CC	O	and	_	0	SENT_264	[p13l1279t3025r1326b3048],
5	B	NN	O	b	nn	6	SENT_264	[p13l1341t3025r1373b3054],
6	)	NN	O	)	dep	2	SENT_264	[p13l1341t3025r1373b3054],
7	and	CC	O	and	_	0	SENT_264	[p13l1390t3025r1437b3048],
8	LLC	NN	O	llc	dep	2	SENT_264	[p13l1452t3025r1581b3048],
9	.	.	O	.	_	0	SENT_264	[p13l1452t3025r1581b3048],

1	—	NN	O	—	_	0	SENT_265	[p13l1452t3025r1581b3048],
2	.	.	O	.	_	0	SENT_265	[p13l1452t3025r1581b3048],

1	PKl	NN	O	pkl	nn	3	SENT_266	[p13l1452t3025r1581b3048],
2	(	NN	O	(	nn	3	SENT_266	[p13l1601t3025r1631b3053],
3	C	NN	O	c	_	0	SENT_266	[p13l1601t3025r1631b3053],
4	and	CC	O	and	_	0	SENT_266	[p13l1649t3025r1695b3048],
5	D	NN	O	d	nn	6	SENT_266	[p13l1711t3025r1744b3054],
6	)	NN	O	)	conj_and	3	SENT_266	[p13l1711t3025r1744b3054],
7	cells	NNS	O	cell	dep	3	SENT_266	[p13l1761t3025r1828b3048],
8	.	.	O	.	_	0	SENT_266	[p13l1761t3025r1828b3048],

1	On	IN	O	on	amod	3	SENT_267	[p13l1846t3025r1885b3048],
2	the	DT	O	the	det	3	SENT_267	[p13l1900t3025r1940b3048],
3	left	NN	O	left	_	0	SENT_267	[p13l1956t3025r2007b3048],
4	:	:	O	:	_	0	SENT_267	[p13l1956t3025r2007b3048],
5	without	IN	O	without	_	0	SENT_267	[p13l2025t3025r2126b3048],
6	fenoﬁbrate	NN	O	fenoﬁbrate	prep_without	3	SENT_267	[p13l34t3066r186b3089],
7	.	.	O	.	_	0	SENT_267	[p13l34t3066r186b3089],

1	On	IN	O	on	dep	3	SENT_268	[p13l199t3066r239b3089],
2	the	DT	O	the	det	3	SENT_268	[p13l250t3066r290b3089],
3	right	NN	O	right	_	0	SENT_268	[p13l302t3066r371b3096],
4	:	:	O	:	_	0	SENT_268	[p13l302t3066r371b3096],
5	after	IN	O	after	dep	15	SENT_268	[p13l386t3066r446b3089],
6	exposure	NN	O	exposure	pobj	5	SENT_268	[p13l458t3073r576b3096],
7	for	IN	O	for	_	0	SENT_268	[p13l588t3066r626b3089],
8	20	CD	DURATION	20	num	9	SENT_268	[p13l638t3066r670b3089],
9	min	NN	DURATION	min	prep_for	6	SENT_268	[p13l679t3066r730b3089],
10	with	IN	O	with	_	0	SENT_268	[p13l742t3066r800b3089],
11	fenoﬁbrate	JJ	O	fenoﬁbrate	amod	12	SENT_268	[p13l812t3066r956b3089],
12	(	NN	O	(	prep_with	9	SENT_268	[p13l969t3066r1012b3095],
13	50	CD	NUMBER	50	num	15	SENT_268	[p13l969t3066r1012b3095],
14	LLM	NN	O	llm	nn	15	SENT_268	[p13l1022t3066r1078b3096],
15	)	NN	O	)	dep	3	SENT_268	[p13l1022t3066r1078b3096],
16	as	IN	O	as	_	0	SENT_268	[p13l1091t3073r1117b3089],
17	Pgp	NNP	O	Pgp	nn	18	SENT_268	[p13l1129t3067r1180b3096],
18	inhibitor	NN	O	inhibitor	prep_as	15	SENT_268	[p13l1192t3066r1310b3089],
19	.	.	O	.	_	0	SENT_268	[p13l1192t3066r1310b3089],

1	evaluating	VBG	O	evaluate	csubjpass	6	SENT_269	[p13l34t3171r209b3210],
2	Pgp	NNP	ORGANIZATION	Pgp	nn	4	SENT_269	[p13l227t3172r292b3210],
3	substrate	NN	O	substrate	nn	4	SENT_269	[p13l311t3171r460b3201],
4	characteristics	NNS	O	characteristic	dobj	1	SENT_269	[p13l478t3171r721b3201],
5	was	VBD	O	be	auxpass	6	SENT_269	[p13l739t3180r803b3201],
6	tested	VBN	O	test	_	0	SENT_269	[p13l822t3171r921b3201],
7	using	VBG	O	use	xcomp	6	SENT_269	[p13l938t3171r1029b3210],
8	the	DT	O	the	det	12	SENT_269	[p13l34t3221r85b3251],
9	known	JJ	O	known	amod	12	SENT_269	[p13l111t3221r225b3251],
10	Pgp	NNP	O	Pgp	nn	12	SENT_269	[p13l251t3222r315b3260],
11	substrate	NN	O	substrate	nn	12	SENT_269	[p13l343t3221r492b3251],
12	loperamide	NN	O	loperamide	dobj	7	SENT_269	[p13l518t3221r718b3260],
13	.	.	O	.	_	0	SENT_269	[p13l518t3221r718b3260],

1	The	DT	O	the	det	3	SENT_270	[p13l747t3221r812b3251],
2	loperamide	NN	O	loperamide	nn	3	SENT_270	[p13l838t3221r1029b3260],
3	uptake	NN	O	uptake	nsubj	6	SENT_270	[p13l34t3272r146b3311],
4	was	VBD	O	be	cop	6	SENT_270	[p13l166t3282r230b3302],
5	signiﬁcantly	RB	O	signiﬁcantly	advmod	6	SENT_270	[p13l251t3272r460b3311],
6	higher	JJR	O	higher	_	0	SENT_270	[p13l479t3272r588b3311],
7	in	IN	O	in	_	0	SENT_270	[p13l607t3272r639b3302],
8	the	DT	O	the	det	11	SENT_270	[p13l659t3272r709b3302],
9	parental	JJ	O	parental	amod	11	SENT_270	[p13l729t3272r866b3311],
10	cell	NN	O	cell	nn	11	SENT_270	[p13l886t3272r946b3302],
11	line	NN	O	line	prep_in	6	SENT_270	[p13l966t3272r1029b3302],
12	compared	VBN	O	compare	_	0	SENT_270	[p13l34t3323r202b3362],
13	to	TO	O	to	prepc_compared_to	6	SENT_270	[p13l224t3327r256b3353],
14	L	NN	O	l	pobj	6	SENT_270	[p13l278t3323r432b3353],
15	.	.	O	.	_	0	SENT_270	[p13l278t3323r432b3353],

1	—	NN	O	—	_	0	SENT_271	[p13l278t3323r432b3353],
2	.	.	O	.	_	0	SENT_271	[p13l278t3323r432b3353],

1	MDRl	NN	O	mdrl	nn	2	SENT_272	[p13l278t3323r432b3353],
2	cells	NNS	O	cell	nsubj	3	SENT_272	[p13l458t3323r534b3353],
3	(	VBP	O	(	_	0	SENT_272	[p13l558t3323r596b3360],
4	P	NN	O	p	npadvmod	5	SENT_272	[p13l558t3323r596b3360],
5	<	JJR	O	<	acomp	3	SENT_272	[p13l612t3329r638b3354],
6	0.01	CD	NUMBER	0.01	num	7	SENT_272	[p13l654t3323r741b3360],
7	)	NN	O	)	dep	5	SENT_272	[p13l654t3323r741b3360],
8	(	CD	NUMBER	(	num	9	SENT_272	[p13l765t3323r842b3362],
9	Fig	NN	O	fig	dep	7	SENT_272	[p13l765t3323r842b3362],
10	.	.	O	.	_	0	SENT_272	[p13l765t3323r842b3362],

1	5A	NN	O	5a	_	0	SENT_273	[p13l867t3323r940b3360],
2	)	NN	O	)	dep	1	SENT_273	[p13l867t3323r940b3360],
3	.	.	O	.	_	0	SENT_273	[p13l867t3323r940b3360],

1	Pgp	NN	O	pgp	nn	2	SENT_274	[p13l964t3324r1029b3362],
2	inhibition	NN	O	inhibition	nsubj	6	SENT_274	[p13l34t3373r200b3403],
3	with	IN	O	with	_	0	SENT_274	[p13l209t3373r284b3403],
4	LY335979	NN	O	ly335979	prep_with	2	SENT_274	[p13l293t3373r471b3404],
5	completely	RB	O	completely	advmod	6	SENT_274	[p13l482t3373r671b3412],
6	abolished	VBD	O	abolish	_	0	SENT_274	[p13l681t3373r843b3403],
7	drug	NN	O	drug	nn	8	SENT_274	[p13l852t3373r928b3412],
8	resistance	NN	O	resistance	dobj	6	SENT_274	[p13l938t3373r1028b3403, p13l34t3429r123b3454],
9	of	IN	O	of	_	0	SENT_274	[p13l140t3424r176b3454],
10	L	NN	O	l	prep_of	8	SENT_274	[p13l189t3424r343b3454],
11	.	.	O	.	_	0	SENT_274	[p13l189t3424r343b3454],

1	—	NN	O	—	_	0	SENT_275	[p13l189t3424r343b3454],
2	.	.	O	.	_	0	SENT_275	[p13l189t3424r343b3454],

1	MDRl	NN	O	mdrl	nn	2	SENT_276	[p13l189t3424r343b3454],
2	cells	NNS	O	cell	_	0	SENT_276	[p13l362t3424r438b3454],
3	leading	VBG	O	lead	partmod	2	SENT_276	[p13l455t3424r579b3463],
4	to	TO	O	to	_	0	SENT_276	[p13l595t3429r627b3454],
5	similar	JJ	O	similar	amod	7	SENT_276	[p13l644t3424r761b3454],
6	concentrationtime	NN	O	concentrationtime	nn	7	SENT_276	[p13l776t3424r1030b3454, p13l1130t3171r1205b3201],
7	proﬁles	NNS	O	proﬁles	prep_to	3	SENT_276	[p13l1231t3171r1358b3210],
8	as	IN	O	as	dep	3	SENT_276	[p13l1386t3180r1418b3201],
9	in	IN	O	in	_	0	SENT_276	[p13l1446t3171r1478b3201],
10	the	DT	O	the	det	15	SENT_276	[p13l1504t3171r1555b3201],
11	parental	JJ	O	parental	amod	15	SENT_276	[p13l1581t3171r1718b3210],
12	cell	NN	O	cell	nn	15	SENT_276	[p13l1745t3171r1806b3201],
13	line	NN	O	line	nn	15	SENT_276	[p13l1833t3171r1895b3201],
14	(	NN	O	(	nn	15	SENT_276	[p13l1923t3171r1962b3208],
15	P	NN	O	p	prep_in	3	SENT_276	[p13l1923t3171r1962b3208],
16	<	VBG	O	<	partmod	15	SENT_276	[p13l1977t3177r2003b3202],
17	0.001	CD	NUMBER	0.001	dobj	16	SENT_276	[p13l2019t3171r2124b3206],
18	,	,	O	,	_	0	SENT_276	[p13l2019t3171r2124b3206],
19	compared	VBN	O	compare	_	0	SENT_276	[p13l1131t3221r1298b3260],
20	to	TO	O	to	prepc_compared_to	16	SENT_276	[p13l1330t3226r1361b3251],
21	L	NN	O	l	pobj	16	SENT_276	[p13l1394t3221r1548b3251],
22	.	.	O	.	_	0	SENT_276	[p13l1394t3221r1548b3251],

1	—	NN	O	—	_	0	SENT_277	[p13l1394t3221r1548b3251],
2	.	.	O	.	_	0	SENT_277	[p13l1394t3221r1548b3251],

1	MDRl	NN	O	mdrl	nn	2	SENT_278	[p13l1394t3221r1548b3251],
2	cells	NNS	O	cell	_	0	SENT_278	[p13l1584t3221r1660b3251],
3	without	IN	O	without	_	0	SENT_278	[p13l1693t3221r1823b3251],
4	LY335979	NN	O	ly335979	nn	5	SENT_278	[p13l1854t3221r2057b3258],
5	)	NN	O	)	prep_without	2	SENT_278	[p13l1854t3221r2057b3258],
6	.	.	O	.	_	0	SENT_278	[p13l1854t3221r2057b3258],

1	In	IN	O	in	_	0	SENT_279	[p13l2091t3222r2125b3251],
2	LLC	NNP	O	LLC	pobj	1	SENT_279	[p13l1130t3272r1295b3302],
3	.	.	O	.	_	0	SENT_279	[p13l1130t3272r1295b3302],

1	—	NN	O	—	_	0	SENT_280	[p13l1130t3272r1295b3302],
2	.	.	O	.	_	0	SENT_280	[p13l1130t3272r1295b3302],

1	PKl	NN	O	pkl	nn	3	SENT_281	[p13l1130t3272r1295b3302],
2	cells	NNS	O	cell	nn	3	SENT_281	[p13l1316t3272r1392b3302],
3	LY335979	NN	O	ly335979	nsubj	4	SENT_281	[p13l1408t3273r1587b3303],
4	had	VBD	O	have	_	0	SENT_281	[p13l1604t3272r1665b3302],
5	no	DT	O	no	det	8	SENT_281	[p13l1681t3282r1722b3302],
6	statistically	RB	O	statistically	advmod	7	SENT_281	[p13l1740t3272r1932b3311],
7	signiﬁcant	JJ	O	signiﬁcant	amod	8	SENT_281	[p13l1950t3272r2125b3311],
8	effect	NN	O	effect	dobj	4	SENT_281	[p13l1131t3323r1226b3353],
9	on	IN	O	on	_	0	SENT_281	[p13l1242t3332r1282b3353],
10	the	DT	O	the	det	14	SENT_281	[p13l1298t3323r1349b3353],
11	loperamide	NN	O	loperamide	nn	14	SENT_281	[p13l1365t3323r1556b3362],
12	uptake	NN	O	uptake	nn	14	SENT_281	[p13l1571t3323r1684b3362],
13	(	CD	NUMBER	(	num	14	SENT_281	[p13l1701t3323r1778b3362],
14	Fig	NN	O	fig	prep_on	8	SENT_281	[p13l1701t3323r1778b3362],
15	.	.	O	.	_	0	SENT_281	[p13l1701t3323r1778b3362],

1	5A	NN	O	5a	_	0	SENT_282	[p13l1796t3323r1869b3360],
2	)	NN	O	)	dep	1	SENT_282	[p13l1796t3323r1869b3360],
3	.	.	O	.	_	0	SENT_282	[p13l1796t3323r1869b3360],

1	In	IN	O	in	_	0	SENT_283	[p13l1173t3374r1207b3403],
2	this	DT	O	this	det	3	SENT_283	[p13l1224t3373r1283b3403],
3	assay	NN	O	assay	prep_in	5	SENT_283	[p13l1302t3383r1391b3412],
4	there	EX	O	there	expl	5	SENT_283	[p13l1409t3373r1493b3403],
5	was	VBD	O	be	_	0	SENT_283	[p13l1509t3383r1573b3403],
6	no	DT	O	no	det	7	SENT_283	[p13l1590t3383r1631b3403],
7	difference	NN	O	difference	nsubj	5	SENT_283	[p13l1649t3373r1819b3403],
8	between	IN	O	between	_	0	SENT_283	[p13l1836t3373r1978b3403],
9	the	DT	O	the	det	12	SENT_283	[p13l1995t3373r2046b3403],
10	two	CD	NUMBER	two	num	12	SENT_283	[p13l2062t3378r2125b3403],
11	cell	NN	O	cell	nn	12	SENT_283	[p13l1131t3424r1191b3454],
12	lines	NNS	O	line	prep_between	7	SENT_283	[p13l1200t3424r1279b3454],
13	in	IN	O	in	_	0	SENT_283	[p13l1289t3424r1321b3454],
14	the	DT	O	the	det	16	SENT_283	[p13l1330t3424r1381b3454],
15	intracellular	JJ	O	intracellular	amod	16	SENT_283	[p13l1390t3424r1597b3454],
16	uptake	NN	O	uptake	prep_in	12	SENT_283	[p13l1605t3424r1718b3463],
17	of	IN	O	of	_	0	SENT_283	[p13l1727t3424r1764b3454],
18	fenoﬁbrate	JJ	O	fenoﬁbrate	amod	20	SENT_283	[p13l1769t3424r1953b3454],
19	(	NN	O	(	nn	20	SENT_283	[p13l1964t3424r2041b3463],
20	Fig	NN	O	fig	prep_of	16	SENT_283	[p13l1964t3424r2041b3463],
21	.	.	O	.	_	0	SENT_283	[p13l1964t3424r2041b3463],

1	SB	NN	O	sb	_	0	SENT_284	[p13l2053t3424r2124b3461],
2	)	NN	O	)	dep	1	SENT_284	[p13l2053t3424r2124b3461],
3	,	,	O	,	_	0	SENT_284	[p13l2053t3424r2124b3461],

1	Fig	NN	O	fig	_	0	SENT_285	[p14l34t808r84b838],
2	.	.	O	.	_	0	SENT_285	[p14l34t808r84b838],

1	4	LS	NUMBER	4	_	0	SENT_286	[p14l98t808r120b831],
2	.	.	O	.	_	0	SENT_286	[p14l98t808r120b831],

1	Confocal	JJ	O	confocal	amod	4	SENT_287	[p14l139t808r260b832],
2	laser	NN	O	laser	nn	4	SENT_287	[p14l272t808r335b831],
3	scanning	NN	O	scanning	nn	4	SENT_287	[p14l347t808r463b838],
4	microscopy	NN	O	microscopy	_	0	SENT_287	[p14l475t808r637b838],
5	:	:	O	:	_	0	SENT_287	[p14l475t808r637b838],
6	bodipy-verapamil	NN	O	bodipy-verapamil	nn	7	SENT_287	[p14l651t808r886b838],
7	uptake	NN	O	uptake	dep	4	SENT_287	[p14l898t808r986b838],
8	into	IN	O	into	_	0	SENT_287	[p14l998t808r1049b831],
9	L-MDRl	JJ	O	l-mdrl	amod	11	SENT_287	[p14l1061t808r1181b831],
10	(	NN	O	(	nn	11	SENT_287	[p14l1197t808r1230b837],
11	A	NN	O	a	prep_into	7	SENT_287	[p14l1197t808r1230b837],
12	and	CC	O	and	_	0	SENT_287	[p14l1243t808r1290b831],
13	B	NN	O	b	nn	15	SENT_287	[p14l1301t808r1333b837],
14	)	NN	O	)	nn	15	SENT_287	[p14l1301t808r1333b837],
15	cells	NNS	O	cell	prep_into	7	SENT_287	[p14l1346t808r1413b831],
16	.	.	O	.	_	0	SENT_287	[p14l1346t808r1413b831],

1	On	IN	O	on	amod	3	SENT_288	[p14l1427t808r1466b832],
2	the	DT	O	the	det	3	SENT_288	[p14l1478t808r1518b831],
3	left	NN	O	left	_	0	SENT_288	[p14l1530t808r1581b831],
4	:	:	O	:	_	0	SENT_288	[p14l1530t808r1581b831],
5	without	IN	O	without	_	0	SENT_288	[p14l1595t808r1696b831],
6	simvastatin	NN	O	simvastatin	prep_without	3	SENT_288	[p14l1709t808r1864b831],
7	.	.	O	.	_	0	SENT_288	[p14l1709t808r1864b831],

1	On	IN	O	on	dep	3	SENT_289	[p14l1879t808r1918b832],
2	the	DT	O	the	det	3	SENT_289	[p14l1930t808r1969b831],
3	right	NN	O	right	_	0	SENT_289	[p14l1981t808r2051b838],
4	:	:	O	:	_	0	SENT_289	[p14l1981t808r2051b838],
5	after	IN	O	after	dep	14	SENT_289	[p14l2066t808r2126b831],
6	exposure	NN	O	exposure	pobj	5	SENT_289	[p14l34t857r152b880],
7	for	IN	O	for	_	0	SENT_289	[p14l164t849r203b873],
8	20	CD	DURATION	20	num	9	SENT_289	[p14l215t849r246b873],
9	min	NN	DURATION	min	prep_for	6	SENT_289	[p14l256t849r307b873],
10	with	IN	O	with	_	0	SENT_289	[p14l319t849r377b873],
11	simvastatin	NN	O	simvastatin	prep_with	9	SENT_289	[p14l389t849r538b873],
12	(	CD	NUMBER	(	num	11	SENT_289	[p14l551t849r592b878],
13	25	CD	NUMBER	25	num	14	SENT_289	[p14l551t849r592b878],
14	uM	NN	O	um	dep	3	SENT_289	[p14l604t849r660b880],
15	)	RB	O	)	advmod	14	SENT_289	[p14l604t849r660b880],
16	as	IN	O	as	_	0	SENT_289	[p14l673t857r698b873],
17	Pgp	NNP	O	Pgp	nn	18	SENT_289	[p14l711t850r761b880],
18	inhibitor	NN	O	inhibitor	prep_as	14	SENT_289	[p14l774t849r892b873],
19	.	.	O	.	_	0	SENT_289	[p14l774t849r892b873],

1	290	CD	NUMBER	290	num	3	SENT_290	[p14l330t955r378b979],
2	M.	NN	NUMBER	m.	nn	3	SENT_290	[p14l919t956r952b979],
3	Ehrhardt	NNP	PERSON	Ehrhardt	_	0	SENT_290	[p14l967t955r1088b979],
4	et	FW	O	et	nn	5	SENT_290	[p14l1099t960r1123b979],
5	al.	FW	O	al.	dep	3	SENT_290	[p14l1134t955r1164b979],
6	/	:	O	/	punct	3	SENT_290	[p14l1171t955r1186b979],
7	Biochemical	JJ	O	biochemical	amod	8	SENT_290	[p14l1188t955r1354b979],
8	Pharmacology	NN	O	pharmacology	dep	3	SENT_290	[p14l1365t955r1560b985],
9	67	CD	NUMBER	67	number	10	SENT_290	[p14l1572t955r1606b979],
10	(	CD	NUMBER	(	num	11	SENT_290	[p14l1617t955r1703b984],
11	2004	CD	DATE	2004	dep	8	SENT_290	[p14l1617t955r1703b984],
12	)	CD	NUMBER	)	number	13	SENT_290	[p14l1617t955r1703b984],
13	285-292	CD	NUMBER	285-292	num	11	SENT_290	[p14l1715t955r1830b979],

1	U1	NN	O	u1	_	0	SENT_291	[p14l271t1167r309b1234],

1	-	:	O	-	_	0	SENT_292	[p14l268t1368r313b1435],
2	l	NN	O	l	dep	3	SENT_292	[p14l268t1368r313b1435],
3	>	JJR	O	>	_	0	SENT_292	[p14l268t1368r313b1435],

1	<	JJR	O	<	_	0	SENT_293	[p14l1032t1639r1089b1696],
2	>	JJR	O	>	amod	3	SENT_293	[p14l1032t1639r1089b1696],
3	LLC-PK1	NN	O	llc-pk1	dep	1	SENT_293	[p14l1155t1645r1801b1694],
4	+	CC	O	+	_	0	SENT_293	[p14l1155t1645r1801b1694],
5	LY335979	NN	O	ly335979	nn	7	SENT_293	[p14l1155t1645r1801b1694],
6	1:1	CD	NUMBER	1:1	num	7	SENT_293	[p14l1042t1745r1089b1792],
7	LLC-PK1	NN	O	llc-pk1	conj_+	3	SENT_293	[p14l1160t1746r1423b1795],
8	A	DT	O	a	det	11	SENT_293	[p14l1041t1848r1090b1897],
9	L-MDR1	NN	O	l-mdr1	nn	11	SENT_293	[p14l1160t1852r1408b1900],
10	o	NN	O	o	nn	11	SENT_293	[p14l1042t1952r1089b1999],
11	L-MDR1	NN	O	l-mdr1	dep	7	SENT_293	[p14l1160t1952r1792b2001],
12	+	CC	O	+	_	0	SENT_293	[p14l1160t1952r1792b2001],
13	LY335979	NN	O	ly335979	conj_+	7	SENT_293	[p14l1160t1952r1792b2001],
14	}	CD	NUMBER	}	num	15	SENT_293	[p14l1869t1878r2154b1997],
15	P	NN	O	p	npadvmod	16	SENT_293	[p14l1869t1878r2154b1997],
16	<	JJR	O	<	amod	13	SENT_293	[p14l1869t1878r2154b1997],
17	0-001	CD	NUMBER	0-001	dep	1	SENT_293	[p14l1869t1878r2154b1997],

1	N	NN	O	n	_	0	SENT_294	[p14l268t1771r312b1838],

1	}	NN	O	}	nn	2	SENT_295	[p14l1513t1756r1543b1876],
2	p	NN	O	p	_	0	SENT_295	[p14l1590t1801r1784b1864],
3	<	JJR	O	<	dep	2	SENT_295	[p14l1590t1801r1784b1864],
4	0.01	CD	NUMBER	0.01	dep	2	SENT_295	[p14l1590t1801r1784b1864],

1	Loperamide	NN	O	loperamide	_	0	SENT_296	[p14l64t1513r152b2011],
2	[	CD	NUMBER	[	num	4	SENT_296	[p14l66t1293r152b1478],
3	uM	NN	O	um	nn	4	SENT_296	[p14l66t1293r152b1478],
4	]	NN	O	]	dep	1	SENT_296	[p14l66t1293r152b1478],

1	_	NN	O	_	nn	3	SENT_297	[p14l199t1973r259b2041],
2	O	NN	O	o	nn	3	SENT_297	[p14l199t1973r259b2041],
3	O	NN	O	o	_	0	SENT_297	[p14l199t1570r242b1638],
4	>	JJR	O	>	dep	3	SENT_297	[p14l278t1973r304b2039],
5	DJ	NNP	O	DJ	dep	3	SENT_297	[p14l271t1570r308b1638],

1	o	NN	O	o	_	0	SENT_298	[p14l270t2174r312b2242],

1	Time	NNP	O	Time	_	0	SENT_299	[p14l890t2411r1094b2478],
2	[	CD	NUMBER	[	num	4	SENT_299	[p14l1133t2411r1329b2495],
3	min	NN	DURATION	min	nn	4	SENT_299	[p14l1133t2411r1329b2495],
4	]	NN	O	]	dep	1	SENT_299	[p14l1133t2411r1329b2495],

1	E	NN	O	e	_	0	SENT_300	[p14l64t2418r167b2504],

1	A	DT	O	a	det	2	SENT_301	[p14l574t2758r621b2806],
2	L-MDR1	NN	O	l-mdr1	_	0	SENT_301	[p14l690t2762r934b2809],
3	O	NN	O	o	nn	4	SENT_301	[p14l575t2895r620b2940],
4	L-MDR1	NN	O	l-mdr1	dep	2	SENT_301	[p14l690t2895r1309b2944],
5	+	CC	O	+	_	0	SENT_301	[p14l690t2895r1309b2944],
6	LY335979	NN	O	ly335979	nn	8	SENT_301	[p14l690t2895r1309b2944],
7	III	CD	NUMBER	iii	num	8	SENT_301	[p14l579t3018r625b3064],
8	LLC-PK1	NN	O	llc-pk1	conj_+	4	SENT_301	[p14l695t3019r953b3067],

1	o	NN	O	o	_	0	SENT_302	[p14l574t3142r631b3198],
2	LLC	NN	O	llc	dep	1	SENT_302	[p14l695t3148r953b3195],
3	.	.	O	.	_	0	SENT_302	[p14l695t3148r953b3195],

1	—	NN	O	—	_	0	SENT_303	[p14l695t3148r953b3195],
2	.	.	O	.	_	0	SENT_303	[p14l695t3148r953b3195],

1	PK1	NN	O	pk1	_	0	SENT_304	[p14l695t3148r953b3195],
2	+	CC	O	+	cc	3	SENT_304	[p14l982t3153r1019b3190],
3	LY335979	NN	O	ly335979	dep	1	SENT_304	[p14l1041t3148r1330b3195],

1	Bezaﬁbrate	JJ	O	bezaﬁbrate	amod	2	SENT_305	[p14l115t3062r182b3527],
2	[	NN	O	[	_	0	SENT_305	[p14l117t2842r201b3026],
3	;	:	O	;	_	0	SENT_305	[p14l117t2842r201b3026],
4	LM	NNP	O	LM	dep	2	SENT_305	[p14l117t2842r201b3026],
5	]	CD	NUMBER	]	num	4	SENT_305	[p14l117t2842r201b3026],

1	3	CD	NUMBER	3	num	2	SENT_306	[p14l272t3556r313b3623],
2	>	JJR	O	>	_	0	SENT_306	[p14l280t3273r305b3339],
3	-	:	O	-	_	0	SENT_306	[p14l280t3273r305b3339],
4	t	NN	O	t	dep	2	SENT_306	[p14l280t3273r305b3339],

1	(	NN	O	(	nn	2	SENT_307	[p15l6t140r114b227],
2	C	NN	O	c	_	0	SENT_307	[p15l6t140r114b227],
3	)	CD	NUMBER	)	num	4	SENT_307	[p15l6t140r114b227],
4	Time	NNP	O	Time	dep	2	SENT_307	[p15l880t158r1081b225],
5	[	CD	NUMBER	[	num	4	SENT_307	[p15l1118t158r1312b240],
6	min	NN	DURATION	min	nn	7	SENT_307	[p15l1118t158r1312b240],
7	]	NN	O	]	dep	2	SENT_307	[p15l1118t158r1312b240],

1	32	CD	NUMBER	32	_	0	SENT_308	[p15l160t471r262b551],
2	A	DT	O	a	det	3	SENT_308	[p15l577t532r634b590],
3	L-MDR1	NN	O	l-mdr1	dep	1	SENT_308	[p15l717t536r1010b592],

1	E	NN	O	e	nn	3	SENT_309	[p15l26t630r124b760],
2	o	NN	O	o	nn	3	SENT_309	[p15l578t696r633b751],
3	L-MDR1	NN	O	l-mdr1	_	0	SENT_309	[p15l718t697r1464b754],
4	+	CC	O	+	_	0	SENT_309	[p15l718t697r1464b754],
5	LY335979	NN	O	ly335979	conj_+	3	SENT_309	[p15l718t697r1464b754],
6	3	CD	NUMBER	3	num	5	SENT_309	[p15l26t763r128b851],
7	-	:	O	-	_	0	SENT_309	[p15l26t763r128b851],
8	25	CD	DATE	25	num	9	SENT_309	[p15l158t759r259b839],
9	o	NN	O	o	dep	3	SENT_309	[p15l48t894r105b939],
10	1:1	CD	NUMBER	1:1	num	12	SENT_309	[p15l584t845r639b901],
11	LLC-PK1	NN	O	llc-pk1	nn	12	SENT_309	[p15l724t846r1035b904],
12	id	NN	O	id	dep	9	SENT_309	[p15l30t941r104b976],
13	,3	CD	NUMBER	,3	number	14	SENT_309	[p15l48t981r105b1086],
14	<	JJR	O	<	amod	16	SENT_309	[p15l577t993r645b1061],
15	>	JJR	O	>	amod	16	SENT_309	[p15l577t993r645b1061],
16	LLC-PK1	NN	O	llc-pk1	dep	12	SENT_309	[p15l724t1001r1487b1059],
17	+	CC	O	+	_	0	SENT_309	[p15l724t1001r1487b1059],
18	LY335979	NN	O	ly335979	nn	20	SENT_309	[p15l724t1001r1487b1059],
19	_	CD	NUMBER	_	num	20	SENT_309	[p15l26t1092r105b1151],
20	Q	NNP	O	Q	conj_+	12	SENT_309	[p15l26t1092r105b1151],
21	18	CD	NUMBER	18	amod	20	SENT_309	[p15l169t1047r261b1128],
22	2.	LS	NUMBER	2.	dep	21	SENT_309	[p15l24t1151r103b1214],
23	:	:	O	:	_	0	SENT_309	[p15l24t1151r103b1214],
24	2	CD	NUMBER	2	num	25	SENT_309	[p15l48t1222r105b1336],
25	O	NN	O	o	dep	3	SENT_309	[p15l48t1344r105b1389],
26	)	CD	NUMBER	)	dep	25	SENT_309	[p15l48t1344r105b1389],
27	In	IN	O	in	_	0	SENT_309	[p15l26t1395r103b1461],
28	11	CD	NUMBER	11	prep_in	3	SENT_309	[p15l169t1334r254b1412],

1	(	NN	O	(	_	0	SENT_310	[p15l7t1914r125b2012],
2	'	''	O	'	_	0	SENT_310	[p15l7t1914r125b2012],
3	3	CD	NUMBER	3	number	4	SENT_310	[p15l7t1914r125b2012],
4	)	CD	NUMBER	)	num	8	SENT_310	[p15l7t1914r125b2012],
5	Time	NNP	O	Time	nn	8	SENT_310	[p15l946t1941r1189b2021],
6	[	CD	NUMBER	[	num	8	SENT_310	[p15l1234t1942r1466b2041],
7	min	NN	DURATION	min	nn	8	SENT_310	[p15l1234t1942r1466b2041],
8	]	NN	O	]	dep	1	SENT_310	[p15l1234t1942r1466b2041],

1	A	DT	O	a	det	2	SENT_311	[p15l538t2307r594b2363],
2	L-MDR1	NN	O	l-mdr1	_	0	SENT_311	[p15l674t2312r959b2366],

1	L	NN	O	l	nn	3	SENT_312	[p15l188t2480r231b2556],
2	)	CD	NUMBER	)	num	3	SENT_312	[p15l188t2480r231b2556],
3	‘	NN	O	‘	_	0	SENT_312	[p15l188t2480r231b2556],
4	:	:	O	:	_	0	SENT_312	[p15l188t2480r231b2556],

1	O	NN	O	o	_	0	SENT_313	[p15l540t2466r593b2520],
2	L-MDR1	NN	O	l-mdr1	dep	1	SENT_313	[p15l674t2468r959b2522],
3	+	CC	O	+	_	0	SENT_313	[p15l993t2474r1036b2517],
4	LY335979	NN	O	ly335979	nn	5	SENT_313	[p15l1062t2468r1398b2524],
5	}	NN	O	}	dep	1	SENT_313	[p15l1436t2497r1470b2635],

1	p	NN	O	p	_	0	SENT_314	[p15l1501t2550r1727b2621],
2	<	JJR	O	<	dep	1	SENT_314	[p15l1501t2550r1727b2621],
3	0.05	CD	NUMBER	0.05	num	4	SENT_314	[p15l1501t2550r1727b2621],
4	(	NN	O	(	dep	2	SENT_314	[p15l1759t2548r1862b2621],
5	30	CD	DURATION	30	num	7	SENT_314	[p15l1759t2548r1862b2621],
6	min	NN	DURATION	min	nn	7	SENT_314	[p15l1889t2548r2034b2621],
7	)	NN	O	)	dep	1	SENT_314	[p15l1889t2548r2034b2621],

1	1	CD	NUMBER	1	_	0	SENT_315	[p15l545t2611r599b2664],
2	:	:	O	:	_	0	SENT_315	[p15l545t2611r599b2664],
3	:	:	O	:	_	0	SENT_315	[p15l545t2611r599b2664],
4	LLC-PK1	NN	O	llc-pk1	dep	1	SENT_315	[p15l680t2612r982b2668],

1	O	NN	O	o	_	0	SENT_316	[p15l539t2755r605b2820],
2	LLC-PK1	NN	O	llc-pk1	dep	1	SENT_316	[p15l680t2762r982b2818],
3	+	CC	O	+	_	0	SENT_316	[p15l1016t2769r1059b2811],
4	LY335979	NN	O	ly335979	dep	1	SENT_316	[p15l1085t2762r1421b2818],

1	Gemﬁbrozil	JJ	O	gemﬁbrozil	amod	3	SENT_317	[p15l55t2649r132b3208],
2	[	NN	O	[	nn	3	SENT_317	[p15l56t2400r155b2613],
3	uM	NN	O	um	_	0	SENT_317	[p15l56t2400r155b2613],
4	]	CD	NUMBER	]	dep	3	SENT_317	[p15l56t2400r155b2613],

1	to	TO	O	to	_	0	SENT_318	[p15l184t3172r234b3248],
2	us	PRP	O	we	pobj	1	SENT_318	[p15l186t2941r230b3019],
3	.	.	O	.	_	0	SENT_318	[p15l183t2710r235b2786],

1	:	:	O	:	_	0	SENT_319	[p15l183t2710r235b2786],
2	>	JJR	O	>	_	0	SENT_319	[p15l183t2710r235b2786],

1	(	NN	O	(	nn	2	SENT_320	[p15l47t3670r171b3768],
2	D	NN	O	d	_	0	SENT_320	[p15l47t3670r171b3768],
3	)	CD	NUMBER	)	num	4	SENT_320	[p15l47t3670r171b3768],
4	Time	NNP	O	Time	dep	2	SENT_320	[p15l897t3674r1132b3752],
5	[	CD	NUMBER	[	num	4	SENT_320	[p15l1175t3674r1401b3770],
6	min	NN	DURATION	min	nn	7	SENT_320	[p15l1175t3674r1401b3770],
7	]	NN	O	]	dep	2	SENT_320	[p15l1175t3674r1401b3770],

1	Fig	NN	O	fig	_	0	SENT_321	[p16l34t29r84b60],
2	.	.	O	.	_	0	SENT_321	[p16l34t29r84b60],

1	5	CD	NUMBER	5	_	0	SENT_322	[p16l96t29r118b53],
2	.	.	O	.	_	0	SENT_322	[p16l96t29r118b53],

1	Uptake	NN	O	uptake	_	0	SENT_323	[p16l137t29r233b60],
2	assay	NN	O	assay	dep	1	SENT_323	[p16l244t37r314b60],
3	of	IN	O	of	_	0	SENT_323	[p16l324t29r353b53],
4	loperamide	NN	O	loperamide	nn	5	SENT_323	[p16l361t29r510b60],
5	(	NN	O	(	prep_of	2	SENT_323	[p16l521t30r544b59],
6	1	CD	NUMBER	1	num	7	SENT_323	[p16l521t30r544b59],
7	uM	NN	O	um	dep	1	SENT_323	[p16l557t30r613b60],
8	)	CD	NUMBER	)	number	9	SENT_323	[p16l557t30r613b60],
9	(	CD	NUMBER	(	num	11	SENT_323	[p16l625t29r676b58],
10	A	DT	O	a	det	11	SENT_323	[p16l625t29r676b58],
11	)	NN	O	)	dep	7	SENT_323	[p16l625t29r676b58],
12	,	,	O	,	_	0	SENT_323	[p16l625t29r676b58],
13	fenoﬁbrate	JJ	O	fenoﬁbrate	amod	14	SENT_323	[p16l688t29r833b53],
14	(	NN	O	(	appos	1	SENT_323	[p16l844t29r885b58],
15	25	CD	NUMBER	25	num	16	SENT_323	[p16l844t29r885b58],
16	uM	NN	O	um	dep	14	SENT_323	[p16l897t30r952b60],
17	)	CD	NUMBER	)	num	20	SENT_323	[p16l897t30r952b60],
18	(	NN	O	(	nn	20	SENT_323	[p16l964t30r1014b58],
19	B	NN	O	b	nn	20	SENT_323	[p16l964t30r1014b58],
20	)	NN	O	)	dep	1	SENT_323	[p16l964t30r1014b58],
21	,	,	O	,	_	0	SENT_323	[p16l964t30r1014b58],
22	bezaﬁbrate	NN	O	bezaﬁbrate	nn	23	SENT_323	[p16l1025t29r1172b53],
23	(	NN	O	(	appos	20	SENT_323	[p16l1183t29r1242b59],
24	100	CD	NUMBER	100	num	25	SENT_323	[p16l1183t29r1242b59],
25	uM	NN	O	um	dep	1	SENT_323	[p16l1253t30r1308b60],
26	)	CD	NUMBER	)	num	29	SENT_323	[p16l1253t30r1308b60],
27	(	NN	O	(	nn	29	SENT_323	[p16l1320t29r1370b58],
28	C	NN	O	c	nn	29	SENT_323	[p16l1320t29r1370b58],
29	)	NN	O	)	dep	25	SENT_323	[p16l1320t29r1370b58],
30	,	,	O	,	_	0	SENT_323	[p16l1320t29r1370b58],
31	and	CC	O	and	_	0	SENT_323	[p16l1382t29r1429b53],
32	gemfibrozil	NN	O	gemfibrozil	nn	33	SENT_323	[p16l1439t29r1592b60],
33	(	NN	O	(	dep	1	SENT_323	[p16l1604t29r1663b58],
34	100	CD	NUMBER	100	num	35	SENT_323	[p16l1604t29r1663b58],
35	uM	NN	O	um	dep	1	SENT_323	[p16l1673t30r1729b60],
36	)	CD	NUMBER	)	num	38	SENT_323	[p16l1673t30r1729b60],
37	(	NN	O	(	nn	38	SENT_323	[p16l1741t30r1784b59],
38	D	NN	O	d	dep	35	SENT_323	[p16l1741t30r1784b59],
39	)	CD	NUMBER	)	dep	1	SENT_323	[p16l1741t30r1784b59],
40	in	IN	O	in	_	0	SENT_323	[p16l1796t29r1821b53],
41	LLC	NNP	O	LLC	prep_in	39	SENT_323	[p16l1830t29r1960b53],
42	.	.	O	.	_	0	SENT_323	[p16l1830t29r1960b53],

1	—	NN	O	—	_	0	SENT_324	[p16l1830t29r1960b53],
2	.	.	O	.	_	0	SENT_324	[p16l1830t29r1960b53],

1	PKl	NN	O	pkl	nn	2	SENT_325	[p16l1830t29r1960b53],
2	cells	NNS	O	cell	_	0	SENT_325	[p16l1973t29r2032b53],
3	and	CC	O	and	_	0	SENT_325	[p16l2044t29r2091b53],
4	in	IN	O	in	conj_and	2	SENT_325	[p16l2101t29r2126b53],
5	L	NN	O	l	pobj	4	SENT_325	[p16l34t71r154b94],
6	.	.	O	.	_	0	SENT_325	[p16l34t71r154b94],

1	—	NN	O	—	_	0	SENT_326	[p16l34t71r154b94],
2	.	.	O	.	_	0	SENT_326	[p16l34t71r154b94],

1	MDRl	NN	O	mdrl	nn	2	SENT_327	[p16l34t71r154b94],
2	cells	NNS	O	cell	conj_and	2	SENT_327	[p16l166t70r225b94],
3	with	IN	O	with	_	0	SENT_327	[p16l235t70r293b94],
4	and	CC	O	and	_	0	SENT_327	[p16l302t70r349b94],
5	without	IN	O	without	_	0	SENT_327	[p16l358t70r459b94],
6	Pgp	NN	O	pgp	nn	7	SENT_327	[p16l467t71r517b101],
7	inhibition	NN	O	inhibition	prep_without	2	SENT_327	[p16l527t70r655b94],
8	by	IN	O	by	_	0	SENT_327	[p16l664t70r696b101],
9	LY335975	NN	O	ly335975	nn	10	SENT_327	[p16l705t70r844b94],
10	(	NN	O	(	prep_by	7	SENT_327	[p16l855t71r878b99],
11	1	CD	NUMBER	1	num	12	SENT_327	[p16l855t71r878b99],
12	uM	NN	O	um	prep_with	2	SENT_327	[p16l891t71r936b101],
13	for	IN	O	for	_	0	SENT_327	[p16l945t70r984b94],
14	the	DT	O	the	det	15	SENT_327	[p16l992t70r1032b94],
15	uptake	NN	O	uptake	prep_for	2	SENT_327	[p16l1041t70r1129b101],
16	with	IN	O	with	_	0	SENT_327	[p16l1137t70r1195b94],
17	loperamide	NN	O	loperamide	prep_with	15	SENT_327	[p16l1204t70r1361b101],
18	;	:	O	;	_	0	SENT_327	[p16l1204t70r1361b101],
19	5	CD	NUMBER	5	num	20	SENT_327	[p16l1372t70r1385b94],
20	uM	NN	O	um	dep	2	SENT_327	[p16l1397t71r1443b101],
21	for	IN	O	for	_	0	SENT_327	[p16l1452t70r1490b94],
22	the	DT	O	the	det	23	SENT_327	[p16l1498t70r1538b94],
23	uptake	NN	O	uptake	prep_for	20	SENT_327	[p16l1547t70r1635b101],
24	with	IN	O	with	_	0	SENT_327	[p16l1643t70r1701b94],
25	the	DT	O	the	det	27	SENT_327	[p16l1710t70r1750b94],
26	fibrates	NNS	O	fibrate	nn	27	SENT_327	[p16l1759t70r1875b99],
27	)	NN	O	)	prep_with	23	SENT_327	[p16l1759t70r1875b99],
28	.	.	O	.	_	0	SENT_327	[p16l1759t70r1875b99],

1	Data	NNS	O	datum	nsubjpass	3	SENT_328	[p16l1885t71r1948b94],
2	are	VBP	O	be	auxpass	3	SENT_328	[p16l1957t78r1996b94],
3	shown	VBN	O	show	_	0	SENT_328	[p16l2006t70r2090b94],
4	as	IN	O	as	_	0	SENT_328	[p16l2099t78r2125b94],
5	mean	NN	O	mean	prep_as	3	SENT_328	[p16l34t118r106b134],
6	:	:	O	:	_	0	SENT_328	[p16l115t122r137b134],
7	:	:	O	:	_	0	SENT_328	[p16l115t122r137b134],
8	SD	NN	O	sd	dobj	3	SENT_328	[p16l147t111r187b134],
9	for	IN	O	for	_	0	SENT_328	[p16l200t111r238b134],
10	N	NN	O	n	prep_for	8	SENT_328	[p16l249t111r273b134],
11	:	:	O	:	_	0	SENT_328	[p16l284t121r306b129],
12	6	CD	NUMBER	6	num	13	SENT_328	[p16l318t111r333b134],
13	wells	NNS	O	well	dep	8	SENT_328	[p16l345t111r421b134],
14	.	.	O	.	_	0	SENT_328	[p16l345t111r421b134],

1	P	NN	O	p	nn	3	SENT_329	[p16l434t111r548b134],
2	—	NN	O	—	nn	3	SENT_329	[p16l434t111r548b134],
3	values	NNS	O	value	nsubjpass	5	SENT_329	[p16l434t111r548b134],
4	were	VBD	O	be	auxpass	5	SENT_329	[p16l561t118r624b134],
5	determined	VBN	O	determine	_	0	SENT_329	[p16l637t111r785b134],
6	by	IN	O	by	_	0	SENT_329	[p16l797t111r829b141],
7	ANOVA	NNP	ORGANIZATION	ANOVA	agent	5	SENT_329	[p16l841t111r954b134],
8	with	IN	O	with	_	0	SENT_329	[p16l964t111r1022b134],
9	Bonferroni	NNP	PERSON	Bonferroni	poss	13	SENT_329	[p16l1033t111r1199b134],
10	’s	POS	O	’s	_	0	SENT_329	[p16l1033t111r1199b134],
11	multiple	JJ	O	multiple	amod	13	SENT_329	[p16l1212t111r1322b141],
12	comparison	NN	O	comparison	nn	13	SENT_329	[p16l1334t111r1488b141],
13	test	NN	O	test	prep_with	5	SENT_329	[p16l1500t114r1546b134],
14	for	IN	O	for	_	0	SENT_329	[p16l1557t111r1596b134],
15	post	NN	O	post	amod	18	SENT_329	[p16l1604t116r1662b141],
16	hoc	FW	O	hoc	dep	15	SENT_329	[p16l1673t111r1720b134],
17	pairwise	JJ	O	pairwise	amod	18	SENT_329	[p16l1732t111r1844b141],
18	comparison	NN	O	comparison	prep_for	13	SENT_329	[p16l1856t111r2016b141],
19	.	.	O	.	_	0	SENT_329	[p16l1856t111r2016b141],

1	bezaﬁbrate	NN	O	bezaﬁbrate	_	0	SENT_330	[p16l7t302r407b366],
2	(	CD	NUMBER	(	num	3	SENT_330	[p16l447t302r612b385],
3	Fig	NN	O	fig	dep	1	SENT_330	[p16l447t302r612b385],
4	.	.	O	.	_	0	SENT_330	[p16l447t302r612b385],

1	SC	NN	O	sc	nn	2	SENT_331	[p16l653t302r807b381],
2	)	NN	O	)	_	0	SENT_331	[p16l653t302r807b381],
3	,	,	O	,	_	0	SENT_331	[p16l653t302r807b381],
4	gemﬁbrozil	NN	O	gemﬁbrozil	nn	6	SENT_331	[p16l846t302r1265b385],
5	(	CD	NUMBER	(	num	6	SENT_331	[p16l1304t302r1469b385],
6	Fig	NN	O	fig	appos	2	SENT_331	[p16l1304t302r1469b385],
7	.	.	O	.	_	0	SENT_331	[p16l1304t302r1469b385],

1	5D	NN	O	5d	nsubj	8	SENT_332	[p16l1511t302r1646b382],
2	)	CD	NUMBER	)	num	1	SENT_332	[p16l1511t302r1646b382],
3	or	CC	O	or	_	0	SENT_332	[p16l1685t322r1760b366],
4	fenoﬁbric	JJ	O	fenoﬁbric	amod	7	SENT_332	[p16l1793t302r2145b366],
5	acid	NN	O	acid	nn	7	SENT_332	[p16l9t411r159b476],
6	(	NN	O	(	nn	7	SENT_332	[p16l195t411r374b491],
7	data	NNS	O	datum	nsubj	8	SENT_332	[p16l195t411r374b491],
8	not	RB	O	not	_	0	SENT_332	[p16l407t421r522b475],
9	shown	VBN	O	show	dep	8	SENT_332	[p16l558t411r837b491],
10	)	NN	O	)	dobj	9	SENT_332	[p16l558t411r837b491],
11	.	.	O	.	_	0	SENT_332	[p16l558t411r837b491],

1	4	LS	NUMBER	4	_	0	SENT_333	[p16l8t652r72b717],
2	.	.	O	.	_	0	SENT_333	[p16l8t652r72b717],

1	Discussion	NN	O	discussion	_	0	SENT_334	[p16l122t652r532b717],

1	The	DT	O	the	det	2	SENT_335	[p16l99t871r239b935],
2	activity	NN	O	activity	nsubj	8	SENT_335	[p16l287t871r553b954],
3	of	IN	O	of	_	0	SENT_335	[p16l602t871r680b935],
4	the	DT	O	the	det	7	SENT_335	[p16l721t871r830b935],
5	efﬂux	NN	O	efﬂux	nn	7	SENT_335	[p16l877t871r1085b935],
6	transporter	NN	O	transporter	nn	7	SENT_335	[p16l1132t881r1524b954],
7	Pgp	NN	ORGANIZATION	pgp	prep_of	2	SENT_335	[p16l1569t873r1707b954],
8	affects	VBZ	O	affect	dep	23	SENT_335	[p16l1756t871r1991b935],
9	the	DT	O	the	det	10	SENT_335	[p16l2039t871r2146b935],
10	pharrnacokinetics	NNS	O	pharrnacokinetic	dobj	8	SENT_335	[p16l7t981r645b1064],
11	of	IN	O	of	_	0	SENT_335	[p16l672t981r751b1045],
12	many	JJ	O	many	amod	13	SENT_335	[p16l769t1001r968b1064],
13	drugs	NNS	O	drug	prep_of	10	SENT_335	[p16l995t981r1190b1064],
14	and	CC	O	and	_	0	SENT_335	[p16l1219t981r1346b1045],
15	contributes	VBZ	O	contribute	dep	23	SENT_335	[p16l1371t981r1768b1045],
16	to	TO	O	to	_	0	SENT_335	[p16l1795t990r1863b1045],
17	numerous	JJ	O	numerous	amod	19	SENT_335	[p16l1888t1001r2145b1045, p16l9t1109r130b1152],
18	pharmacokinetic	JJ	O	pharmacokinetic	amod	19	SENT_335	[p16l154t1088r758b1171],
19	drug	NN	O	drug	prep_to	15	SENT_335	[p16l785t1088r1159b1171],
20	—	NN	O	—	nn	22	SENT_335	[p16l785t1088r1159b1171],
21	drug	NN	O	drug	nn	22	SENT_335	[p16l785t1088r1159b1171],
22	interactions	NNS	O	interaction	nsubj	23	SENT_335	[p16l1184t1088r1603b1152],
23	[	VBP	O	[	_	0	SENT_335	[p16l1636t1089r1796b1166],
24	21	CD	NUMBER	21	num	25	SENT_335	[p16l1636t1089r1796b1166],
25	]	CD	NUMBER	]	dobj	23	SENT_335	[p16l1636t1089r1796b1166],
26	.	.	O	.	_	0	SENT_335	[p16l1636t1089r1796b1166],

1	Hitherto	NNP	O	Hitherto	nsubjpass	22	SENT_336	[p16l1825t1088r2145b1164],
2	,	,	O	,	_	0	SENT_336	[p16l1825t1088r2145b1164],
3	the	DT	O	the	det	4	SENT_336	[p16l7t1197r117b1261],
4	role	NN	O	role	appos	1	SENT_336	[p16l162t1197r301b1261],
5	of	IN	O	of	_	0	SENT_336	[p16l349t1197r427b1261],
6	Pgp	NNP	ORGANIZATION	Pgp	prep_of	4	SENT_336	[p16l466t1199r603b1280],
7	for	IN	O	for	_	0	SENT_336	[p16l651t1197r755b1261],
8	the	DT	O	the	det	9	SENT_336	[p16l799t1197r908b1261],
9	bioavailability	NN	O	bioavailability	prep_for	6	SENT_336	[p16l953t1197r1487b1280],
10	,	,	O	,	_	0	SENT_336	[p16l953t1197r1487b1280],
11	distribution	NN	O	distribution	prep_for	6	SENT_336	[p16l1537t1197r1969b1273],
12	,	,	O	,	_	0	SENT_336	[p16l1537t1197r1969b1273],
13	and	CC	O	and	_	0	SENT_336	[p16l2020t1197r2149b1261],
14	excretion	NN	O	excretion	prep_for	6	SENT_336	[p16l8t1308r344b1372],
15	of	IN	O	of	_	0	SENT_336	[p16l360t1308r438b1372],
16	lipid	NN	O	lipid	prep_of	9	SENT_336	[p16l448t1308r614b1391],
17	lowering	VBG	O	lower	partmod	16	SENT_336	[p16l628t1308r945b1391],
18	ﬁbrates	NNS	O	ﬁbrates	dobj	17	SENT_336	[p16l964t1308r1225b1372],
19	has	VBZ	O	have	aux	22	SENT_336	[p16l1242t1308r1361b1372],
20	not	RB	O	not	neg	22	SENT_336	[p16l1378t1318r1492b1372],
21	been	VBN	O	be	auxpass	22	SENT_336	[p16l1506t1308r1677b1372],
22	investigated	VBN	O	investigate	_	0	SENT_336	[p16l1693t1308r2143b1391],
23	.	.	O	.	_	0	SENT_336	[p16l1693t1308r2143b1391],

1	Especially	RB	O	especially	amod	5	SENT_337	[p16l7t1415r383b1498],
2	with	IN	O	with	_	0	SENT_337	[p16l407t1416r566b1480],
3	statins	NNS	O	statin	prep_with	1	SENT_337	[p16l592t1416r816b1480],
4	severe	JJ	O	severe	amod	5	SENT_337	[p16l844t1436r1067b1480],
5	interactions	NNS	O	interaction	nsubj	7	SENT_337	[p16l1090t1416r1509b1480],
6	have	VBP	O	have	aux	7	SENT_337	[p16l1533t1416r1700b1480],
7	occurred	VBN	O	occur	_	0	SENT_337	[p16l1725t1416r2057b1480],
8	.	.	O	.	_	0	SENT_337	[p16l1725t1416r2057b1480],

1	A	DT	O	a	det	4	SENT_338	[p16l2084t1416r2148b1479],
2	well	RB	O	well	advmod	3	SENT_338	[p16l8t1524r162b1588],
3	known	VBN	O	know	amod	4	SENT_338	[p16l193t1524r436b1588],
4	example	NN	O	example	nsubj	8	SENT_338	[p16l468t1524r772b1607],
5	is	VBZ	O	be	cop	8	SENT_338	[p16l805t1524r861b1588],
6	the	DT	O	the	det	8	SENT_338	[p16l894t1524r1003b1588],
7	increased	VBN	O	increase	amod	8	SENT_338	[p16l1035t1524r1376b1588],
8	risk	NN	O	risk	_	0	SENT_338	[p16l1406t1524r1542b1588],
9	for	IN	O	for	_	0	SENT_338	[p16l1572t1524r1676b1588],
10	rhabdomyo	NN	O	rhabdomyo	nn	12	SENT_338	[p16l1705t1524r2145b1607],
11	—	NN	O	—	nn	12	SENT_338	[p16l1705t1524r2145b1607],
12	lysis	NN	O	lysis	prep_for	8	SENT_338	[p16l8t1633r170b1716],
13	emerging	VBG	O	emerge	partmod	12	SENT_338	[p16l208t1633r547b1716],
14	from	IN	O	from	_	0	SENT_338	[p16l585t1633r760b1697],
15	the	DT	O	the	det	16	SENT_338	[p16l795t1633r904b1697],
16	combination	NN	O	combination	prep_from	13	SENT_338	[p16l941t1633r1393b1697],
17	of	IN	O	of	_	0	SENT_338	[p16l1431t1633r1510b1697],
18	cerivastatin	NN	O	cerivastatin	prep_of	16	SENT_338	[p16l1540t1633r1952b1697],
19	with	IN	O	with	_	0	SENT_338	[p16l1989t1633r2148b1697],
20	gemﬁbrozil	NN	O	gemﬁbrozil	prep_with	13	SENT_338	[p16l9t1744r444b1827],
21	,	,	O	,	_	0	SENT_338	[p16l9t1744r444b1827],
22	which	WDT	O	which	nsubj	24	SENT_338	[p16l478t1744r698b1808],
23	recently	RB	DATE	recently	advmod	24	SENT_338	[p16l728t1744r1019b1827],
24	lead	VBP	O	lead	rcmod	20	SENT_338	[p16l1051t1744r1201b1808],
25	to	TO	O	to	_	0	SENT_338	[p16l1231t1754r1299b1808],
26	the	DT	O	the	det	27	SENT_338	[p16l1330t1744r1439b1808],
27	withdrawal	NN	O	withdrawal	prep_to	24	SENT_338	[p16l1469t1744r1874b1808],
28	of	IN	O	of	_	0	SENT_338	[p16l1906t1744r1985b1808],
29	cerivastatin	NN	O	cerivastatin	prep_of	27	SENT_338	[p16l2010t1764r2145b1808, p16l8t1851r310b1916],
30	from	IN	O	from	_	0	SENT_338	[p16l326t1851r501b1915],
31	the	DT	O	the	det	35	SENT_338	[p16l516t1851r625b1915],
32	European	JJ	MISC	european	amod	35	SENT_338	[p16l640t1853r988b1934],
33	and	CC	O	and	_	0	SENT_338	[p16l1005t1851r1134b1915],
34	US	NNP	LOCATION	US	conj_and	32	SENT_338	[p16l1148t1852r1258b1916],
35	market	NN	O	market	prep_from	24	SENT_338	[p16l1277t1851r1546b1915],
36	.	.	O	.	_	0	SENT_338	[p16l1277t1851r1546b1915],

1	Interestingly	RB	O	interestingly	advmod	9	SENT_339	[p16l1567t1851r2022b1934],
2	the	DT	O	the	det	3	SENT_339	[p16l2039t1851r2148b1915],
3	incidence	NN	O	incidence	nsubj	9	SENT_339	[p16l8t1960r354b2024],
4	of	IN	O	of	_	0	SENT_339	[p16l390t1960r469b2024],
5	these	DT	O	these	det	8	SENT_339	[p16l497t1960r681b2024],
6	adverse	JJ	O	adverse	amod	8	SENT_339	[p16l719t1960r990b2025],
7	drug	NN	O	drug	nn	8	SENT_339	[p16l1027t1960r1189b2043],
8	reactions	NNS	O	reaction	prep_of	3	SENT_339	[p16l1224t1960r1548b2024],
9	depends	VBZ	O	depend	_	0	SENT_339	[p16l1586t1960r1878b2043],
10	on	IN	O	on	_	0	SENT_339	[p16l1916t1980r2004b2024],
11	the	DT	O	the	det	13	SENT_339	[p16l2039t1960r2148b2024],
12	individual	JJ	O	individual	amod	13	SENT_339	[p16l8t2071r372b2135],
13	statin	NN	O	statin	prep_on	9	SENT_339	[p16l402t2071r593b2135],
14	and	CC	O	and	_	0	SENT_339	[p16l622t2071r750b2135],
15	ﬁbrate	NN	O	ﬁbrate	prep_on	9	SENT_339	[p16l776t2071r1005b2135],
16	and	CC	O	and	_	0	SENT_339	[p16l1034t2071r1162b2135],
17	the	DT	O	the	det	19	SENT_339	[p16l1187t2071r1296b2135],
18	particular	JJ	O	particular	amod	19	SENT_339	[p16l1322t2071r1671b2154],
19	combination	NN	O	combination	prep_on	9	SENT_339	[p16l1696t2071r2149b2135],
20	chosen	VBN	O	choose	partmod	19	SENT_339	[p16l8t2179r276b2243],
21	.	.	O	.	_	0	SENT_339	[p16l8t2179r276b2243],

1	For	IN	O	for	_	0	SENT_340	[p16l307t2180r432b2243],
2	instance	NN	O	instance	prep_for	24	SENT_340	[p16l457t2179r752b2243],
3	in	IN	O	in	_	0	SENT_340	[p16l780t2179r849b2242],
4	the	DT	O	the	det	6	SENT_340	[p16l876t2179r983b2243],
5	published	VBN	O	publish	amod	6	SENT_340	[p16l1011t2179r1363b2261],
6	cases	NNS	O	case	prep_in	2	SENT_340	[p16l1390t2199r1577b2243],
7	of	IN	O	of	_	0	SENT_340	[p16l1607t2178r1685b2243],
8	rhabdomyo	NN	O	rhabdomyo	prep_of	6	SENT_340	[p16l1705t2179r2145b2261],
9	—	NN	O	—	nn	10	SENT_340	[p16l1705t2179r2145b2261],
10	lysis	NN	O	lysis	nsubjpass	24	SENT_340	[p16l8t2287r170b2370],
11	after	IN	O	after	_	0	SENT_340	[p16l210t2287r375b2351],
12	a	DT	O	a	det	22	SENT_340	[p16l412t2307r450b2351],
13	ﬁbrate	JJ	O	ﬁbrate	amod	22	SENT_340	[p16l487t2287r937b2352],
14	/	:	O	/	punct	16	SENT_340	[p16l487t2287r937b2352],
15	statin	NN	O	statin	nn	16	SENT_340	[p16l487t2287r937b2352],
16	combination	NN	O	combination	dep	22	SENT_340	[p16l975t2287r1427b2351],
17	between	IN	O	between	_	0	SENT_340	[p16l1463t2287r1765b2351],
18	1989	CD	DATE	1989	prep_between	16	SENT_340	[p16l1811t2288r1979b2352],
19	and	CC	DATE	and	_	0	SENT_340	[p16l2020t2287r2149b2351],
20	July	NNP	DATE	July	prep_between	16	SENT_340	[p16l7t2396r156b2479],
21	2000	CD	DATE	2000	num	20	SENT_340	[p16l188t2397r365b2461],
22	gemﬁbrozil	NN	O	gemﬁbrozil	prep_after	10	SENT_340	[p16l397t2396r812b2479],
23	was	VBD	O	be	auxpass	24	SENT_340	[p16l843t2416r979b2460],
24	incriminated	VBN	O	incriminate	_	0	SENT_340	[p16l1011t2396r1469b2460],
25	in	IN	O	in	_	0	SENT_340	[p16l1499t2396r1568b2459],
26	each	DT	O	each	det	27	SENT_340	[p16l1598t2396r1763b2460],
27	case	NN	O	case	prep_in	24	SENT_340	[p16l1793t2416r1946b2460],
28	[	CD	NUMBER	[	number	29	SENT_340	[p16l1983t2397r2142b2474],
29	22	CD	NUMBER	22	num	30	SENT_340	[p16l1983t2397r2142b2474],
30	]	NN	O	]	dep	24	SENT_340	[p16l1983t2397r2142b2474],
31	.	.	O	.	_	0	SENT_340	[p16l1983t2397r2142b2474],

1	Furthermore	RB	O	furthermore	advmod	14	SENT_341	[p16l7t2507r479b2582],
2	,	,	O	,	_	0	SENT_341	[p16l7t2507r479b2582],
3	about	IN	O	about	_	0	SENT_341	[p16l533t2507r733b2571],
4	25	CD	PERCENT	25	num	5	SENT_341	[p16l781t2507r941b2571],
5	%	NN	PERCENT	%	prep_about	14	SENT_341	[p16l781t2507r941b2571],
6	of	IN	O	of	_	0	SENT_341	[p16l995t2507r1074b2571],
7	the	DT	O	the	det	8	SENT_341	[p16l1117t2507r1226b2571],
8	rhabdomyolysis	NN	O	rhabdomyolysis	prep_of	5	SENT_341	[p16l1275t2507r1851b2590],
9	related	JJ	O	related	amod	10	SENT_341	[p16l1901t2507r2149b2571],
10	mortality	NN	O	mortality	nsubjpass	14	SENT_341	[p16l8t2614r338b2697],
11	with	IN	O	with	_	0	SENT_341	[p16l376t2614r535b2679],
12	cerivastatin	NN	O	cerivastatin	prep_with	10	SENT_341	[p16l572t2614r985b2679],
13	was	VBD	O	be	auxpass	14	SENT_341	[p16l1022t2635r1159b2679],
14	associated	VBN	O	associate	_	0	SENT_341	[p16l1199t2614r1569b2678],
15	with	IN	O	with	_	0	SENT_341	[p16l1606t2614r1765b2679],
16	cerivastatin	NN	O	cerivastatin	nn	20	SENT_341	[p16l1802t2614r2145b2679, p16l7t2725r564b2808],
17	—	NN	O	—	nn	20	SENT_341	[p16l1802t2614r2145b2679, p16l7t2725r564b2808],
18	gemﬁbrozil	NN	O	gemﬁbrozil	nn	20	SENT_341	[p16l1802t2614r2145b2679, p16l7t2725r564b2808],
19	combination	NN	O	combination	nn	20	SENT_341	[p16l593t2725r1045b2789],
20	therapy	NN	O	therapy	prep_with	14	SENT_341	[p16l1071t2725r1340b2808],
21	[	CD	NUMBER	[	number	22	SENT_341	[p16l1375t2725r1534b2802],
22	23	CD	NUMBER	23	num	23	SENT_341	[p16l1375t2725r1534b2802],
23	]	NN	O	]	dep	20	SENT_341	[p16l1375t2725r1534b2802],
24	.	.	O	.	_	0	SENT_341	[p16l1375t2725r1534b2802],

1	Whereas	IN	O	whereas	mark	7	SENT_342	[p16l1565t2725r1880b2789],
2	part	NN	O	part	nsubj	7	SENT_342	[p16l1908t2735r2049b2808],
3	of	IN	O	of	_	0	SENT_342	[p16l2075t2725r2154b2789],
4	this	DT	O	this	det	5	SENT_342	[p16l8t2834r134b2898],
5	interaction	NN	O	interaction	prep_of	2	SENT_342	[p16l171t2834r559b2898],
6	is	VBZ	O	be	cop	7	SENT_342	[p16l593t2834r649b2898],
7	likely	JJ	O	likely	advcl	22	SENT_342	[p16l686t2834r890b2917],
8	caused	VBN	O	cause	dep	7	SENT_342	[p16l926t2834r1171b2898],
9	by	IN	O	by	_	0	SENT_342	[p16l1204t2834r1294b2917],
10	inhibition	NN	O	inhibition	prep_by	8	SENT_342	[p16l1329t2834r1680b2898],
11	of	IN	O	of	_	0	SENT_342	[p16l1715t2834r1794b2898],
12	CYP2C8	NN	O	cyp2c8	prep_of	10	SENT_342	[p16l1824t2834r2144b2898],
13	[	CD	NUMBER	[	num	12	SENT_342	[p16l14t2942r218b3019],
14	7,24	CD	NUMBER	7,24	num	16	SENT_342	[p16l14t2942r218b3019],
15	]	NN	O	]	nn	16	SENT_342	[p16l14t2942r218b3019],
16	cerivastatin	NN	O	cerivastatin	nsubj	22	SENT_342	[p16l249t2942r661b3006],
17	and	CC	O	and	_	0	SENT_342	[p16l687t2942r816b3006],
18	many	JJ	O	many	amod	20	SENT_342	[p16l839t2962r1037b3024],
19	other	JJ	O	other	amod	20	SENT_342	[p16l1064t2942r1249b3006],
20	statins	NNS	O	statin	nsubj	22	SENT_342	[p16l1275t2942r1499b3006],
21	also	RB	O	also	advmod	22	SENT_342	[p16l1527t2942r1668b3006],
22	interact	VBP	O	interact	_	0	SENT_342	[p16l1694t2942r1965b3006],
23	with	IN	O	with	_	0	SENT_342	[p16l1989t2942r2148b3006],
24	Pgp	NN	O	pgp	nn	26	SENT_342	[p16l8t3054r146b3135],
25	[	CD	NUMBER	[	num	26	SENT_342	[p16l175t3052r583b3129],
26	l3	NN	O	l3	prep_with	22	SENT_342	[p16l175t3052r583b3129],
27	—	CD	NUMBER	—	num	28	SENT_342	[p16l175t3052r583b3129],
28	l6	NN	O	l6	dep	26	SENT_342	[p16l175t3052r583b3129],
29	,25	CD	NUMBER	,25	num	30	SENT_342	[p16l175t3052r583b3129],
30	]	NN	O	]	dep	28	SENT_342	[p16l175t3052r583b3129],
31	.	.	O	.	_	0	SENT_342	[p16l175t3052r583b3129],

1	A	DT	O	a	det	3	SENT_343	[p16l610t3053r674b3115],
2	further	JJ	O	further	amod	3	SENT_343	[p16l695t3052r941b3116],
3	explanation	NN	O	explanation	nsubj	20	SENT_343	[p16l962t3052r1382b3135],
4	for	IN	O	for	_	0	SENT_343	[p16l1404t3052r1509b3116],
5	the	DT	O	the	det	6	SENT_343	[p16l1529t3052r1638b3116],
6	accumulation	NN	O	accumulation	prep_for	3	SENT_343	[p16l1662t3052r2148b3116],
7	of	IN	O	of	_	0	SENT_343	[p16l9t3159r87b3224],
8	statin	NN	O	statin	nn	9	SENT_343	[p16l125t3160r317b3224],
9	metabolites	NNS	O	metabolite	prep_of	6	SENT_343	[p16l357t3160r773b3224],
10	during	IN	O	during	_	0	SENT_343	[p16l815t3159r1049b3242],
11	co	NN	O	co	nn	13	SENT_343	[p16l1091t3160r1728b3224],
12	—	CD	NUMBER	—	num	13	SENT_343	[p16l1091t3160r1728b3224],
13	adn1inistration	NN	O	adn1inistration	prep_during	9	SENT_343	[p16l1091t3160r1728b3224],
14	of	IN	O	of	_	0	SENT_343	[p16l1770t3159r1849b3224],
15	ﬁbrates	NNS	O	ﬁbrates	prep_of	13	SENT_343	[p16l1884t3159r2146b3224],
16	could	MD	O	could	aux	20	SENT_343	[p16l8t3270r208b3334],
17	therefore	RB	O	therefore	advmod	20	SENT_343	[p16l225t3270r550b3334],
18	be	VB	O	be	cop	20	SENT_343	[p16l567t3270r651b3334],
19	an	DT	O	a	det	20	SENT_343	[p16l672t3290r754b3334],
20	interaction	NN	O	interaction	_	0	SENT_343	[p16l771t3270r1159b3334],
21	at	IN	O	at	_	0	SENT_343	[p16l1178t3279r1241b3334],
22	the	DT	O	the	det	23	SENT_343	[p16l1257t3270r1366b3334],
23	level	NN	O	level	prep_at	20	SENT_343	[p16l1385t3270r1556b3334],
24	of	IN	O	of	_	0	SENT_343	[p16l1575t3270r1654b3334],
25	Pgp	NN	O	pgp	prep_of	23	SENT_343	[p16l1665t3271r1803b3353],
26	by	IN	O	by	_	0	SENT_343	[p16l1820t3270r1910b3353],
27	which	WDT	O	which	agent	31	SENT_343	[p16l1928t3270r2148b3334],
28	statins	NNS	O	statin	nsubjpass	31	SENT_343	[p16l11t3377r235b3441],
29	are	VBP	O	be	auxpass	31	SENT_343	[p16l268t3397r374b3441],
30	actively	RB	O	actively	advmod	31	SENT_343	[p16l407t3377r687b3460],
31	transported	VBN	O	transport	rcmod	20	SENT_343	[p16l717t3377r1123b3460],
32	[	CD	NUMBER	[	number	33	SENT_343	[p16l1159t3377r1431b3455],
33	13,16	CD	NUMBER	13,16	num	34	SENT_343	[p16l1159t3377r1431b3455],
34	]	NN	O	]	dobj	31	SENT_343	[p16l1159t3377r1431b3455],
35	.	.	O	.	_	0	SENT_343	[p16l1159t3377r1431b3455],

1	The	DT	O	the	det	2	SENT_344	[p16l101t3486r240b3550],
2	aim	NN	O	aim	nsubj	8	SENT_344	[p16l274t3486r409b3550],
3	of	IN	O	of	_	0	SENT_344	[p16l440t3486r519b3550],
4	this	DT	O	this	prep_of	2	SENT_344	[p16l543t3486r672b3550],
5	in	FW	O	in	nn	6	SENT_344	[p16l708t3489r773b3550],
6	vitro	FW	O	vitro	advmod	7	SENT_344	[p16l802t3489r968b3551],
7	study	NN	O	study	rcmod	4	SENT_344	[p16l1003t3486r1195b3569],
8	was	VBD	O	be	_	0	SENT_344	[p16l1228t3507r1365b3551],
9	to	TO	O	to	aux	10	SENT_344	[p16l1398t3496r1466b3550],
10	elucidate	VB	O	elucidate	xcomp	8	SENT_344	[p16l1499t3486r1828b3550],
11	whether	IN	O	whether	complm	14	SENT_344	[p16l1858t3486r2153b3551],
12	ﬁbrates	NNS	O	ﬁbrates	nsubjpass	14	SENT_344	[p16l10t3595r275b3659],
13	are	VBP	O	be	auxpass	14	SENT_344	[p16l298t3616r405b3659],
14	transported	VBN	O	transport	ccomp	10	SENT_344	[p16l426t3595r838b3678],
15	by	IN	O	by	_	0	SENT_344	[p16l856t3595r946b3678],
16	Pgp	NNP	ORGANIZATION	Pgp	agent	14	SENT_344	[p16l966t3597r1105b3678],
17	and	CC	O	and	_	0	SENT_344	[p16l1127t3595r1256b3659],
18	whether	IN	O	whether	complm	20	SENT_344	[p16l1276t3595r1571b3660],
19	they	PRP	O	they	nsubj	20	SENT_344	[p16l1589t3595r1744b3678],
20	inhibit	VBP	O	inhibit	conj_and	14	SENT_344	[p16l1764t3595r2003b3659],
21	this	DT	O	this	det	23	SENT_344	[p16l2021t3595r2150b3659],
22	drug	NN	O	drug	nn	23	SENT_344	[p16l10t3706r173b3789],
23	transporter	NN	O	transporter	dobj	20	SENT_344	[p16l222t3716r632b3789],
24	.	.	O	.	_	0	SENT_344	[p16l222t3716r632b3789],

1	An	DT	O	a	det	2	SENT_345	[p16l685t3707r794b3769],
2	evaluation	NN	O	evaluation	nsubjpass	31	SENT_345	[p16l843t3706r1220b3770],
3	of	IN	O	of	_	0	SENT_345	[p16l1269t3706r1348b3770],
4	both	CC	O	both	dep	7	SENT_345	[p16l1388t3706r1551b3770],
5	properties	NNS	O	property	nsubj	7	SENT_345	[p16l1597t3706r1962b3789],
6	was	VBD	O	be	cop	7	SENT_345	[p16l2013t3726r2150b3770],
7	necessary	JJ	O	necessary	prepc_of	2	SENT_345	[p17l9t39r363b101],
8	because	IN	O	because	mark	14	SENT_345	[p17l416t19r705b83],
9	some	DT	O	some	det	11	SENT_345	[p17l763t39r949b83],
10	Pgp	NNP	ORGANIZATION	Pgp	nn	11	SENT_345	[p17l1003t20r1142b101],
11	substrates	NNS	O	substrate	nsubj	14	SENT_345	[p17l1200t19r1553b83],
12	do	VBP	O	do	aux	14	SENT_345	[p17l1610t19r1697b83],
13	not	RB	O	not	neg	14	SENT_345	[p17l1751t28r1868b83],
14	act	VB	O	act	advcl	7	SENT_345	[p17l1921t28r2026b83],
15	as	IN	O	as	mark	18	SENT_345	[p17l2080t39r2150b83],
16	Pgp	NN	O	pgp	nn	17	SENT_345	[p17l9t131r147b212],
17	inhibitors	NNS	O	inhibitor	nsubj	18	SENT_345	[p17l183t129r531b193],
18	(	VBP	O	(	advcl	14	SENT_345	[p17l570t130r723b212],
19	e.g.	FW	O	e.g.	nsubj	20	SENT_345	[p17l570t130r723b212],
20	digoxin	NN	O	digoxin	xcomp	18	SENT_345	[p17l763t129r1068b212],
21	)	CD	NUMBER	)	num	20	SENT_345	[p17l763t129r1068b212],
22	[	CD	NUMBER	[	num	23	SENT_345	[p17l1112t129r1478b206],
23	l8	NN	O	l8	dep	20	SENT_345	[p17l1112t129r1478b206],
24	,26,27	CD	NUMBER	,26,27	num	25	SENT_345	[p17l1112t129r1478b206],
25	]	NN	O	]	dep	20	SENT_345	[p17l1112t129r1478b206],
26	and	CC	O	and	_	0	SENT_345	[p17l1521t129r1650b193],
27	some	DT	O	some	det	28	SENT_345	[p17l1687t149r1874b193],
28	inhibitors	NNS	O	inhibitor	dep	20	SENT_345	[p17l1909t129r2149b193, p17l9t246r142b300],
29	are	VBP	O	be	auxpass	31	SENT_345	[p17l182t256r290b300],
30	not	RB	O	not	neg	31	SENT_345	[p17l328t246r444b300],
31	transported	VBN	O	transport	_	0	SENT_345	[p17l479t236r891b319],
32	[	NN	O	[	nn	34	SENT_345	[p17l934t237r1096b314],
33	27	CD	NUMBER	27	num	34	SENT_345	[p17l934t237r1096b314],
34	]	NN	O	]	dobj	31	SENT_345	[p17l934t237r1096b314],
35	.	.	O	.	_	0	SENT_345	[p17l934t237r1096b314],

1	All	DT	O	all	det	2	SENT_346	[p17l1137t236r1252b299],
2	assays	NNS	O	assay	nsubjpass	4	SENT_346	[p17l1291t256r1519b319],
3	were	VBD	O	be	auxpass	4	SENT_346	[p17l1559t256r1733b301],
4	performed	VBN	O	perform	_	0	SENT_346	[p17l1770t236r2152b319],
5	with	IN	O	with	_	0	SENT_346	[p17l9t347r170b411],
6	the	DT	O	the	det	9	SENT_346	[p17l194t347r303b411],
7	cell	NN	O	cell	nn	9	SENT_346	[p17l330t347r459b411],
8	line	NN	O	line	nn	9	SENT_346	[p17l485t347r620b411],
9	L	NN	O	l	prep_with	4	SENT_346	[p17l645t347r976b410],
10	.	.	O	.	_	0	SENT_346	[p17l645t347r976b410],

1	—	NN	O	—	_	0	SENT_347	[p17l645t347r976b410],
2	.	.	O	.	_	0	SENT_347	[p17l645t347r976b410],

1	MDRl	NN	O	mdrl	_	0	SENT_348	[p17l645t347r976b410],
2	overexpressing	VBG	O	overexpress	partmod	1	SENT_348	[p17l1010t347r1559b430],
3	human	JJ	O	human	amod	4	SENT_348	[p17l1584t347r1832b411],
4	Pgp	NN	O	pgp	dobj	2	SENT_348	[p17l1857t348r1995b430],
5	and	CC	O	and	_	0	SENT_348	[p17l2024t347r2153b411],
6	the	DT	O	the	det	11	SENT_348	[p17l9t454r118b518],
7	corresponding	JJ	O	corresponding	amod	11	SENT_348	[p17l183t454r705b537],
8	native	JJ	O	native	amod	11	SENT_348	[p17l768t454r988b518],
9	cell	NN	O	cell	nn	11	SENT_348	[p17l1053t454r1182b518],
10	line	NN	O	line	nn	11	SENT_348	[p17l1247t454r1381b518],
11	LLC-PKl	NN	O	llc-pkl	conj_and	4	SENT_348	[p17l1445t455r1801b519],
12	without	IN	O	without	_	0	SENT_348	[p17l1874t454r2153b519],
13	human	JJ	O	human	amod	14	SENT_348	[p17l8t565r257b629],
14	Pgp	NN	PERSON	pgp	prep_without	2	SENT_348	[p17l301t566r439b648],
15	as	IN	O	as	_	0	SENT_348	[p17l487t585r557b629],
16	a	DT	O	a	det	17	SENT_348	[p17l605t585r642b629],
17	control	NN	O	control	prep_as	14	SENT_348	[p17l686t565r962b629],
18	.	.	O	.	_	0	SENT_348	[p17l686t565r962b629],

1	Thus	RB	O	thus	advmod	11	SENT_349	[p17l1011t565r1211b641],
2	,	,	O	,	_	0	SENT_349	[p17l1011t565r1211b641],
3	effects	NNS	O	effect	nsubjpass	11	SENT_349	[p17l1260t565r1498b629],
4	only	RB	O	only	advmod	5	SENT_349	[p17l1545t565r1704b648],
5	seen	VBN	O	see	partmod	3	SENT_349	[p17l1752t585r1910b629],
6	in	IN	O	in	_	0	SENT_349	[p17l1954t565r2023b628],
7	LMDRI	NN	O	lmdrus	nn	8	SENT_349	[p17l2067t566r2149b628, p17l8t675r253b737],
8	cells	NNS	O	cell	prep_in	5	SENT_349	[p17l330t674r493b738],
9	can	MD	O	can	aux	11	SENT_349	[p17l564t694r689b738],
10	be	VB	O	be	auxpass	11	SENT_349	[p17l755t674r840b738],
11	attributed	VBN	O	attribute	_	0	SENT_349	[p17l911t674r1260b738],
12	to	TO	O	to	_	0	SENT_349	[p17l1327t684r1395b738],
13	functional	JJ	O	functional	amod	14	SENT_349	[p17l1465t674r1836b738],
14	human	JJ	O	human	amod	15	SENT_349	[p17l1903t674r2152b738],
15	Pgp	NN	O	pgp	prep_to	11	SENT_349	[p17l9t784r167b865],
16	.	.	O	.	_	0	SENT_349	[p17l9t784r167b865],

1	Except	IN	O	except	_	0	SENT_350	[p17l191t784r446b865],
2	simvastatin	NN	O	simvastatin	prep_except	6	SENT_350	[p17l469t782r881b847],
3	all	DT	O	all	det	4	SENT_350	[p17l904t782r991b846],
4	compounds	NNS	O	compound	nsubj	6	SENT_350	[p17l1013t782r1431b865],
5	tested	VBN	O	test	partmod	4	SENT_350	[p17l1453t782r1666b846],
6	had	VBD	O	have	_	0	SENT_350	[p17l1685t782r1817b846],
7	no	DT	O	no	det	8	SENT_350	[p17l1836t802r1924b846],
8	effect	NN	O	effect	dobj	6	SENT_350	[p17l1947t782r2152b846],
9	in	IN	O	in	_	0	SENT_350	[p17l9t893r78b956],
10	LLC-PKl	NN	O	llc-pkl	nn	11	SENT_350	[p17l126t893r483b957],
11	cells	NNS	O	cell	prep_in	8	SENT_350	[p17l542t893r725b957],
12	.	.	O	.	_	0	SENT_350	[p17l542t893r725b957],

1	The	DT	O	the	det	2	SENT_351	[p17l779t893r919b957],
2	fact	NN	O	fact	nsubj	8	SENT_351	[p17l969t893r1124b969],
3	,	,	O	,	_	0	SENT_351	[p17l969t893r1124b969],
4	that	IN	O	that	dep	5	SENT_351	[p17l1177t893r1314b957],
5	simvastatin	NN	O	simvastatin	dep	2	SENT_351	[p17l1366t893r1777b957],
6	not	RB	O	not	neg	5	SENT_351	[p17l1827t902r1943b957],
7	only	RB	O	only	advmod	8	SENT_351	[p17l1992t893r2151b976],
8	increases	VBZ	O	increase	_	0	SENT_351	[p17l9t1000r342b1064],
9	the	DT	O	the	det	10	SENT_351	[p17l377t1000r487b1064],
10	uptake	NN	O	uptake	dobj	8	SENT_351	[p17l520t1000r763b1083],
11	of	IN	O	of	_	0	SENT_351	[p17l799t1000r878b1064],
12	bodipy	JJ	O	bodipy	amod	14	SENT_351	[p17l904t1000r1556b1083],
13	—	NN	O	—	nn	14	SENT_351	[p17l904t1000r1556b1083],
14	verapamil	NN	O	verapamil	prep_of	10	SENT_351	[p17l904t1000r1556b1083],
15	and	CC	O	and	_	0	SENT_351	[p17l1592t1000r1721b1064],
16	of	IN	O	of	_	0	SENT_351	[p17l1756t1000r1834b1064],
17	calceinAM	NN	O	calceinam	prep_of	18	SENT_351	[p17l1863t1000r2149b1064, p17l8t1110r153b1172],
18	in	IN	O	in	conj_and	10	SENT_351	[p17l184t1110r253b1172],
19	L	NN	O	l	pobj	18	SENT_351	[p17l283t1110r613b1172],
20	.	.	O	.	_	0	SENT_351	[p17l283t1110r613b1172],

1	—	NN	O	—	_	0	SENT_352	[p17l283t1110r613b1172],
2	.	.	O	.	_	0	SENT_352	[p17l283t1110r613b1172],

1	MDRl	NN	O	mdrl	nn	2	SENT_353	[p17l283t1110r613b1172],
2	cells	NNS	O	cell	nsubj	23	SENT_353	[p17l653t1110r838b1185],
3	,	,	O	,	_	0	SENT_353	[p17l653t1110r838b1185],
4	but	CC	O	but	cc	6	SENT_353	[p17l871t1110r988b1173],
5	also	RB	O	also	advmod	6	SENT_353	[p17l1018t1110r1160b1173],
6	revealed	VBD	O	reveal	dep	2	SENT_353	[p17l1191t1110r1501b1173],
7	a	DT	O	a	det	9	SENT_353	[p17l1532t1130r1570b1173],
8	minor	JJ	O	minor	amod	9	SENT_353	[p17l1599t1110r1817b1173],
9	effect	NN	O	effect	dobj	6	SENT_353	[p17l1847t1109r2053b1173],
10	in	IN	O	in	_	0	SENT_353	[p17l2083t1110r2152b1172],
11	LLC-PKl	NN	O	llc-pkl	nn	12	SENT_353	[p17l8t1218r365b1282],
12	cells	NNS	O	cell	prep_in	6	SENT_353	[p17l404t1217r568b1281],
13	and	CC	O	and	_	0	SENT_353	[p17l602t1217r731b1281],
14	of	IN	O	of	_	0	SENT_353	[p17l761t1217r840b1281],
15	calcein-AM	NN	O	calcein-am	prep_of	6	SENT_353	[p17l865t1217r1300b1281],
16	in	IN	O	in	_	0	SENT_353	[p17l1331t1217r1401b1281],
17	LLC-PKl	NN	O	llc-pkl	prep_in	15	SENT_353	[p17l1430t1218r1787b1282],
18	(	CD	NUMBER	(	num	19	SENT_353	[p17l1828t1217r2008b1296],
19	data	NNS	O	datum	npadvmod	20	SENT_353	[p17l1828t1217r2008b1296],
20	not	RB	O	not	neg	21	SENT_353	[p17l2037t1227r2153b1281],
21	shown	VBN	O	show	partmod	17	SENT_353	[p17l12t1328r271b1407],
22	)	NN	O	)	dobj	21	SENT_353	[p17l12t1328r271b1407],
23	indicates	VBZ	O	indicate	dep	40	SENT_353	[p17l296t1328r619b1392],
24	that	IN	O	that	complm	28	SENT_353	[p17l643t1328r780b1392],
25	simvastatin	NN	O	simvastatin	nsubj	28	SENT_353	[p17l804t1328r1216b1392],
26	not	RB	O	not	dep	27	SENT_353	[p17l1238t1337r1354b1392],
27	only	RB	O	only	advmod	28	SENT_353	[p17l1376t1328r1535b1411],
28	inhibits	VBZ	O	inhibit	ccomp	23	SENT_353	[p17l1558t1328r1829b1392],
29	Pgp	NNP	O	Pgp	nn	35	SENT_353	[p17l1853t1329r2012b1411],
30	,	,	O	,	_	0	SENT_353	[p17l1853t1329r2012b1411],
31	but	CC	O	but	cc	29	SENT_353	[p17l2037t1328r2153b1392],
32	possibly	RB	O	possibly	advmod	29	SENT_353	[p17l8t1437r311b1520],
33	also	RB	O	also	advmod	29	SENT_353	[p17l345t1437r487b1501],
34	other	JJ	O	other	dep	29	SENT_353	[p17l522t1437r708b1501],
35	transporters	NNS	O	transporter	dobj	28	SENT_353	[p17l738t1446r1168b1520],
36	like	IN	O	like	_	0	SENT_353	[p17l1201t1437r1336b1501],
37	multidrug	JJ	O	multidrug	amod	39	SENT_353	[p17l1369t1437r1728b1520],
38	resistanceassociated	JJ	O	resistanceassociated	amod	39	SENT_353	[p17l1760t1437r2149b1501, p17l10t1544r385b1608],
39	proteins	NNS	O	protein	prep_like	28	SENT_353	[p17l417t1544r710b1627],
40	(	VBP	O	(	_	0	SENT_353	[p17l748t1545r1051b1623],
41	MRPS	NNS	O	mrp	dobj	40	SENT_353	[p17l748t1545r1051b1623],
42	)	CD	NUMBER	)	nsubj	40	SENT_353	[p17l748t1545r1051b1623],
43	.	.	O	.	_	0	SENT_353	[p17l748t1545r1051b1623],

1	In	IN	O	in	_	0	SENT_354	[p17l100t1657r174b1718],
2	agreement	NN	O	agreement	prep_in	11	SENT_354	[p17l200t1664r581b1738],
3	with	IN	O	with	_	0	SENT_354	[p17l603t1655r764b1719],
4	earlier	JJR	O	earlier	amod	5	SENT_354	[p17l788t1655r1022b1719],
5	investigations	NNS	O	investigation	prep_with	2	SENT_354	[p17l1045t1655r1548b1738],
6	simvastatin	NN	O	simvastatin	nsubj	11	SENT_354	[p17l1576t1655r1989b1719],
7	was	VBD	O	be	cop	11	SENT_354	[p17l2013t1675r2150b1719],
8	more	RBR	O	more	advmod	9	SENT_354	[p17l9t1783r194b1827],
9	potent	JJ	O	potent	amod	11	SENT_354	[p17l234t1772r464b1845],
10	an	DT	O	a	det	11	SENT_354	[p17l504t1783r587b1827],
11	inhibitor	NN	O	inhibitor	_	0	SENT_354	[p17l627t1762r943b1827],
12	of	IN	O	of	_	0	SENT_354	[p17l983t1763r1062b1827],
13	Pgp	NN	O	pgp	prep_of	11	SENT_354	[p17l1095t1764r1234b1845],
14	than	IN	O	than	_	0	SENT_354	[p17l1275t1763r1431b1827],
15	lovastatin	NN	O	lovastatin	prep_than	11	SENT_354	[p17l1471t1763r1824b1827],
16	[	CD	NUMBER	[	number	17	SENT_354	[p17l1871t1762r2147b1840],
17	14,15	CD	NUMBER	14,15	num	18	SENT_354	[p17l1871t1762r2147b1840],
18	]	NN	O	]	dep	11	SENT_354	[p17l1871t1762r2147b1840],
19	.	.	O	.	_	0	SENT_354	[p17l1871t1762r2147b1840],

1	Moreover	RB	O	moreover	advmod	5	SENT_355	[p17l8t1873r383b1947],
2	,	,	O	,	_	0	SENT_355	[p17l8t1873r383b1947],
3	our	PRP$	O	we	poss	4	SENT_355	[p17l434t1892r554b1936],
4	study	NN	O	study	nsubj	5	SENT_355	[p17l602t1872r794b1954],
5	demonstrates	VBZ	O	demonstrate	_	0	SENT_355	[p17l842t1872r1323b1936],
6	that	IN	O	that	complm	12	SENT_355	[p17l1371t1872r1508b1936],
7	gemﬁbrozil	NN	O	gemﬁbrozil	nsubj	12	SENT_355	[p17l1554t1871r1974b1954],
8	and	CC	O	and	_	0	SENT_355	[p17l2024t1872r2153b1936],
9	bezaﬁbrate	NN	O	bezaﬁbrate	nsubj	12	SENT_355	[p17l7t1980r410b2044],
10	do	VBP	O	do	aux	12	SENT_355	[p17l446t1980r534b2044],
11	not	RB	O	not	neg	12	SENT_355	[p17l569t1990r685b2044],
12	interact	VB	O	interact	ccomp	5	SENT_355	[p17l719t1980r995b2044],
13	with	IN	O	with	_	0	SENT_355	[p17l1029t1980r1190b2044],
14	Pgp	NNP	PERSON	Pgp	prep_with	12	SENT_355	[p17l1225t1982r1383b2063],
15	,	,	O	,	_	0	SENT_355	[p17l1225t1982r1383b2063],
16	whereas	IN	O	whereas	mark	18	SENT_355	[p17l1423t1980r1718b2044],
17	fenoﬁbrate	JJ	O	fenoﬁbrate	amod	18	SENT_355	[p17l1756t1980r2151b2044],
18	acts	NNS	O	act	advcl	12	SENT_355	[p17l10t2100r147b2155],
19	as	IN	O	as	dep	18	SENT_355	[p17l171t2111r241b2155],
20	a	DT	O	a	det	22	SENT_355	[p17l264t2111r302b2155],
21	Pgp	NNP	O	Pgp	nn	22	SENT_355	[p17l320t2092r459b2174],
22	inhibitor	NN	O	inhibitor	pobj	19	SENT_355	[p17l480t2091r808b2155],
23	.	.	O	.	_	0	SENT_355	[p17l480t2091r808b2155],

1	In	IN	O	in	_	0	SENT_356	[p17l833t2092r906b2154],
2	line	NN	O	line	prep_in	15	SENT_356	[p17l925t2091r1060b2155],
3	with	IN	O	with	_	0	SENT_356	[p17l1079t2091r1240b2155],
4	the	DT	O	the	det	5	SENT_356	[p17l1259t2091r1369b2155],
5	model	NN	O	model	prep_with	2	SENT_356	[p17l1389t2091r1616b2155],
6	established	VBN	O	establish	partmod	5	SENT_356	[p17l1637t2091r2044b2155],
7	by	IN	O	by	_	0	SENT_356	[p17l2061t2091r2151b2174],
8	Seelig	NNP	PERSON	Seelig	agent	6	SENT_356	[p17l11t2198r235b2281],
9	[	CD	NUMBER	[	num	8	SENT_356	[p17l286t2199r449b2276],
10	28	CD	NUMBER	28	num	11	SENT_356	[p17l286t2199r449b2276],
11	]	NN	O	]	dep	8	SENT_356	[p17l286t2199r449b2276],
12	,	,	O	,	_	0	SENT_356	[p17l286t2199r449b2276],
13	all	DT	O	all	det	14	SENT_356	[p17l497t2198r584b2262],
14	ﬁbrates	NNS	O	ﬁbrates	nsubj	15	SENT_356	[p17l629t2198r893b2262],
15	contain	VBP	O	contain	_	0	SENT_356	[p17l938t2198r1206b2262],
16	electron	NN	O	electron	nn	18	SENT_356	[p17l1250t2198r1543b2262],
17	donor	NN	O	donor	nn	18	SENT_356	[p17l1587t2198r1799b2262],
18	patterns	NNS	O	pattern	dobj	15	SENT_356	[p17l1839t2208r2148b2281],
19	,	,	O	,	_	0	SENT_356	[p17l1839t2208r2148b2281],
20	which	WDT	O	which	nsubj	22	SENT_356	[p17l9t2307r231b2372],
21	might	MD	O	might	aux	22	SENT_356	[p17l251t2307r465b2390],
22	interact	VB	O	interact	rcmod	18	SENT_356	[p17l485t2307r760b2371],
23	with	IN	O	with	_	0	SENT_356	[p17l780t2307r941b2372],
24	Pgp	NN	O	pgp	prep_with	22	SENT_356	[p17l962t2309r1119b2390],
25	.	.	O	.	_	0	SENT_356	[p17l962t2309r1119b2390],

1	However	RB	O	however	advmod	27	SENT_357	[p17l1145t2309r1491b2383],
2	,	,	O	,	_	0	SENT_357	[p17l1145t2309r1491b2383],
3	whereas	IN	O	whereas	mark	8	SENT_357	[p17l1515t2307r1812b2372],
4	the	DT	O	the	det	6	SENT_357	[p17l1834t2307r1944b2371],
5	other	JJ	O	other	amod	6	SENT_357	[p17l1967t2307r2153b2371],
6	ﬁbrates	NNS	O	ﬁbrates	nsubj	8	SENT_357	[p17l10t2418r275b2482],
7	are	VBP	O	be	cop	8	SENT_357	[p17l305t2438r413b2482],
8	anionic	JJ	O	anionic	nsubj	29	SENT_357	[p17l444t2418r708b2482],
9	and	CC	O	and	_	0	SENT_357	[p17l739t2418r868b2482],
10	hydrophilic	JJ	O	hydrophilic	amod	11	SENT_357	[p17l894t2418r1315b2501],
11	compounds	NNS	O	compound	nsubj	27	SENT_357	[p17l1345t2418r1763b2501],
12	which	WDT	O	which	nsubj	17	SENT_357	[p17l1793t2418r2015b2482],
13	are	VBP	O	be	cop	17	SENT_357	[p17l2043t2438r2151b2482],
14	normally	RB	O	normally	advmod	17	SENT_357	[p17l9t2526r338b2608],
15	weak	JJ	O	weak	amod	17	SENT_357	[p17l362t2526r555b2590],
16	Pgp	NNP	O	Pgp	nn	17	SENT_357	[p17l576t2527r715b2608],
17	substrates	NNS	O	substrate	rcmod	11	SENT_357	[p17l742t2526r1096b2590],
18	if	IN	O	if	_	0	SENT_357	[p17l1122t2525r1182b2589],
19	at	IN	O	at	quantmod	23	SENT_357	[p17l1201t2535r1264b2590],
20	all	DT	O	all	quantmod	23	SENT_357	[p17l1287t2526r1375b2590],
21	[	CD	NUMBER	[	number	23	SENT_357	[p17l1405t2526r1542b2603],
22	10	CD	NUMBER	10	number	23	SENT_357	[p17l1405t2526r1542b2603],
23	]	CD	NUMBER	]	prep_if	17	SENT_357	[p17l1405t2526r1542b2603],
24	only	RB	O	only	advmod	25	SENT_357	[p17l1573t2526r1732b2608],
25	fenoﬁbrate	NN	O	fenoﬁbrate	dep	23	SENT_357	[p17l1756t2525r2151b2590],
26	is	VBZ	O	be	cop	27	SENT_357	[p17l9t2635r65b2699],
27	lipophilic	JJ	O	lipophilic	_	0	SENT_357	[p17l111t2634r460b2717],
28	and	CC	O	and	_	0	SENT_357	[p17l506t2635r636b2699],
29	neutral	JJ	O	neutral	conj_and	27	SENT_357	[p17l678t2635r931b2699],
30	which	WDT	O	which	nsubj	31	SENT_357	[p17l975t2635r1198b2699],
31	predicts	VBZ	O	predict	ccomp	27	SENT_357	[p17l1239t2635r1528b2717],
32	high	JJ	O	high	amod	33	SENT_357	[p17l1572t2635r1733b2717],
33	afﬁnity	NN	O	afﬁnity	dobj	31	SENT_357	[p17l1778t2634r2038b2717],
34	to	TO	O	to	_	0	SENT_357	[p17l2083t2644r2151b2699],
35	Pgp	NNP	O	Pgp	prep_to	31	SENT_357	[p17l9t2745r167b2826],
36	.	.	O	.	_	0	SENT_357	[p17l9t2745r167b2826],

1	Therefore	RB	O	therefore	advmod	11	SENT_358	[p17l211t2743r591b2819],
2	,	,	O	,	_	0	SENT_358	[p17l211t2743r591b2819],
3	our	PRP$	O	we	poss	4	SENT_358	[p17l635t2763r755b2807],
4	ﬁnding	NN	O	ﬁnding	nsubjpass	11	SENT_358	[p17l793t2743r1048b2826],
5	that	IN	O	that	complm	7	SENT_358	[p17l1088t2743r1226b2807],
6	fenoﬁbrate	NN	O	fenoﬁbrate	nsubj	7	SENT_358	[p17l1264t2743r1660b2807],
7	inhibits	VBZ	O	inhibit	dep	4	SENT_358	[p17l1699t2743r1971b2807],
8	Pgp	NNP	O	Pgp	dobj	7	SENT_358	[p17l2012t2745r2151b2826],
9	could	MD	O	could	aux	11	SENT_358	[p17l9t2854r211b2918],
10	be	VB	O	be	auxpass	11	SENT_358	[p17l247t2854r332b2918],
11	expected	VBN	O	expect	_	0	SENT_358	[p17l372t2854r714b2937],
12	.	.	O	.	_	0	SENT_358	[p17l372t2854r714b2937],

1	It	PRP	O	it	nsubj	6	SENT_359	[p17l756t2855r811b2918],
2	is	VBZ	O	be	cop	6	SENT_359	[p17l848t2854r926b2930],
3	,	,	O	,	_	0	SENT_359	[p17l848t2854r926b2930],
4	however	RB	O	however	advmod	6	SENT_359	[p17l966t2854r1292b2930],
5	,	,	O	,	_	0	SENT_359	[p17l966t2854r1292b2930],
6	surprising	JJ	O	surprising	_	0	SENT_359	[p17l1337t2854r1697b2937],
7	that	IN	O	that	complm	8	SENT_359	[p17l1736t2854r1873b2918],
8	fenoﬁM	NN	O	fenoﬁm	dep	6	SENT_359	[p17l1910t2854r2149b2918, p17l330t3013r363b3036],
9	.	.	O	.	_	0	SENT_359	[p17l1910t2854r2149b2918, p17l330t3013r363b3036],

1	Ehrhardt	NNP	PERSON	Ehrhardt	_	0	SENT_360	[p17l377t3012r498b3036],
2	et	FW	O	et	nn	3	SENT_360	[p17l510t3017r534b3036],
3	al.	FW	O	al.	dep	1	SENT_360	[p17l544t3012r764b3036],
4	/	:	O	/	punct	1	SENT_360	[p17l544t3012r764b3036],
5	Biochemical	JJ	O	biochemical	amod	6	SENT_360	[p17l544t3012r764b3036],
6	Pharmacology	NN	O	pharmacology	dep	1	SENT_360	[p17l776t3012r970b3042],
7	67	CD	NUMBER	67	number	8	SENT_360	[p17l983t3012r1016b3036],
8	(	CD	NUMBER	(	num	9	SENT_360	[p17l1027t3012r1113b3041],
9	2004	CD	DATE	2004	dep	6	SENT_360	[p17l1027t3012r1113b3041],
10	)	CD	NUMBER	)	number	11	SENT_360	[p17l1027t3012r1113b3041],
11	285-292 291	CD	NUMBER	285-292 291	num	9	SENT_360	[p17l1784t3012r1829b3036],[p17l1126t3012r1240b3036],

1	brate	NN	O	brate	nsubj	2	SENT_361	[p17l7t3180r189b3244],
2	appeared	VBD	O	appear	_	0	SENT_361	[p17l215t3180r544b3263],
3	not	RB	O	not	neg	6	SENT_361	[p17l566t3190r681b3244],
4	to	TO	O	to	aux	6	SENT_361	[p17l703t3190r772b3244],
5	be	VB	O	be	auxpass	6	SENT_361	[p17l794t3180r878b3244],
6	transported	VBN	O	transport	xcomp	2	SENT_361	[p17l902t3180r1332b3263],
7	,	,	O	,	_	0	SENT_361	[p17l902t3180r1332b3263],
8	because	IN	O	because	_	0	SENT_361	[p17l1358t3180r1647b3244],
9	no	DT	O	no	det	10	SENT_361	[p17l1670t3200r1758b3244],
10	difference	NN	O	difference	prep_because	6	SENT_361	[p17l1783t3180r2150b3244],
11	between	IN	O	between	_	0	SENT_361	[p17l7t3287r312b3351],
12	the	DT	O	the	det	13	SENT_361	[p17l344t3287r453b3351],
13	uptake	NN	O	uptake	prep_between	10	SENT_361	[p17l484t3287r726b3370],
14	into	IN	O	into	_	0	SENT_361	[p17l759t3287r898b3351],
15	the	DT	O	the	det	21	SENT_361	[p17l930t3287r1040b3351],
16	parental	JJ	O	parental	amod	21	SENT_361	[p17l1070t3287r1365b3370],
17	cell	NN	O	cell	nn	21	SENT_361	[p17l1398t3287r1527b3351],
18	line	NN	O	line	nn	21	SENT_361	[p17l1559t3287r1694b3351],
19	(	NN	O	(	nn	21	SENT_361	[p17l1729t3288r2149b3366],
20	LLC-PKl	NN	O	llc-pkl	nn	21	SENT_361	[p17l1729t3288r2149b3366],
21	)	NN	O	)	prep_into	13	SENT_361	[p17l1729t3288r2149b3366],
22	and	CC	O	and	_	0	SENT_361	[p17l10t3397r140b3461],
23	the	DT	O	the	det	28	SENT_361	[p17l186t3397r296b3461],
24	overexpressing	VBG	O	overexpress	amod	28	SENT_361	[p17l345t3397r893b3479],
25	cell	NN	O	cell	nn	28	SENT_361	[p17l943t3397r1073b3461],
26	line	NN	O	line	nn	28	SENT_361	[p17l1122t3396r1256b3461],
27	(	NN	O	(	nn	28	SENT_361	[p17l1308t3397r1702b3476],
28	L	NN	O	l	conj_and	21	SENT_361	[p17l1308t3397r1702b3476],
29	.	.	O	.	_	0	SENT_361	[p17l1308t3397r1702b3476],

1	—	NN	O	—	_	0	SENT_362	[p17l1308t3397r1702b3476],
2	.	.	O	.	_	0	SENT_362	[p17l1308t3397r1702b3476],

1	MDRl	NN	O	mdrl	nn	2	SENT_363	[p17l1308t3397r1702b3476],
2	)	NN	O	)	nsubjpass	4	SENT_363	[p17l1308t3397r1702b3476],
3	was	VBD	O	be	auxpass	4	SENT_363	[p17l1753t3417r1890b3461],
4	found	VBN	O	find	_	0	SENT_363	[p17l1940t3397r2152b3461],
5	(	CD	NUMBER	(	num	6	SENT_363	[p17l11t3505r177b3588],
6	Fig	NN	O	fig	dobj	4	SENT_363	[p17l11t3505r177b3588],
7	.	.	O	.	_	0	SENT_363	[p17l11t3505r177b3588],

1	5B	NN	O	5b	_	0	SENT_364	[p17l237t3505r389b3584],
2	)	NN	O	)	dep	1	SENT_364	[p17l237t3505r389b3584],
3	.	.	O	.	_	0	SENT_364	[p17l237t3505r389b3584],

1	Therefore	RB	O	therefore	advmod	9	SENT_365	[p17l447t3505r827b3581],
2	,	,	O	,	_	0	SENT_365	[p17l447t3505r827b3581],
3	similar	JJ	O	similar	advmod	9	SENT_365	[p17l888t3505r1139b3569],
4	to	TO	O	to	_	0	SENT_365	[p17l1192t3515r1259b3569],
5	verapamil	NN	O	verapamil	prep_to	3	SENT_365	[p17l1313t3505r1698b3588],
6	,	,	O	,	_	0	SENT_365	[p17l1313t3505r1698b3588],
7	fenoﬁbrate	NN	O	fenoﬁbrate	nsubj	15	SENT_365	[p17l1756t3505r2151b3569],
8	might	MD	O	might	aux	9	SENT_365	[p17l8t3616r222b3699],
9	exhibit	VB	O	exhibit	_	0	SENT_365	[p17l283t3616r537b3680],
10	a	DT	O	a	det	13	SENT_365	[p17l598t3636r636b3680],
11	high	JJ	O	high	amod	13	SENT_365	[p17l696t3616r857b3699],
12	intrinsic	JJ	O	intrinsic	amod	13	SENT_365	[p17l919t3616r1215b3680],
13	permeability	NN	O	permeability	dobj	9	SENT_365	[p17l1278t3616r1742b3699],
14	and	CC	O	and	_	0	SENT_365	[p17l1806t3616r1936b3680],
15	pass	VB	O	pass	conj_and	9	SENT_365	[p17l1996t3636r2149b3699],
16	through	IN	O	through	_	0	SENT_365	[p17l8t3725r292b3808],
17	the	DT	O	the	det	19	SENT_365	[p17l331t3725r441b3789],
18	cell	NN	O	cell	nn	19	SENT_365	[p17l482t3725r612b3789],
19	membrane	NN	O	membrane	prep_through	15	SENT_365	[p17l653t3725r1039b3789],
20	faster	RBR	O	faster	advmod	15	SENT_365	[p17l1080t3725r1282b3789],
21	than	IN	O	than	mark	24	SENT_365	[p17l1321t3725r1478b3789],
22	it	PRP	O	it	nsubjpass	24	SENT_365	[p17l1517t3725r1567b3789],
23	is	VBZ	O	be	auxpass	24	SENT_365	[p17l1606t3725r1663b3789],
24	removed	VBN	O	remove	dep	20	SENT_365	[p17l1704t3725r2023b3789],
25	by	IN	O	by	prep	24	SENT_365	[p17l2061t3725r2151b3808],

1	Pgp	NNP	O	Pgp	_	0	SENT_366	[p18l8t21r147b102],
2	[	CD	NUMBER	[	num	1	SENT_366	[p18l176t20r338b97],
3	27	CD	NUMBER	27	num	4	SENT_366	[p18l176t20r338b97],
4	]	NN	O	]	dep	1	SENT_366	[p18l176t20r338b97],
5	.	.	O	.	_	0	SENT_366	[p18l176t20r338b97],

1	In	IN	O	in	_	0	SENT_367	[p18l363t21r438b83],
2	this	DT	O	this	det	3	SENT_367	[p18l458t19r586b83],
3	case	NN	O	case	prep_in	10	SENT_367	[p18l611t40r785b95],
4	,	,	O	,	_	0	SENT_367	[p18l611t40r785b95],
5	the	DT	O	the	det	6	SENT_367	[p18l809t19r919b83],
6	transport	NN	O	transport	nsubj	10	SENT_367	[p18l941t29r1267b102],
7	will	MD	O	will	aux	10	SENT_367	[p18l1287t19r1426b84],
8	not	RB	O	not	neg	10	SENT_367	[p18l1448t29r1564b83],
9	be	VB	O	be	cop	10	SENT_367	[p18l1583t19r1668b83],
10	detectable	JJ	O	detectable	_	0	SENT_367	[p18l1690t19r2061b83],
11	in	IN	O	in	_	0	SENT_367	[p18l2083t19r2152b83],
12	an	DT	O	a	det	14	SENT_367	[p18l10t150r93b194],
13	uptake	NN	O	uptake	nn	14	SENT_367	[p18l125t130r368b213],
14	assay	NN	O	assay	prep_in	10	SENT_367	[p18l404t150r611b213],
15	.	.	O	.	_	0	SENT_367	[p18l404t150r611b213],

1	In	IN	O	in	_	0	SENT_368	[p18l100t239r174b301],
2	agreement	NN	O	agreement	prep_in	10	SENT_368	[p18l195t247r576b320],
3	with	IN	O	with	_	0	SENT_368	[p18l595t238r756b302],
4	the	DT	O	the	det	5	SENT_368	[p18l775t238r884b302],
5	lack	NN	O	lack	prep_with	2	SENT_368	[p18l905t238r1058b302],
6	of	IN	O	of	_	0	SENT_368	[p18l1077t237r1156b302],
7	Pgp	NN	O	pgp	nn	8	SENT_368	[p18l1169t239r1307b320],
8	inhibition	NN	O	inhibition	prep_of	5	SENT_368	[p18l1328t237r1684b302],
9	there	EX	O	there	expl	10	SENT_368	[p18l1703t238r1884b302],
10	was	VBD	O	be	_	0	SENT_368	[p18l1903t258r2041b302],
11	no	DT	O	no	det	12	SENT_368	[p18l2062t258r2150b302],
12	difference	NN	O	difference	nsubj	10	SENT_368	[p18l9t346r376b411],
13	in	IN	O	in	_	0	SENT_368	[p18l424t347r493b410],
14	the	DT	O	the	det	15	SENT_368	[p18l539t347r648b411],
15	uptake	NN	O	uptake	prep_in	12	SENT_368	[p18l695t347r938b429],
16	of	IN	O	of	_	0	SENT_368	[p18l987t346r1065b411],
17	gemﬁbrozil	NN	O	gemﬁbrozil	prep_of	15	SENT_368	[p18l1106t346r1526b429],
18	and	CC	O	and	_	0	SENT_368	[p18l1575t347r1704b411],
19	bezaﬁbrate	NN	O	bezaﬁbrate	conj_and	17	SENT_368	[p18l1749t347r2151b411],
20	between	IN	O	between	_	0	SENT_368	[p18l7t455r312b519],
21	the	DT	O	the	det	24	SENT_368	[p18l339t455r448b519],
22	two	CD	NUMBER	two	num	24	SENT_368	[p18l475t465r609b519],
23	cell	NN	O	cell	nn	24	SENT_368	[p18l638t455r767b519],
24	lines	NNS	O	line	prep_between	12	SENT_368	[p18l795t455r964b519],
25	(	CD	NUMBER	(	num	26	SENT_368	[p18l995t455r1161b538],
26	Fig	NN	O	fig	dep	24	SENT_368	[p18l995t455r1161b538],
27	.	.	O	.	_	0	SENT_368	[p18l995t455r1161b538],

1	5C	NN	O	5c	nsubj	6	SENT_369	[p18l1194t455r1295b520],
2	and	CC	O	and	_	0	SENT_369	[p18l1325t455r1454b519],
3	D	NN	O	d	nn	4	SENT_369	[p18l1480t456r1593b534],
4	)	NN	O	)	nsubj	6	SENT_369	[p18l1480t456r1593b534],
5	,	,	O	,	_	0	SENT_369	[p18l1480t456r1593b534],
6	indicating	VBG	O	indicate	_	0	SENT_369	[p18l1622t455r1988b538],
7	that	IN	O	that	complm	12	SENT_369	[p18l2015t455r2152b519],
8	these	DT	O	these	det	9	SENT_369	[p18l8t566r194b630],
9	compounds	NNS	O	compound	nsubjpass	12	SENT_369	[p18l229t566r647b649],
10	are	VBP	O	be	auxpass	12	SENT_369	[p18l684t586r792b630],
11	not	RB	O	not	neg	12	SENT_369	[p18l826t575r942b630],
12	transported	VBN	O	transport	ccomp	6	SENT_369	[p18l974t566r1386b649],
13	by	IN	O	by	_	0	SENT_369	[p18l1417t566r1507b649],
14	Pgp	NNP	O	Pgp	agent	12	SENT_369	[p18l1540t567r1699b649],
15	.	.	O	.	_	0	SENT_369	[p18l1540t567r1699b649],

1	The	DT	O	the	det	3	SENT_370	[p18l100t675r240b739],
2	present	JJ	DATE	present	amod	3	SENT_370	[p18l264t684r528b758],
3	results	NNS	O	result	nsubj	4	SENT_370	[p18l551t675r786b739],
4	implicate	VBP	O	implicate	_	0	SENT_370	[p18l813t675r1152b758],
5	that	IN	O	that	complm	33	SENT_370	[p18l1177t675r1314b739],
6	the	DT	O	the	det	7	SENT_370	[p18l1337t675r1447b739],
7	interactions	NNS	O	interaction	nsubj	33	SENT_370	[p18l1471t675r1895b739],
8	occurring	VBG	O	occur	partmod	7	SENT_370	[p18l1922t695r2149b739, p18l7t782r153b865],
9	between	IN	O	between	_	0	SENT_370	[p18l176t782r480b847],
10	drugs	NNS	O	drug	prep_between	8	SENT_370	[p18l505t782r703b865],
11	and	CC	O	and	_	0	SENT_370	[p18l731t782r860b846],
12	the	DT	O	the	det	14	SENT_370	[p18l882t782r992b846],
13	ﬁbrates	NNS	O	ﬁbrates	nn	14	SENT_370	[p18l1018t782r1281b846],
14	gemﬁbrozil	NN	O	gemﬁbrozil	prep_between	8	SENT_370	[p18l1308t782r1727b865],
15	and	CC	O	and	_	0	SENT_370	[p18l1753t782r1882b846],
16	bezaﬁbrate	NN	O	bezaﬁbrate	conj_and	10	SENT_370	[p18l1904t782r2150b846, p18l7t892r209b967],
17	,	,	O	,	_	0	SENT_370	[p18l1904t782r2150b846, p18l7t892r209b967],
18	as	RB	O	as	_	0	SENT_370	[p18l242t912r313b955],
19	well	RB	O	well	_	0	SENT_370	[p18l343t892r498b956],
20	as	IN	O	as	_	0	SENT_370	[p18l529t912r598b955],
21	the	DT	O	the	det	23	SENT_370	[p18l629t892r738b955],
22	known	JJ	O	known	amod	23	SENT_370	[p18l766t892r1012b956],
23	differences	NNS	O	difference	conj_and	10	SENT_370	[p18l1041t892r1440b955],
24	in	IN	O	in	_	0	SENT_370	[p18l1470t892r1540b955],
25	their	PRP$	O	they	poss	30	SENT_370	[p18l1567t892r1735b955],
26	interaction	NN	O	interaction	nn	30	SENT_370	[p18l1762t892r2153b955],
27	pattern	NN	O	pattern	nn	30	SENT_370	[p18l7t1009r261b1082],
28	[	NN	O	[	nn	30	SENT_370	[p18l295t1000r432b1077],
29	29	CD	NUMBER	29	num	30	SENT_370	[p18l295t1000r432b1077],
30	]	NN	O	]	prep_in	23	SENT_370	[p18l295t1000r432b1077],
31	are	VBP	O	be	cop	33	SENT_370	[p18l469t1020r576b1064],
32	not	RB	O	not	neg	33	SENT_370	[p18l605t1009r721b1064],
33	due	JJ	O	due	ccomp	4	SENT_370	[p18l749t1000r877b1064],
34	to	TO	O	to	_	0	SENT_370	[p18l906t1009r974b1064],
35	interactions	NNS	O	interaction	prep_to	33	SENT_370	[p18l1004t1000r1427b1064],
36	with	IN	O	with	_	0	SENT_370	[p18l1457t1000r1618b1064],
37	Pgp	NN	O	pgp	prep_with	35	SENT_370	[p18l1646t1001r1803b1082],
38	.	.	O	.	_	0	SENT_370	[p18l1646t1001r1803b1082],

1	We	PRP	O	we	nsubj	18	SENT_371	[p18l1834t1001r1953b1064],
2	have	VBP	O	have	aux	4	SENT_371	[p18l1982t1000r2151b1064],
3	not	RB	O	not	neg	4	SENT_371	[p18l8t1119r125b1173],
4	studied	VBN	O	study	_	0	SENT_371	[p18l144t1108r402b1173],
5	all	DT	O	all	det	7	SENT_371	[p18l421t1109r509b1173],
6	known	JJ	O	known	amod	7	SENT_371	[p18l526t1109r770b1173],
7	ﬁbrates	NNS	O	ﬁbrates	dobj	4	SENT_371	[p18l789t1108r1053b1173],
8	and	CC	O	and	_	0	SENT_371	[p18l1073t1109r1202b1173],
9	not	RB	O	not	dobj	4	SENT_371	[p18l1218t1118r1335b1173],
10	all	DT	O	all	dep	7	SENT_371	[p18l1353t1109r1440b1173],
11	of	IN	O	of	_	0	SENT_371	[p18l1458t1108r1537b1173],
12	their	PRP$	O	they	poss	13	SENT_371	[p18l1548t1109r1716b1173],
13	metabolites	NNS	O	metabolite	prep_of	10	SENT_371	[p18l1732t1109r2150b1173],
14	and	CC	O	and	_	0	SENT_371	[p18l10t1217r139b1281],
15	hence	RB	O	hence	advmod	18	SENT_371	[p18l162t1217r373b1281],
16	can	MD	O	can	aux	18	SENT_371	[p18l399t1227r641b1281],
17	not	RB	O	not	neg	18	SENT_371	[p18l399t1227r641b1281],
18	rule	VB	O	rule	conj_and	4	SENT_371	[p18l663t1217r803b1281],
19	out	RP	O	out	prt	18	SENT_371	[p18l829t1227r944b1281],
20	that	IN	O	that	complm	25	SENT_371	[p18l966t1217r1103b1281],
21	some	DT	O	some	nsubj	25	SENT_371	[p18l1129t1237r1316b1281],
22	of	IN	O	of	_	0	SENT_371	[p18l1341t1217r1420b1281],
23	them	PRP	O	they	prep_of	21	SENT_371	[p18l1438t1217r1620b1281],
24	might	MD	O	might	aux	25	SENT_371	[p18l1643t1217r1857b1300],
25	interact	VB	O	interact	ccomp	18	SENT_371	[p18l1879t1217r2153b1281],
26	with	IN	O	with	_	0	SENT_371	[p18l9t1328r170b1392],
27	human	JJ	O	human	amod	28	SENT_371	[p18l222t1328r470b1392],
28	Pgp	NNP	O	Pgp	prep_with	25	SENT_371	[p18l523t1329r681b1411],
29	.	.	O	.	_	0	SENT_371	[p18l523t1329r681b1411],

1	However	RB	O	however	advmod	17	SENT_372	[p18l739t1329r1083b1404],
2	,	,	O	,	_	0	SENT_372	[p18l739t1329r1083b1404],
3	a	DT	O	a	det	7	SENT_372	[p18l1142t1348r1180b1392],
4	major	JJ	O	major	amod	7	SENT_372	[p18l1233t1328r1447b1411],
5	active	JJ	O	active	amod	7	SENT_372	[p18l1500t1328r1712b1392],
6	metabolite	NN	O	metabolite	nn	7	SENT_372	[p18l1766t1328r2151b1392],
7	(	NN	O	(	nsubj	17	SENT_372	[p18l11t1435r390b1514],
8	fenoﬁbric	JJ	O	fenoﬁbric	amod	10	SENT_372	[p18l11t1435r390b1514],
9	acid	NN	O	acid	nn	10	SENT_372	[p18l423t1435r599b1514],
10	)	NN	O	)	dep	7	SENT_372	[p18l423t1435r599b1514],
11	and	CC	O	and	_	0	SENT_372	[p18l634t1435r763b1499],
12	the	DT	O	the	det	13	SENT_372	[p18l791t1435r901b1499],
13	lipid	NN	O	lipid	nsubj	17	SENT_372	[p18l931t1435r1098b1518],
14	lowering	VBG	O	lower	partmod	13	SENT_372	[p18l1127t1435r1446b1518],
15	parent	NN	O	parent	nn	16	SENT_372	[p18l1475t1445r1704b1518],
16	compounds	NNS	O	compound	dobj	14	SENT_372	[p18l1733t1435r2150b1518],
17	(	VBP	O	(	_	0	SENT_372	[p18l11t1544r478b1627],
18	gemﬁbrozil	NN	O	gemﬁbrozil	nn	21	SENT_372	[p18l11t1544r478b1627],
19	,	,	O	,	_	0	SENT_372	[p18l11t1544r478b1627],
20	bezaﬁbrate	JJ	O	bezaﬁbrate	amod	21	SENT_372	[p18l504t1544r932b1623],
21	)	NN	O	)	nsubj	25	SENT_372	[p18l504t1544r932b1623],
22	clearly	RB	O	clearly	advmod	25	SENT_372	[p18l960t1544r1206b1627],
23	did	VBD	O	do	aux	25	SENT_372	[p18l1232t1544r1347b1608],
24	not	RB	O	not	neg	25	SENT_372	[p18l1369t1554r1485b1608],
25	interact	VB	O	interact	ccomp	17	SENT_372	[p18l1508t1544r1782b1608],
26	with	IN	O	with	_	0	SENT_372	[p18l1806t1544r1966b1609],
27	Pgp	NN	ORGANIZATION	pgp	prep_with	25	SENT_372	[p18l1989t1546r2147b1627],
28	.	.	O	.	_	0	SENT_372	[p18l1989t1546r2147b1627],

1	Based	VBN	O	base	_	0	SENT_373	[p18l100t1655r323b1719],
2	on	IN	O	on	prepc_based_on	18	SENT_373	[p18l370t1675r458b1719],
3	our	PRP$	O	we	poss	4	SENT_373	[p18l505t1675r626b1719],
4	results	NNS	O	result	pobj	18	SENT_373	[p18l670t1655r906b1719],
5	only	RB	O	only	advmod	4	SENT_373	[p18l956t1655r1115b1738],
6	for	IN	O	for	_	0	SENT_373	[p18l1163t1655r1269b1719],
7	fenoﬁbrate	NN	O	fenoﬁbrate	prep_for	4	SENT_373	[p18l1314t1655r1709b1719],
8	an	DT	O	a	dep	7	SENT_373	[p18l1758t1675r1841b1719],
9	in	FW	O	in	prep	7	SENT_373	[p18l1890t1657r1955b1719],
10	vivo	FW	O	vivo	pobj	9	SENT_373	[p18l2000t1657r2150b1720],
11	interaction	NN	O	interaction	nsubj	18	SENT_373	[p18l8t1763r401b1827],
12	on	IN	O	on	_	0	SENT_373	[p18l445t1783r533b1827],
13	the	DT	O	the	det	14	SENT_373	[p18l575t1763r685b1827],
14	level	NN	O	level	prep_on	11	SENT_373	[p18l729t1763r902b1827],
15	of	IN	O	of	_	0	SENT_373	[p18l947t1762r1026b1827],
16	Pgp	NNP	O	Pgp	prep_of	14	SENT_373	[p18l1063t1764r1201b1845],
17	is	VBZ	O	be	cop	18	SENT_373	[p18l1246t1763r1302b1827],
18	conceivable	JJ	O	conceivable	_	0	SENT_373	[p18l1348t1763r1799b1827],
19	.	.	O	.	_	0	SENT_373	[p18l1348t1763r1799b1827],

1	Because	IN	O	because	_	0	SENT_374	[p18l1847t1764r2150b1827],
2	fenoﬁbrate	JJ	O	fenoﬁbrate	prep_because	12	SENT_374	[p18l9t1871r404b1935],
3	proved	VBN	O	prove	partmod	2	SENT_374	[p18l448t1871r701b1954],
4	to	TO	O	to	aux	7	SENT_374	[p18l744t1881r813b1935],
5	be	VB	O	be	cop	7	SENT_374	[p18l857t1871r942b1935],
6	an	DT	O	a	det	7	SENT_374	[p18l990t1891r1072b1935],
7	inhibitor	NN	O	inhibitor	xcomp	3	SENT_374	[p18l1116t1871r1433b1935],
8	of	IN	O	of	_	0	SENT_374	[p18l1477t1871r1556b1935],
9	Pgp	NNP	ORGANIZATION	Pgp	prep_of	7	SENT_374	[p18l1595t1873r1733b1954],
10	it	PRP	O	it	nsubj	12	SENT_374	[p18l1779t1871r1829b1935],
11	appears	VBZ	O	appear	cop	12	SENT_374	[p18l1875t1891r2150b1954],
12	possible	JJ	O	possible	_	0	SENT_374	[p18l7t1980r306b2063],
13	that	IN	O	that	complm	23	SENT_374	[p18l345t1980r482b2044],
14	the	DT	O	the	det	15	SENT_374	[p18l519t1980r629b2044],
15	bioavailability	NN	O	bioavailability	nsubj	23	SENT_374	[p18l667t1980r1195b2063],
16	of	IN	O	of	_	0	SENT_374	[p18l1236t1980r1315b2044],
17	statins	NNS	O	statin	prep_of	15	SENT_374	[p18l1350t1980r1577b2044],
18	and	CC	O	and	_	0	SENT_374	[p18l1620t1980r1749b2044],
19	other	JJ	O	other	amod	21	SENT_374	[p18l1788t1980r1975b2044],
20	Pgp	NNP	ORGANIZATION	Pgp	nn	21	SENT_374	[p18l2012t1982r2150b2063],
21	substrates	NNS	O	substrate	prep_of	15	SENT_374	[p18l11t2091r366b2155],
22	will	MD	O	will	aux	23	SENT_374	[p18l401t2091r541b2155],
23	increase	VB	O	increase	ccomp	12	SENT_374	[p18l573t2091r872b2155],
24	during	IN	O	during	_	0	SENT_374	[p18l906t2091r1141b2174],
25	co	NN	O	co	nn	27	SENT_374	[p18l1175t2091r1822b2155],
26	—	CD	NUMBER	—	num	27	SENT_374	[p18l1175t2091r1822b2155],
27	administration	NN	O	administration	prep_during	23	SENT_374	[p18l1175t2091r1822b2155],
28	of	IN	O	of	_	0	SENT_374	[p18l1855t2091r1934b2155],
29	fenoﬁbrate	NN	O	fenoﬁbrate	prep_of	27	SENT_374	[p18l1960t2091r2149b2155, p18l10t2198r259b2262],
30	.	.	O	.	_	0	SENT_374	[p18l1960t2091r2149b2155, p18l10t2198r259b2262],

1	However	RB	O	however	advmod	18	SENT_375	[p18l292t2200r638b2274],
2	,	,	O	,	_	0	SENT_375	[p18l292t2200r638b2274],
3	if	IN	O	if	mark	11	SENT_375	[p18l669t2198r729b2262],
4	occurring	VBG	O	occur	csubjpass	11	SENT_375	[p18l752t2198r1100b2281],
5	at	IN	O	at	_	0	SENT_375	[p18l1132t2208r1195b2262],
6	all	PDT	O	all	predet	8	SENT_375	[p18l1224t2198r1311b2262],
7	these	DT	O	these	det	8	SENT_375	[p18l1340t2198r1526b2262],
8	interactions	NNS	O	interaction	prep_at	4	SENT_375	[p18l1555t2198r1981b2262],
9	will	MD	O	will	aux	11	SENT_375	[p18l2011t2198r2151b2263],
10	be	VB	O	be	auxpass	11	SENT_375	[p18l7t2307r92b2371],
11	limited	VBN	O	limit	csubj	18	SENT_375	[p18l134t2307r393b2371],
12	to	TO	O	to	_	0	SENT_375	[p18l433t2317r502b2371],
13	gastrointestinal	JJ	O	gastrointestinal	amod	14	SENT_375	[p18l545t2307r1103b2390],
14	Pgp	NN	O	pgp	prep_to	11	SENT_375	[p18l1145t2309r1284b2390],
15	because	IN	O	because	_	0	SENT_375	[p18l1325t2307r1615b2371],
16	fenoﬁbrate	NN	O	fenoﬁbrate	prep_because	11	SENT_375	[p18l1656t2307r2052b2371],
17	is	VBZ	O	be	aux	18	SENT_375	[p18l2093t2307r2150b2371],
18	undergoing	VBG	O	undergo	_	0	SENT_375	[p18l8t2418r423b2501],
19	a	DT	O	a	det	26	SENT_375	[p18l478t2438r515b2482],
20	nearly	RB	O	nearly	advmod	21	SENT_375	[p18l567t2418r793b2501],
21	complete	JJ	O	complete	amod	26	SENT_375	[p18l847t2418r1181b2501],
22	presystemic	JJ	O	presystemic	amod	26	SENT_375	[p18l1233t2418r1670b2501],
23	metabolism	NN	O	metabolism	nn	26	SENT_375	[p18l1724t2418r2152b2482],
24	[	CD	NUMBER	[	number	25	SENT_375	[p18l15t2525r246b2603],
25	6,30	CD	NUMBER	6,30	num	26	SENT_375	[p18l15t2525r246b2603],
26	]	NN	O	]	dobj	18	SENT_375	[p18l15t2525r246b2603],
27	.	.	O	.	_	0	SENT_375	[p18l15t2525r246b2603],

1	Whether	IN	O	whether	complm	4	SENT_376	[p18l286t2526r604b2590],
2	this	DT	O	this	det	3	SENT_376	[p18l639t2525r767b2590],
3	interaction	NN	O	interaction	nsubj	4	SENT_376	[p18l806t2526r1198b2590],
4	occurs	VBZ	O	occur	csubj	11	SENT_376	[p18l1237t2546r1470b2590],
5	and	CC	O	and	_	0	SENT_376	[p18l1511t2525r1641b2590],
6	whether	IN	O	whether	dep	10	SENT_376	[p18l1677t2526r1972b2590],
7	it	PRP	O	it	nsubj	10	SENT_376	[p18l2007t2526r2057b2590],
8	is	VBZ	O	be	cop	10	SENT_376	[p18l2093t2526r2150b2590],
9	clinically	RB	O	clinically	advmod	10	SENT_376	[p18l9t2636r350b2719],
10	relevant	JJ	O	relevant	conj_and	4	SENT_376	[p18l383t2636r676b2700],
11	has	VBZ	O	have	_	0	SENT_376	[p18l708t2636r826b2700],
12	to	TO	O	to	aux	14	SENT_376	[p18l862t2645r930b2700],
13	be	VB	O	be	auxpass	14	SENT_376	[p18l964t2636r1049b2700],
14	elucidated	VBN	O	elucidate	xcomp	11	SENT_376	[p18l1084t2636r1461b2700],
15	in	IN	O	in	_	0	SENT_376	[p18l1497t2638r1562b2700],
16	viva	FW	O	viva	prep_in	14	SENT_376	[p18l1594t2638r1764b2701],
17	.	.	O	.	_	0	SENT_376	[p18l1594t2638r1764b2701],

1	However	RB	O	however	advmod	13	SENT_377	[p18l1802t2638r2148b2712],
2	,	,	O	,	_	0	SENT_377	[p18l1802t2638r2148b2712],
3	one	CD	NUMBER	one	nsubj	13	SENT_377	[p18l10t2763r138b2807],
4	of	IN	O	of	_	0	SENT_377	[p18l183t2743r262b2807],
5	the	DT	O	the	det	9	SENT_377	[p18l300t2743r410b2807],
6	very	RB	O	very	advmod	7	SENT_377	[p18l453t2763r611b2826],
7	few	JJ	O	few	amod	9	SENT_377	[p18l656t2743r789b2807],
8	interaction	NN	O	interaction	nn	9	SENT_377	[p18l833t2743r1225b2807],
9	studies	NNS	O	study	prep_of	3	SENT_377	[p18l1273t2743r1520b2807],
10	performed	VBN	O	perform	partmod	9	SENT_377	[p18l1565t2743r1947b2826],
11	with	IN	O	with	_	0	SENT_377	[p18l1991t2743r2152b2807],
12	fenoﬁbrate	NN	O	fenoﬁbrate	prep_with	10	SENT_377	[p18l9t2854r404b2918],
13	suggests	VBZ	O	suggest	_	0	SENT_377	[p18l441t2864r744b2937],
14	that	IN	O	that	complm	18	SENT_377	[p18l779t2854r916b2918],
15	it	PRP	O	it	nsubj	18	SENT_377	[p18l949t2854r999b2918],
16	does	VBZ	O	do	aux	18	SENT_377	[p18l1031t2854r1195b2918],
17	not	RB	O	not	neg	18	SENT_377	[p18l1229t2864r1346b2918],
18	affect	VB	O	affect	ccomp	13	SENT_377	[p18l1380t2854r1585b2918],
19	the	DT	O	the	det	20	SENT_377	[p18l1617t2854r1726b2918],
20	pharmacokinetics	NNS	O	pharmacokinetic	nsubj	27	SENT_377	[p18l1759t2854r2148b2937, p18l8t2961r290b3025],
21	of	IN	O	of	_	0	SENT_377	[p18l330t2961r409b3025],
22	oral	JJ	O	oral	amod	23	SENT_377	[p18l440t2961r579b3025],
23	cyclosporine	NN	O	cyclosporine	prep_of	20	SENT_377	[p18l616t2961r1081b3044],
24	A	DT	O	a	det	27	SENT_377	[p18l1118t2962r1182b3024],
25	[	NN	O	[	nn	27	SENT_377	[p18l1224t2962r1361b3039],
26	31	CD	NUMBER	31	num	27	SENT_377	[p18l1224t2962r1361b3039],
27	]	NN	O	]	xcomp	18	SENT_377	[p18l1224t2962r1361b3039],
28	whose	WP$	O	whose	poss	29	SENT_377	[p18l1404t2961r1634b3025],
29	absorption	NN	O	absorption	nsubjpass	31	SENT_377	[p18l1673t2961r2057b3044],
30	is	VBZ	O	be	auxpass	31	SENT_377	[p18l2093t2961r2150b3025],
31	modulated	VBN	O	modulate	rcmod	27	SENT_377	[p18l8t3072r396b3136],
32	by	IN	O	by	_	0	SENT_377	[p18l427t3072r516b3155],
33	intestinal	JJ	O	intestinal	amod	34	SENT_377	[p18l550t3072r886b3136],
34	Pgp	NNP	O	Pgp	agent	31	SENT_377	[p18l920t3073r1058b3155],
35	[	CD	NUMBER	[	number	36	SENT_377	[p18l1099t3072r1261b3149],
36	32	CD	NUMBER	32	num	37	SENT_377	[p18l1099t3072r1261b3149],
37	]	NN	O	]	dep	31	SENT_377	[p18l1099t3072r1261b3149],
38	.	.	O	.	_	0	SENT_377	[p18l1099t3072r1261b3149],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_378	[p18l8t3317r706b3397],

1	The	DT	O	the	det	2	SENT_379	[p18l100t3534r240b3598],
2	authors	NNS	O	author	nsubj	4	SENT_379	[p18l266t3534r531b3598],
3	would	MD	O	would	aux	4	SENT_379	[p18l556t3534r783b3598],
4	like	VB	O	like	_	0	SENT_379	[p18l807t3534r942b3598],
5	to	TO	O	to	aux	6	SENT_379	[p18l966t3544r1033b3598],
6	thank	VB	O	thank	xcomp	4	SENT_379	[p18l1059t3534r1263b3598],
7	Stephanie	NNP	PERSON	Stephanie	nn	8	SENT_379	[p18l1287t3534r1644b3617],
8	Fuchs	NNP	PERSON	Fuchs	dobj	6	SENT_379	[p18l1668t3534r1883b3598],
9	for	IN	O	for	_	0	SENT_379	[p18l1909t3534r2014b3598],
10	her	PRP$	O	she	poss	13	SENT_379	[p18l2036t3534r2153b3598],
11	excellent	JJ	O	excellent	amod	13	SENT_379	[p18l9t3643r340b3707],
12	technical	JJ	O	technical	amod	13	SENT_379	[p18l372t3643r703b3707],
13	assistance	NN	O	assistance	prep_for	8	SENT_379	[p18l739t3643r1122b3718],
14	,	,	O	,	_	0	SENT_379	[p18l739t3643r1122b3718],
15	Dr.	NNP	O	Dr.	nn	17	SENT_379	[p18l1159t3645r1267b3707],
16	Gerd	NNP	PERSON	Gerd	nn	17	SENT_379	[p18l1306t3643r1487b3707],
17	Mikus	NNP	PERSON	Mikus	dobj	6	SENT_379	[p18l1519t3643r1749b3707],
18	for	IN	O	for	_	0	SENT_379	[p18l1785t3643r1891b3707],
19	all	DT	O	all	det	21	SENT_379	[p18l1925t3643r2012b3707],
20	his	PRP$	O	he	poss	21	SENT_379	[p18l2046t3643r2150b3707],
21	support	NN	O	support	prep_for	17	SENT_379	[p19l11t33r301b107],
22	,	,	O	,	_	0	SENT_379	[p19l11t33r301b107],
23	Dr.	NNP	O	Dr.	nn	27	SENT_379	[p19l330t25r438b88],
24	M.	NNP	PERSON	M.	nn	27	SENT_379	[p19l469t25r566b88],
25	Maurer	NNP	PERSON	Maurer	nn	27	SENT_379	[p19l597t25r867b88],
26	(	NNP	O	(	nn	27	SENT_379	[p19l895t24r1304b107],
27	University	NNP	ORGANIZATION	University	conj_and	8	SENT_379	[p19l895t24r1304b107],
28	of	IN	ORGANIZATION	of	_	0	SENT_379	[p19l1333t24r1411b88],
29	Kassel	NNP	ORGANIZATION	Kassel	nn	30	SENT_379	[p19l1434t24r1702b103],
30	)	NNP	O	)	prep_of	27	SENT_379	[p19l1434t24r1702b103],
31	for	IN	O	for	_	0	SENT_379	[p19l1732t24r1838b88],
32	acquisition	NN	O	acquisition	prep_for	30	SENT_379	[p19l1864t24r2148b107, p19l8t131r149b195],
33	of	IN	O	of	_	0	SENT_379	[p19l170t131r249b195],
34	the	DT	O	the	det	36	SENT_379	[p19l263t131r373b195],
35	NMR	NN	O	nmr	nn	36	SENT_379	[p19l393t133r600b195],
36	data	NNS	O	datum	prep_of	32	SENT_379	[p19l620t131r772b195],
37	of	IN	O	of	_	0	SENT_379	[p19l792t131r871b195],
38	simvastatin	NN	O	simvastatin	prep_of	36	SENT_379	[p19l888t131r1299b195],
39	and	CC	O	and	_	0	SENT_379	[p19l1322t131r1451b195],
40	fenoﬁbric	JJ	O	fenoﬁbric	amod	41	SENT_379	[p19l1470t131r1823b195],
41	acid	NN	O	acid	dobj	6	SENT_379	[p19l1847t131r2015b206],
42	,	,	O	,	_	0	SENT_379	[p19l1847t131r2015b206],
43	Dr.	NNP	O	Dr.	nn	46	SENT_379	[p19l2039t133r2147b195],
44	Alfred	NNP	PERSON	Alfred	nn	46	SENT_379	[p19l8t240r247b304],
45	H.	NNP	PERSON	H.	nn	46	SENT_379	[p19l274t242r355b304],
46	Schinkel	NNP	PERSON	Schinkel	appos	41	SENT_379	[p19l390t240r706b304],
47	(	CD	NUMBER	(	num	46	SENT_379	[p19l737t240r905b319],
48	The	DT	O	the	det	52	SENT_379	[p19l737t240r905b319],
49	Netherlands	NNP	ORGANIZATION	Netherlands	nn	52	SENT_379	[p19l933t240r1374b304],
50	Cancer	NNP	ORGANIZATION	Cancer	nn	52	SENT_379	[p19l1404t240r1663b304],
51	Institute	NNP	ORGANIZATION	Institute	nn	52	SENT_379	[p19l1689t240r2016b319],
52	)	NN	O	)	dep	46	SENT_379	[p19l1689t240r2016b319],
53	for	IN	O	for	_	0	SENT_379	[p19l2047t240r2153b304],
54	generously	RB	O	generously	advmod	55	SENT_379	[p19l9t350r409b433],
55	providing	VBG	O	provide	prepc_for	6	SENT_379	[p19l438t350r792b433],
56	the	DT	O	the	det	59	SENT_379	[p19l822t350r932b414],
57	cell	NN	O	cell	nn	59	SENT_379	[p19l963t350r1092b414],
58	line	NN	O	line	nn	59	SENT_379	[p19l1123t350r1258b414],
59	L	NN	O	l	dobj	55	SENT_379	[p19l1288t351r1647b426],
60	.	.	O	.	_	0	SENT_379	[p19l1288t351r1647b426],

1	—	NN	O	—	_	0	SENT_380	[p19l1288t351r1647b426],
2	.	.	O	.	_	0	SENT_380	[p19l1288t351r1647b426],

1	MDR1	NN	O	mdr1	_	0	SENT_381	[p19l1288t351r1647b426],
2	,	,	O	,	_	0	SENT_381	[p19l1288t351r1647b426],
3	and	CC	O	and	_	0	SENT_381	[p19l1681t350r1811b414],
4	Eli	NNP	ORGANIZATION	Eli	nn	6	SENT_381	[p19l1839t350r1943b413],
5	Lilly	NNP	ORGANIZATION	Lilly	nn	6	SENT_381	[p19l1974t350r2151b433],
6	company	NN	O	company	conj_and	1	SENT_381	[p19l9t478r342b540],
7	for	IN	O	for	_	0	SENT_381	[p19l384t457r490b522],
8	providing	VBG	O	provide	prepc_for	6	SENT_381	[p19l528t457r883b540],
9	LY335979	NN	O	ly335979	dobj	8	SENT_381	[p19l924t457r1329b523],
10	.	.	O	.	_	0	SENT_381	[p19l924t457r1329b523],

1	This	DT	O	this	det	2	SENT_382	[p19l1375t458r1534b522],
2	study	NN	O	study	nsubjpass	4	SENT_382	[p19l1581t458r1773b540],
3	was	VBD	O	be	auxpass	4	SENT_382	[p19l1816t478r1953b522],
4	supported	VBN	O	support	_	0	SENT_382	[p19l2000t478r2149b540, p19l7t566r241b649],
5	by	IN	O	by	_	0	SENT_382	[p19l260t566r350b649],
6	the	DT	O	the	det	8	SENT_382	[p19l371t566r480b630],
7	German	NNP	O	German	nn	8	SENT_382	[p19l503t567r795b631],
8	Ministry	NNP	ORGANIZATION	Ministry	agent	4	SENT_382	[p19l815t566r1128b649],
9	for	IN	ORGANIZATION	for	_	0	SENT_382	[p19l1150t566r1255b630],
10	Education	NNP	ORGANIZATION	Education	prep_for	8	SENT_382	[p19l1274t566r1645b630],
11	and	CC	ORGANIZATION	and	_	0	SENT_382	[p19l1667t566r1797b630],
12	Research	NNP	ORGANIZATION	Research	agent	4	SENT_382	[p19l1816t566r2152b630],
13	(	CD	NUMBER	(	num	12	SENT_382	[p19l11t676r318b754],
14	BMBF	NN	O	bmbf	nn	17	SENT_382	[p19l11t676r318b754],
15	)	CD	NUMBER	)	num	17	SENT_382	[p19l11t676r318b754],
16	grant	NN	O	grant	nn	17	SENT_382	[p19l356t685r542b758],
17	01EC9902	NN	O	01ec9902	dep	12	SENT_382	[p19l575t676r983b740],
18	.	.	O	.	_	0	SENT_382	[p19l575t676r983b740],

1	References	NNS	O	reference	_	0	SENT_383	[p19l9t920r423b984],

1	[	NN	O	[	_	0	SENT_384	[p19l49t1147r121b1207],
2	1	CD	NUMBER	1	number	3	SENT_384	[p19l49t1147r121b1207],
3	]	CD	NUMBER	]	dep	1	SENT_384	[p19l49t1147r121b1207],
4	Shepherd	NNP	O	Shepherd	nn	5	SENT_384	[p19l167t1146r434b1212],
5	J	NNP	O	J	dep	3	SENT_384	[p19l457t1148r483b1197],
6	.	.	O	.	_	0	SENT_384	[p19l488t1188r496b1197],

1	Fibrates	NNS	O	fibrate	_	0	SENT_385	[p19l524t1146r751b1197],
2	and	CC	O	and	_	0	SENT_385	[p19l778t1147r878b1197],
3	statins	NNS	O	statin	conj_and	1	SENT_385	[p19l904t1147r1081b1197],
4	in	IN	O	in	_	0	SENT_385	[p19l1106t1146r1160b1196],
5	the	DT	O	the	det	6	SENT_385	[p19l1184t1146r1269b1197],
6	treatment	NN	O	treatment	prep_in	1	SENT_385	[p19l1294t1154r1564b1197],
7	of	IN	O	of	_	0	SENT_385	[p19l1588t1146r1649b1197],
8	hyperlipidaernia	NN	O	hyperlipidaernium	prep_of	6	SENT_385	[p19l1667t1146r2147b1212],
9	:	:	O	:	_	0	SENT_385	[p19l1667t1146r2147b1212],
10	an	DT	O	a	det	11	SENT_385	[p19l166t1252r231b1286],
11	appraisal	NN	O	appraisal	dep	1	SENT_385	[p19l258t1236r513b1301],
12	of	IN	O	of	_	0	SENT_385	[p19l540t1236r601b1286],
13	their	PRP$	O	they	poss	14	SENT_385	[p19l622t1236r753b1286],
14	efficacy	NN	O	efficacy	prep_of	11	SENT_385	[p19l778t1236r1003b1301],
15	and	CC	O	and	_	0	SENT_385	[p19l1031t1236r1131b1286],
16	safety	NN	O	safety	prep_of	11	SENT_385	[p19l1159t1236r1335b1301],
17	.	.	O	.	_	0	SENT_385	[p19l1159t1236r1335b1301],

1	Eur	NNP	O	Eur	nn	3	SENT_386	[p19l1364t1237r1467b1286],
2	Heart	NNP	O	Heart	nn	3	SENT_386	[p19l1492t1237r1649b1286],
3	J	NNP	O	J	_	0	SENT_386	[p19l1674t1237r1700b1286],
4	1995	CD	DATE	1995	num	3	SENT_386	[p19l1732t1236r1864b1287],
5	;	:	O	;	_	0	SENT_386	[p19l1873t1235r2135b1295],
6	16:5	CD	NUMBER	16:5	number	7	SENT_386	[p19l1873t1235r2135b1295],
7	-13	CD	NUMBER	-13	dep	3	SENT_386	[p19l1873t1235r2135b1295],
8	.	.	O	.	_	0	SENT_386	[p19l1873t1235r2135b1295],

1	[	NN	O	[	_	0	SENT_387	[p19l49t1325r121b1386],
2	2	CD	NUMBER	2	number	3	SENT_387	[p19l49t1325r121b1386],
3	]	CD	NUMBER	]	dep	1	SENT_387	[p19l49t1325r121b1386],
4	Farmer	NNP	O	Farmer	nn	5	SENT_387	[p19l164t1326r370b1375],
5	JA	NNP	O	JA	dep	3	SENT_387	[p19l394t1325r482b1375],
6	.	.	O	.	_	0	SENT_387	[p19l394t1325r482b1375],

1	Learning	NNP	O	Learning	_	0	SENT_388	[p19l512t1325r768b1390],
2	from	IN	O	from	_	0	SENT_388	[p19l794t1325r932b1375],
3	the	DT	O	the	det	5	SENT_388	[p19l957t1325r1042b1375],
4	cerivastatin	NN	O	cerivastatin	nn	5	SENT_388	[p19l1069t1325r1395b1375],
5	experience	NN	O	experience	prep_from	1	SENT_388	[p19l1421t1325r1743b1390],
6	.	.	O	.	_	0	SENT_388	[p19l1421t1325r1743b1390],

1	Lancet	NNP	O	Lancet	_	0	SENT_389	[p19l1772t1326r1966b1375],
2	2001	CD	DATE	2001	num	1	SENT_389	[p19l1992t1325r2149b1384],
3	;	:	O	;	_	0	SENT_389	[p19l1992t1325r2149b1384],

1	[	NN	O	[	nn	5	SENT_390	[p19l42t1504r114b1564],
2	3	CD	NUMBER	3	num	5	SENT_390	[p19l42t1504r114b1564],
3	]	CD	NUMBER	]	num	5	SENT_390	[p19l42t1504r114b1564],
4	Staffa	NNP	O	Staffa	nn	5	SENT_390	[p19l160t1503r326b1554],
5	JA	NNP	O	JA	_	0	SENT_390	[p19l346t1504r435b1563],
6	,	,	O	,	_	0	SENT_390	[p19l346t1504r435b1563],
7	Chang	NNP	PERSON	Chang	nn	8	SENT_390	[p19l459t1503r642b1568],
8	J	NNP	PERSON	J	conj_and	5	SENT_390	[p19l663t1505r689b1554],
9	,	,	O	,	_	0	SENT_390	[p19l694t1545r704b1563],
10	Green	NNP	PERSON	Green	nn	12	SENT_390	[p19l728t1504r901b1554],
11	L.	NNP	PERSON	L.	nn	12	SENT_390	[p19l920t1505r977b1554],
12	Cerivastatin	NNP	PERSON	Cerivastatin	conj_and	5	SENT_390	[p19l1002t1503r1344b1554],
13	and	CC	O	and	_	0	SENT_390	[p19l1366t1503r1466b1554],
14	reports	NNS	O	report	conj_and	5	SENT_390	[p19l1485t1511r1682b1568],
15	of	IN	O	of	_	0	SENT_390	[p19l1704t1503r1766b1554],
16	fatal	JJ	O	fatal	amod	18	SENT_390	[p19l1781t1503r1906b1554],
17	rhabdo	NN	O	rhabdo	nn	18	SENT_390	[p19l1926t1503r2146b1554],
18	—	NN	O	—	prep_of	5	SENT_390	[p19l1926t1503r2146b1554],

1	myolysis	NN	O	myolysis	_	0	SENT_391	[p19l158t1593r429b1658],
2	.	.	O	.	_	0	SENT_391	[p19l158t1593r429b1658],

1	N	NN	O	n	nn	3	SENT_392	[p19l458t1595r508b1644],
2	Engl	NNP	O	Engl	nn	3	SENT_392	[p19l532t1593r666b1658],
3	J	NNP	O	J	nsubj	4	SENT_392	[p19l692t1595r718b1644],
4	Med	VBD	O	med	_	0	SENT_392	[p19l743t1593r873b1644],
5	2002	CD	DATE	2002	dobj	4	SENT_392	[p19l900t1593r1416b1653],
6	;	:	O	;	_	0	SENT_392	[p19l900t1593r1416b1653],
7	346:539	CD	NUMBER	346:539	num	8	SENT_392	[p19l900t1593r1416b1653],
8	-40	CD	NUMBER	-40	dep	5	SENT_392	[p19l900t1593r1416b1653],
9	.	.	O	.	_	0	SENT_392	[p19l900t1593r1416b1653],

1	[	NN	O	[	_	0	SENT_393	[p19l42t1684r114b1744],
2	4	CD	NUMBER	4	number	3	SENT_393	[p19l42t1684r114b1744],
3	]	CD	NUMBER	]	num	4	SENT_393	[p19l42t1684r114b1744],
4	Bays	NNS	O	bay	dep	1	SENT_393	[p19l158t1685r297b1748],
5	HE	PRP	O	he	dep	1	SENT_393	[p19l316t1685r424b1743],
6	,	,	O	,	_	0	SENT_393	[p19l316t1685r424b1743],
7	Duj	NN	O	duj	nn	9	SENT_393	[p19l443t1683r544b1748],
8	ovne	NN	O	ovne	nn	9	SENT_393	[p19l552t1699r687b1734],
9	CA	NNP	O	CA	appos	5	SENT_393	[p19l705t1684r816b1734],
10	.	.	O	.	_	0	SENT_393	[p19l705t1684r816b1734],

1	Drug	NN	O	drug	nn	2	SENT_394	[p19l835t1685r980b1748],
2	interactions	NNS	O	interaction	_	0	SENT_394	[p19l997t1683r1329b1734],
3	of	IN	O	of	_	0	SENT_394	[p19l1348t1683r1410b1734],
4	lipid	NN	O	lipid	nn	5	SENT_394	[p19l1422t1683r1795b1748],
5	—	NN	O	—	prep_of	2	SENT_394	[p19l1422t1683r1795b1748],
6	altering	VBG	O	alter	partmod	2	SENT_394	[p19l1422t1683r1795b1748],
7	drugs	NNS	O	drug	dobj	6	SENT_394	[p19l1812t1683r1983b1748],
8	.	.	O	.	_	0	SENT_394	[p19l1812t1683r1983b1748],

1	Drug	NN	O	drug	_	0	SENT_395	[p19l2003t1685r2147b1748],

1	Saf	FW	O	saf	_	0	SENT_396	[p19l160t1773r256b1823],
2	1998	CD	DATE	1998	dep	1	SENT_396	[p19l284t1773r758b1832],
3	;	:	O	;	_	0	SENT_396	[p19l284t1773r758b1832],
4	19:355	CD	NUMBER	19:355	num	5	SENT_396	[p19l284t1773r758b1832],
5	-71	CD	NUMBER	-71	dep	1	SENT_396	[p19l284t1773r758b1832],
6	.	.	O	.	_	0	SENT_396	[p19l284t1773r758b1832],

1	[	NN	O	[	nn	5	SENT_397	[p19l42t1862r114b1922],
2	5	CD	NUMBER	5	num	5	SENT_397	[p19l42t1862r114b1922],
3	]	CD	NUMBER	]	num	5	SENT_397	[p19l42t1862r114b1922],
4	Jacobsen	NNP	PERSON	Jacobsen	nn	5	SENT_397	[p19l157t1862r415b1912],
5	W	NNP	PERSON	W	nsubj	16	SENT_397	[p19l443t1863r518b1921],
6	,	,	O	,	_	0	SENT_397	[p19l443t1863r518b1921],
7	Kirchner	NNP	PERSON	Kirchner	nn	8	SENT_397	[p19l552t1862r804b1911],
8	G	NNP	PERSON	G	appos	5	SENT_397	[p19l833t1862r897b1921],
9	,	,	O	,	_	0	SENT_397	[p19l833t1862r897b1921],
10	Hallensleben	NNP	PERSON	Hallensleben	nn	11	SENT_397	[p19l929t1862r1301b1911],
11	K	NNP	PERSON	K	appos	5	SENT_397	[p19l1331t1863r1395b1921],
12	,	,	O	,	_	0	SENT_397	[p19l1331t1863r1395b1921],
13	Mancinelli	NNP	PERSON	Mancinelli	nn	14	SENT_397	[p19l1426t1862r1735b1911],
14	L	NNP	PERSON	L	appos	5	SENT_397	[p19l1765t1863r1822b1920],
15	,	,	O	,	_	0	SENT_397	[p19l1765t1863r1822b1920],
16	Deters	VBZ	O	deter	_	0	SENT_397	[p19l1854t1863r2038b1911],
17	M	NN	O	m	dobj	16	SENT_397	[p19l2068t1863r2145b1921],
18	,	,	O	,	_	0	SENT_397	[p19l2068t1863r2145b1921],
19	Hackbarth	NNP	PERSON	Hackbarth	nn	23	SENT_397	[p19l158t1951r455b2001],
20	I	PRP	O	I	dep	23	SENT_397	[p19l489t1952r526b2010],
21	,	,	O	,	_	0	SENT_397	[p19l489t1952r526b2010],
22	Benet	NNP	PERSON	Benet	dep	23	SENT_397	[p19l563t1952r730b2001],
23	LZ	NNP	O	LZ	appos	17	SENT_397	[p19l763t1952r864b2010],
24	,	,	O	,	_	0	SENT_397	[p19l763t1952r864b2010],
25	Sewing	NNP	O	Sewing	nn	30	SENT_397	[p19l903t1951r1112b2016],
26	KF	NNP	O	KF	nn	30	SENT_397	[p19l1148t1952r1246b2010],
27	,	,	O	,	_	0	SENT_397	[p19l1148t1952r1246b2010],
28	Christians	NNS	ORGANIZATION	christian	dep	30	SENT_397	[p19l1284t1951r1571b2001],
29	U.	NNP	ORGANIZATION	U.	nn	30	SENT_397	[p19l1605t1952r1669b2001],
30	Comparison	NN	ORGANIZATION	comparison	dobj	16	SENT_397	[p19l1708t1951r2056b2016],
31	of	IN	O	of	_	0	SENT_397	[p19l2091t1951r2153b2001],
32	cytochrome	NN	O	cytochrome	nn	34	SENT_397	[p19l158t2041r494b2106],
33	P-450-dependent	JJ	O	p-450-dependent	amod	34	SENT_397	[p19l548t2041r1036b2106],
34	metabolism	NN	O	metabolism	prep_of	30	SENT_397	[p19l1089t2041r1422b2091],
35	and	CC	O	and	_	0	SENT_397	[p19l1477t2041r1578b2091],
36	drug	NN	O	drug	nn	37	SENT_397	[p19l1632t2041r1760b2106],
37	interactions	NNS	O	interaction	conj_and	34	SENT_397	[p19l1814t2041r2147b2091],
38	of	IN	O	of	_	0	SENT_397	[p19l159t2131r220b2181],
39	the	DT	O	the	det	45	SENT_397	[p19l251t2131r336b2181],
40	3-hydroxy-3	JJ	O	3-hydroxy-3	amod	45	SENT_397	[p19l373t2131r1332b2196],
41	—	NN	O	—	nn	45	SENT_397	[p19l373t2131r1332b2196],
42	methylglutaryl-CoA	NN	O	methylglutaryl-coa	nn	45	SENT_397	[p19l373t2131r1332b2196],
43	reductase	NN	O	reductase	nn	45	SENT_397	[p19l1365t2131r1634b2181],
44	inhibitors	NNS	O	inhibitor	nn	45	SENT_397	[p19l1669t2131r1941b2181],
45	lovastatin	NN	O	lovastatin	prep_of	37	SENT_397	[p19l1977t2131r2146b2181, p19l158t2221r284b2271],
46	and	CC	O	and	_	0	SENT_397	[p19l329t2221r430b2271],
47	pravastatin	NN	O	pravastatin	conj_and	17	SENT_397	[p19l472t2221r784b2286],
48	in	IN	O	in	_	0	SENT_397	[p19l828t2221r882b2271],
49	the	DT	O	the	det	50	SENT_397	[p19l926t2221r1011b2271],
50	liver	NN	O	liver	prep_in	47	SENT_397	[p19l1055t2221r1193b2271],
51	.	.	O	.	_	0	SENT_397	[p19l1055t2221r1193b2271],

1	Drug	NN	O	drug	nn	3	SENT_398	[p19l1241t2222r1385b2286],
2	Metab	NNP	O	Metab	nn	3	SENT_398	[p19l1429t2221r1610b2271],
3	Dispos	NNP	O	Dispos	_	0	SENT_398	[p19l1655t2221r1850b2286],
4	1999	CD	DATE	1999	num	3	SENT_398	[p19l1902t2222r2143b2281],
5	;	:	O	;	_	0	SENT_398	[p19l1902t2222r2143b2281],
6	27	CD	NUMBER	27	num	8	SENT_398	[p19l1902t2222r2143b2281],
7	:	:	O	:	_	0	SENT_398	[p19l1902t2222r2143b2281],
8	173-9	CD	NUMBER	173-9	dep	3	SENT_398	[p19l165t2312r349b2362],
9	.	.	O	.	_	0	SENT_398	[p19l165t2312r349b2362],

1	[	NN	O	[	nn	3	SENT_399	[p19l42t2401r114b2462],
2	6	CD	NUMBER	6	num	3	SENT_399	[p19l42t2401r114b2462],
3	]	NN	O	]	_	0	SENT_399	[p19l42t2401r114b2462],
4	Miller	NNP	PERSON	Miller	nn	5	SENT_399	[p19l157t2401r337b2451],
5	DB	NNP	O	DB	dep	3	SENT_399	[p19l378t2402r490b2461],
6	,	,	O	,	_	0	SENT_399	[p19l378t2402r490b2461],
7	Spence	NNP	O	Spence	nn	8	SENT_399	[p19l537t2402r740b2466],
8	JD	NNP	O	JD	appos	5	SENT_399	[p19l782t2402r874b2452],
9	.	.	O	.	_	0	SENT_399	[p19l782t2402r874b2452],

1	Clinical	JJ	O	clinical	amod	2	SENT_400	[p19l921t2401r1146b2452],
2	pharmacokinetics	NNS	O	pharmacokinetic	nsubj	7	SENT_400	[p19l1188t2401r1692b2466],
3	of	IN	O	of	_	0	SENT_400	[p19l1737t2401r1798b2451],
4	fibric	JJ	O	fibric	amod	6	SENT_400	[p19l1835t2401r1986b2451],
5	acid	NN	O	acid	nn	6	SENT_400	[p19l2031t2401r2148b2451],
6	derivatives	NNS	O	derivative	prep_of	2	SENT_400	[p19l158t2491r465b2541],
7	(	VBP	O	(	_	0	SENT_400	[p19l493t2491r765b2552],
8	fibrates	NNS	O	fibrate	dobj	7	SENT_400	[p19l493t2491r765b2552],
9	)	CD	NUMBER	)	tmod	7	SENT_400	[p19l493t2491r765b2552],
10	.	.	O	.	_	0	SENT_400	[p19l493t2491r765b2552],

1	Clin	NNP	O	Clin	nn	2	SENT_401	[p19l795t2491r916b2541],
2	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_401	[p19l942t2491r1371b2541],
3	1998	CD	DATE	1998	num	2	SENT_401	[p19l1403t2491r1877b2550],
4	;	:	O	;	_	0	SENT_401	[p19l1403t2491r1877b2550],
5	34:155	CD	NUMBER	34:155	number	6	SENT_401	[p19l1403t2491r1877b2550],
6	-62	CD	NUMBER	-62	dep	2	SENT_401	[p19l1403t2491r1877b2550],
7	.	.	O	.	_	0	SENT_401	[p19l1403t2491r1877b2550],

1	[	NN	O	[	nn	4	SENT_402	[p19l42t2582r114b2642],
2	7	CD	NUMBER	7	num	4	SENT_402	[p19l42t2582r114b2642],
3	]	NN	O	]	nn	4	SENT_402	[p19l42t2582r114b2642],
4	Backman	NN	PERSON	backman	_	0	SENT_402	[p19l158t2581r427b2631],
5	J	NN	PERSON	j	nn	6	SENT_402	[p19l443t2582r469b2631],
6	T	NN	PERSON	t	dep	4	SENT_402	[p19l471t2582r523b2640],
7	,	,	O	,	_	0	SENT_402	[p19l471t2582r523b2640],
8	Kyrklund	NN	O	kyrklund	nn	9	SENT_402	[p19l543t2581r814b2646],
9	C	NN	O	c	appos	6	SENT_402	[p19l830t2581r889b2640],
10	,	,	O	,	_	0	SENT_402	[p19l830t2581r889b2640],
11	Kivisto	NNP	ORGANIZATION	Kivisto	nn	12	SENT_402	[p19l910t2581r1116b2631],
12	KT	NNP	ORGANIZATION	KT	appos	6	SENT_402	[p19l1134t2582r1237b2640],
13	,	,	O	,	_	0	SENT_402	[p19l1134t2582r1237b2640],
14	Wang	NNP	PERSON	Wang	nn	16	SENT_402	[p19l1255t2582r1419b2646],
15	J	NNP	PERSON	J	nn	16	SENT_402	[p19l1436t2582r1462b2631],
16	S	NN	PERSON	s	appos	6	SENT_402	[p19l1465t2581r1516b2640],
17	,	,	O	,	_	0	SENT_402	[p19l1465t2581r1516b2640],
18	Neuvonen	NNP	O	Neuvonen	nn	19	SENT_402	[p19l1535t2582r1827b2631],
19	PJ	NNP	O	PJ	appos	6	SENT_402	[p19l1843t2582r1922b2631],
20	.	.	O	.	_	0	SENT_402	[p19l1843t2582r1922b2631],

1	Plasma	NN	O	plasma	nn	2	SENT_403	[p19l1943t2581r2149b2631],
2	concentrations	NNS	O	concentration	nsubjpass	8	SENT_403	[p19l158t2671r573b2721],
3	of	IN	O	of	_	0	SENT_403	[p19l591t2671r653b2721],
4	active	JJ	O	active	amod	6	SENT_403	[p19l666t2671r831b2721],
5	simvastatin	NN	O	simvastatin	nn	6	SENT_403	[p19l851t2671r1173b2721],
6	acid	NN	O	acid	prep_of	2	SENT_403	[p19l1190t2671r1308b2721],
7	are	VBP	O	be	auxpass	8	SENT_403	[p19l1325t2687r1409b2721],
8	increased	VBN	O	increase	_	0	SENT_403	[p19l1426t2671r1696b2721],
9	by	IN	O	by	_	0	SENT_403	[p19l1711t2671r1781b2736],
10	gemfibrozil	NN	O	gemfibrozil	agent	8	SENT_403	[p19l1798t2671r2144b2736],
11	.	.	O	.	_	0	SENT_403	[p19l1798t2671r2144b2736],

1	Clin	NNP	O	Clin	nn	3	SENT_404	[p19l158t2761r280b2811],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_404	[p19l305t2761r610b2810],
3	Ther	NNP	O	Ther	_	0	SENT_404	[p19l636t2761r771b2810],
4	2000	CD	DATE	2000	num	3	SENT_404	[p19l795t2761r1240b2819],
5	;	:	O	;	_	0	SENT_404	[p19l795t2761r1240b2819],
6	68	CD	NUMBER	68	num	8	SENT_404	[p19l795t2761r1240b2819],
7	:	:	O	:	_	0	SENT_404	[p19l795t2761r1240b2819],
8	l22-9	CD	NUMBER	l22-9	dep	3	SENT_404	[p19l795t2761r1240b2819],
9	.	.	O	.	_	0	SENT_404	[p19l795t2761r1240b2819],

1	[	NN	O	[	nn	5	SENT_405	[p19l42t2849r114b2910],
2	8	CD	NUMBER	8	num	5	SENT_405	[p19l42t2849r114b2910],
3	]	CD	NUMBER	]	num	5	SENT_405	[p19l42t2849r114b2910],
4	Schinkel	NNP	PERSON	Schinkel	nn	5	SENT_405	[p19l160t2849r406b2899],
5	AH	NNP	O	AH	_	0	SENT_405	[p19l426t2849r543b2908],
6	,	,	O	,	_	0	SENT_405	[p19l426t2849r543b2908],
7	Smit	NNP	PERSON	Smit	nn	8	SENT_405	[p19l567t2849r700b2899],
8	JJ	NN	PERSON	jj	appos	5	SENT_405	[p19l719t2850r788b2909],
9	,	,	O	,	_	0	SENT_405	[p19l719t2850r788b2909],
10	van	NN	PERSON	van	nn	12	SENT_405	[p19l811t2865r911b2899],
11	Tellingen	NNP	PERSON	Tellingen	nn	12	SENT_405	[p19l931t2849r1200b2914],
12	O	NNP	PERSON	O	appos	8	SENT_405	[p19l1221t2849r1284b2908],
13	,	,	O	,	_	0	SENT_405	[p19l1221t2849r1284b2908],
14	Beijnen	NNP	O	Beijnen	nn	15	SENT_405	[p19l1307t2849r1529b2914],
15	JH	NNP	O	JH	appos	8	SENT_405	[p19l1548t2850r1641b2908],
16	,	,	O	,	_	0	SENT_405	[p19l1548t2850r1641b2908],
17	Wagenaar	NNP	PERSON	Wagenaar	nn	18	SENT_405	[p19l1663t2850r1949b2914],
18	E	NNP	PERSON	E	appos	8	SENT_405	[p19l1967t2850r2025b2909],
19	,	,	O	,	_	0	SENT_405	[p19l1967t2850r2025b2909],
20	van	NNP	PERSON	van	nn	22	SENT_405	[p19l2047t2865r2148b2899],
21	Deemter	NNP	PERSON	Deemter	nn	22	SENT_405	[p19l158t2940r405b2989],
22	L	NNP	PERSON	L	appos	8	SENT_405	[p19l433t2940r490b2998],
23	,	,	O	,	_	0	SENT_405	[p19l433t2940r490b2998],
24	Mol	NNP	ORGANIZATION	Mol	nn	25	SENT_405	[p19l524t2939r641b2989],
25	CA	NNP	O	CA	appos	8	SENT_405	[p19l672t2939r784b2998],
26	,	,	O	,	_	0	SENT_405	[p19l672t2939r784b2998],
27	van	NNP	PERSON	van	nn	30	SENT_405	[p19l818t2955r917b2989],
28	der	NNP	PERSON	der	nn	30	SENT_405	[p19l949t2939r1039b2989],
29	Valk	NNP	PERSON	Valk	nn	30	SENT_405	[p19l1069t2939r1200b2989],
30	MA	NNP	O	MA	appos	8	SENT_405	[p19l1229t2939r1357b2998],
31	,	,	O	,	_	0	SENT_405	[p19l1229t2939r1357b2998],
32	Robanus-Maandag	NNP	O	Robanus-Maandag	nn	33	SENT_405	[p19l1390t2939r1928b3004],
33	EC	NNP	ORGANIZATION	EC	appos	8	SENT_405	[p19l1959t2939r2064b2998],
34	,	,	O	,	_	0	SENT_405	[p19l1959t2939r2064b2998],
35	te	FW	O	te	nn	36	SENT_405	[p19l2097t2947r2147b2989],
36	Riele	FW	O	riele	appos	8	SENT_405	[p19l158t3029r307b3079],
37	HP	NNP	O	HP	dep	36	SENT_405	[p19l325t3030r420b3079],
38	.	.	O	.	_	0	SENT_405	[p19l325t3030r420b3079],

1	Disruption	NN	O	disruption	nsubj	8	SENT_406	[p19l441t3029r746b3094],
2	of	IN	O	of	_	0	SENT_406	[p19l763t3029r825b3079],
3	the	DT	O	the	det	7	SENT_406	[p19l837t3029r922b3079],
4	mouse	NN	O	mouse	nn	7	SENT_406	[p19l940t3045r1124b3079],
5	mdrla	NN	O	mdrlum	nn	7	SENT_406	[p19l1142t3029r1324b3079],
6	P-glycoprotein	NN	MISC	p-glycoprotein	nn	7	SENT_406	[p19l1340t3029r1764b3094],
7	gene	NN	O	gene	prep_of	1	SENT_406	[p19l1781t3045r1914b3094],
8	leads	VBZ	O	lead	_	0	SENT_406	[p19l1931t3029r2075b3079],
9	to	TO	O	to	_	0	SENT_406	[p19l2094t3037r2147b3079],
10	a	DT	O	a	det	11	SENT_406	[p19l159t3135r189b3169],
11	deficiency	NN	O	deficiency	prep_to	8	SENT_406	[p19l211t3119r505b3184],
12	in	IN	O	in	_	0	SENT_406	[p19l528t3119r582b3169],
13	the	DT	O	the	det	17	SENT_406	[p19l604t3119r690b3169],
14	blood	NN	O	blood	nn	17	SENT_406	[p19l711t3119r1056b3169],
15	—	NN	O	—	nn	17	SENT_406	[p19l711t3119r1056b3169],
16	brain	NN	O	brain	nn	17	SENT_406	[p19l711t3119r1056b3169],
17	barrier	NN	O	barrier	prep_in	11	SENT_406	[p19l1077t3119r1269b3169],
18	and	CC	O	and	_	0	SENT_406	[p19l1291t3119r1392b3169],
19	to	TO	O	to	_	0	SENT_406	[p19l1413t3126r1466b3169],
20	increased	VBN	O	increase	amod	21	SENT_406	[p19l1490t3119r1759b3169],
21	sensitivity	NN	O	sensitivity	conj_and	11	SENT_406	[p19l1783t3119r2071b3184],
22	to	TO	O	to	_	0	SENT_406	[p19l2094t3127r2147b3169],
23	drugs	NNS	O	drug	prep_to	21	SENT_406	[p19l158t3209r329b3274],
24	.	.	O	.	_	0	SENT_406	[p19l158t3209r329b3274],

1	Cell	NN	O	cell	_	0	SENT_407	[p19l359t3209r475b3259],
2	1994	CD	DATE	1994	num	1	SENT_407	[p19l509t3209r1019b3268],
3	;	:	O	;	_	0	SENT_407	[p19l509t3209r1019b3268],
4	77:491	CD	NUMBER	77:491	number	5	SENT_407	[p19l509t3209r1019b3268],
5	-502	CD	NUMBER	-502	dep	1	SENT_407	[p19l509t3209r1019b3268],
6	.	.	O	.	_	0	SENT_407	[p19l509t3209r1019b3268],

1	[	NN	O	[	nn	4	SENT_408	[p19l42t3300r114b3360],
2	9	CD	NUMBER	9	num	4	SENT_408	[p19l42t3300r114b3360],
3	]	NN	O	]	nn	4	SENT_408	[p19l42t3300r114b3360],
4	van	NN	PERSON	van	_	0	SENT_408	[p19l158t3315r258b3350],
5	Asperen	NNP	PERSON	Asperen	nn	6	SENT_408	[p19l274t3300r511b3365],
6	J	NNP	PERSON	J	dep	4	SENT_408	[p19l526t3301r553b3350],
7	,	,	O	,	_	0	SENT_408	[p19l557t3341r567b3359],
8	van	NNP	PERSON	van	nn	10	SENT_408	[p19l586t3315r687b3350],
9	Tellingen	NNP	PERSON	Tellingen	nn	10	SENT_408	[p19l702t3300r972b3365],
10	O	NNP	PERSON	O	appos	6	SENT_408	[p19l988t3300r1052b3359],
11	,	,	O	,	_	0	SENT_408	[p19l988t3300r1052b3359],
12	Beijnen	NNP	PERSON	Beijnen	nn	15	SENT_408	[p19l1070t3300r1293b3365],
13	J	NNP	O	J	nn	15	SENT_408	[p19l1307t3301r1334b3350],
14	H.	NNP	O	H.	nn	15	SENT_408	[p19l1336t3301r1399b3350],
15	The	NNP	O	The	appos	6	SENT_408	[p19l1419t3300r1529b3350],
16	pharmacological	JJ	O	pharmacological	amod	17	SENT_408	[p19l1544t3300r2021b3365],
17	role	NN	O	role	dep	4	SENT_408	[p19l2037t3300r2147b3350],
18	of	IN	O	of	_	0	SENT_408	[p19l159t3389r220b3440],
19	P-glycoprotein	NN	O	p-glycoprotein	prep_of	17	SENT_408	[p19l230t3389r654b3455],
20	in	IN	O	in	_	0	SENT_408	[p19l669t3390r723b3439],
21	the	DT	O	the	det	23	SENT_408	[p19l738t3390r824b3440],
22	intestinal	JJ	O	intestinal	amod	23	SENT_408	[p19l840t3390r1102b3440],
23	epithelium	NN	O	epithelium	prep_in	19	SENT_408	[p19l1117t3389r1437b3455],
24	.	.	O	.	_	0	SENT_408	[p19l1117t3389r1437b3455],

1	Pharmacol	NNP	O	Pharmacol	nn	2	SENT_409	[p19l1454t3389r1760b3440],
2	Res	NNP	O	Res	_	0	SENT_409	[p19l1775t3391r1878b3440],
3	1998	CD	DATE	1998	num	2	SENT_409	[p19l1902t3390r2033b3441],
4	;	:	O	;	_	0	SENT_409	[p19l2043t3390r2143b3449],
5	37	CD	NUMBER	37	num	7	SENT_409	[p19l2043t3390r2143b3449],
6	:	:	O	:	_	0	SENT_409	[p19l2043t3390r2143b3449],
7	429-35	CD	NUMBER	429-35	dep	2	SENT_409	[p19l157t3479r385b3531],
8	.	.	O	.	_	0	SENT_409	[p19l157t3479r385b3531],

1	[	NN	O	[	_	0	SENT_410	[p19l6t3570r114b3631],
2	10	CD	NUMBER	10	num	1	SENT_410	[p19l6t3570r114b3631],
3	]	CD	NUMBER	]	num	5	SENT_410	[p19l6t3570r114b3631],
4	Kusuhara	NN	O	kusuhara	nn	5	SENT_410	[p19l159t3570r430b3620],
5	H	NN	O	h	dep	1	SENT_410	[p19l453t3571r518b3629],
6	,	,	O	,	_	0	SENT_410	[p19l453t3571r518b3629],
7	Suzuki	NNP	PERSON	Suzuki	nn	8	SENT_410	[p19l546t3570r741b3620],
8	H	NNP	PERSON	H	dep	1	SENT_410	[p19l765t3571r830b3629],
9	,	,	O	,	_	0	SENT_410	[p19l765t3571r830b3629],
10	Sugiyama	NNP	PERSON	Sugiyama	nn	13	SENT_410	[p19l859t3570r1143b3635],
11	Y.	NNP	O	Y.	nn	13	SENT_410	[p19l1166t3571r1220b3620],
12	The	NNP	O	The	nn	13	SENT_410	[p19l1248t3570r1358b3620],
13	role	NN	O	role	conj_and	5	SENT_410	[p19l1382t3570r1492b3620],
14	of	IN	O	of	_	0	SENT_410	[p19l1517t3570r1579b3620],
15	P-glycoprotein	NN	O	p-glycoprotein	prep_of	13	SENT_410	[p19l1598t3570r2023b3635],
16	and	CC	O	and	_	0	SENT_410	[p19l2048t3570r2149b3620],
17	canalicular	JJ	O	canalicular	amod	21	SENT_410	[p19l158t3660r472b3710],
18	multispecific	JJ	O	multispecific	amod	21	SENT_410	[p19l487t3660r858b3725],
19	organic	JJ	O	organic	amod	21	SENT_410	[p19l876t3660r1086b3725],
20	anion	NN	O	anion	nn	21	SENT_410	[p19l1104t3660r1260b3710],
21	transporter	NN	O	transporter	conj_and	5	SENT_410	[p19l1276t3667r1586b3725],
22	in	IN	O	in	_	0	SENT_410	[p19l1600t3660r1654b3709],
23	the	DT	O	the	det	25	SENT_410	[p19l1669t3660r1754b3710],
24	hepatobiliary	JJ	O	hepatobiliary	amod	25	SENT_410	[p19l1770t3660r2147b3725],
25	excretion	NN	O	excretion	prep_in	1	SENT_410	[p20l158t19r422b69],
26	of	IN	O	of	_	0	SENT_410	[p20l449t19r511b69],
27	drugs	NNS	O	drug	prep_of	25	SENT_410	[p20l532t19r702b84],
28	.	.	O	.	_	0	SENT_410	[p20l532t19r702b84],

1	J	NNP	O	J	nn	3	SENT_411	[p20l731t20r757b69],
2	Pharm	NNP	O	Pharm	nn	3	SENT_411	[p20l783t19r969b69],
3	Sci	NNP	O	Sci	_	0	SENT_411	[p20l996t19r1083b69],
4	1998	CD	DATE	1998	num	3	SENT_411	[p20l1116t19r1626b78],
5	;	:	O	;	_	0	SENT_411	[p20l1116t19r1626b78],
6	87:1025	CD	NUMBER	87:1025	number	7	SENT_411	[p20l1116t19r1626b78],
7	—	CD	NUMBER	—	dep	3	SENT_411	[p20l1116t19r1626b78],
8	40	CD	NUMBER	40	dep	7	SENT_411	[p20l1116t19r1626b78],
9	.	.	O	.	_	0	SENT_411	[p20l1116t19r1626b78],

1	Chiou	NNP	PERSON	Chiou	nn	2	SENT_412	[p20l158t109r331b159],
2	WL	NNP	O	WL	_	0	SENT_412	[p20l357t110r484b168],
3	,	,	O	,	_	0	SENT_412	[p20l357t110r484b168],
4	Chung	NNP	PERSON	Chung	nn	5	SENT_412	[p20l515t109r702b174],
5	SM	NNP	O	SM	appos	2	SENT_412	[p20l732t109r847b168],
6	,	,	O	,	_	0	SENT_412	[p20l732t109r847b168],
7	Wu	NNP	O	Wu	nn	8	SENT_412	[p20l876t110r975b159],
8	TC	NNP	O	TC	appos	5	SENT_412	[p20l1003t109r1107b159],
9	.	.	O	.	_	0	SENT_412	[p20l1003t109r1107b159],

1	Potential	JJ	O	potential	amod	2	SENT_413	[p20l1138t109r1392b159],
2	role	NN	O	role	_	0	SENT_413	[p20l1418t109r1529b159],
3	of	IN	O	of	_	0	SENT_413	[p20l1558t109r1619b159],
4	P-glycoprotein	NN	O	p-glycoprotein	prep_of	2	SENT_413	[p20l1642t109r2066b174],
5	in	IN	O	in	_	0	SENT_413	[p20l2094t109r2148b158],
6	affecting	VBG	O	affect	prepc_in	4	SENT_413	[p20l159t199r409b264],
7	hepatic	JJ	O	hepatic	amod	8	SENT_413	[p20l435t199r640b264],
8	metabolism	NN	O	metabolism	dobj	6	SENT_413	[p20l667t199r1001b249],
9	of	IN	O	of	_	0	SENT_413	[p20l1026t199r1088b249],
10	drugs	NNS	O	drug	prep_of	8	SENT_413	[p20l1109t199r1280b264],
11	.	.	O	.	_	0	SENT_413	[p20l1109t199r1280b264],

1	Pharm	NNP	O	Pharm	nn	2	SENT_414	[p20l1309t199r1495b249],
2	Res	NNP	O	Res	_	0	SENT_414	[p20l1520t200r1624b249],
3	2000	CD	DATE	2000	num	2	SENT_414	[p20l1651t199r2096b258],
4	;	:	O	;	_	0	SENT_414	[p20l1651t199r2096b258],
5	17:903	CD	NUMBER	17:903	number	6	SENT_414	[p20l1651t199r2096b258],
6	-5	CD	NUMBER	-5	dep	2	SENT_414	[p20l1651t199r2096b258],
7	.	.	O	.	_	0	SENT_414	[p20l1651t199r2096b258],

1	Boyd	NNP	PERSON	Boyd	nn	2	SENT_415	[p20l158t288r311b353],
2	RA	NN	O	ra	nsubj	27	SENT_415	[p20l339t289r452b348],
3	,	,	O	,	_	0	SENT_415	[p20l339t289r452b348],
4	Stern	NNP	PERSON	Stern	nn	5	SENT_415	[p20l485t289r633b339],
5	RH	NNP	O	RH	appos	2	SENT_415	[p20l660t290r773b348],
6	,	,	O	,	_	0	SENT_415	[p20l660t290r773b348],
7	Stewart	NNP	PERSON	Stewart	nn	8	SENT_415	[p20l806t289r1020b339],
8	BH	NNP	O	BH	appos	2	SENT_415	[p20l1048t290r1160b348],
9	,	,	O	,	_	0	SENT_415	[p20l1048t290r1160b348],
10	Wu	NNP	O	Wu	nn	11	SENT_415	[p20l1190t290r1289b339],
11	X	NNP	O	X	appos	2	SENT_415	[p20l1318t290r1383b348],
12	,	,	O	,	_	0	SENT_415	[p20l1318t290r1383b348],
13	Reyner	NNP	ORGANIZATION	Reyner	nn	14	SENT_415	[p20l1414t290r1620b353],
14	EL	NNP	ORGANIZATION	EL	appos	2	SENT_415	[p20l1646t290r1748b348],
15	,	,	O	,	_	0	SENT_415	[p20l1646t290r1748b348],
16	Zegarac	NNP	ORGANIZATION	Zegarac	nn	17	SENT_415	[p20l1779t290r2007b353],
17	EA	NN	ORGANIZATION	ea	appos	2	SENT_415	[p20l2036t289r2145b348],
18	,	,	O	,	_	0	SENT_415	[p20l2036t289r2145b348],
19	Randinitis	NNP	O	Randinitis	nn	20	SENT_415	[p20l158t378r449b429],
20	EJ	NNP	O	EJ	appos	2	SENT_415	[p20l486t380r571b438],
21	,	,	O	,	_	0	SENT_415	[p20l486t380r571b438],
22	Whitﬁeld	NNP	ORGANIZATION	Whitﬁeld	nn	25	SENT_415	[p20l608t378r882b429],
23	L.	NNP	ORGANIZATION	L.	nn	25	SENT_415	[p20l916t380r972b429],
24	Atorvastatin	NNP	ORGANIZATION	Atorvastatin	nn	25	SENT_415	[p20l1011t378r1363b429],
25	coadministration	NN	O	coadministration	appos	2	SENT_415	[p20l1398t378r1878b429],
26	may	MD	O	may	aux	27	SENT_415	[p20l1913t394r2034b443],
27	increase	VB	O	increase	dep	40	SENT_415	[p20l2070t378r2146b428, p20l158t484r335b519],
28	digoxin	NN	O	digoxin	nn	29	SENT_415	[p20l361t468r578b533],
29	concentrations	NNS	O	concentration	dobj	27	SENT_415	[p20l602t468r1017b519],
30	by	IN	O	by	_	0	SENT_415	[p20l1042t468r1112b533],
31	inhibition	NN	O	inhibition	prep_by	27	SENT_415	[p20l1137t468r1415b519],
32	of	IN	O	of	_	0	SENT_415	[p20l1440t468r1502b519],
33	intestinal	JJ	O	intestinal	amod	36	SENT_415	[p20l1522t468r1783b519],
34	P	NN	O	p	nn	36	SENT_415	[p20l1808t468r2146b533],
35	—	NN	O	—	nn	36	SENT_415	[p20l1808t468r2146b533],
36	glycopro	NN	O	glycopro	prep_of	31	SENT_415	[p20l1808t468r2146b533],
37	—	CD	NUMBER	—	num	39	SENT_415	[p20l1808t468r2146b533],
38	tein	NN	O	tein	nn	39	SENT_415	[p20l158t558r552b608],
39	—	NN	O	—	nsubj	40	SENT_415	[p20l158t558r552b608],
40	mediated	VBD	O	mediate	_	0	SENT_415	[p20l158t558r552b608],
41	secretion	NN	O	secretion	dobj	40	SENT_415	[p20l579t559r848b608],
42	.	.	O	.	_	0	SENT_415	[p20l579t559r848b608],

1	J	NNP	O	J	nn	3	SENT_416	[p20l877t560r903b609],
2	Clin	NNP	O	Clin	nn	3	SENT_416	[p20l929t559r1051b609],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_416	[p20l1076t559r1381b608],
4	2000	CD	DATE	2000	num	3	SENT_416	[p20l1407t559r1816b617],
5	;	:	O	;	_	0	SENT_416	[p20l1407t559r1816b617],
6	40:91	CD	NUMBER	40:91	number	7	SENT_416	[p20l1407t559r1816b617],
7	—	CD	NUMBER	—	dep	3	SENT_416	[p20l1407t559r1816b617],
8	8	CD	NUMBER	8	dep	7	SENT_416	[p20l1407t559r1816b617],
9	.	.	O	.	_	0	SENT_416	[p20l1407t559r1816b617],

1	Wu	NNP	O	Wu	nn	2	SENT_417	[p20l157t649r256b698],
2	X	NNP	O	X	_	0	SENT_417	[p20l272t649r338b707],
3	,	,	O	,	_	0	SENT_417	[p20l272t649r338b707],
4	Whitfield	NNP	ORGANIZATION	Whitfield	nn	5	SENT_417	[p20l356t647r630b698],
5	LR	NNP	ORGANIZATION	LR	appos	2	SENT_417	[p20l645t649r751b707],
6	,	,	O	,	_	0	SENT_417	[p20l645t649r751b707],
7	Stewart	NNP	PERSON	Stewart	nn	8	SENT_417	[p20l772t648r986b698],
8	BH	NNP	O	BH	appos	5	SENT_417	[p20l1002t649r1113b698],
9	.	.	O	.	_	0	SENT_417	[p20l1002t649r1113b698],

1	Atorvastatin	NNP	O	Atorvastatin	nn	2	SENT_418	[p20l1133t647r1485b698],
2	transport	NN	O	transport	_	0	SENT_418	[p20l1501t655r1754b713],
3	in	IN	O	in	_	0	SENT_418	[p20l1769t648r1824b697],
4	the	DT	O	the	det	6	SENT_418	[p20l1840t648r1925b698],
5	Caco	NNP	O	Caco	nn	6	SENT_418	[p20l1944t648r2148b698],
6	—	NN	O	—	prep_in	2	SENT_418	[p20l1944t648r2148b698],
7	2	CD	NUMBER	2	num	9	SENT_418	[p20l1944t648r2148b698],
8	cell	NN	O	cell	nn	9	SENT_418	[p20l158t737r260b788],
9	model	NN	O	model	dep	2	SENT_418	[p20l283t738r476b788],
10	:	:	O	:	_	0	SENT_418	[p20l283t738r476b788],
11	contributions	NNS	O	contribution	dep	2	SENT_418	[p20l505t738r878b788],
12	of	IN	O	of	_	0	SENT_418	[p20l904t737r966b788],
13	P-glycoprotein	NN	O	p-glycoprotein	prep_of	11	SENT_418	[p20l984t738r1408b803],
14	and	CC	O	and	_	0	SENT_418	[p20l1432t738r1533b788],
15	the	DT	O	the	det	22	SENT_418	[p20l1556t738r1641b788],
16	proton	NN	O	proton	nn	22	SENT_418	[p20l1664t745r2147b803],
17	—	NN	O	—	nn	22	SENT_418	[p20l1664t745r2147b803],
18	monocar	NN	O	monocar	nn	22	SENT_418	[p20l1664t745r2147b803],
19	—	NN	O	—	nn	22	SENT_418	[p20l1664t745r2147b803],
20	boxylic	JJ	O	boxylic	amod	22	SENT_418	[p20l157t828r370b893],
21	acid	NN	O	acid	nn	22	SENT_418	[p20l398t828r515b878],
22	co	NN	O	co	conj_and	11	SENT_418	[p20l541t835r951b893],
23	—	CD	NUMBER	—	num	24	SENT_418	[p20l541t835r951b893],
24	transporter	NN	O	transporter	dep	22	SENT_418	[p20l541t835r951b893],
25	.	.	O	.	_	0	SENT_418	[p20l541t835r951b893],

1	Pharm	NNP	O	Pharm	nn	2	SENT_419	[p20l980t828r1166b878],
2	Res	NNP	O	Res	_	0	SENT_419	[p20l1190t829r1294b878],
3	2000	CD	DATE	2000	num	2	SENT_419	[p20l1322t827r1803b887],
4	;	:	O	;	_	0	SENT_419	[p20l1322t827r1803b887],
5	17:209	CD	NUMBER	17:209	number	6	SENT_419	[p20l1322t827r1803b887],
6	—	CD	NUMBER	—	dep	2	SENT_419	[p20l1322t827r1803b887],
7	15	CD	NUMBER	15	dep	6	SENT_419	[p20l1322t827r1803b887],
8	.	.	O	.	_	0	SENT_419	[p20l1322t827r1803b887],

1	Bogman	NNP	PERSON	Bogman	nn	2	SENT_420	[p20l158t919r399b983],
2	K	NNP	PERSON	K	_	0	SENT_420	[p20l433t919r496b977],
3	,	,	O	,	_	0	SENT_420	[p20l433t919r496b977],
4	Peyer	NNP	ORGANIZATION	Peyer	nn	5	SENT_420	[p20l531t919r694b983],
5	AK	NNP	ORGANIZATION	AK	appos	2	SENT_420	[p20l724t918r841b977],
6	,	,	O	,	_	0	SENT_420	[p20l724t918r841b977],
7	Torok	NNP	PERSON	Torok	nn	8	SENT_420	[p20l876t918r1045b968],
8	M	NNP	O	M	appos	2	SENT_420	[p20l1076t919r1153b977],
9	,	,	O	,	_	0	SENT_420	[p20l1076t919r1153b977],
10	Kiisters	NNP	O	Kiisters	nn	11	SENT_420	[p20l1190t919r1403b968],
11	E	NNP	O	E	appos	2	SENT_420	[p20l1436t919r1494b977],
12	,	,	O	,	_	0	SENT_420	[p20l1436t919r1494b977],
13	Drewe	NNP	PERSON	Drewe	nn	14	SENT_420	[p20l1529t919r1715b968],
14	J.	NNP	O	J.	appos	2	SENT_420	[p20l1748t919r1789b968],
15	HMG	NN	O	hmg	dep	14	SENT_420	[p20l1825t918r2149b968],
16	.	.	O	.	_	0	SENT_420	[p20l1825t918r2149b968],

1	—	NN	O	—	_	0	SENT_421	[p20l1825t918r2149b968],
2	.	.	O	.	_	0	SENT_421	[p20l1825t918r2149b968],

1	CoA	NN	O	coa	_	0	SENT_422	[p20l1825t918r2149b968],
2	reductase	NN	O	reductase	nn	3	SENT_422	[p20l157t1007r427b1057],
3	inhibitors	NNS	O	inhibitor	dep	1	SENT_422	[p20l453t1007r723b1057],
4	and	CC	O	and	_	0	SENT_422	[p20l752t1007r853b1057],
5	P-glycoprotein	NN	O	p-glycoprotein	nn	6	SENT_422	[p20l878t1007r1303b1072],
6	modulation	NN	O	modulation	dep	1	SENT_422	[p20l1328t1007r1667b1057],
7	.	.	O	.	_	0	SENT_422	[p20l1328t1007r1667b1057],

1	Br	NN	O	br	nn	3	SENT_423	[p20l1696t1008r1767b1057],
2	J	NN	O	j	nn	3	SENT_423	[p20l1791t1008r1818b1058],
3	Pharmacol	NN	O	pharmacol	_	0	SENT_423	[p20l1843t1007r2148b1057],
4	2001	CD	DATE	2001	dep	3	SENT_423	[p20l159t1098r293b1147],
5	;	:	O	;	_	0	SENT_423	[p20l306t1098r442b1156],
6	132	CD	NUMBER	132	dep	3	SENT_423	[p20l306t1098r442b1156],
7	:	:	O	:	_	0	SENT_423	[p20l306t1098r442b1156],
8	1	CD	NUMBER	1	number	9	SENT_423	[p20l456t1098r476b1146],
9	183-92	CD	NUMBER	183-92	dep	6	SENT_423	[p20l491t1098r710b1148],
10	.	.	O	.	_	0	SENT_423	[p20l491t1098r710b1148],

1	Wang	NNP	PERSON	Wang	nn	2	SENT_424	[p20l157t1187r321b1251],
2	E	NNP	PERSON	E	_	0	SENT_424	[p20l366t1187r423b1246],
3	,	,	O	,	_	0	SENT_424	[p20l366t1187r423b1246],
4	Casciano	NNP	O	Casciano	nn	5	SENT_424	[p20l471t1186r730b1237],
5	CN	NN	O	cn	appos	2	SENT_424	[p20l776t1186r888b1246],
6	,	,	O	,	_	0	SENT_424	[p20l776t1186r888b1246],
7	Clement	NNP	ORGANIZATION	Clement	nn	8	SENT_424	[p20l935t1186r1177b1237],
8	RP	NNP	ORGANIZATION	RP	appos	2	SENT_424	[p20l1220t1187r1313b1246],
9	,	,	O	,	_	0	SENT_424	[p20l1220t1187r1313b1246],
10	Johnson	NNP	PERSON	Johnson	nn	11	SENT_424	[p20l1359t1186r1592b1237],
11	WW	NNP	O	WW	appos	2	SENT_424	[p20l1634t1187r1777b1236],
12	.	.	O	.	_	0	SENT_424	[p20l1634t1187r1777b1236],

1	HMG	NN	O	hmg	_	0	SENT_425	[p20l1825t1186r2148b1237],
2	.	.	O	.	_	0	SENT_425	[p20l1825t1186r2148b1237],

1	—	NN	O	—	_	0	SENT_426	[p20l1825t1186r2148b1237],
2	.	.	O	.	_	0	SENT_426	[p20l1825t1186r2148b1237],

1	CoA	NN	O	coa	nn	3	SENT_427	[p20l1825t1186r2148b1237],
2	reducatase	NN	O	reducatase	nn	3	SENT_427	[p20l157t1276r458b1326],
3	inhibitors	NNS	O	inhibitor	nsubj	4	SENT_427	[p20l495t1276r766b1326],
4	(	VBP	O	(	_	0	SENT_427	[p20l807t1276r1032b1337],
5	statins	NNS	O	statin	nsubj	7	SENT_427	[p20l807t1276r1032b1337],
6	)	JJ	O	)	dep	7	SENT_427	[p20l807t1276r1032b1337],
7	characterized	VBN	O	characterize	xcomp	4	SENT_427	[p20l1071t1276r1452b1326],
8	as	IN	O	as	_	0	SENT_427	[p20l1489t1292r1544b1326],
9	direct	JJ	O	direct	amod	10	SENT_427	[p20l1583t1276r1745b1326],
10	inhibitors	NNS	O	inhibitor	prep_as	7	SENT_427	[p20l1780t1276r2052b1326],
11	of	IN	O	of	_	0	SENT_427	[p20l2090t1276r2152b1326],
12	P-glycoprotein	NN	O	p-glycoprotein	prep_of	10	SENT_427	[p20l158t1365r596b1430],
13	.	.	O	.	_	0	SENT_427	[p20l158t1365r596b1430],

1	Pharm	NNP	O	Pharm	nn	2	SENT_428	[p20l625t1365r811b1416],
2	Res	NNP	O	Res	_	0	SENT_428	[p20l836t1367r940b1416],
3	2001	CD	DATE	2001	num	2	SENT_428	[p20l968t1365r1412b1425],
4	;	:	O	;	_	0	SENT_428	[p20l968t1365r1412b1425],
5	18:800	CD	NUMBER	18:800	number	6	SENT_428	[p20l968t1365r1412b1425],
6	—	CD	NUMBER	—	dep	2	SENT_428	[p20l968t1365r1412b1425],
7	6	CD	NUMBER	6	dep	6	SENT_428	[p20l968t1365r1412b1425],
8	.	.	O	.	_	0	SENT_428	[p20l968t1365r1412b1425],

1	J	NN	O	j	nn	3	SENT_429	[p20l157t1457r184b1506],
2	acobsen	NN	O	acobsen	nn	3	SENT_429	[p20l187t1455r415b1506],
3	W	NN	O	w	dep	19	SENT_429	[p20l437t1457r513b1515],
4	,	,	O	,	_	0	SENT_429	[p20l437t1457r513b1515],
5	Djuve	NNP	O	Djuve	nn	6	SENT_429	[p20l540t1455r712b1520],
6	S	NNP	O	S	appos	3	SENT_429	[p20l738t1456r789b1515],
7	,	,	O	,	_	0	SENT_429	[p20l738t1456r789b1515],
8	Hirai	NNP	PERSON	Hirai	nn	9	SENT_429	[p20l817t1455r961b1506],
9	S	NNP	O	S	appos	3	SENT_429	[p20l987t1456r1038b1515],
10	,	,	O	,	_	0	SENT_429	[p20l987t1456r1038b1515],
11	Benet	NNP	PERSON	Benet	nn	12	SENT_429	[p20l1066t1457r1232b1506],
12	LZ	NNP	O	LZ	appos	3	SENT_429	[p20l1255t1457r1356b1515],
13	,	,	O	,	_	0	SENT_429	[p20l1255t1457r1356b1515],
14	Christians	NNS	MISC	christian	appos	3	SENT_429	[p20l1384t1455r1670b1506],
15	U.	NNP	MISC	U.	nn	16	SENT_429	[p20l1696t1457r1760b1506],
16	Human	NNP	MISC	Human	dep	19	SENT_429	[p20l1787t1457r1996b1506],
17	liver	NN	O	liver	nn	19	SENT_429	[p20l2020t1455r2150b1506],
18	microsomal	JJ	O	microsomal	amod	19	SENT_429	[p20l158t1545r495b1596],
19	metabolism	NN	O	metabolism	dep	22	SENT_429	[p20l550t1545r885b1596],
20	and	CC	O	and	_	0	SENT_429	[p20l941t1545r1042b1596],
21	P-glycoprotein	NN	O	p-glycoprotein	conj_and	19	SENT_429	[p20l1097t1545r1522b1610],
22	mediated	VBD	O	mediate	_	0	SENT_429	[p20l1577t1545r1839b1596],
23	transport	NN	O	transport	dobj	22	SENT_429	[p20l1895t1553r2149b1610],
24	through	IN	O	through	_	0	SENT_429	[p20l158t1635r379b1700],
25	MDCK	NN	O	mdck	prep_through	22	SENT_429	[p20l420t1636r847b1686],
26	.	.	O	.	_	0	SENT_429	[p20l420t1636r847b1686],

1	—	NN	O	—	_	0	SENT_430	[p20l420t1636r847b1686],
2	.	.	O	.	_	0	SENT_430	[p20l420t1636r847b1686],

1	MDR1	NN	O	mdr1	nn	3	SENT_431	[p20l420t1636r847b1686],
2	cell	NN	O	cell	nn	3	SENT_431	[p20l897t1635r998b1686],
3	monolayers	NNS	O	monolayer	_	0	SENT_431	[p20l1040t1635r1371b1700],
4	of	IN	O	of	_	0	SENT_431	[p20l1415t1635r1477b1686],
5	HMG	NN	O	hmg	prep_of	3	SENT_431	[p20l1514t1636r1837b1686],
6	.	.	O	.	_	0	SENT_431	[p20l1514t1636r1837b1686],

1	—	NN	O	—	_	0	SENT_432	[p20l1514t1636r1837b1686],
2	.	.	O	.	_	0	SENT_432	[p20l1514t1636r1837b1686],

1	CoA	NN	O	coa	nn	3	SENT_433	[p20l1514t1636r1837b1686],
2	reductase	NN	O	reductase	nn	3	SENT_433	[p20l1878t1635r2148b1686],
3	inhibitors	NNS	O	inhibitor	_	0	SENT_433	[p20l158t1725r430b1775],
4	in	IN	O	in	_	0	SENT_433	[p20l457t1725r511b1775],
5	comparison	NN	O	comparison	prep_in	3	SENT_433	[p20l536t1725r883b1790],
6	.	.	O	.	_	0	SENT_433	[p20l536t1725r883b1790],

1	Drug	NN	O	drug	_	0	SENT_434	[p20l912t1726r1056b1790],
2	Metab	NNP	O	Metab	nn	4	SENT_434	[p20l1081t1725r1262b1775],
3	Rev	NN	O	rev	nn	4	SENT_434	[p20l1289t1726r1400b1775],
4	200l	NN	O	200l	dep	1	SENT_434	[p20l1428t1725r1849b1790],
5	;	:	O	;	_	0	SENT_434	[p20l1428t1725r1849b1790],
6	33	CD	NUMBER	33	num	8	SENT_434	[p20l1428t1725r1849b1790],
7	(	CD	NUMBER	(	num	8	SENT_434	[p20l1428t1725r1849b1790],
8	Supp1	NN	O	supp1	dep	1	SENT_434	[p20l1428t1725r1849b1790],
9	1	CD	NUMBER	1	number	10	SENT_434	[p20l1882t1725r2074b1787],
10	)	CD	NUMBER	)	num	11	SENT_434	[p20l1882t1725r2074b1787],
11	:181	CD	NUMBER	:181	dep	8	SENT_434	[p20l1882t1725r2074b1787],
12	.	.	O	.	_	0	SENT_434	[p20l1882t1725r2074b1787],

1	Schinkel	NNP	PERSON	Schinkel	nn	2	SENT_435	[p20l160t1815r406b1865],
2	AH	NNP	O	AH	nsubj	22	SENT_435	[p20l431t1815r547b1874],
3	,	,	O	,	_	0	SENT_435	[p20l431t1815r547b1874],
4	Wagenaar	NNP	PERSON	Wagenaar	nn	5	SENT_435	[p20l573t1816r859b1880],
5	E	NNP	O	E	appos	2	SENT_435	[p20l881t1816r939b1874],
6	,	,	O	,	_	0	SENT_435	[p20l881t1816r939b1874],
7	Mol	NNP	ORGANIZATION	Mol	nn	8	SENT_435	[p20l966t1815r1083b1865],
8	CA	NNP	O	CA	appos	2	SENT_435	[p20l1108t1815r1220b1874],
9	,	,	O	,	_	0	SENT_435	[p20l1108t1815r1220b1874],
10	van	NNP	PERSON	van	nn	13	SENT_435	[p20l1247t1831r1347b1865],
11	Deemter	NNP	PERSON	Deemter	nn	13	SENT_435	[p20l1371t1816r1617b1865],
12	L.	NNP	PERSON	L.	nn	13	SENT_435	[p20l1639t1816r1696b1865],
13	P-glycoprotein	NN	PERSON	p-glycoprotein	appos	2	SENT_435	[p20l1724t1815r2148b1880],
14	in	IN	O	in	_	0	SENT_435	[p20l158t1905r212b1955],
15	the	DT	O	the	det	19	SENT_435	[p20l242t1905r328b1955],
16	blood	NN	O	blood	nn	19	SENT_435	[p20l358t1905r703b1955],
17	—	NN	O	—	nn	19	SENT_435	[p20l358t1905r703b1955],
18	brain	NN	O	brain	nn	19	SENT_435	[p20l358t1905r703b1955],
19	barrier	NN	O	barrier	prep_in	13	SENT_435	[p20l733t1905r924b1955],
20	of	IN	O	of	_	0	SENT_435	[p20l955t1905r1016b1955],
21	mice	NNS	O	mouse	prep_of	19	SENT_435	[p20l1042t1905r1180b1955],
22	inﬂuences	VBZ	O	inﬂuences	_	0	SENT_435	[p20l1211t1905r1503b1955],
23	the	DT	O	the	det	25	SENT_435	[p20l1534t1905r1619b1955],
24	brain	NN	O	brain	nn	25	SENT_435	[p20l1649t1905r1796b1955],
25	penetration	NN	O	penetration	dobj	22	SENT_435	[p20l1826t1905r2148b1970],
26	and	CC	O	and	_	0	SENT_435	[p20l159t1995r260b2045],
27	pharmacological	JJ	O	pharmacological	amod	28	SENT_435	[p20l285t1995r762b2060],
28	activity	NN	O	activity	conj_and	25	SENT_435	[p20l791t1995r1001b2060],
29	of	IN	O	of	_	0	SENT_435	[p20l1029t1995r1091b2045],
30	many	JJ	O	many	amod	31	SENT_435	[p20l1113t2011r1269b2060],
31	drugs	NNS	O	drug	prep_of	25	SENT_435	[p20l1297t1995r1467b2060],
32	.	.	O	.	_	0	SENT_435	[p20l1297t1995r1467b2060],

1	J	NNP	O	J	nn	3	SENT_436	[p20l1497t1996r1523b2046],
2	Clin	NNP	O	Clin	nn	3	SENT_436	[p20l1551t1995r1672b2046],
3	Invest	NNP	O	Invest	_	0	SENT_436	[p20l1699t1996r1870b2045],
4	1996	CD	DATE	1996	num	3	SENT_436	[p20l1902t1995r2143b2055],
5	;	:	O	;	_	0	SENT_436	[p20l1902t1995r2143b2055],
6	97	CD	NUMBER	97	num	8	SENT_436	[p20l1902t1995r2143b2055],
7	:	:	O	:	_	0	SENT_436	[p20l1902t1995r2143b2055],
8	2517-24	CD	NUMBER	2517-24	dep	3	SENT_436	[p20l159t2085r421b2136],
9	.	.	O	.	_	0	SENT_436	[p20l159t2085r421b2136],

1	Weiss	NNP	PERSON	Weiss	nn	2	SENT_437	[p20l157t2175r324b2225],
2	J	NNP	PERSON	J	_	0	SENT_437	[p20l358t2176r400b2235],
3	,	,	O	,	_	0	SENT_437	[p20l358t2176r400b2235],
4	Dormann	NNP	PERSON	Dormann	nn	5	SENT_437	[p20l435t2176r704b2225],
5	S-MG	NNP	O	S-MG	appos	2	SENT_437	[p20l738t2176r928b2235],
6	,	,	O	,	_	0	SENT_437	[p20l738t2176r928b2235],
7	Martin-Facklam	NNP	O	Martin-Facklam	nn	8	SENT_437	[p20l963t2175r1427b2225],
8	M	NNP	O	M	appos	5	SENT_437	[p20l1459t2176r1536b2235],
9	,	,	O	,	_	0	SENT_437	[p20l1459t2176r1536b2235],
10	Kerpen	NNP	LOCATION	Kerpen	nn	11	SENT_437	[p20l1573t2176r1779b2240],
11	CJ	NNP	O	CJ	appos	5	SENT_437	[p20l1813t2176r1901b2235],
12	,	,	O	,	_	0	SENT_437	[p20l1813t2176r1901b2235],
13	KetabiKiyanvash	NNP	O	KetabiKiyanvash	nn	14	SENT_437	[p20l1937t2175r2146b2225, p20l159t2265r458b2330],
14	N	NNP	O	N	appos	5	SENT_437	[p20l493t2266r558b2325],
15	,	,	O	,	_	0	SENT_437	[p20l493t2266r558b2325],
16	Haefeli	NNP	O	Haefeli	nn	17	SENT_437	[p20l596t2265r804b2315],
17	WE	NNP	O	WE	appos	5	SENT_437	[p20l839t2266r965b2315],
18	.	.	O	.	_	0	SENT_437	[p20l839t2266r965b2315],

1	Inhibition	NN	O	inhibition	_	0	SENT_438	[p20l1003t2265r1285b2315],
2	of	IN	O	of	_	0	SENT_438	[p20l1320t2265r1382b2315],
3	P-glycoprotein	NN	O	p-glycoprotein	prep_of	1	SENT_438	[p20l1412t2265r1836b2330],
4	by	IN	O	by	_	0	SENT_438	[p20l1870t2265r1940b2330],
5	newer	JJR	O	newer	amod	6	SENT_438	[p20l1976t2281r2149b2315],
6	antidepressants	NNS	O	antidepressant	prep_by	1	SENT_438	[p20l159t2355r608b2420],
7	.	.	O	.	_	0	SENT_438	[p20l159t2355r608b2420],

1	J	NNP	O	J	nn	4	SENT_439	[p20l637t2357r663b2406],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_439	[p20l688t2355r993b2406],
3	Exp	NNP	O	Exp	nn	4	SENT_439	[p20l1018t2357r1132b2420],
4	Ther	NNP	O	Ther	_	0	SENT_439	[p20l1158t2355r1293b2406],
5	2003	CD	DATE	2003	num	4	SENT_439	[p20l1318t2355r1870b2415],
6	;	:	O	;	_	0	SENT_439	[p20l1318t2355r1870b2415],
7	305:197	CD	NUMBER	305:197	num	8	SENT_439	[p20l1318t2355r1870b2415],
8	—	NN	O	—	dep	4	SENT_439	[p20l1318t2355r1870b2415],
9	204	CD	NUMBER	204	dep	8	SENT_439	[p20l1318t2355r1870b2415],
10	.	.	O	.	_	0	SENT_439	[p20l1318t2355r1870b2415],

1	Weiss	NNP	PERSON	Weiss	nn	2	SENT_440	[p20l157t2446r324b2496],
2	J	NNP	PERSON	J	_	0	SENT_440	[p20l353t2447r379b2496],
3	,	,	O	,	_	0	SENT_440	[p20l384t2487r394b2505],
4	Kerpen	NNP	LOCATION	Kerpen	nn	5	SENT_440	[p20l425t2447r632b2511],
5	CJ	NNP	O	CJ	appos	2	SENT_440	[p20l660t2446r748b2505],
6	,	,	O	,	_	0	SENT_440	[p20l660t2446r748b2505],
7	Lindenmaier	NNP	O	Lindenmaier	nn	8	SENT_440	[p20l778t2446r1144b2496],
8	H	NNP	O	H	appos	2	SENT_440	[p20l1171t2447r1235b2505],
9	,	,	O	,	_	0	SENT_440	[p20l1171t2447r1235b2505],
10	Dormann	NNP	PERSON	Dormann	nn	11	SENT_440	[p20l1265t2447r1534b2496],
11	S-MG	NNP	O	S-MG	appos	2	SENT_440	[p20l1563t2446r1753b2505],
12	,	,	O	,	_	0	SENT_440	[p20l1563t2446r1753b2505],
13	Haefeli	NNP	O	Haefeli	nn	14	SENT_440	[p20l1783t2446r1992b2496],
14	WE	NNP	O	WE	appos	2	SENT_440	[p20l2019t2447r2144b2496],
15	.	.	O	.	_	0	SENT_440	[p20l2019t2447r2144b2496],

1	Interaction	NN	O	interaction	_	0	SENT_441	[p20l158t2536r468b2586],
2	of	IN	O	of	_	0	SENT_441	[p20l484t2536r545b2586],
3	antiepileptic	JJ	O	antiepileptic	amod	4	SENT_441	[p20l558t2536r909b2601],
4	drugs	NNS	O	drug	prep_of	1	SENT_441	[p20l927t2536r1082b2601],
5	with	IN	O	with	_	0	SENT_441	[p20l1100t2536r1225b2586],
6	human	JJ	O	human	amod	7	SENT_441	[p20l1240t2536r1434b2586],
7	P-glycoprotein	NN	O	p-glycoprotein	prep_with	1	SENT_441	[p20l1450t2536r1874b2601],
8	in	FW	O	in	nn	9	SENT_441	[p20l1892t2538r1943b2586],
9	vitro	FW	O	vitro	dep	7	SENT_441	[p20l1958t2538r2102b2586],
10	.	.	O	.	_	0	SENT_441	[p20l1958t2538r2102b2586],

1	J	NNP	O	J	nn	4	SENT_442	[p20l2121t2537r2148b2586],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_442	[p20l158t2626r462b2676],
3	Exp	NNP	O	Exp	nn	4	SENT_442	[p20l488t2627r601b2691],
4	Ther	NNP	O	Ther	_	0	SENT_442	[p20l627t2626r763b2676],
5	2003	CD	DATE	2003	num	4	SENT_442	[p20l787t2626r944b2685],
6	;	:	O	;	_	0	SENT_442	[p20l787t2626r944b2685],
7	307	CD	NUMBER	307	num	9	SENT_442	[p20l975t2626r1094b2676],
8	:	:	O	:	_	0	SENT_442	[p20l975t2626r1094b2676],
9	262-7	CD	NUMBER	262-7	dep	4	SENT_442	[p20l1126t2626r1316b2676],
10	.	.	O	.	_	0	SENT_442	[p20l1126t2626r1316b2676],

1	Ganssmann	NN	PERSON	ganssmann	nn	2	SENT_443	[p20l159t2715r490b2765],
2	B	NN	PERSON	b	_	0	SENT_443	[p20l523t2716r584b2774],
3	,	,	O	,	_	0	SENT_443	[p20l523t2716r584b2774],
4	Klingmann	NNP	O	Klingmann	nn	5	SENT_443	[p20l622t2715r941b2780],
5	A	NNP	O	A	conj_and	2	SENT_443	[p20l975t2715r1040b2774],
6	,	,	O	,	_	0	SENT_443	[p20l975t2715r1040b2774],
7	Burhenne	NNP	PERSON	Burhenne	nn	8	SENT_443	[p20l1076t2715r1352b2765],
8	J	NNP	PERSON	J	conj_and	2	SENT_443	[p20l1385t2716r1412b2765],
9	,	,	O	,	_	0	SENT_443	[p20l1416t2757r1427b2774],
10	Tayrouz	NNP	O	Tayrouz	nn	11	SENT_443	[p20l1464t2716r1695b2780],
11	Y	NN	O	y	conj_and	2	SENT_443	[p20l1729t2716r1785b2774],
12	,	,	O	,	_	0	SENT_443	[p20l1729t2716r1785b2774],
13	Aderjan	JJ	PERSON	aderjan	amod	14	SENT_443	[p20l1821t2715r2050b2780],
14	R	NN	PERSON	r	conj_and	2	SENT_443	[p20l2084t2716r2145b2774],
15	,	,	O	,	_	0	SENT_443	[p20l2084t2716r2145b2774],
16	Mikus	NNP	PERSON	Mikus	nn	19	SENT_443	[p20l157t2805r337b2855],
17	G.	NNP	PERSON	G.	nn	19	SENT_443	[p20l357t2805r420b2855],
18	Simultaneous	JJ	PERSON	simultaneous	amod	19	SENT_443	[p20l443t2805r828b2855],
19	determination	NN	O	determination	conj_and	2	SENT_443	[p20l848t2805r1244b2855],
20	of	IN	O	of	_	0	SENT_443	[p20l1262t2805r1324b2855],
21	loperamide	NN	O	loperamide	prep_of	19	SENT_443	[p20l1337t2805r1657b2870],
22	and	CC	O	and	_	0	SENT_443	[p20l1677t2805r1778b2855],
23	its	PRP$	O	its	conj_and	2	SENT_443	[p20l1795t2805r1860b2855],
24	demethylated	VBN	O	demethylate	partmod	2	SENT_443	[p20l1879t2805r2146b2870, p20l158t2895r296b2945],
25	metabolites	NNS	O	metabolite	dobj	24	SENT_443	[p20l323t2895r652b2945],
26	in	IN	O	in	_	0	SENT_443	[p20l680t2895r734b2945],
27	plasma	NN	O	plasma	prep_in	25	SENT_443	[p20l761t2895r964b2960],
28	and	CC	O	and	_	0	SENT_443	[p20l992t2895r1092b2945],
29	urine	NN	O	urine	prep_in	25	SENT_443	[p20l1119t2895r1265b2945],
30	by	IN	O	by	_	0	SENT_443	[p20l1291t2895r1361b2960],
31	high	JJ	O	high	amod	36	SENT_443	[p20l1388t2895r1515b2960],
32	pressure	NN	O	pressure	nn	36	SENT_443	[p20l1541t2911r1778b2960],
33	liquid	NN	O	liquid	nn	36	SENT_443	[p20l1805t2895r1972b2960],
34	chromatography/API	NN	O	chromatography/api	nn	36	SENT_443	[p20l1999t2895r2146b2945, p20l158t2985r633b3050],
35	mass	NN	O	mass	nn	36	SENT_443	[p20l692t3001r831b3035],
36	spectrometry	NN	O	spectrometry	agent	24	SENT_443	[p20l894t2992r1273b3050],
37	.	.	O	.	_	0	SENT_443	[p20l894t2992r1273b3050],

1	Chromatographia	NNP	O	Chromatographia	_	0	SENT_444	[p20l1337t2985r1837b3050],
2	2001	CD	DATE	2001	num	1	SENT_444	[p20l1896t2985r2143b3044],
3	;	:	O	;	_	0	SENT_444	[p20l1896t2985r2143b3044],
4	53	CD	NUMBER	53	num	6	SENT_444	[p20l1896t2985r2143b3044],
5	:	:	O	:	_	0	SENT_444	[p20l1896t2985r2143b3044],
6	656-60	CD	NUMBER	656-60	dep	1	SENT_444	[p20l159t3075r385b3126],
7	.	.	O	.	_	0	SENT_444	[p20l159t3075r385b3126],

1	Yu	NNP	O	Yu	nn	2	SENT_445	[p20l158t3167r235b3216],
2	DK	NNP	O	DK	_	0	SENT_445	[p20l255t3167r371b3216],
3	.	.	O	.	_	0	SENT_445	[p20l255t3167r371b3216],

1	The	DT	O	the	det	2	SENT_446	[p20l394t3166r503b3216],
2	contribution	NN	O	contribution	_	0	SENT_446	[p20l524t3165r872b3216],
3	of	IN	O	of	_	0	SENT_446	[p20l892t3165r954b3216],
4	P-glycoprotein	NN	O	p-glycoprotein	prep_of	2	SENT_446	[p20l969t3165r1394b3231],
5	to	TO	O	to	_	0	SENT_446	[p20l1412t3173r1466b3216],
6	pharmacokinetic	JJ	O	pharmacokinetic	amod	8	SENT_446	[p20l1485t3165r1961b3231],
7	drugdrug	NN	O	drugdrug	nn	8	SENT_446	[p20l1983t3166r2149b3231, p20l158t3255r286b3321],
8	interactions	NNS	O	interaction	prep_to	2	SENT_446	[p20l312t3256r661b3306],
9	.	.	O	.	_	0	SENT_446	[p20l312t3256r661b3306],

1	J	NNP	O	J	nn	3	SENT_447	[p20l689t3257r715b3306],
2	Clin	NNP	O	Clin	nn	3	SENT_447	[p20l741t3255r862b3306],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_447	[p20l888t3256r1192b3306],
4	1999	CD	DATE	1999	num	3	SENT_447	[p20l1225t3256r1736b3315],
5	;	:	O	;	_	0	SENT_447	[p20l1225t3256r1736b3315],
6	39:1203	CD	NUMBER	39:1203	number	7	SENT_447	[p20l1225t3256r1736b3315],
7	—	CD	NUMBER	—	dep	3	SENT_447	[p20l1225t3256r1736b3315],
8	11	CD	NUMBER	11	dep	7	SENT_447	[p20l1225t3256r1736b3315],
9	.	.	O	.	_	0	SENT_447	[p20l1225t3256r1736b3315],

1	Shek	NNP	PERSON	Shek	nn	2	SENT_448	[p20l159t3346r301b3396],
2	A	NNP	O	A	_	0	SENT_448	[p20l316t3346r381b3405],
3	,	,	O	,	_	0	SENT_448	[p20l316t3346r381b3405],
4	Ferrill	NNP	PERSON	Ferrill	nn	5	SENT_448	[p20l402t3346r580b3396],
5	MJ	NNP	O	MJ	appos	2	SENT_448	[p20l598t3347r701b3396],
6	.	.	O	.	_	0	SENT_448	[p20l598t3347r701b3396],

1	Statin	JJ	O	statin	amod	3	SENT_449	[p20l725t3346r1098b3396],
2	—	NN	O	—	nn	3	SENT_449	[p20l725t3346r1098b3396],
3	ﬁbrate	NN	O	ﬁbrate	_	0	SENT_449	[p20l725t3346r1098b3396],
4	combination	NN	O	combination	nn	5	SENT_449	[p20l1117t3346r1474b3396],
5	therapy	NN	O	therapy	dep	3	SENT_449	[p20l1492t3346r1714b3411],
6	.	.	O	.	_	0	SENT_449	[p20l1492t3346r1714b3411],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_450	[p20l1736t3346r1858b3395],
2	Pharmacother	NNP	PERSON	Pharmacother	_	0	SENT_450	[p20l1875t3346r2146b3396, p20l159t3436r305b3486],
3	2001	CD	DATE	2001	num	2	SENT_450	[p20l330t3436r810b3494],
4	;	:	O	;	_	0	SENT_450	[p20l330t3436r810b3494],
5	35:908	CD	NUMBER	35:908	number	6	SENT_450	[p20l330t3436r810b3494],
6	—	CD	NUMBER	—	dep	2	SENT_450	[p20l330t3436r810b3494],
7	17	CD	NUMBER	17	dep	6	SENT_450	[p20l330t3436r810b3494],
8	.	.	O	.	_	0	SENT_450	[p20l330t3436r810b3494],

1	Evans	NNP	PERSON	Evans	nn	2	SENT_451	[p20l157t3526r328b3575],
2	M	NNP	O	M	_	0	SENT_451	[p20l363t3526r440b3584],
3	,	,	O	,	_	0	SENT_451	[p20l363t3526r440b3584],
4	Rees	NNP	PERSON	Rees	nn	7	SENT_451	[p20l477t3526r613b3575],
5	A.	NNP	O	A.	nn	7	SENT_451	[p20l649t3525r712b3575],
6	The	NNP	O	The	nn	7	SENT_451	[p20l751t3525r860b3575],
7	myotoxicity	NN	O	myotoxicity	appos	2	SENT_451	[p20l895t3525r1239b3590],
8	of	IN	O	of	_	0	SENT_451	[p20l1275t3525r1337b3575],
9	statins	NNS	O	statin	prep_of	7	SENT_451	[p20l1369t3525r1562b3575],
10	.	.	O	.	_	0	SENT_451	[p20l1369t3525r1562b3575],

1	Curr	NNP	O	Curr	nn	3	SENT_452	[p20l1600t3525r1730b3575],
2	Opin	NNP	O	Opin	nn	3	SENT_452	[p20l1764t3525r1904b3590],
3	Lipidol	NNP	O	Lipidol	_	0	SENT_452	[p20l1938t3525r2148b3590],
4	2002	CD	DATE	2002	num	3	SENT_452	[p20l159t3614r639b3671],
5	;	:	O	;	_	0	SENT_452	[p20l159t3614r639b3671],
6	13:415	CD	NUMBER	13:415	number	7	SENT_452	[p20l159t3614r639b3671],
7	—	CD	NUMBER	—	dep	3	SENT_452	[p20l159t3614r639b3671],
8	20	CD	NUMBER	20	dep	7	SENT_452	[p20l159t3614r639b3671],
9	.	.	O	.	_	0	SENT_452	[p20l159t3614r639b3671],

1	292	CD	NUMBER	292	num	3	SENT_453	[p20l330t3746r378b3770],
2	M.	NN	NUMBER	m.	nn	3	SENT_453	[p20l919t3747r952b3770],
3	Ehrhardt	NNP	PERSON	Ehrhardt	_	0	SENT_453	[p20l967t3746r1088b3770],
4	et	FW	O	et	nn	5	SENT_453	[p20l1099t3751r1123b3770],
5	al.	FW	O	al.	dep	3	SENT_453	[p20l1134t3746r1354b3770],
6	/	:	O	/	punct	3	SENT_453	[p20l1134t3746r1354b3770],
7	Biochemical	JJ	O	biochemical	amod	8	SENT_453	[p20l1134t3746r1354b3770],
8	Pharmacology	NN	O	pharmacology	dep	3	SENT_453	[p20l1365t3746r1560b3776],
9	67	CD	NUMBER	67	number	10	SENT_453	[p20l1572t3746r1606b3770],
10	(	CD	NUMBER	(	num	11	SENT_453	[p20l1617t3746r1703b3775],
11	2004	CD	DATE	2004	dep	8	SENT_453	[p20l1617t3746r1703b3775],
12	)	CD	NUMBER	)	number	13	SENT_453	[p20l1617t3746r1703b3775],
13	285-292	CD	NUMBER	285-292	num	11	SENT_453	[p20l1715t3746r1830b3770],

1	Wang	NNP	PERSON	Wang	nn	2	SENT_454	[p21l157t114r322b177],
2	J	NNP	PERSON	J	_	0	SENT_454	[p21l346t114r373b163],
3	S	NN	PERSON	s	dep	2	SENT_454	[p21l376t113r427b172],
4	,	,	O	,	_	0	SENT_454	[p21l376t113r427b172],
5	Neuvonen	NN	O	neuvonen	nn	6	SENT_454	[p21l454t114r746b163],
6	M	NN	O	m	appos	3	SENT_454	[p21l770t114r847b172],
7	,	,	O	,	_	0	SENT_454	[p21l770t114r847b172],
8	Wen	NN	O	wen	nn	9	SENT_454	[p21l874t114r1003b163],
9	X	NN	O	x	appos	3	SENT_454	[p21l1027t114r1092b172],
10	,	,	O	,	_	0	SENT_454	[p21l1027t114r1092b172],
11	Backman	NNP	PERSON	Backman	nn	12	SENT_454	[p21l1120t112r1389b163],
12	JT	NNP	O	JT	appos	3	SENT_454	[p21l1412t114r1493b172],
13	,	,	O	,	_	0	SENT_454	[p21l1412t114r1493b172],
14	Neuvonen	NNP	O	Neuvonen	nn	15	SENT_454	[p21l1520t114r1811b163],
15	PJ	NNP	O	PJ	appos	3	SENT_454	[p21l1836t114r1916b163],
16	.	.	O	.	_	0	SENT_454	[p21l1836t114r1916b163],

1	Gemfi	JJ	O	gemfi	amod	3	SENT_455	[p21l1945t112r2146b163],
2	—	NN	O	—	nn	3	SENT_455	[p21l1945t112r2146b163],
3	brozil	NN	O	brozil	nsubj	4	SENT_455	[p21l157t202r323b253],
4	inhibits	VBZ	O	inhibit	_	0	SENT_455	[p21l351t202r563b253],
5	CYP2C8	NN	O	cyp2c8	nn	6	SENT_455	[p21l591t202r1134b253],
6	—	NN	O	—	nsubj	7	SENT_455	[p21l591t202r1134b253],
7	mediated	VBD	O	mediate	ccomp	4	SENT_455	[p21l591t202r1134b253],
8	cerivastatin	NN	O	cerivastatin	nn	9	SENT_455	[p21l1161t202r1488b253],
9	metabolism	NN	O	metabolism	dobj	7	SENT_455	[p21l1514t202r1848b253],
10	in	IN	O	in	_	0	SENT_455	[p21l1874t202r1928b252],
11	human	JJ	O	human	amod	13	SENT_455	[p21l1954t202r2149b253],
12	liver	NN	O	liver	nn	13	SENT_455	[p21l158t292r287b343],
13	microsomes	NNS	O	microsome	prep_in	7	SENT_455	[p21l312t292r670b343],
14	.	.	O	.	_	0	SENT_455	[p21l312t292r670b343],

1	Drug	NN	O	drug	nn	3	SENT_456	[p21l699t294r843b357],
2	Metab	NNP	O	Metab	nn	3	SENT_456	[p21l869t292r1050b343],
3	Dispos	NNP	O	Dispos	_	0	SENT_456	[p21l1076t292r1271b357],
4	2002	CD	DATE	2002	num	3	SENT_456	[p21l1299t292r1708b352],
5	;	:	O	;	_	0	SENT_456	[p21l1299t292r1708b352],
6	30:1352	CD	NUMBER	30:1352	dep	3	SENT_456	[p21l1299t292r1708b352],
7	.	.	O	.	_	0	SENT_456	[p21l1299t292r1708b352],

1	Williams	NNP	PERSON	Williams	nn	2	SENT_457	[p21l157t382r416b433],
2	D	NNP	O	D	_	0	SENT_457	[p21l440t384r504b442],
3	,	,	O	,	_	0	SENT_457	[p21l440t384r504b442],
4	Feely	NNP	O	Feely	nn	5	SENT_457	[p21l529t382r687b447],
5	J	NNP	O	J	appos	2	SENT_457	[p21l709t384r735b433],
6	.	.	O	.	_	0	SENT_457	[p21l741t424r749b433],

1	Pharmacokinetic	JJ	O	pharmacokinetic	amod	2	SENT_458	[p21l776t382r1820b447],
2	—	NN	O	—	_	0	SENT_458	[p21l776t382r1820b447],
3	pharmacodynamic	JJ	O	pharmacodynamic	amod	5	SENT_458	[p21l776t382r1820b447],
4	drug	NN	O	drug	nn	5	SENT_458	[p21l1844t382r1972b447],
5	interactions	NNS	O	interaction	dep	2	SENT_458	[p21l1995t382r2146b433, p21l159t472r358b522],
6	with	IN	O	with	_	0	SENT_458	[p21l398t472r524b522],
7	HMG-CoA	NN	O	hmg-coa	nn	9	SENT_458	[p21l562t472r885b522],
8	reductase	NN	O	reductase	nn	9	SENT_458	[p21l922t472r1191b522],
9	inhibitors	NNS	O	inhibitor	prep_with	5	SENT_458	[p21l1231t472r1518b522],
10	.	.	O	.	_	0	SENT_458	[p21l1231t472r1518b522],

1	Clin	NNP	O	Clin	nn	2	SENT_459	[p21l1561t472r1682b522],
2	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_459	[p21l1719t472r2149b522],
3	2002	CD	DATE	2002	num	2	SENT_459	[p21l159t562r639b621],
4	;	:	O	;	_	0	SENT_459	[p21l159t562r639b621],
5	41:343	CD	NUMBER	41:343	number	6	SENT_459	[p21l159t562r639b621],
6	—	CD	NUMBER	—	dep	2	SENT_459	[p21l159t562r639b621],
7	70	CD	NUMBER	70	dep	6	SENT_459	[p21l159t562r639b621],
8	.	.	O	.	_	0	SENT_459	[p21l159t562r639b621],

1	Barecki-Roach	NNP	O	Barecki-Roach	nn	2	SENT_460	[p21l158t651r586b701],
2	M	NNP	O	M	_	0	SENT_460	[p21l620t652r697b710],
3	,	,	O	,	_	0	SENT_460	[p21l620t652r697b710],
4	Wang	NNP	PERSON	Wang	nn	5	SENT_460	[p21l734t652r898b716],
5	E-J	NNP	PERSON	E-J	appos	2	SENT_460	[p21l933t652r1042b710],
6	,	,	O	,	_	0	SENT_460	[p21l933t652r1042b710],
7	Johnson	NNP	PERSON	Johnson	nn	8	SENT_460	[p21l1079t651r1312b701],
8	WW	NNP	O	WW	appos	5	SENT_460	[p21l1345t652r1488b701],
9	.	.	O	.	_	0	SENT_460	[p21l1345t652r1488b701],

1	Many	JJ	O	many	amod	3	SENT_461	[p21l1525t652r1690b716],
2	P-glycoprotein	NN	O	p-glycoprotein	nn	3	SENT_461	[p21l1724t651r2148b716],
3	substrates	NNS	O	substrate	nsubj	6	SENT_461	[p21l160t741r437b791],
4	do	VBP	O	do	aux	6	SENT_461	[p21l460t741r528b791],
5	not	RB	O	not	neg	6	SENT_461	[p21l550t749r640b791],
6	inhibit	VB	O	inhibit	_	0	SENT_461	[p21l661t741r847b791],
7	the	DT	O	the	det	9	SENT_461	[p21l867t741r953b791],
8	transport	NN	O	transport	nn	9	SENT_461	[p21l974t748r1228b806],
9	process	NN	O	process	dobj	6	SENT_461	[p21l1246t757r1459b806],
10	across	IN	O	across	_	0	SENT_461	[p21l1482t757r1656b791],
11	cell	NN	O	cell	nn	12	SENT_461	[p21l1679t741r1780b791],
12	membranes	NNS	O	membrane	prep_across	6	SENT_461	[p21l1802t741r2144b791],
13	.	.	O	.	_	0	SENT_461	[p21l1802t741r2144b791],

1	Xenobiotica	NNP	O	Xenobiotica	_	0	SENT_462	[p21l158t831r508b881],
2	2003	CD	DATE	2003	num	1	SENT_462	[p21l534t832r670b881],
3	;	:	O	;	_	0	SENT_462	[p21l681t832r780b890],
4	33	CD	NUMBER	33	num	6	SENT_462	[p21l681t832r780b890],
5	:	:	O	:	_	0	SENT_462	[p21l681t832r780b890],
6	131-40	CD	NUMBER	131-40	dep	1	SENT_462	[p21l794t831r1014b881],
7	.	.	O	.	_	0	SENT_462	[p21l794t831r1014b881],

1	Schwab	NNP	PERSON	Schwab	nn	2	SENT_463	[p21l160t920r382b971],
2	D	NNP	PERSON	D	_	0	SENT_463	[p21l398t921r463b980],
3	,	,	O	,	_	0	SENT_463	[p21l398t921r463b980],
4	Fischer	NNP	PERSON	Fischer	nn	5	SENT_463	[p21l482t920r693b970],
5	H	NNP	O	H	appos	2	SENT_463	[p21l708t921r773b980],
6	,	,	O	,	_	0	SENT_463	[p21l708t921r773b980],
7	T	NN	O	t	nn	9	SENT_463	[p21l791t921r833b970],
8	abatabeai	NN	O	abatabeaus	nn	9	SENT_463	[p21l832t920r1099b970],
9	A	NN	O	a	appos	2	SENT_463	[p21l1117t921r1181b980],
10	,	,	O	,	_	0	SENT_463	[p21l1117t921r1181b980],
11	Poli	NNP	LOCATION	Poli	nn	12	SENT_463	[p21l1200t920r1313b970],
12	S	NNP	LOCATION	S	appos	2	SENT_463	[p21l1332t921r1383b980],
13	,	,	O	,	_	0	SENT_463	[p21l1332t921r1383b980],
14	Huwyler	NNP	O	Huwyler	nn	15	SENT_463	[p21l1402t920r1652b985],
15	J	NNP	O	J	appos	2	SENT_463	[p21l1666t921r1692b971],
16	.	.	O	.	_	0	SENT_463	[p21l1698t962r1706b970],

1	Comparison	NN	O	comparison	_	0	SENT_464	[p21l1727t920r2075b985],
2	of	IN	O	of	prep	1	SENT_464	[p21l2091t920r2153b970],
3	in	FW	O	in	nn	4	SENT_464	[p21l160t1012r211b1060],
4	vitro	FW	O	vitro	advmod	7	SENT_464	[p21l238t1012r367b1061],
5	P-glycoprotein	NN	MISC	p-glycoprotein	nn	7	SENT_464	[p21l395t1010r819b1075],
6	screening	NN	O	screening	nn	7	SENT_464	[p21l849t1010r1118b1075],
7	assays	NNS	O	assay	dep	2	SENT_464	[p21l1148t1026r1342b1075],
8	:	:	O	:	_	0	SENT_464	[p21l1148t1026r1342b1075],
9	recommendations	NNS	O	recommendation	dep	1	SENT_464	[p21l1373t1010r1881b1060],
10	for	IN	O	for	_	0	SENT_464	[p21l1909t1010r1992b1060],
11	their	PRP$	O	they	poss	12	SENT_464	[p21l2018t1010r2150b1060],
12	use	NN	O	use	prep_for	9	SENT_464	[p21l158t1116r251b1150],
13	in	IN	O	in	_	0	SENT_464	[p21l278t1100r332b1150],
14	drug	NN	O	drug	nn	15	SENT_464	[p21l357t1100r485b1165],
15	discovery	NN	O	discovery	prep_in	12	SENT_464	[p21l513t1100r796b1165],
16	.	.	O	.	_	0	SENT_464	[p21l513t1100r796b1165],

1	J	NN	O	j	nsubj	2	SENT_465	[p21l825t1101r852b1151],
2	Med	VBD	O	med	_	0	SENT_465	[p21l877t1100r1007b1150],
3	Chem	NNP	O	Chem	dobj	2	SENT_465	[p21l1033t1100r1202b1151],
4	2003	CD	DATE	2003	num	3	SENT_465	[p21l1228t1100r1744b1160],
5	;	:	O	;	_	0	SENT_465	[p21l1228t1100r1744b1160],
6	46:1716	CD	NUMBER	46:1716	number	7	SENT_465	[p21l1228t1100r1744b1160],
7	—	CD	NUMBER	—	dep	3	SENT_465	[p21l1228t1100r1744b1160],
8	25	CD	NUMBER	25	dep	7	SENT_465	[p21l1228t1100r1744b1160],
9	.	.	O	.	_	0	SENT_465	[p21l1228t1100r1744b1160],

1	Seelig	NNP	O	Seelig	nn	3	SENT_466	[p21l160t1191r335b1256],
2	A.	NNP	O	A.	nn	3	SENT_466	[p21l360t1191r423b1241],
3	A	NNP	O	A	_	0	SENT_466	[p21l452t1191r502b1240],
4	general	JJ	O	general	amod	5	SENT_466	[p21l527t1191r735b1256],
5	pattern	NN	O	pattern	dep	3	SENT_466	[p21l759t1198r958b1256],
6	for	IN	O	for	_	0	SENT_466	[p21l982t1191r1065b1241],
7	substrate	NN	O	substrate	nn	8	SENT_466	[p21l1090t1191r1340b1241],
8	recognition	NN	O	recognition	prep_for	5	SENT_466	[p21l1364t1191r1691b1256],
9	by	IN	O	by	_	0	SENT_466	[p21l1713t1191r1783b1256],
10	P	NN	O	p	prep_by	8	SENT_466	[p21l1808t1191r2147b1256],
11	—	CD	NUMBER	—	num	12	SENT_466	[p21l1808t1191r2147b1256],
12	glycopro	NN	O	glycopro	dep	3	SENT_466	[p21l1808t1191r2147b1256],
13	—	CD	NUMBER	—	num	14	SENT_466	[p21l1808t1191r2147b1256],
14	tein	NN	O	tein	dep	12	SENT_466	[p21l158t1281r279b1331],
15	.	.	O	.	_	0	SENT_466	[p21l158t1281r279b1331],

1	Eur	NNP	O	Eur	nn	3	SENT_467	[p21l308t1282r411b1331],
2	J	NNP	O	J	nn	3	SENT_467	[p21l434t1282r461b1331],
3	Biochem	NNP	O	Biochem	_	0	SENT_467	[p21l486t1281r745b1331],
4	1998	CD	DATE	1998	num	3	SENT_467	[p21l776t1281r1286b1339],
5	;	:	O	;	_	0	SENT_467	[p21l776t1281r1286b1339],
6	251:252	CD	NUMBER	251:252	number	7	SENT_467	[p21l776t1281r1286b1339],
7	—	CD	NUMBER	—	dep	3	SENT_467	[p21l776t1281r1286b1339],
8	61	CD	NUMBER	61	dep	7	SENT_467	[p21l776t1281r1286b1339],
9	.	.	O	.	_	0	SENT_467	[p21l776t1281r1286b1339],

1	Kyrklund	NN	O	kyrklund	nn	2	SENT_468	[p21l159t1370r430b1435],
2	C	NN	O	c	_	0	SENT_468	[p21l473t1370r533b1429],
3	,	,	O	,	_	0	SENT_468	[p21l473t1370r533b1429],
4	Backman	NNP	PERSON	Backman	nn	5	SENT_468	[p21l579t1370r848b1420],
5	JT	NNP	O	JT	appos	2	SENT_468	[p21l891t1371r971b1429],
6	,	,	O	,	_	0	SENT_468	[p21l891t1371r971b1429],
7	Kivisto	NNP	ORGANIZATION	Kivisto	nn	8	SENT_468	[p21l1018t1370r1224b1420],
8	KT	NNP	ORGANIZATION	KT	appos	5	SENT_468	[p21l1269t1371r1371b1429],
9	,	,	O	,	_	0	SENT_468	[p21l1269t1371r1371b1429],
10	Neuvonen	NNP	O	Neuvonen	nn	11	SENT_468	[p21l1416t1371r1709b1420],
11	M	NNP	O	M	appos	5	SENT_468	[p21l1751t1371r1828b1429],
12	,	,	O	,	_	0	SENT_468	[p21l1751t1371r1828b1429],
13	Laitila	NNP	PERSON	Laitila	nn	14	SENT_468	[p21l1874t1370r2062b1420],
14	J	NNP	PERSON	J	appos	5	SENT_468	[p21l2104t1371r2130b1420],
15	,	,	O	,	_	0	SENT_468	[p21l2135t1411r2145b1429],
16	Neuvonen	NNP	O	Neuvonen	nn	17	SENT_468	[p21l158t1460r449b1509],
17	PJ	NNP	O	PJ	appos	5	SENT_468	[p21l486t1460r565b1509],
18	.	.	O	.	_	0	SENT_468	[p21l486t1460r565b1509],

1	Plasma	NN	O	plasma	nn	2	SENT_469	[p21l605t1459r811b1509],
2	concentrations	NNS	O	concentration	nsubjpass	9	SENT_469	[p21l846t1459r1261b1509],
3	of	IN	O	of	_	0	SENT_469	[p21l1300t1459r1361b1509],
4	active	JJ	O	active	amod	6	SENT_469	[p21l1394t1459r1560b1509],
5	lovastatin	NN	O	lovastatin	nn	6	SENT_469	[p21l1597t1459r1872b1509],
6	acid	NN	O	acid	prep_of	2	SENT_469	[p21l1909t1459r2026b1509],
7	are	VBP	O	be	auxpass	9	SENT_469	[p21l2063t1475r2148b1509],
8	markedly	RB	O	markedly	advmod	9	SENT_469	[p21l158t1550r428b1615],
9	increased	VBN	O	increase	_	0	SENT_469	[p21l471t1550r741b1601],
10	by	IN	O	by	_	0	SENT_469	[p21l783t1550r853b1615],
11	gemfibrozil	NN	O	gemfibrozil	agent	9	SENT_469	[p21l898t1550r1229b1615],
12	but	CC	O	but	_	0	SENT_469	[p21l1272t1550r1363b1601],
13	not	RB	O	not	_	0	SENT_469	[p21l1405t1558r1496b1601],
14	by	IN	O	by	_	0	SENT_469	[p21l1537t1550r1608b1615],
15	bezafibrate	NN	O	bezafibrate	agent	9	SENT_469	[p21l1650t1550r1983b1601],
16	.	.	O	.	_	0	SENT_469	[p21l1650t1550r1983b1601],

1	Clin	NNP	O	Clin	nn	3	SENT_470	[p21l2030t1550r2151b1601],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_470	[p21l158t1641r464b1691],
3	Ther	NNP	O	Ther	_	0	SENT_470	[p21l489t1641r625b1691],
4	2001	CD	DATE	2001	num	3	SENT_470	[p21l650t1641r1095b1700],
5	;	:	O	;	_	0	SENT_470	[p21l650t1641r1095b1700],
6	69:340	CD	NUMBER	69:340	number	7	SENT_470	[p21l650t1641r1095b1700],
7	—	CD	NUMBER	—	dep	3	SENT_470	[p21l650t1641r1095b1700],
8	5	CD	NUMBER	5	dep	7	SENT_470	[p21l650t1641r1095b1700],
9	.	.	O	.	_	0	SENT_470	[p21l650t1641r1095b1700],

1	Balfour	NNP	O	Balfour	nn	2	SENT_471	[p21l158t1731r378b1782],
2	JA	NNP	O	JA	_	0	SENT_471	[p21l395t1732r484b1791],
3	,	,	O	,	_	0	SENT_471	[p21l395t1732r484b1791],
4	McTavish	NNP	PERSON	McTavish	nn	5	SENT_471	[p21l506t1731r790b1782],
5	D	NNP	O	D	appos	2	SENT_471	[p21l808t1733r873b1791],
6	,	,	O	,	_	0	SENT_471	[p21l808t1733r873b1791],
7	Heel	NNP	O	Heel	nn	8	SENT_471	[p21l896t1731r1029b1782],
8	RC	NNP	O	RC	appos	5	SENT_471	[p21l1049t1732r1157b1782],
9	.	.	O	.	_	0	SENT_471	[p21l1049t1732r1157b1782],

1	A	DT	O	a	det	2	SENT_472	[p21l1180t1732r1230b1781],
2	review	NN	O	review	_	0	SENT_472	[p21l1249t1731r1440b1782],
3	of	IN	O	of	_	0	SENT_472	[p21l1461t1731r1523b1782],
4	its	PRP$	O	its	poss	8	SENT_472	[p21l1536t1731r1601b1782],
5	pharmacodynamic	JJ	O	pharmacodynamic	amod	8	SENT_472	[p21l1621t1731r2150b1796],
6	and	CC	O	and	_	0	SENT_472	[p21l160t1822r261b1873],
7	pharmacokinetic	JJ	O	pharmacokinetic	conj_and	5	SENT_472	[p21l282t1822r759b1887],
8	properties	NNS	O	property	prep_of	2	SENT_472	[p21l782t1822r1067b1887],
9	and	CC	O	and	_	0	SENT_472	[p21l1093t1822r1194b1873],
10	therapeutic	JJ	O	therapeutic	amod	11	SENT_472	[p21l1215t1822r1532b1887],
11	use	NN	O	use	conj_and	8	SENT_472	[p21l1556t1838r1650b1873],
12	in	IN	O	in	_	0	SENT_472	[p21l1673t1822r1727b1872],
13	dyslipidaemia	NN	O	dyslipidaemia	nn	14	SENT_472	[p21l1751t1822r2152b1887],
14	fenofibrate	NN	O	fenofibrate	prep_in	2	SENT_472	[p21l159t1913r486b1963],
15	.	.	O	.	_	0	SENT_472	[p21l159t1913r486b1963],

1	Drugs	NNS	O	drug	_	0	SENT_473	[p21l515t1914r686b1978],
2	1990	CD	DATE	1990	num	1	SENT_473	[p21l720t1913r1194b1972],
3	;	:	O	;	_	0	SENT_473	[p21l720t1913r1194b1972],
4	40:260	CD	NUMBER	40:260	number	5	SENT_473	[p21l720t1913r1194b1972],
5	—	CD	NUMBER	—	dep	1	SENT_473	[p21l720t1913r1194b1972],
6	90	CD	NUMBER	90	dep	5	SENT_473	[p21l720t1913r1194b1972],
7	.	.	O	.	_	0	SENT_473	[p21l720t1913r1194b1972],

1	deLorgeril	NN	O	delorgeril	nn	2	SENT_474	[p21l159t2004r459b2069],
2	M	NN	O	m	_	0	SENT_474	[p21l492t2005r569b2063],
3	,	,	O	,	_	0	SENT_474	[p21l492t2005r569b2063],
4	Boissonnat	NNP	PERSON	Boissonnat	nn	5	SENT_474	[p21l605t2004r923b2054],
5	P	NN	PERSON	p	appos	2	SENT_474	[p21l954t2005r1000b2064],
6	,	,	O	,	_	0	SENT_474	[p21l954t2005r1000b2064],
7	Bizollon	NNP	PERSON	Bizollon	nn	8	SENT_474	[p21l1036t2004r1282b2054],
8	CA	NNP	O	CA	appos	5	SENT_474	[p21l1315t2004r1427b2063],
9	,	,	O	,	_	0	SENT_474	[p21l1315t2004r1427b2063],
10	Guidollet	NNP	PERSON	Guidollet	nn	11	SENT_474	[p21l1464t2004r1733b2054],
11	J	NNP	PERSON	J	appos	5	SENT_474	[p21l1765t2005r1806b2063],
12	,	,	O	,	_	0	SENT_474	[p21l1765t2005r1806b2063],
13	Faucon	NNP	O	Faucon	nn	14	SENT_474	[p21l1842t2005r2050b2054],
14	G	NNP	O	G	appos	5	SENT_474	[p21l2085t2004r2149b2064],
15	,	,	O	,	_	0	SENT_474	[p21l2085t2004r2149b2064],
16	Guichard	NNP	ORGANIZATION	Guichard	nn	17	SENT_474	[p21l159t2095r424b2145],
17	JP	NNP	ORGANIZATION	JP	appos	5	SENT_474	[p21l488t2096r561b2154],
18	,	,	O	,	_	0	SENT_474	[p21l488t2096r561b2154],
19	Levy-Prades-Sauron	NNP	PERSON	Levy-Prades-Sauron	nn	20	SENT_474	[p21l628t2095r1214b2160],
20	R	NNP	PERSON	R	appos	5	SENT_474	[p21l1278t2096r1340b2155],
21	,	,	O	,	_	0	SENT_474	[p21l1278t2096r1340b2155],
22	Renaud	NNP	PERSON	Renaud	nn	23	SENT_474	[p21l1408t2095r1626b2145],
23	S	NNP	O	S	appos	5	SENT_474	[p21l1691t2095r1742b2154],
24	,	,	O	,	_	0	SENT_474	[p21l1691t2095r1742b2154],
25	Dureau	NNP	PERSON	Dureau	nn	27	SENT_474	[p21l1809t2096r2019b2145],
26	G.	NNP	PERSON	G.	nn	27	SENT_474	[p21l2085t2095r2148b2145],
27	Pharmacokinetics	NNP	PERSON	Pharmacokinetics	appos	5	SENT_474	[p21l158t2186r666b2236],
28	of	IN	O	of	_	0	SENT_474	[p21l720t2186r782b2236],
29	cyclosporine	NN	O	cyclosporine	prep_of	27	SENT_474	[p21l830t2186r1193b2251],
30	in	IN	O	in	_	0	SENT_474	[p21l1246t2186r1300b2236],
31	hyperlipidaemic	JJ	O	hyperlipidaemic	amod	33	SENT_474	[p21l1351t2186r1816b2251],
32	long-term	JJ	O	long-term	amod	33	SENT_474	[p21l1870t2186r2152b2251],
33	survivors	NNS	O	survivor	prep_in	5	SENT_474	[p21l161t2277r419b2327],
34	of	IN	O	of	_	0	SENT_474	[p21l468t2277r529b2327],
35	heart	NN	O	heart	nn	36	SENT_474	[p21l571t2277r714b2327],
36	transplantation	NN	O	transplantation	prep_of	33	SENT_474	[p21l760t2277r1198b2342],
37	.	.	O	.	_	0	SENT_474	[p21l760t2277r1198b2342],

1	Lack	NN	O	lack	_	0	SENT_475	[p21l1249t2277r1393b2327],
2	of	IN	O	of	_	0	SENT_475	[p21l1438t2277r1500b2327],
3	interaction	NN	O	interaction	prep_of	1	SENT_475	[p21l1541t2277r1847b2327],
4	with	IN	O	with	_	0	SENT_475	[p21l1893t2277r2019b2328],
5	the	DT	O	the	det	8	SENT_475	[p21l2065t2277r2151b2327],
6	lipid-lowering	JJ	O	lipid-lowering	amod	8	SENT_475	[p21l159t2368r565b2433],
7	agent	NN	O	agent	nn	8	SENT_475	[p21l609t2376r762b2433],
8	fenoﬁbrate	NN	O	fenoﬁbrate	prep_with	1	SENT_475	[p21l804t2368r1130b2418],
9	.	.	O	.	_	0	SENT_475	[p21l804t2368r1130b2418],

1	Eur	NNP	O	Eur	nn	4	SENT_476	[p21l1175t2369r1279b2418],
2	J	NNP	O	J	nn	4	SENT_476	[p21l1319t2369r1345b2419],
3	Clin	NNP	O	Clin	nn	4	SENT_476	[p21l1388t2368r1509b2419],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_476	[p21l1551t2368r1856b2418],
5	1992	CD	DATE	1992	num	4	SENT_476	[p21l1905t2368r2146b2428],
6	;	:	O	;	_	0	SENT_476	[p21l1905t2368r2146b2428],
7	43	CD	NUMBER	43	num	9	SENT_476	[p21l1905t2368r2146b2428],
8	:	:	O	:	_	0	SENT_476	[p21l1905t2368r2146b2428],
9	161-5	CD	NUMBER	161-5	dep	4	SENT_476	[p21l166t2459r350b2510],
10	.	.	O	.	_	0	SENT_476	[p21l166t2459r350b2510],

1	Lown	NNP	PERSON	Lown	nn	2	SENT_477	[p21l158t2552r322b2601],
2	KS	NN	O	k	_	0	SENT_477	[p21l367t2551r470b2610],
3	,	,	O	,	_	0	SENT_477	[p21l367t2551r470b2610],
4	Mayo	NNP	ORGANIZATION	Mayo	nn	5	SENT_477	[p21l516t2552r681b2615],
5	RR	NNP	ORGANIZATION	RR	appos	2	SENT_477	[p21l724t2552r833b2610],
6	,	,	O	,	_	0	SENT_477	[p21l724t2552r833b2610],
7	Leichtman	NNP	ORGANIZATION	Leichtman	nn	8	SENT_477	[p21l879t2550r1186b2601],
8	AB	NNP	ORGANIZATION	AB	appos	5	SENT_477	[p21l1229t2551r1341b2610],
9	,	,	O	,	_	0	SENT_477	[p21l1229t2551r1341b2610],
10	Hsiao	NNP	ORGANIZATION	Hsiao	nn	11	SENT_477	[p21l1387t2550r1552b2601],
11	HL	NNS	ORGANIZATION	hl	appos	5	SENT_477	[p21l1596t2552r1705b2610],
12	,	,	O	,	_	0	SENT_477	[p21l1596t2552r1705b2610],
13	Turgeon	NNP	PERSON	Turgeon	nn	14	SENT_477	[p21l1751t2552r1989b2615],
14	DK	NNP	O	DK	appos	5	SENT_477	[p21l2032t2552r2149b2610],
15	,	,	O	,	_	0	SENT_477	[p21l2032t2552r2149b2610],
16	Schmiedlin	NNP	PERSON	Schmiedlin	appos	5	SENT_477	[p21l160t2642r623b2692],
17	.	.	O	.	_	0	SENT_477	[p21l160t2642r623b2692],

1	—	NN	O	—	_	0	SENT_478	[p21l160t2642r623b2692],
2	.	.	O	.	_	0	SENT_478	[p21l160t2642r623b2692],

1	Ren	VB	PERSON	ren	_	0	SENT_479	[p21l160t2642r623b2692],
2	P	NN	PERSON	p	dobj	1	SENT_479	[p21l645t2643r690b2700],
3	,	,	O	,	_	0	SENT_479	[p21l645t2643r690b2700],
4	Brown	NNP	PERSON	Brown	nn	5	SENT_479	[p21l715t2643r906b2692],
5	MB	NNP	O	MB	appos	2	SENT_479	[p21l928t2643r1053b2700],
6	,	,	O	,	_	0	SENT_479	[p21l928t2643r1053b2700],
7	Guo	NNP	PERSON	Guo	nn	8	SENT_479	[p21l1078t2642r1198b2692],
8	W	NNP	PERSON	W	appos	2	SENT_479	[p21l1220t2643r1296b2700],
9	,	,	O	,	_	0	SENT_479	[p21l1220t2643r1296b2700],
10	Rossi	NNP	PERSON	Rossi	nn	11	SENT_479	[p21l1321t2642r1477b2692],
11	SJ	NNP	O	SJ	appos	2	SENT_479	[p21l1502t2642r1581b2700],
12	,	,	O	,	_	0	SENT_479	[p21l1502t2642r1581b2700],
13	Benet	NNP	PERSON	Benet	nn	14	SENT_479	[p21l1605t2643r1772b2692],
14	LZ	NNP	O	LZ	appos	2	SENT_479	[p21l1792t2643r1894b2700],
15	,	,	O	,	_	0	SENT_479	[p21l1792t2643r1894b2700],
16	Watkins	NNP	ORGANIZATION	Watkins	nn	17	SENT_479	[p21l1918t2642r2150b2692],
17	PB	NN	ORGANIZATION	pb	appos	2	SENT_479	[p21l158t2733r258b2782],
18	.	.	O	.	_	0	SENT_479	[p21l158t2733r258b2782],

1	Role	NN	O	role	nsubj	5	SENT_480	[p21l284t2732r418b2782],
2	of	IN	O	of	_	0	SENT_480	[p21l442t2732r504b2782],
3	intestinal	JJ	O	intestinal	amod	4	SENT_480	[p21l521t2732r783b2782],
4	P	NN	O	p	prep_of	1	SENT_480	[p21l806t2732r1230b2797],
5	—	CD	NUMBER	—	_	0	SENT_480	[p21l806t2732r1230b2797],
6	glycoprotein	NN	O	glycoprotein	nn	9	SENT_480	[p21l806t2732r1230b2797],
7	(	CD	NUMBER	(	num	9	SENT_480	[p21l1255t2732r1448b2794],
8	mdrl	NN	O	mdrl	nn	9	SENT_480	[p21l1255t2732r1448b2794],
9	)	NN	O	)	dobj	5	SENT_480	[p21l1255t2732r1448b2794],
10	in	IN	O	in	_	0	SENT_480	[p21l1473t2732r1527b2781],
11	interpatient	JJ	O	interpatient	amod	12	SENT_480	[p21l1550t2732r1877b2797],
12	variation	NN	O	variation	prep_in	9	SENT_480	[p21l1899t2732r2152b2782],
13	in	IN	O	in	_	0	SENT_480	[p21l158t2822r213b2872],
14	the	DT	O	the	det	16	SENT_480	[p21l254t2822r340b2872],
15	oral	JJ	O	oral	amod	16	SENT_480	[p21l382t2822r491b2872],
16	bioavailability	NN	O	bioavailability	prep_in	5	SENT_480	[p21l532t2822r944b2887],
17	of	IN	O	of	_	0	SENT_480	[p21l986t2822r1048b2872],
18	cyclosporine	NN	O	cyclosporine	prep_of	16	SENT_480	[p21l1085t2822r1463b2887],
19	.	.	O	.	_	0	SENT_480	[p21l1085t2822r1463b2887],

1	Clin	NNP	O	Clin	nn	3	SENT_481	[p21l1508t2822r1630b2872],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_481	[p21l1671t2822r1976b2872],
3	Ther	NNP	O	Ther	_	0	SENT_481	[p21l2017t2822r2153b2872],
4	1997	CD	DATE	1997	num	3	SENT_481	[p21l166t2913r641b2970],
5	;	:	O	;	_	0	SENT_481	[p21l166t2913r641b2970],
6	62:248	CD	NUMBER	62:248	number	7	SENT_481	[p21l166t2913r641b2970],
7	—	CD	NUMBER	—	dep	3	SENT_481	[p21l166t2913r641b2970],
8	60	CD	NUMBER	60	dep	7	SENT_481	[p21l166t2913r641b2970],
9	.	.	O	.	_	0	SENT_481	[p21l166t2913r641b2970],

